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Thesis Abstract  
 
The aim of this thesis is ‘’Improving the Assessment of Exercise Capacity and 
Cardiorespiratory Fitness in Patients Attending Exercise-Based Cardiac 
Rehabilitation’’.  
 
Cardiorespiratory capacity is an important predictor of morbidity and mortality in 
cardiac patients, due to the prognostic power, is an essential outcome to measure in 
cardiac patients in clinical practice. In cardiac rehabilitation programmes the 
assessment of cardiorespiratory capacity (by field tests or treadmill test) is an essential 
practice supported by U.K., European and U.S.A. guidelines, which gives support to 
patients risk evaluation and stratification, setting individual patients goals, exercise 
prescription, and evaluation of the same. 
 
Overall, the findings of this thesis, which were generate by meta-analysis, cross-
sectional studies and laboratory research, provide an insight into the factors 
associated with patients’ initial performance, and oxygen cost in functional capacity 
tests. Together, this data may improve the application, interpretation and patient 
understanding of these test results. One aim of CR is to improve patients’ functional 
capacity; we provide a standard value for ΔFitness, and information on factors which 
clinicians may need to consider when setting patient goals and interpreting changes 
in functional capacity, or ΔFitness due to CR. 
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Improving the Assessment of Exercise Capacity and Cardiorespiratory Fitness 
in Patients Attending Exercise-Based Cardiac Rehabilitation 
 
 
Chapter 1: Introduction and Thesis Overview 
 
1.1. Motivation 
 
Exercise-based CR is effective in reducing all-cause mortality, cardiac mortality, and 
risk factors for CHD (Oldridge, et al. 1988; O'Connor, et al. 1989; Jolliffe, et al. 2001; 
Taylor, et al. 2004; Taylor, et al. 2006; Clark, et al. 2005; Heran, et al. 2011). All the 
above analyses included exercise-based CR programmes but only clinical endpoints 
were included in the analysis of mortality, which didn’t fully explain how exercise-based 
CR is effective in reducing cardiac and all-cause mortality. It was surprising that none 
of the past studies examined change in fitness as an outcome, which is dependent on 
the dose of exercise used (only outcome measured) and may be the explanation for 
the positive effect of exercise-base CR.  
 
Gains in fitness achieved by patients in CR are closely, inversely, related to patient 
mortality and morbidity and the evidence for this is strong and abundant (Ades, et al. 
2006; Williams, et al. 2006; Balady, et al. 1996). These studies showed the cross-
sectional associations between fitness and mortality, other studies have demonstrated 
the degree of impact that fitness gains had on mortality due to CR programmes (Myers, 
et al. 2002; Dorn, Naughton et al. 1999; Kavanagh, et al. 2003; Vanhees, et al. 1995). 
These studies did not give a standard reference for change in fitness to be used in CR 
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programs and they do not fully explain the heterogeneity of changes in fitness reported 
in CR studies.  
 
The outcome of the ISWT is meters, this absolute value is used in clinical practice to 
classify cardiac patient performance (exercise capacity) at entry to CR programmes. 
However, ISWT performance is not dependent solely on the patient’s cardiorespiratory 
fitness. Fowler and Singh (2005) found that 63% of the variance in ISWT performance 
in cardiac patients was explained by cardiorespiratory fitness, but this univariate 
regression did not facilitate the assessment of alternative performance predictors 
identified elsewhere in cardiac patients such as height and BMI (Pepera, et al. 2013). 
The Incremental Shuttle Walk Test (ISWT) may be used to predict cardiorespiratory 
fitness (Fowler and Singh 2005), although the accuracy of any estimation of 
cardiorespiratory fitness is of some doubt (Woolf-May and Ferrett 2008 and Almodhy, 
et al. 2014).   
 
1.2. Aim of the Thesis 
 
The overall aim of this thesis was ‘’Improving the assessment of exercise capacity and 
cardiorespiratory fitness in patients attending exercise-based Cardiac Rehabilitation’’. 
The tests included in the analysis were the Exercise Treadmill Test (ETT), and the 10 
m Incremental Shuttle Walk Test (ISWT) applied in the assessment of patients with 
coronary heart disease (CHD). 
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The data reported in this thesis is of clinical importance and applicability. It improves 
the interpretation of changes in performance in tests due to CR. It has enabled the 
creation of a reference value for expected change in cardiorespiratory fitness due to 
CR programmes and has helped interpret predictors of change. The results also 
improve the interpretation of performance in the field test ISWT, creating reference 
values for performance interpretation and oxygen consumption quantification of the 
levels in the ISWT.  
 
1.3. Structure and Main Outcome of the Thesis  
 
 
This thesis is divided into 6 chapters. Chapter 1 is a general introduction that 
continues on to Chapter 2, including a general introduction of the evidence about the 
effectiveness of CR in reducing morbidity, mortality, and its ability to reduce risk factors 
and improve quality of life.  The literature also summarizes the recent state of the ISWT 
assessment in cardiac patients, highlighting gaps and potential future research.  
 
Chapter 3 provides the first meta-analysis to quantify the gains in cardiorespiratory 
fitness of patients attending exercise-based CR. The analysis also identifies some of 
the characteristics (service or patient) that can influence the cardiorespiratory fitness 
gains in patients involved in CR. Service variables, such as including >36 sessions in 
the CR programme of aerobic or mixed aerobic and resistance exercise with a 
programme length of 12 weeks. The treadmill protocol used to assess 
cardiorespiratory fitness in patients has a major impact on the estimate of fitness 
improvement. Patients variables such as being young and male cause bigger 
increases in fitness and this population may benefit more from CR than older, female 
4 
 
patients, who have lower changes in fitness. It is recommended that there is provision 
of exercise sessions for same sex groups and that patients should be allocated 
according to their age. This would help practitioners to differentiate between who 
achieves optimal increases in cardiorespiratory fitness in CR and not, improving 
exercise prescription in CR and expected outcomes according to the individual 
differences of the CHD patients. This chapter was published in the International 
Journal of Cardiology.  
 
In Chapter 4 reference data for the incremental shuttle-walking test (ISWT) in patients 
at entry to CR is provided for the first time. Distance walked in the ISWT varied greatly 
due to non-modifiable patient characteristics; particularly age and sex. It is proposed 
that clinicians may better-interpret ISWT performance by comparing absolute 
(distance walked) values with the age- and sex-specific reference values presented 
here. This practice may provide a more meaningful and individualised assessment of 
patients’ functional capacity, exercise prescription, and magnitude of change in 
cardiorespiratory fitness expected at entry to CR programmes. Consequently, this may 
help ‘triage’ patients by better interpreting ISWT performance, taking into account 
patient age and sex at entry to outpatient- hospital CR and potentially identifying 
individuals who can be ‘fast tracked’ or can be referred back to CR. Regression 
equations based on the healthy population had little or no clinical utility in cardiac 
patients (Accepted for Publication in Journal of Sports Sciences, Dec 2015.).  
 
Following a Pilot Study (published in BMJ Open), in Chapter 5 a larger study was 
completed combining data from Essex and Chester. We reviewed historical studies on 
the oxygen costs of walking and then compared and critiqued the current results and 
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those of previous similar studies on the ISWT. This resulted in further confirmation of 
the curvilinear nature of ܸ̇O2peak (ml·kg-1·min-1) as a function of walking speed. During 
the ISWT, it appears that CR participants have a ܸ̇O2peak (ml·kg-1·min-1) up to 30% 
higher than age-matched controls. Together, these findings suggest studies may have 
underestimated the ܸ̇O2peak (ml·kg-1·min-1) of cardiac patients as well as improvements 
in ܸ̇O2peak (ml·kg-1·min-1) following a programme of exercise-based CR. In estimating 
ܸ̇O2peak (ml·kg-1·min-1) from the walking speeds of the ISWT in CR participants, the 
following median equation was derived: ܸ̇O2peak (ml·kg-1·min-1) = 4.5e0.37· walking 
speed (mph) (Accepted for Publication in British Journal of Sports Medicine, Dec 
2015).  
 
Following Chapter 3 were moderators of change in fitness were determined, Chapter 
6, confirmed some findings from Chapter 3, and further identify and non-modifiable 
and modifiable predictors of change, in ISWT and treadmill exercise test performance 
at the end of CR (post-CR). Findings suggest that CR should be tailored according to 
sex/age group. Sex/age- tailored CR including patients with high waist circumference, 
who smoke, should have a higher dose of exercise than others. Patients with high 
baseline fitness can be fast-tracked to community CR programmes. Females and older 
patients exercising in mixed-CR, those who smoke and have a higher waist 
circumference should exercise in higher doses to benefit as much as young and male 
patients who don’t smoke and have a lower was circumference, in cardiorespiratory 
fitness changes due to CR programmes. 
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Chapter 2.  Literature Review: Efficacy of Cardiac Rehabilitation and 
the Role of Assessing Functional Capacity. 
  
Abstract 
 
Exercise-based CR programmes (exercise-only CR and comprehensive-CR) in CHD 
patients are an effective treatment for preventing cardiac mortality, morbidity, all cause 
of death and improved quality of life. Such evidence is strongly provided by 
randomized control trials and meta-analysis. It is thought that CR is an effective 
therapy due to the positive impact in reducing risk factors for CVD (strong evidence 
for hypertension, smoking and total cholesterol) and by the improvement in 
cardiorespiratory capacity due to exercise in cardiac patients.  
 
Assessment of functional capacity is an important component of clinical care, enabling 
decisions on diagnosis, prognosis, treatment effect and exercise prescription of 
cardiac patients, based on objective measures. Field tests are practical and simple to 
use in clinical or community settings in the absence of laboratory tests in all phases of 
Cardiac Rehabilitation.  The test when compared with golden test treadmill shows a 
reasonable validity in cardiorespiratory capacity assessment. The studies show that 
the test is reliable from the first assessment when used in Cardiac Rehabilitation to 
measure changes in functional capacity due to exercise. In a short period of time or 
when the effect to measure is of low magnitude as a therapy effect  for more reliable 
results and less error in assessment the studies, a practice attempt is suggested. The 
test shows sensibility to measure ~ 100 m changes in performance due to Cardiac 
Rehabilitation in a period of 6 to 12 weeks. In heart failure patients the ISWT is able 
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to diagnose low functional capacity, showing the performance and prognosis of major 
cardiac events in one years' time. The ability of the test to quantify performance based 
on meters has been proved, but no real quantification of performance in METs have 
been included in the studies. As METs are a measure of functional capacity used in 
clinical setting given support to diagnose, prognoses and exercise prescription in 
cardiac rehabilitation, the test performance in METs is needed to quantify, specifically 
the stage and speed that 5 METs cut point is achieved. Achieving a value higher than 
5 METs is used to upgrade cardiac patients from phase III to phase IV, and is the value 
which insurance companies ask for as a minimum to provide cover to patients 
recovering from cardiac events.      
  
2.1. Evidence for the Efficacy of Cardiac Rehabilitation (CR) 
 
2.1.1. Reducing Mortality 
 
Oldridge, et al. (1988) produced the first meta-analysis to report the effect of CR in 
patients suffering from myocardial infarction (MI) on all cause of death, cardiovascular 
(CV) mortality and recurrent MI.  This meta-analysis focused on 10 randomized clinical 
trials (RCT’s) conducted from 1972 to 1985. A control group of 2,202 patients, and an 
intervention group undertaking comprehensive-CR (exercise plus education in risk 
factor management) made up of 2,145 randomized patients were assessed.  
In those patients enrolled in Cardiac Rehabilitation all-cause mortality was reduced by 
24% over a two year follow up (OR 0.76; 95%CI: 0.63 to 0.92); and a 25% reduction 
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of cardiovascular (CV) death (OR 0.75; 95%CI: 0.62 to 0.93) compared with the control 
group. There were no significant differences between groups in the rate of non-fatal 
re-infarction, (OR 1.15; 95%CI: 0.93 to 1.42). Sub-group analyses demonstrated a 
benefit for all-cause mortality in longer CR programmes (>36 months), producing 
significant reductions of around 35% (OR 0.65; 95%CI: 0.45 to 0.94); whereas no such 
effect was seen in shorter CR programmes (<12 weeks or 12 to 52 weeks) or in CV 
mortality in longer comprehensive CR programmes (Oldridge, et al. 1988).  
 
This review included mainly studies of low risk, male patients who had suffered an MI. 
This meta-analysis makes it difficult to conclude the effects of CR in rates of mortality 
in different coronary heart disease (CHD) patients, in high risk patients, in women and 
elderly patients, as RCT’s commonly excluded patients >65 years. Due to the 
heterogeneity in results in the RCT’s included, it is difficult to conclude what the optimal 
duration of a CR programme is, and what is the mechanism by which CR has a positive 
influence in decreasing mortality, as not all trials show a decrease in risk factors and 
improvements in cardiorespiratory fitness.  
 
O'Connor, et al. (1989) one year later, published a second meta-analysis trying to 
determine the benefit of CR in MI Patients. This study contained data from 22 RCT’s 
including n=4554 patients that had suffered a myocardial infarction between 1960 and 
1989, the entire intervention group took part in comprehensive-CR (exercise plus 
education in risk factor management). This meta-analysis, including 11 new RCT’s not 
included by Oldridge, et al. (1988). End points included: overall and CV mortality, 
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sudden death, fatal and non-fatal re-infarction identified and measured in one year 
intervals, with a three year mean follow-up.  
 
The results were largely in accordance with those of Oldridge et al. (1988). Over a 
period of 3 years in the comprehensive-CR group compared with the control group 
there was a 20% decrease in all-cause mortality (OR= 0.80; 95%CI: 0.66 to 0.96), a 
22% decrease in CV mortality (OR= 0.78; 95%CI: 0.63 to 0.96) and a 25% decrease 
in fatal re-infarction (OR=0.75; 95%CI: 0.59 to 0.95). Sudden death was reduced by 
37% up to one year follow-up (OR= 0.63; 95%CI: 0.41 to 0.97), and this effect 
continued over two to three years although to a not significant extent. The rate of non-
fatal re-infarction was not different to that in the control group, although was more 
common in the comprehensive-CR group than in the comparison group, 10.2 % vs. 
9.5%.  
 
Women comprised only 3% of the total sample in the 22 RCT’s included by O’Connor, 
et al. (1989) and only four RCT’s included any women at all. The main age range 
analysed was 50 to 60 years old, and RCT’s commonly excluded patients >65 years, 
and some large RCT’s included patients age from 40 to 55 years old. All the studies 
included exercise-based CR (exercise-only CR and comprehensive-CR), only 6 RCT’s 
based on exercise-only CR as an intervention were included in the 22 RCT’s analysed 
(O’Connor et al, 1989), making it impossible to understand the added benefit of the 
risk factor management component in to exercise component of CR. The studies 
showed that exercise with a risk factor component had a better effect in decreasing 
CV death and sudden death. The odds (OR) ratios for cardiovascular-related mortality 
12 
 
and for sudden death were substantially lower in the comprehensive-CR RCT’s than 
in the exercise-only CR RCT’s. However, the relatively small number of exercise only-
CR RCT’s compared with comprehensive CR trials did not allow for definitive 
conclusions of which type of exercise-based CR is more effective to use in CHD 
patients. The lack of female patients, lack of different CHD patients and lack of 
inclusion of patients older than 65 years, made it difficult to conclude about the 
effectiveness of CR in this group of patients. 
 
The two reviews (Oldrige, et al. 1988; O’ Connor, et al. 1999)  both suggested a 22-
25% lower rate of CV mortality over 3 years in patients attending comprehensive CR, 
compared with patients receiving standard medical care (at that time, rest, health 
education and medication such as β-blockers). There is no evidence for the reduction 
of risk of no-fatal MI between the comprehensive-CR group and control group in both 
meta-analyses. The tendency for higher rates of non-fatal MI in O’ Connor’s review 
may be explained by higher survival capacity of fatal events, the exercise group may 
be protected against fatal events, due to the positive effects of the exercise in CV 
function, such as: Improved myocardial revascularization, better protection against 
dysrhythmias, better cardiovascular risk factor profile, improvement in 
cardiorespiratory capacity adopting healthy behaviours (modification of diet and 
smoking habits) and better surveillance by clinicians. These factors can also explain 
the positive effect of comprehensive-CR in reducing mortality (Oldridge, et al. 1988; 
O’ Connor, et al. 1999).  
Oldridge, et al. (1988) argued that the explanation for reduction in total and cardiac 
mortality may due to better cardiac function as improvements in cardiorespiratory 
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capacity, although improvements were not consistently reported. O’Connor, et al. 
(1999), supported the view that the lower mortality rates reported in comprehensive-
CR could be due to improvements in functional work capacity, a quantification of 
improvement in cardiorespiratory capacity, which, surprisingly, was not done in is 
study. 
. 
There are some limitations to consider in the meta-analyses of Oldridge, et al. (1988); 
and O’ Connor, et al. (1999) in regards to the results. The RCT’s included in both 
studies had poor methodological quality and most of them were composed of a small 
number of patients, furthermore the RCT’s mainly included only low risk MI male 
patients with a mean age of 52 years old, included in World Health Organization trials 
published in 1984 (Oldridge, et al. 1988; O’ Connor, et al. 1999). The RCT’s results 
revealed a great deal of heterogeneity, although this reflects the reality of different 
studies in CHD populations from different parts of the world, having differences in the 
RCT’s variables such as: criteria for patient selection, baseline variability of patients 
included, the time to randomization, initiation of CR after MI, type and length of 
exercise interventions, and time of follow up.  
 
The results make it impossible to conclude the impact of exercise only-based CR 
programmes in women, elderly patients and other forms of CHD than MI patients. The 
effectiveness of exercise-only CR (CR programme only based around the exercise 
component, without education on risk factors and behavioural change) in rehabilitation 
was impossible to determine, as most of the RCT’s were based in comprehensive-CR 
programmes (Oldridge, et al. 1988; O’ Connor, et al. 1999). 
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Twelve years after O’ Connor, et al. (1999), Jollife et al. (2001) produced a systematic 
review of the available evidence assessing the effectiveness of CR. This review 
compared comprehensive CR (programmes including exercise and educational/ 
psycho-social interventions) with exercise-only CR. for reducing patient mortality and 
morbidity. As discussed, previous reviews had not been able to compare the 
effectiveness of these distinct types of CR interventions. Data from n=8440 patients 
(n=2845 patients in exercise-only group; n=5595 in the comprehensive CR), n=7,683 
patients from 32 RCT’s published from 1972 until the end of 1998 were included. 
Patient numbers were double those included in previous meta-analyses as data from 
n=27 new RCT’s were included.  
 
The patient inclusion criteria were broader than previous meta-analyses that only 
included MI patients. Joliffe, et al. (2001) included men and women of all ages 
attending programmes offered in both hospital and community settings. They also 
included a greater variety of CHD patients such as: MI, CHD patients who've had 
revascularization surgery (Percutaneous Transluminal Coronary Angioplasty -PTCA), 
and (Coronary Artery Bypass Grafting - CABG), angina pectoris and patients with 
known CHD defined by angiography.  
Exercise-only CR reduced the risk of all-cause mortality by 27% (OR=0.73; 95%CI: 
0.54 to 0.98) compared with only 13% in comprehensive-CR group (OR=0.87; 95%CI: 
071 to 1.05), There was a 31% reduction in CV mortality in exercise-only CR 
(OR=0.69; 95%CI: 0.51 to 0.94) compared with a 26% reduction in studies of 
comprehensive-CR (OR=0.74; 95%CI: 0.57 to 0.96). The authors found no difference 
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in the incidence of sudden death and non-fatal re-infarctions. No difference was found 
in the incidence of revascularization rate (PTCA, CABG) in both modes of CR 
programme, although CABG as an outcome was only reported in five RCT’s and PTCA 
only reported in one RCT’s, making it difficult to make conclusions about the CR 
effectiveness on these outcomes (Jollife, et al. 2001).   
 
Jollife, et al. (2001) conducted a meta-analysis indicating a greater impact of CR 
programmes on all-cause mortality: 27% compared with a 20-24% reduction (Oldridge, 
et al. 1988; O’Connor, et al. 1989), and a 31% reduction in cardiac deaths, compare 
with 22-25% (Oldridge, et al. 1988; O’Connor, et al. 1989). There is no explanation for 
better CR outcomes reported in the exercise-only CR group compared with 
comprehensive-CR group intervention. Joliffe, et al. (2001) concluded that there was 
insufficient data to determine if exercise-only CR programmes were more effective 
than comprehensive programmes. Again, all end points used were of a clinical nature. 
Quantification of cardiorespiratory capacity gains may have helped to explain the 
differences between the two modes of CR. While all the studies reviewed were 
exercise-based, no such analysis was performed and there was no mention of 
patients’ cardiorespiratory capacity or functional capacity. 
 
This review (Jollife, et al. 2001) still had the limitations of previous meta-analyses 
(Oldridge, et al. 1988; O’Connor, et al. 1989). The individual trials overall were under-
powered, and the quality of the earlier trials included was very poor (no randomization 
method reported or blinding assessment outcomes). One in three of the trials included 
had a 20% participant drop out to follow up. The number of women participants in trials 
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was still low and was unequal in the different comparisons (4.4% in exercise-only an 
11% in comprehensive CR) and the age of the patients included had a limit of 65 years 
old and a mean age of 53 years and 56 years in exercise-only CR and comprehensive-
CR respectively. Patients involved in the study were of low risk, those excluded from 
the analyses included patients having undergone heart transplant, heart valve surgery 
or heart failure. Lastly, the studies didn’t report ethnic origin.  
 
Use of exercise in exercise-based CR compared with standard medical care has 
proved to be more effective, although these early study limitations and the 
development of new drug therapies may reflect an overestimation of the benefit of 
exercise-base CR programmes in CHD patients compared with usual medical care 
patients. This review (Jollife, et al. 2001) included trials since 1972, the medication 
prescribed for CHD patients was β-blockers and calcium channel antagonists. In 1998 
when the last studies were included in the analysis, patients were also medicated with 
statins, ACE inhibitors, aspirin, and thrombolytics prescribed more recently (Oldridge, 
et al. 1988; O’Connor, et al. 1989; Jollife, et al. 2001).  
 
Since the last meta-analyses were published (Oldridge, et al. 1988; O’Connor, et al. 
1989), five new RCT’s of exercise-only CR groups were included in the analysis. It 
was reported that patients were not receiving statins and 50% of them were just on β-
blockers. In the comprehensive CR group fifteen new RCT’s were included in the 
analysis, all published after 1995, these studies reported more prescription of statins 
and β-blockers, but only three RCT’s reported the use of aspirin, and one RCT 
reported thrombolytic treatment. This review (Jollife, et al. 2001) concluded the 
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benefits of CR programmes on mortality where all patients are medicated with aspirin, 
statins and ACE inhibitors, have not yet been studied.  
 
Applicability of the evidence offered in previous meta-analyses (Oldridge, et al. 1988; 
O’Connor, et al. 1989; Jollife et al. 2001) of health policy change with the aim to provide 
better clinical practice is not yet clear. The past meta-analyses were under powered 
in testing the effectiveness of CR in several outcomes including mortality and morbidity 
of CHD patients. There was also a failure to consider a true representation of all 
diagnoses of CHD patients. There is a need to understand the effectiveness of CR 
programmes and how they complement the new variety of drug therapies, which were 
not available at the time of the last meta-analysis, this may have caused an 
overestimation of the effectiveness of the CR programmes on decreasing mortality 
and morbidity rates (Taylor, et al. 2004).  
 
Three years later than Joliffe, et al. (2001), (Taylor, et al. 2004) performed yet another 
systematic review aiming to determine whether exercise-based CR could reduce 
mortality and morbidity in patients with CHD. They included data from trials of 
exercise-only CR, or in exercise in combination with psychosocial and educational 
interventions (Comprehensive CR). Outcomes of patients receiving both modes of CR 
programme were compared with those from control patients receiving normal care 
(prescribed medication but receiving no formal, structured exercise planning or 
education). Data from n=48 RCT’s (18 exercise only trials, and 30 trials of 
comprehensive-CR) representing n=8940 patients and published from 1972 until 
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March of 2003. Taylor, et al. (2004) included 16 additional trials of a higher quality 
compared with the study of Jollife, et al. (2001).  
 
Included studies had at least 6 months follow-up and included patients with several 
conditions CHD (MI, CABG, PTCA), angina pectoris and presence of CHD defined by 
angiography. All patients were involved in exercise programming including: supervised 
or unsupervised; different types of programmes: inpatient or outpatient; in community 
developed or home based (exercising independently). This is the first review to report 
what patients actually did during exercise-based CR sessions. Taylor, et al.'s (2001) 
review tested six hypotheses regarding CR’s effects on patient mortality: 
 
1. Different CHD diagnoses (MI-only trials vs others CHD trials);  
2. Type of CR programme (Exercise-only CR vs Comprehensive CR);  
3. Dose of exercise (duration in weeks x number of sessions x number of session per 
week x) (1000 < Units dose vs 1000 >Units dose); 
4. Follow up period (≤12 months vs ≥12 months);  
5. RCT’s trial quality (jadad score ≤ 3 vs jadad score ≥3);  
6. Year of publication of the trials (before 1995 vs 1995 or later). 
 
The authors found a 20% decrease in all-cause mortality (OR=0.80; 95%CI: 0.68 to 
0.93) and a 26% decrease in cardiac mortality (OR=0.74; 95%CI: 0.61 to 0.96) in 
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patients attending CR. No significant differences were found for non-fatal MI, or the 
need for subsequent revascularization (Taylor, et al. 2004).  
 
Exercise-only CR, (n=19 RCT’s, n=2984 patients), decreased cardiac mortality by 
28% (RR= 0.72; 95%CI: 0.55 to 0.95) (Taylor, et al. 2006). However, the authors found 
no differences in patient mortality according to patients’ initial diagnosis, type of CR 
programme, dose of exercise, follow up period, trial quality or year of publication 
(Taylor, et al. 2004). 
 
The results of this review are in accordance with the earliest reviews (Oldridge, et al. 
1998; O’Connor, et al. 1999) in terms of CR’s effectiveness in reducing mortality in 
CHD patients. Estimates are much lower than those in Jollife, et al.'s (2001) review, 
this decrease is probably due to the increase and development of new pharmaceutical 
therapies used in medical care of CHD patients in the new RCT’s, such as acute 
thrombolytic therapy, beta-adrenergic blockers, aspirin and lipid management therapy. 
The last RCT’s continue to reveal a positive effect on mortality due to exercise-based 
CR programmes (Taylor, et al. 2004).       
  
This review was more representative of patients being treated for angina pectoris and 
revascularization procedures (CABG and PCTA). Overall, n=16 trials (37%) included 
revascularization patients compared with only n=6 trials of re-vascularized patients in 
the review by Jollife, et al. (2001). Trials of Post-MI patients still made up the majority 
of studies (n=32, 67% of all trials included). Women were represented in half of the 
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RCT’s (27 RCT’s) representing 54% of all RCT’s), women account for only 20% of the 
patients included, although the number increased compared with Jollife, et al. (2001), 
where women made up 4.4% of participants in exercise-only trials and 11% of those 
receiving comprehensive-CR.  
 
Importantly, Taylor, et al. (2004) were the first authors who attempted to quantify the 
impact of exercise dose; where dose is defined as: duration in weeks * number of 
sessions * number of sessions per week. The analysis in exercise dose were 
completed based in cut-point between 1000 units vs. dose >1000 units. It would had 
been simpler to report the final effect in the outcome of all the variables, including the 
cardiorespiratory fitness of CHD patients, which also should be reported in these 
studies.  
 
Taylor, et all’s (2004) review still possesses some of the limitations found in earlier 
reviews. The mean age was still only 55 years, data gained was from mainly low risk, 
male patients who had suffered an acute MI. The poor methodological quality of many 
trials, didn't provide details of the process of randomization, allocation concealment or 
blinding outcome assessment. Therefore, quality of the trials didn’t improve with time 
in this research field (Taylor, et al. 2004).    
Just one year after Taylor, et al. (2004), a new review was published (Clark, et al. 
2005). They produced an updated review aiming to determine the effectiveness of 
three modalities of secondary prevention programmes. These were classified as 
exercise-only CR, comprehensive CR, and secondary prevention without exercise; 
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including interventions based on education about CHD risk factors and/or 
psychosocial counselling. Again, the primary outcome measures were patient 
mortality and morbidity, only clinical outcomes were assessed in this review, there was 
no attempt of quantify the dose of exercise in exercise-based CR trials, as in previous 
review (Taylor, et al. 2004). Clark, et al. (2005) analysed data from n=21295 CHD 
patients included in n= 63 RCT’s published between 1966 and 2004. With n=23 
additional trials Clarke, et al.’s (2005) review included three times as many patients 
than the most recent review (Taylor, et al. 2004).       
 
There was a 15% (RR= 0.85; 95% CI: .82 to 1.14) decrease in all-cause mortality 
(n=40 trials, n= 16142 patients). There were no statistical differences in effect in all-
cause mortality in the three types of secondary prevention. Combining all RCT’s 
including exercise in CR (n=27 trials, n= 6940 patients) a 17% (RR=.83; 95%CI: 0.72 
to 0.96) decrease is reported compared with a 13% (RR=.87; 95%CI: 0.76 to 0.99) 
reduction in all cause of mortality by non-exercise CR programmes (n=14 trials, n= 
9202 patients) (Clark, et al. 2005).   
 
This study report for the first time that different secondary prevention programmes, 
including exercise-based CR, have a different effect in all-cause mortality in the long 
term, an overall 0.3% (RR= 0.97; 95%CI: 0.82 to 1.14) decrease at 12 months is 
reported. This is compared with a 47% (RR= 0.53; 95%CI: 0.35 to 0.81) decrease at 
24 months of follow up, an effect of 23% (RR= 0.77; 95%CI: 0.63 to 0.93) is reported 
at a period of 5 years of follow up, being the limit in the trials being conducted. MI re-
infarction was 17% lower (RR= 0.83; 95%CI: 0.74 to 0.94) after 12 months in CR 
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including exercise, compared with group of usual care. The effects of the 3 types of 
CR didn’t change during the time of follow up. Exercise-based CR produced a 27% 
(RR= 0.73; 95%CI: 0.6 to 0.89) reduction of re-infarction compared with only 14% 
(RR= 0.86; 95%CI: 0.72 to 1.03) in CR programmes without exercise (Clark, et al. 
2005).  
 
This review confirms the benefits of all modalities of CR for the secondary prevention 
of all-cause mortality over five years. The overall reduction in all-cause mortality (17%) 
is the smallest value reported in a systematic review. The value is low compared with 
the 20% to 27% reported previously (Oldridge, et al. 1988; O’Connor, et al. 1999; 
Joliffe, et al. 2001; Taylor, et al. 2004, 2006).  
 
Mortality was 47% lower after two years, this high impact after 2 years follow up was 
never reported, this may be explained by the time taken for the effect of reduced risk 
factors in the reduction of atherosclerotic plaque instability or coronary artery diameter 
(Clark, et al. 2005). All meta-analyses published before (Oldridge, et al. 1988; 
O’Connor, et al. 1999; Joliffe, et al. 2001; Taylor, et al. 2004, 2006) never reported a 
significant lowering in the rate of re-infarction of CHD patients, as this study did for the 
first time. RCT’s included in this meta-analysis had highly selected study samples. The 
higher benefit of usual care only as secondary prevention of CHD in this study, may 
be caused by the setting in which RCT’s were performed, the fact that the 
management of the CHD patients was optimal. No attempt to report changes in 
cardiorespiratory capacity is made. 
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Clark's (2005) review is more superior than previous reviews (Oldridge, et al. 1988; 
O’Connor, et al. 1999; Joliffe, et al. 2001; Taylor, et al. 2004, 2006). Women 
represented less than 50% of the patients included in the analysis, although this was 
much higher than the 20% included in past meta-analysis (Taylor, et al. 2004). Only 
n=15 trials adequately described allocation of condition and method of concealment, 
all these factors are likely to effect the estimation of CR’s effectiveness. 
 
Heran, et al. (2011) updated the results for the effectiveness of exercise-based CR 
programmes (exercise-only and Comprehensive-CR) in reducing mortality, and 
morbidity in CHD patients using data from n=47 RCT’s (n=17 exercise-only CR trials, 
and n=29 trials of comprehensive-CR). They included trials published until 2009 which 
included a follow-up of at least six months. This review included n=17 RCT’s published 
between 2000 and 2009 updating the findings of the most recent review (Clark, et al. 
2005). The authors included data from n=10794 patients (mean age of 56 years old) 
suffering from an MI, having received revascularization, having angina pectoris or 
coronary artery disease defined by angiography. Patients receiving valvuloplasty, 
patients with heart failure, heart transplants, implanted with cardiac-resynchronization 
therapy or implantable defibrillators were, however, were all excluded from the 
analysis.  In this review exercise is quantified again as in Taylor, et al. (2004). The 
authors tested five hypotheses according to different variables presented in trials, 
concerning the effectiveness of CR in reducing mortality: 
  
1. Different CHD diagnoses (MI-only trials vs others CHD trials);  
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2. Type of CR programme (Exercise-only CR vs Comprehensive CR); 
3. Dose of exercise (duration in weeks x number of sessions x number of session per 
week x) (1000 < Units dose vs 1000 >Units dose);  
4. Follow up period (≤12 months vs ≥12 months); 
 5. Year of publication of the trials (before 1995 vs. 1995 or later). 
 
In studies (n= 30 trials, n=8971 patients) with a follow-up of at least 12 months, there 
was a 13% (RR= 0.87; 95%CI: 0.75 to 0.99) reduction in total mortality in patients 
attending exercise-based CR compared with the control group. No significant 
differences in total mortality were found in follow-ups less than 12 months. Cardiac 
mortality was reported in 19 RCT’s (n=6583 patients), in studies with a follow-up longer 
than 12 months, there was a 24% (RR= 0.76; 95%CI: 0.63 to 0.87) reduction in cardiac 
mortality due to exercise-based CR. Not significant differences in cardiac mortality was 
found in just 12 months follow-up in both groups (Heran, et al. 2011).  
 
There were no differences in rates of re-infarction or revascularization over 12 months 
or longer between patients receiving exercise-based CR and controls. When the 
hospitalizations were considered, a 31% (RR=0.69; 95%CI:0.51 to 0.93) reduction 
was reported in exercise-based CR compared with the control group at a follow up of 
12 months, no significant changes were seen in follow-ups longer than 12 months. In 
this study no differences were reported in CR effectiveness on mortality between 
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different CHD diagnoses, type of CR programme, dose of exercise, follow up period, 
trial quality, and between years of trial publication (Heran, et al. 2011).  
 
Heran, et al.'s (2011) meta-analysis, assessing the effect of exercise based CR on 
mortality at a follow up longer than 12 months confirms the data from past meta-
analysis (Clark, et al. 2005), although only half of the effect was reported. CV mortality 
was 24% compared with a 47% decrease in a past review (Clark, et al. 2005). Non 
significant differences in total mortality were found at just 12 months follow-up, 
confirming the little effect reported in past meta-analyses (Clark, et al. 2005). The 
effect on cardiac mortality was the same as reported in previous reviews (Oldridge, et 
al. 1988; O’Connor, et al. 1999; Taylor, et al. 2004).   
 
The introduction of new drug therapies for CHD patients in trials that were not available 
in the earliest meta-analyses (Oldridge, et al. 1988; O’Connor, et al. 1999; Taylor, et 
al. 2004), may have contributed to the reduced effect of exercise-based CR on all-
cause mortality. Analysis of this review showed no differences between the two types 
of exercise-based CR, confirming the conclusions of Taylor, et al. (2004) and Clark, et 
al. (2005). This was the second meta-analysis that attempted to quantify the impact of 
exercise dose. The analysis in exercise dose were completed based in cut-point 
between, 1000 units vs. dose >1000 units. It would have been simpler to report the 
final effect of the outcome of all these variables, what is the cardiorespiratory fitness 
of CHD patients, which also would be reported in studies. 
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Heran, et al. (2011) supported the view that exercise-based CR programmes had a 
more positive impact on reducing all-cause and cardiac mortality, more so than past 
analyses. Although this paper still possessed the same limitations as previous reviews 
(Oldridge, et al. 1988; O’Connor, et al. 1999; Joliffe, et al. 2001; Taylor, et al. 2004, 
2006; and Clark, et al. 2005). The patients in the included RCT’s analysed were of low 
risk; most of them post-MI men and with an average age of 55 years old and there 
were few patients included older than 70. This is not representative of the mean age 
of CHD patients which, in reality, is older. There was an under representation of 
cardiac groups (post-revascularization and angina pectoris), elderly women, and those 
from different ethnic origins, making it impossible to understand which groups benefit 
more from CR programmes. There was poor methodological quality in many of the 
trials, which failed to provide details of the process of randomization, allocation 
concealment or blinding outcome assessment. Losses to follow-up and drop out were 
relatively high, ranging from 21% to 48% in 12 trials. Follow-up of 80% or more was 
achieved in 33/47 (70%) studies. Further RCT’s are needed to explain much of the 
variability presented in CHD and the implications of different clinical outcomes and 
mortality rates. 
 
The literature on this topic is extensive (Oldridge, et al. 1988; O’Connor, et al. 1999; 
Joliffe, et al. 2001; Taylor, et al. 2004, 2006; and Clark, et al. 2005, Heran, et al. 2011). 
There is clear evidence of the effectiveness of exercise-based CR (exercise-only CR 
and comprehensive- CR) in reducing all-cause mortality and cardiac death, supporting 
strongly by the guidelines that now state the use of exercise-based CR as the core or 
central element in CR programmes of secondary prevention in CHD patients (NICE, 
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2007; Balady, et al. 2007). Because of the focus on mortality and clinical endpoint in 
the outcomes of the analyses, is it not known which mechanism is behind the positive 
effect reported on survival of CHD patients. The mechanism could be the positive 
effect of exercise in cardiac function, or the improvement in cardiorespiratory fitness 
(which was never quantified in the meta-analyses). The positive influence of exercise-
base CR has in reversing endothelium dysfunction and inflammation of vascular wall, 
which leads the process of arteriosclerosis to CHD, can be also one of the causes that 
explain the efficacy of CR in reducing morbidity and mortality in cardiac patients.   
 
Endothelial cell is the inner tissue in the structure of the entire vascular system, from 
the heart to the smallest capillaries. It is a thin layer that makes the interface between 
circulating blood and the rest of the vessel wall. Endothelial cells are involved in many 
aspects of biology vascular homeostasis, such as: allowing the continuous adjustment 
of vascular tone by vasoconstriction or vasodilation (controlling blood pressure), has 
a semi-selective barrier function between the vessel lumen and surrounding tissues, 
(performing physiological regulation of several materials and leukocyte traffic into and 
out of the bloodstream), is involved in inflammation process, prevents blood clotting 
(thrombosis & fibrinolysis), and induces formation of new blood vessels 
(angiogenesis). Endothelial dysfunction, or the loss of proper endothelial function, is 
expressed by an alteration in the basal endothelial phenotype (vasorelaxant, 
anticoagulant, antiplatelet and profibrinolytic), which is turn in vasoconstrictive, 
procoagulant, platelet-activating, and antifibrinolytic, characterizing the 
atherosclerosis process that leads to CHD. (Ribeiro, et al. 2010) 
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Exercise-base CR is effective in improving endothelium function and diminish the 
vascular inflammation and consequently reversing arteriosclerosis, although the 
mechanisms by which this work is not fully understood. Evidence suggest that the 
improvement of nitric oxide bioavailability that is diminish in endothelium dysfunction, 
is one of the mechanism by which exercise works. Nitric oxide is responsible for the 
inhibition of platelet aggregation, control of the cytokine adhesion to the vessel wall, 
and mostly important by the regulation of vascular tone, increasing the endothelium-
dependent vasodilatation, each explains the reduction of myocardial ischemia due to 
exercise base CR. Antioxidant defences are also increase with exercise which reduces 
the nitric oxide degradation, formation of foam cells (fat-laden macrophages seen in 
the process of atherosclerosis) and vascular inflammation. Exercise can be also 
effective in reduction of endothelial adhesiveness of circulating leukocytes, increasing 
the number of circulating endothelial progenitor cells, which represents the capacity of 
the endothelium to regenerate after injury and angiogenesis, and also diminishes the 
level of inflammatory markers, that include the decrease in cytokine production by the 
adipose tissue, skeletal muscles, endothelial cells, and blood mononuclear cells 
namely proinflammatory cytokines and C-reactive protein (Ribeiro, et al. 2010; Ribeiro, 
et al. 2013). Furthermore, the exercise effect on the reduction of risk factors for 
atherosclerotic disease could be also an explanation for the positive effect of exercise 
based CR has on survival of CHD patients. 
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2.1.2. Risk factor reduction 
 
Jollife, et al. (2001) produced the first systematic review to examine the effects of 
exercise-only and comprehensive-CR programmes on modifiable risk factors for CHD 
(total cholesterol, LDL, triglycerides, blood pressure, and smoking), they suggested 
some potential mechanisms explaining why CR is effective in reducing mortality. Total 
cholesterol (OR= -0.57 mml/l; 95% CI: -0.83 to -0.31) and LDL (-0.51mml/l; 95%CI: -
0.82 to -0.19) and lipoproteins were significantly reduced with comprehensive CR. 
There is no explanation for differences seen between only-exercise CR and 
comprehensive CR. This can be explained due to different medication taken during 
the RCT’s included, also exercise-only CR didn’t show any reduction in risk factors, 
only five RCT’s were available for analysis for risk factors in both groups. The risk 
factors analysed were limited to poor trials, reports in both groups were composed of 
a low number of trials that included the risk factor outcome, showing heterogeneity in 
the results.   
 
Taylor, et al. (2004) three years later produced another systematic review focusing on 
the function of exercise-based CR in reducing risk factors specifically in CHD patients. 
Patients receiving exercise-only CR programmes, supervised or unsupervised, 
showed significant reductions in total cholesterol (RR= -0.37mml/l; 95%CI: -0.68 to -
0.11), triglycerides (RR= -0.23; 95%CI: -0.39 to -0.07), systolic blood pressure (RR= -
3.2mm Hg; 95%CI: -5.4 to -0.9) and likelihood of smoking cessation (OR=0.64; 95% 
CI: 0.50-.83). No significant changes in levels of LDL or HDL cholesterol were found.    
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This data (Taylor, et al. 2004) was used to examine how much of the 28% (RR= 0.72; 
95%CI: 0.55 to 0.95) reduction in patient mortality could be attributed to the indirect 
effect of exercise-based CR on cardiac risk factors. Taylor et al. (2004) found that the 
58% reduction in patient mortality due to exercise-based CR could be explained by 
risk factor modification; 24% due to smoking cessation, 19.7% from modification of 
plasma cholesterol and 15% due to reductions in systolic blood pressure. 
 
The reduction of risk factors was an indirect positive outcome and disease related 
effect witnessed in exercise-base CR programmes in CHD patients, although other 
measures of the general state of health such the well-being of the patients should be 
taken in account in the overall assessment of the CHD patients. Health-related quality 
of life questionnaires are important tools, the outcome of which reflects the CHD 
patient performance in society and should be part of every CR programme design.  
World Health Organization, in 1997, mentioned in a document called:  ‘’Measuring 
quality of life’’ that health related quality of life could be defined as: 
 
‘’Quality of Life is the individual’s perception of their position in life in the context of the 
culture and value systems in which they live and in relation to their goals, expectations, 
standards and concerns. It is a broad ranging concept affected in a complex way by 
the person's physical health, psychological state, level of independence, social 
relationships, personal beliefs and their relationship to salient features of their 
environment.’’   
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2.1.3. Health-related quality of life 
 
Jollife, et al. (2001) produced the first systematic review to understand the 
effectiveness of CR exercise based programmes and comprehensive programmes 
(Educational and psycho-social interventions) on health-related quality of life (HRQoL) 
in CHD patients. No clear changes in HRQoL were witnessed in the results. The 
difficulty in analysing the HRQoL is due to the heterogeneity of tools used to assess it 
between the RCT’s. A total of 18 different tools used to assess HRQoL were identified 
in the RCT’s, four of them were un-validated self-reported instruments and some of 
the psychological questionnaires used are not suitable in general CR practise.  
 
Taylor, et al. (2004) concluded that the heterogeneity of trials and outcome measures 
used to assess HRQoL in the trials made it impossible to analyse the data. Many of 
the measures were generic, showing lack of sensitivity to detect changes and without 
inclusion of disease-specific measures. Although an improvement is seen in all RCT’s 
that assessed HRQoL in CHD patients, the same improvements were seen in the 
control groups. Only 2 trials possessed 250 CHD patients, which had power enough 
to detect changes between groups, showing benefits over the control group. 
 
Heran, et al. (2011), produced a review updating the results of the effectiveness of 
exercise-based CR programmes in improving health related quality of life of CHD 
patients compared to a control group receiving usual medical care in secondary 
prevention.  A range of validated, disease-specific and generic tools for outcomes 
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assessment were used, although the heterogeneity of how the results were assessed 
and presented makes it impossible to meta-analyse the data. In 7 RCT’s of the 10 
analysed, a significant improvement in HRQoL in exercise-base CR was reported, 
although an improvement was reported within control groups too.  
 
2.1.4. Effectiveness of Cardiac Rehabilitation: A Critical Summary of the 
Evidence 
 
 
Exercise-based CR is effective in reducing total and cardiac mortality, and risk factors 
for CHD. All the discussed analyses included exercise-based CR programmes but only 
clinical endpoints were included in the analysis of mortality, which don’t explain fully 
how exercise-based CR is effective in reducing cardiac and total mortality. It was 
surprising that none of them examined change in fitness as an outcome, which is 
dependent on the dose of exercise used (only outcome measured), and may be the 
explanation for the positive effect of exercise-based CR (Oldridge et al, 1988; 
O’Connor, et al. 1999; Joliffe, et al. 2001; Taylor, et al, 2004, 2006; and Clark, et al., 
2005, Heran, et al. 2011).  
 
Gains in fitness achieved by patients in CR are closely, inversely, related to patient 
mortality and morbidity, and evidence is strong and abundant (Ades, et al. 2006 
Williams, et al. 2006; Blair, et al. 1995; Balady, et al. 1996; Gulati, et al. 2003). These 
studies show us the cross-sectional associations between fitness and mortality, others 
studies have demonstrated the degree of impact that fitness gains have on mortality 
due to CR programmemes (Myers, et al. 2002; Dorn, et al. 1999; Kavanagh, et al. 
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2003; Vanhess, et al. 1995). Kavanagh et al. (2006) demonstrated that each increase 
of 1 ml·kg-1·min-1 in ܸ̇O2peak was related with a 10% reduction in cardiac mortality. 
Vanhess, et al. (1995) demonstrated that each increase of 1% in ܸ̇O2peak was related 
with a 2% reduction in mortality. Myers, et al. (2002) showed that a 1 MET increase in 
fitness was related with 12% reduction in mortality, also Dorn, et al. (1999) showed 
that a 1 MET increase was related with 10% decrease in mortality in male MI patients. 
Levels of fitness gains are recognized to have clinical importance in cardiac patients, 
however only limited studies have tried to synthesise such information (Conn, et al. 
2009; Swain, et al. 2006).       
 
2.2. Incremental Shuttle Walk Test 
 
2.2.1. Background of testing cardiorespiratory capacity   
 
Assessment of functional capacity (an individual's ability to perform meaningful tasks 
on a safe and dependable basis in daily life) is an important component of clinical care, 
enabling decisions on diagnosis, prognosis, treatment effect and exercise prescription 
of patient’s, based on objective measures (gas analysis). Laboratory tests such as 
incremental treadmill exercise or cycle ergometer tests with gas analysis are the ‘Gold 
Standard’ protocols for cardiorespiratory fitness (a health-related component of 
physical fitness, which is defined as, the ability of the circulatory, respiratory, and 
muscular systems to supply oxygen during sustained physical activity) assessments 
in cardiac patients.  
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All the studies that show cross-sectional associations between fitness and mortality 
(Ades, et al. 2006 Williams, et al. 2006; Blair, et al. 1995; Balady, et al. 1996; Gulati, 
et al. 2003), and studies that have demonstrated the degree of impact that fitness 
gains have on mortality due to CR programmes (Myers, et al. 2002; Dorn, et al. 1999; 
Kavanagh, et al. 2003; Vanhess, et al. 1995) were based on the treadmill exercise 
test. Incremental treadmill exercise possess some limitations, they are not simple to 
use, there is a need for technical expertise, and involves expensive equipment, 
consequently it is not widely available in health care units (Bruce, et al. 1963; Ades, et 
al. 2006). 
 
In the UK, the department of health recommends the use of exercise tests to evaluate 
patients at the beginning of Cardiac Rehabilitation, allowing risk stratification and 
prescribing exercise at the correct intensity, (SIGN, 2002; NICE, 2007). They also 
recommend summative assessment as an outcome measure or in Cardiac 
Rehabilitation to evaluate improvements due to attending the programme. European 
and UK guidance suggests that patients should achieve exercise intensity (sometimes 
referred to as functional capacity) equal to five Metabolic Equivalents (METS). One 
metabolic equivalent (MET) is defined as the amount of oxygen consumed while sitting 
at rest and is equal to 3.5 ml O2 per kg body weight x min. There are a number of 
walking field tests available to assess CR patients’ cardiorespiratory fitness when the 
treadmill exercise test is not available, such as the 10 m ISW test.  
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2.2.2. Walking field tests in cardiac patients 
  
2.2.2.1.  Development of walking tests  
 
The large volume of expensive laboratory equipment used to test functional capacity 
in chronic bronchitis patients in many hospitals, meant that most of diagnostic 
decisions made at the level of patient disability were based on Spirometry testing. That 
is, assessing pulmonary function and using respiratory questionnaires with potential 
to assess the level of everyday disability. Unsatisfied with the subjective nature of self-
reported symptoms; Mc Gavin (1976) developed a field test which was simple to apply 
and had no need of expensive equipment; the 12 min walking test (12MWT). It was 
designed to objectively measure functional capacity and define specifically the level of 
disability in these patients according to their test performance.  
 
The distance achieved in 12 minutes, gives an estimation of functional capacity of the 
patient. This idea had been developed by Cooper, (1968) when he validated the 12 
min run test (12 MRT) in 150 young healthy men with a highly validity of R=.897; 
significantly predicting ܸ̇O2peak with accuracy (+/1 3.5 ml.kg-1min-1) when correlated 
with ܸ̇O2peak measured during incremental treadmill testing.  The length of 12 minutes 
of the test was supported by Katch (1973) as a good endurance time measure in his 
study done on cycle ergometer performance. The findings stated that the optimal 
duration for testing aerobic capacity during incremental testing was 8 to 12 minutes, 
and no further gains will be obtained in tests of longer duration.  
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Butland, et al. (1982) realised that for severely impaired pulmonary patients with a 
certain degree of disability performing the 12-minute length of the walk test required a 
high level of physical effort. Butland, et al. (1982) proposed that tests of shorter 
duration would be more suitable for functional assessment of these type of patients. 
The performance of different lengths of walk tests were analysed, 2 minutes, 6 minutes 
and 12-minute walk. Thirty patients with stable chronic pulmonary disease (61±12 
years) performed the three distances of walking tests in a randomized design in 
different days, a high correlation was found between the tests length of 12 m vs. 6 m 
(r=.955), a high correlation between 12 m vs. 6 m walk test (r= .97) was found too by 
Bernstein, et al. (1994), suggesting the distance walked in six minutes was a suitable 
time length for functional capacity assessment. This was first applied as the 6 MWT in 
a study of heart failure patients by Guyatt, et al. (1985).  
 
Tests that assess physical performance based on a walking distance covered in times 
such as 6 or 12 minutes present some limitations in the assessment of the clinical 
population's functional capacity. The test performance is self-paced in nature, which 
is highly influenced by patients’ motivation and external encouragement (Guyatt, et al. 
1984). Due to the constant work rate featured in the test it tends not to elicit a true 
maximal or symptom-limited performance in patients. This provides poor information 
about physiological responses to exercise, when the pace in performing of the test is 
analysed, it is seen that patients only push themselves in the first two minutes of the 
test, maintaining a comfortable pace in subsequent intervals of two minutes (Butland, 
et al.1982). This makes it difficult to objectively determinate the degree of disability 
and true functional capacity, not allowing for intra- or inter-patient comparison due to 
this lack of test standardization (Singh, et al. 1992).  
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The 12-MWT tends to show reliable results after the third attempt of the test (Mungall 
and Hainsworth, 1979; Butland, et al. 1982; Guyatt, et al. 1984) and in some studies 
only after four practice test walks (Swinburn, et al. 1985; Knox, et al. 1988). There is 
also only a low-to-moderate relationship between V’O2 max directly measured on a 
cycle ergometer and distance walked in the test, (McGavin, et al. 1976; Allison and 
Anderson, 1981; Swinburn, et al. 1985; Bernstein, et al. 1994). Such low correlations 
between measures of functional capacity taken from the self-paced walk test, can be 
explained by the variables that the test is subjected to when used in a wide range of 
functional capacity levels.         
 
2.2.2.2. 10 m Incremental shuttle walk test (ISWT) 
 
Limitations of self-paced tests, inspired Singh, et al. (1992) to develop a new field test 
to be used in the clinical population in order to try and overcome the limitations of the 
past self-pace walk tests. The 10 m ISW test (ISWT) is a standard test, externally 
paced with a progressive, incremental walking speed protocol, able to elicit enough 
effort to provoke symptom limited maximal performance in patients. The ISWT was 
adapted from the 20 m shuttle run test developed by Leger and Lambert (1982).  
 
Unlike the more commonly used 6 min walk test, the incremental shuttle walk test 
(Singh, et al. 1992, 1994; Fowler, et al. 2005) of functional capacity, is not a self-paced 
test, but is standardized to create an incremental, progressive structure of 12 speed 
levels. The test is paced externally by a CD, inducing the patient to exercise to a 
symptom limited maximal effort. The design of the test is a 10 m course, with a cone 
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of 0.5 m before the 10m point at both extremes, allowing the patient to round the 
cones. The speed of the test increases by 0.17 m·s-1 every minute, starting at 0.50 
m·s-1 at level one and finishing with a speed of 2.37 m·s-1 at level 12. The explanation 
of the test is pre-recorded, and is standardized for all patients before the test starts. At 
the start of the test, and every minute after, a triple bleep is heard (indicating a new 
level). The patient is paced during the level by a single bleep which, when heard, 
means they should be rounding the cone and turning round for the next lap. The test 
may be terminated volitionally by the patient if they feel unable to continue, or by the 
technician, when the patients fails to reach the cone by more than 0.5 m. The test is 
also terminated if the patient reaches 85% of maximal heart rate (Singh, et al. 1992) 
or reports their rating of perceived exertion (RPE) to be at 16 or more (SIGN, 2002).  
 
The originally studied test was able to predict ܸ̇O2peak in a healthy population of 91 
adults (32 females, mean age 25 years). There was a high correlation with ܸ̇O2peak 
direct measure and the 20 m shuttle run test (r=.84, SEE= 5.4 ml·kg-1·min-1). The same 
work load is applied to all patients due to the standard protocol design, allowing 
performance comparison between patients, what was not possible before with other 
field tests due to the variation in performance (distance achieved) during the test time. 
Due to the external pace, the test is less influenced by operator encouragement and 
patient motivation. The test overcomes problems found in previous self-paced tests, 
showing applicability in pulmonary chronic diseases in predicting functional capacity 
in a wide range of functional capacities. It is also capable of being used in other 
populations suffering disabilities from diseases such as cardiovascular disease (CVD). 
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To be clinically applicable the 10 m ISW test needs to meet certain criteria such as 
test-retest reliability, sensitivity and validity in the outcome measures. 
 
2.2.2.3.  Test-retest Reliability 
 
Reproducibility of the results is an important characteristic to take into consideration 
when testing physical capacities. A test should be able to report reliable results when 
used at different times, in similar patient groups. 
 
The reliability of the ISWT was first assessed by Singh, et al. (1992) when they 
developed the test. Three ISWT tests were conducted at same time of day at one 
week intervals, in 10 patients with chronic airway obstruction. The mean distance 
covered in three trials was: 345 m, 376 m and 378 m, there was a significant difference 
between 1st and 2nd trials, but no difference between 2nd and 3rd  trials  The  mean 
difference in distance walked was -2.0, indicating very small systematic error. 
Confidence intervals indicated random error (95% CI -21.9 to 17.9) m. The larger 
difference found between 1st and 2nd attempts was interpreted by the test performance 
being influenced by learning effects. The authors concluded that the ISWT showed 
reproducibility after one walk practice.     
 
Payne, et al. (1996) were the first to apply the ISWT in cardiac patients. These authors, 
assessed the reliability and the ability of the test to detect changes due to programming 
patients’ rate-responsive pacemakers. Again, three ISWTs were performed by ten 
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patients (4 female, aged 60 to 74 years,), with an interval between them of 20 minutes 
rest. The mean performance was reported in minutes, the differences between the 
three tests were not significant: 7.6 (1.7) min; 7.7 (1.6) min and 7.7 (1.7) minutes. The 
authors claim these results show good reproducibility of the test from the first attempt, 
suggesting that the learning effect was small and not as significant as it was previously 
(Singh, et al. 1992).  Unfortunately, no acceptable measure of reliability was provided 
as a simple lack of statistically significant difference in means did not describe the 
systematic differences between pairs of test scores adequately. 
 
In a more statistically rigorous analysis, Arnott (1997) assessed the reliability of the 
ISWT in patients who had undergone surgery (CABG) in the past 12 months. The 
study included n=30 patients (mean age 62, range 42 – 68 years) divided into group 
A, (n=20 patients that had not received CR) and group B, (n=10 patients who 
completed a CR programme).  Patients were tested three times in one week, with at 
least 24 hours between tests. The results showed an improvement in final mean 
distance of 4.7% between test 1 and 2, and a 0.9% improvement between test 2 and 
test 3. The test performance is influenced by learning and training as showed by Singh, 
et al. (1992), although this influences were not significant in this study, suggesting a 
good reproducibility from the first attempt, even when assessing different levels of 
functional capacity.    
 
Morales, et al. (1999) assessed the reliability of the ISWT and the 6 MWT in 17 heart 
failure patients (aged 53±10 years) who were clinically stable with an ejection fraction 
<40% (mean 23 ±8%) and a New York Heart Association Class of 2 to 4 (mean 2.8 
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±0.7). Patients performed trials of each test in a randomized order. No more than two 
tests were completed in a single day, with all tests being conducted within a two-week 
period. The mean distance walked during the three ISWT trials attempts was 445 m, 
478 m and 485 m. The mean distance found in 6 MWT over three trials was 475 m, 
496 m and 505 m.  Significant differences in mean distance walked were found 
between trials one and two in both the ISWT and 6 MWT. There were no significant 
differences in distance walked between trials two and three in either test. The mean 
difference in the ISWT was -7m and the test-test correlation between trials 2 and 3 
was (r=0.99). The tests show reliability after just one first practice attempt. The 
researchers explain this significance found between first and second attempt in both 
tests, as being due to training effect, as patients were subjected to six tests (three 
SWT and three 6 MWT) done in a short period of time of 12 weeks.     
 
Lewis, et al. (2001) assessed the reliability of treadmill exercise test and ISWT in 25 
heart failure patients (21 males, 53 [range 33-69] years). Patients performed three 
ISWT trials (1st test being a practice trial), and two trials of Naughton protocol treadmill 
tests with expired gas analysis to determine ܸ̇O2peak. The performance achieved in 
treadmill trial 1 (ܸ̇O2peak= 15.2 ±4.4 mlkg-1min-1) and 2 (ܸ̇O2peak =15.0 ±4.4 mlkg-
1min-1) correlated well (r=0.83 p<0.0001) showing good reliability from the first 
attempt. After one practice attempt, mean distance walked during the second trial of 
the ISWT (400 ±146 m) was very similar to the third trials (401 ±129 m). Scores on 
these tests correlated very well (r=0 .90, p<0.0001), showing high repeatability after a 
first practise attempt. Results of the practice attempted were not reported so no 
comparison is possible with the second walk test to investigate if this test showed 
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reliability from the first attempt. Furthermore, the study showed poor statistical 
description, no indication of random error in confidence intervals of distances 
measured between test 2 and test 3 were made.    
 
Fowler, et al. (2005), investigated the reliability of the ISWT in predicting ܸ̇O2peak in 39 
cardiac patients (34 males, mean age 61.2±8.5) years) who had been through CABG 
surgery in the previous 6 to 8 weeks. Patients performed 3 ISWT's in one week, one 
test on the first visit and on the second visit they performed two ISWT's separated by 
45 minutes. The mean distances walked in the three tests were: 444.3 ±134 m; 
485.3±147m and 478 ±141.1 m). A strong relationship was found between the three 
walk test distances and there were no statistically significant differences in means 
(p=.361). A small learning effect can explain an increase in mean distance achieved 
between performance in tests 1 and 2.  The mean distance achieved between test 2 
and 3 was 1.7 m (95%CI: -1.9 – 5.3) compared with mean distance achieved between 
test 1 and test 2 of 40.3 m (48.2) (95%CI: 24.4 – 56.1), this mean distance and 
systematic error found between attempt two and three of 1.7 m is smaller than 2 m as 
found previously (Singh, et al. 1992).  No significant difference was found between 
attempt 1 and 2 of the ISWT, suggesting that the test is reliable from the first attempt, 
as suggested previously (Arnott, 1997). However, due to effect of learning seen in the 
coefficient of reliability between tests, 40.3 m is a large range of variance between 
tests, even if no significant differences were found between mean distance achieved 
in test 1 and test 2. Consequently, if the test is used for therapy or rehabilitation 
assessment effect, the results could be misleading.  
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Jolly, et al. (2008) investigated the reliability of the ISWT, questioning whether one 
practice walk of the test is really needed, or if the test shows reliability from the first 
attempt as showed by Arnott (1997). Significant differences between second and third 
attempt were not seen in all previous studies. The 353 patients (mean age 61.6 (SD 
10.2) years; 282 (79%) male; 165 (46.7%) post-MI; 188 (53.3%) post-
revascularisation; 68 (19.35) from a minority ethnic group) in the study were recruited 
from the Birmingham Rehabilitation Uptake Maximization (BRUM) trial of Cardiac 
rehabilitation. After the patients performed a practice walk of the ISWT, follow by 
another ISWT with only a 30 min interval. 1457 ISWTs were conducted, 353 pairs of 
ISWT were analysed for reliability between first and second attempt. There was a 
significant increase in mean distance achieved between the practice walk (358 ±152 
m) and the second test (415 ±158 m P<.001). This significant increase was seen in all 
the sub-groups tested. There was a significant difference between mean distance in 
attempt 1 and 2. The test was deemed safe to apply to this large population of patients 
suffering from ischaemic symptoms, the heart rate recorded in both trials showed no 
significant difference. This suggests there was a similar effort applied throughout. The 
significant difference in distance achieved in ISWT was due to the learning effect of 
patients and not to motivational reasons. The study confirmed that a first practice 
attempt is needed to achieve reliability in the ISWT, supporting previous studies 
(Singh, et al. 1994; Morales, et al. 1999; Lewis, et al. 2001).    
 
Based on the studies reviewed above, a practice walk is recommended in a clinical 
setting for more accurate, reliable results. The reliability in this study was assessed 
over a short term period (1 week) similar to previous studies of ISWT reliability, ranging 
from 3 days to 1 weeks’ time. The results were under influence of learning and training 
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effect due the amount of testing done in a short period of time (Singh, et al. 1992; 
Arnott, 1997; Morales, et al. 1999; Lewis, et al. 2001). It’s important that studies in the 
future will test the reliability between first attempt and second with a better 
methodology design allowing enough rest time between tests. The long term reliability 
of the ISWT was not, however studied. 
 
In comparison with the above-mentioned studies of short-term reliability, Pepera, et al. 
(2008) studied the long term reliability of the ISWT, which was never analysed before. 
All other reliability studies had included tests done in a short period of time (1-week 
time). This is important as the ISWT is supported by guidelines (SIGN, 2002; BACPR, 
2012) to be used as a measure of changes in cardiorespiratory capacity due to Cardiac 
Rehabilitation and exercise prescription, in phase III and phase IV, varying the 
rehabilitation in a time of 6 to 8 in UK (Brodie, et al. 2006), so there is a need to 
understand the long term reliability of the test when used in real Cardiac Rehabilitation 
conditions.  
 
Thirty stable cardiac patients (15 males; age 55 to 80 years), performed two ISWTs a 
minimum of eight weeks apart. There was no statistically significant difference in mean 
distance walked between test one (502 ± 101 m) and two (509 ±146 m). Total distance 
walked showed ICC of 0.80 (95% CI 0.62 + 0.90) and a test, re-test bias of only -7 m. 
Suggesting that there was no learning effect between the two trials of the ISWT. This 
suggests that a practice attempt of the ISWT may not be necessary if the test is applied 
over a longer interval such as 8 weeks. This is contrary to the results of studies 
assessing short reliability (Arnott, et al. 1997; Fowler, et al. 2005), although the limits 
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of agreement found of -203 to 189 m were greater than those reported by previous 
studies done between the first and second test in a short time period (Singh, et al. 
1992; Jolly, et al. 2008) and between pre and post Cardiac Rehabilitation (Fowler, et 
al. 2005; Arnold, et al. 2007).       
 
Pepera, et al.'s (2008) study revealed low inter-individual test-retest reliability, the big 
range seen in the limits of agreement of -203 to 189 m showed a large inter-individual 
variance in performance between the tests. This random variation was bigger than the 
critical mean value of 100 m increase observed due to Cardiac Rehabilitation over a 
6 to 12 week interval (Tobin and Thow, 1999; Fowler, et al. 2005). This study, due to 
the influence of biological variation, change in symptoms, patients’ motivation, 
changes in exercise training frequency and capacity due to attendance; didn't measure 
changes in cardiorespiratory capacity due to Cardiac Rehabilitation. This study 
supported that no learning effect was present in long term reliability of 8 weeks, a 
practice walk of the ISWT was not deemed necessary if the aim is to assess the effects 
of the Cardiac Rehabilitation in clinically stable CVD patients, although further studies 
are needed to support this conclusion.     
 
Woolf-May and Ferrett (2008) assessed oxygen consumption, expressed in metabolic 
equivalents (METs) achieved in two ISWTs performed by 31 men post myocardial 
infarction (mean age 63.5 range 53-77 years, involved in phase IV cardiac 
rehabilitation) and in 19 men not affected by cardiac disease (mean age 64.6 (7.5) 
range 51-76 years). There were no significant differences in performance between test 
1 and test 2 in both populations assessed.  Healthy adults walked 550 (93 m) vs 560 
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±110 m in trial one, and 430 ±100 m in trial two vs 424 ±116 shuttles in post myocardial 
infarction patients. This study suggests a practice attempt is not needed to achieve 
reliable results from the ISWT and is supported by previous studies on short term 
reliability (Arnott 1997; Fowler, et al 2005). However, the study reveals poor statistical 
description, no indication of random error in confidence intervals of distances 
measured between test 1 and test 2, make it difficult to compare with previous studies.  
 
Short term reliability of the ISWT is good, with the suggestion of a practice walk. 
Longer term reliability of the ISWT, is reported as stronger than short term reliability, 
but possesses more systematic error in the final outcome of ISWT. There is a need 
for the ISWT to possess enough sensitivity to measure changes in ISWT performance 
due to exercise-based CR programmes. 
 
2.2.2.4. Sensitivity  
 
When measuring cardiorespiratory capacity, it is important that a test reports ability to 
discriminate changes in patients’ functional capacity due to training, disease state 
variation or the effect of some change in pharmacotherapy. In general terms this 
characteristic of the test is termed sensitivity. 
 
Payne, et al. (1996), for the first time, assessed the ability of the ISWT to discriminate 
between differences in functional capacity with or without rate responsive pacemakers. 
They tested ten patients (mean age 60 to 74 years, 4 women), one group to a fixed 
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rate of 70 beats/min, and other group to a fixed rate response (as recommended by 
the manufacturer). The patients were tested twice in a randomized way, with 20 
minutes between tests.  In patients with a rate responsive pacemaker, the exercise 
time was significantly greater than the fixed rate pacemaker group: 8.8 (1.3) compared 
with 8.1 (1.3) minutes, P<0.003, and the diastolic volume/min was greater again in 
rate responsive group, 70 (24) volume/min compared with the non-responsive group, 
52 (15), P<0.009). The test was therefore useful and sensitive enough to discriminate 
between different cardiac patients levels of exercise capacity with chronotropic 
incompetence, using a pacemaker. 
 
Arnott (1997), applied the ISWT in CABG patients that had undergone surgery in past 
12 months. The study was performed in 30 patients with a mean age of 62 years 
(range 42-68). Patients were divided into group A, 20 patients that had not gone to 
Cardiac Rehabilitation and group B, 10 patients that completed a Cardiac 
Rehabilitation programme. Before Cardiac Rehabilitation, Group A, patients achieved 
a mean distance of: 401,5m (SD 103.9); 421.5m (SD 115.4) and 425.5m (SD117.7); 
after Cardiac Rehabilitation, group B achieved a mean distance of: 523m (± 102.4); 
549m (SD 115.6) and 554m (SD 114.6).  The ISWT was able of differentiate between 
cardio respiratory capacity, in patients before Cardiac Rehabilitation and patients’ after 
completed a 10 weeks of Cardiac Rehabilitation programme.  
 
Tobin and Thow, (1999) assessed the ability of the ISWT to assess changes in 
cardiorespiratory capacity after 12 weeks of exercise based rehabilitation (2 sessions 
a week, one hour each) in 19 patients’ (7 females, between 42-80 years, mean age 
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61 years) that went through CABG surgery (previous 6 months, with a mean of 10 
weeks before rehabilitation). Pre and post rehabilitation cardiorespiratory capacity, 
showed an increase of 18% in test performance (mean distance increase of 117 
meters), representing a mean increase of 0.71 METS, p<0.01. The results suggest 
that exercise interventions will improve patients’ cardiorespiratory capacity, although 
due to ethical reasons no control group of CABG was able to be analysed for 
comparative measures.    
 
Fowler, et al. (2005), investigated the sensitivity of the ISWT in detecting changes in 
performance due to 6 weeks of Cardiac Rehabilitation effect, in thirty-nine cardiac 
patients (age 61.2 ±8.5 years) who had undergone CABG surgery in the previous 6 to 
8 weeks. After the 6 weeks a significant increase in mean distance of ISWT was seen 
(p<.001), showing a mean difference between the pre and post rehabilitation test of 
81.8 m (95%CI; 53.2-110.4m). This change reported between pre and post 
rehabilitation was greater than the natural variability of test reliability [attempt 2 and 3 
show a mean distance of 1.7 m (10.4) (95% interval of -1.9 – 5.3)], showing the test 
sensibility to detect changes in performance due to Cardiac Rehabilitation. Further 
studies are needed to quantify and understand the ISWT ability to measure change.  
 
Arnold, et al. (2007) investigated the benefit of two sessions over one session a week 
of Cardiac Rehabilitation in a period of 6 weeks assessed by ISWT. The study was 
done in 206 post-myocardial infarction patients divided in two groups, one group did 
one session a week with 85 patients [65 men, mean age 61.8 (10.27) years] and a 
second group of 121 patients [94 men, mean age 59.24 (10.03) years] performing two 
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sessions a week. There was a significant increase in mean distance achieved in ISWT 
in both groups. The bi-weekly group achieved a mean distance of 88.44 m (95% 70.3 
to 106.59) (p<.001) and 100.71 m (95% confidence interval 80.81 to 120.60) (p<.001). 
In the group exercising once a week, there were no significant differences between 
the 2 groups in median distance achieved in the ISWT. The study concluded that no 
benefit comes after 6 weeks short term from adding one more lesson a week to the 
Cardiac Rehabilitation of patients, showing the ISWT sensibility to detect changes in 
both groups of this study. The magnitude of change in mean distance due to Cardiac 
Rehabilitation is supported by a previous study done by Fowler, et al. (2005).  
 
2.2.2.5. Validity   
 
Validity is a fundamental characteristic of testing; it is necessary that the test used is 
accurately measuring what it is supposed to measure. The ‘Gold-Standard’ measure 
of cardiorespiratory fitness is incremental treadmill test, so a high correlation should 
be reported to consider the ISWT a test of fitness. 
 
2.2.2.5.1. Validity of ISWT in Chronic Obstructive Pulmonary Disease patients  
 
Singh, et al. (1994) studied, for the first time, the validity of the ISWT in measuring 
cardiorespiratory capacity in pulmonary patients. He had previously demonstrated that 
the test is applicable for disability assessment in these patients. This proved useful in 
categorizing and comparing patients according to their functional capacity level, 
(Singh, et al. 1992). The relationship between the ISWT performance and the modified 
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Balke treadmill protocol with oxygen consumption measures, with the use of Douglas 
bag (golden test for functional capacity assessment) was compared. The study 
included 19 patients (17 males) suffering from stable chronic airflow, with a mean age 
of 61 (SD 7) years. They were tested during 3 visits to the hospital with one week 
apart.  In the first visit a treadmill protocol was performed and a practice shuttle walk 
test, and in the second and third visit a randomized design of the patients was applied, 
i.e. a treadmill test followed one week later by an ISWT.  The distance achieved in the 
second ISWT was used for the study proposal. A strong relationship (r=.88) was found 
between distance walked performing the ISWT and the direct measure of ܸ̇O2peak in 
treadmill test.    
 
Singh, et al. (1994) after assessing the strong validity of the test to predict ܸ̇O2peak, 
analysed the oxygen consumption during the ISWT by measuring the ܸ̇O2peak of the 
pulmonary patients with a portable oxygen consumption meter, during the test.  10 
stable pulmonary patients (6 males, mean age 64 (7) years), performed two ISWTs on 
different visits to the hospital in a randomized balanced way, doing one test with 
portable gas analyses and one test without. A strong relationship (r=0.81) was found 
supporting the previous study focusing on ISWT distance achieved and ܸ̇O2peak direct 
measure.  A linear increase in ܸ̇O2peak was seen as the test stages progressed 
suggesting the ISWT was able to provoke physical effort at symptom limited responses 
in patients, similar to a treadmill test. Heart rates of patients performing the treadmill 
test were higher than in ISWT at submaximal velocities. Singh, et al. (1994) also 
compared performance in the treadmill test and the ISWT with direct ܸ̇O2peak measured 
in both tests in 7 patients. The mean ܸ̇O2peak measure during the treadmill testing was 
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12.9 (±3.6) ml.kg-1min-1 compared with 11.1 (±4.2) ml.kg-1min-1 during the ISWT. No 
significant difference was found and the mean difference was small (1.8 95%CI -0.9 
to 4.5 ml.kg-1min-1) with a correlation of r=.86.   
 
The ability of the performance in ISWT to predict ܸ̇O2peak as analysed in this study 
confirms the ISWT as a valid tool to assess cardiorespiratory capacity in pulmonary 
patients. No other field test used before in these patients or in a limit disease 
population has been so strong in predicting ܸ̇O2peak. The results support the safety of 
the test due to the gradual physiological response that provokes patients. The effort is 
similar to that produced in the treadmill protocol, due to the protocol design of 
incremental speed (1.7 m·s-1 increase) the ISWT is able of elicit maximum effort in 
patients, not seen before in other field tests (6 min walk test). Due to the standardized 
protocol the test is able a secure intra-inter subject comparison, also not possible 
before in other field tests. The test is easily applied to hospital conditions and is 
generally well accepted and preferred by patients compared to the treadmill test. The 
ISWT is an objective measure of cardiorespiratory capacity, although it doesn’t replace 
the laboratory test. (Singh, et al. 1994)   
     
2.2.2.5.2. Validity of ISWT in heart failure and heart transplant patients 
 
Morales, et al. (1999) assessed the validity of the ISWT in heart failure patients 
compared to the cycle ergometer cardiopulmonary test (with a protocol design with a 
first stage 1 minute unloaded being followed by a 10 W/min stage increase). The study 
included the validity of the 6 minute test in predicting ܸ̇O2peak in these patients 
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compared with the ISWT. The assessment was performed in 46 patients, aged 53 
years (± 10 years) who were clinically stable and categorized with an ejection fraction 
<40% (mean 23%, ± 8%) also classified by the New York Heart Association as class 
2 to 4 (mean 2.8 ±0.7).  ܸ̇O2peak from the cycle ergometer test and distance walked in 
ISWT showed a high correlation (r=.83, p<.001), but the 6 minute test distance in this 
group of patients only showed a moderate correlation (r=.67, p<.001) with ܸ̇O2peak 
achieved in cycle ergometer test. The following formulae to predict ܸ̇O2peak were 
developed: 
- ܸ̇O2peak = [0.023 x distance (m) SWT] + 5.9;  
 r=0.83; r2=0.69; SEE= 2.55 p<.001.   
 
- ܸ̇O2peak = [0.024 x distance (m) SWT] – [0.006 x weight (Kg)] + [0.06 x age (years)] 
+ 6.44;  
r= 0.86; r2=0.74; SEE 2.37; P<.001. 
 
Receiver operating characteristic curves (ROC) indicated that the ISWT had a 
significant diagnostic accuracy (ROC 0.97 and 0.83 p=.2) above the 6 min walk test. 
A distance <450 m in the ISWT was seen as a good predictor of peak ܸ̇O2peak < 14 
ml.kg-1min-1, although larger studies are needed to support the prognostic power of 
ISWT to predict ܸ̇O2peak in cardiac patients, particularly heart failure patients (Morales, 
et al. 1999). In this study, a stepwise multivariate regression analysis showed that the 
distance walked in ISWT was the strongest independent predictor of peak ܸ̇O2peak 
(P<.0001), this was not the case for the 6 MWT (p=.64). The analysis took into account 
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factors such as clinical and hemodynamic resting, echocardiographic and 
radionuclide-angiographic data. 
 
Morales, et al. (1999) concluded that the ISWT is simple to apply, with the patients 
having no difficulty performing the test and coordinating their pace easily using the 
bleep sounds. The test was shown to be a valid diagnostic tool in predicting ܸ̇O2peak in 
moderate and severe heart failure patients, although this study possessed some 
limitations on the validation aspect. The validation process was based in cycle 
ergometer protocol which is known to underestimate ܸ̇O2peak by 5% to 10%, compared 
with golden test of cardiorespiratory capacity the treadmill test. So further studies are 
needed to support and fully understand the real capacity of the ISWT in predicting 
ܸ̇O2peak, such as validating it against the treadmill protocol in this population and testing 
its' prognostic power. 
  
The n= 46 heart failure patients involved in the study done by Morales, et al. (1999) 
were followed up in a mean time of 17 months (SD 8 months; range 8-28 months). 
After follow up, 15 of them (33%) had suffered a major cardiac event (5 cardiac deaths, 
2 heart transplantations, and 8 of the patients had mechanical and inotropic hospital 
support.  The best predictor of outcome at one year of follow up was the distance 
achieved in ISWT (P<.03), further demonstrating that distance in the 6 MWT had no 
predictive power (p<.07). A distance achieved of less than 450 m allowed identification 
of high risk patients having a major event in a short time period. This study suggested 
the ISWT predicts event free survival better them the 6 MWT in chronic heart failure 
patients over one year (Morales, et al. 2000). 
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Lewis, et al. (2001) included patients for heart transplantation, and was the first to 
assess the validity of ISWT in cardiac patients, by comparing it against the standard 
golden test for assessing cardiorespiratory capacity, the treadmill test. The study 
assessed 25 patients, 21 males, with a mean age 53 years (range: 33-69 years), who 
performed three ISWTs (1st test was practice), and two treadmill tests with gas 
ventilation assessment to determine ܸ̇O2peak, using the modified Naughton protocol. 
The study results showed that the ܸ̇O2peak on the treadmill was highly correlated with 
the distance achieved in ISWT, R=.73, p<.001; a predictive equation was developed 
for estimating ܸ̇O2peak = 6.4 + (0.022 x Shuttle Walk Distance). They concluded that 
ISWT was easy to perform and had high applicability, was well tolerated and preferred 
by the patients in relation to the treadmill test. The ISWT was shown to be a valid test 
to assess patients with wide ranging functional capacity, and to predict ܸ̇O2peak in heart 
failure patients, being useful in clinical prognosis, prior to cardiac transplant surgery. 
 
Lewis et al.'s (2001) study analysed the discriminative power of ISWT in 25 heart 
failure patients (21 males, mean age 53 years, range 33-69 years) before heart 
transplantation. From ROC curve analysis (Campbell, et al. 2007), a range between 
370 and 430 m/s performance in ISWT, was identified with sensitivity and specificity 
to predict at 75%, a ܸ ̇ O2peak higher than 14 ml.kg-1min-1 in this patients. The cut-off point 
of 450 m/s determined to predict a ܸ̇O2peak of 14 ml.kg-1min-1 has high clinical 
importance in the prognosis of heart failure patients before transplantation, as levels 
of ܸ̇O2peak under this cut point have shown to be related to high short term mortality 
(Morales, et al. 2000). A clinical decision made on this cut point could help to prioritise 
which patients should take priority for heart transplantation. This cut point of 450 m 
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had been detected before in a previous study in heart failure patients (Morales, et al. 
1999) supporting the conclusions of this study.  
 
2.2.2.5.3. Validity of ISWT in CHD patients 
 
Fowler, et al. (2005), investigated the validity of ISWT in predicting ܸ̇O2peak in 39 
cardiac patients (n=34 males, mean age 61.2 (SD 8.5) years) who had undergone 
CABG surgery in last 6 to 8 weeks. Until this, the test had only been validated in 
chronic, stable pulmonary patients (Singh, et al.1994), and in heart failure patients 
(Morales, et al. 1999; Lewis, et al. 2001). However, heart failure patients don’t 
represent the major cardiac population, they are a population with low 
cardiorespiratory capacity levels and are representative of a final stage of cardiac 
disease. In a week's time three ISWT were performed one in the first visit to the 
hospital and two tests on the second visit with 45 minutes of interval between them. 
On the third visit a modified Balke treadmill protocol was performed with Oxygen 
uptake measures. A strong relationship was found between distances walked in the 
three ISWT performed and ܸ̇O2peak measured directly in treadmill test (r= .79; r= 86; 
r=.87), being an equation produced to predict ܸ̇O2peak 
-  ܸ̇O2peak= 7.81 + [0.03 x ISWT distance (meters)]. (no S.E.E was given) 
 
A significant difference (p<.001) in mean maximal heart rate achieved in ISWT (133 
bpm) compare with treadmill exercise (144 bpm), although a high correlation (r=.74) 
is seen between both maximal heart rates achieved in both tests. The ISWT is a valid 
tool to assess cardiorespiratory capacity in CABG patients after surgery, predicting 
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strongly the ܸ̇O2peak, easy to apply and with good acceptability from the patients; The 
relation with the direct measure of ܸ̇O2peak in treadmill is as strong as Singh, et al. 
(1994) had reported on first validation of the test in chronic pulmonary patients, and 
stronger then studies done before in cardiac patients with heart failure (Morales, et al. 
1999; Lewis, et al. 2001).   
 
Woolf-May and Ferrett, (2008) assessed the oxygen consumption, expressed in 
metabolic equivalents (METs) achieved in the ISWT by n=31 men post myocardial 
infarction [mean age 63.5 (6.5), range 53-77 years, involved in cardiac rehabilitation 
Phase IV] and in 19 men no affected by cardiac disease [mean age 64.6 (7.5) range 
51-76 years]. In their study it was analysed the effect of the turn performed by patients 
on the end and beginning of 10 m length in shuttle walk test against performing the 
walk test without turns walking uninterrupted, and if there were differences in METs 
achieved between both performances.  
 
The METs values achieved in ISWT performance by Cardiac patients are used in 
clinical decisions and exercise prescription. Although the METs values are not specific 
for this population as they were achieved in by healthy people performing flat walk, 
what is not the specific performance done in the shuttle walk test effort as this one 
involves turns in the performance. Furthermore, the MET values in healthy adults have 
been seen to be stable, although influenced by factors such as age, body weight, 
cardiorespiratory capacity and comorbidities. Cardiac patients, on average, are of 
advanced age, with low cardiorespiratory capacity, overweight, and possessing 
several co morbidities. MET values are supposed to be different between cardiac 
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patients and healthy adult people. In prescription, an inaccurate METs assessment of 
the patient my lead to a poor training effect or over exerting the patient which could 
lead to further cardiac events.  
 
Patients and healthy adults performed two ISWT with direct measures of ܸ̇O2peak done 
by portable gas analyser. The tests were performed at different occasions, and the 
results were taken from the second test done due to the learning effect variance seen 
by previous studies between test one and test 2 as previously discussed. Due to 
ethical reasons healthy adults performed 2 treadmill tests using the same protocol as 
the ISWT, performing the test walking flat. Due to learning effect on performance 
witnessed in previous studies the second attempt was taken for results analyses.  
 
The results of the study revealed that there were no significant differences on METs 
assessment between ISWT and the same incremental protocol (walking flat on the 
treadmill) performed by healthy adults. A limits of agreement analysis showed 
acceptability between both tests measured (mean difference -1.1 (8.8) (1.96 SD; 95% 
CI 7.7 to 9.9)). The variation between both measures was small and highly correlated 
(r=.88; r2=.48, p<.001). These results are in accordance with previous studies of test 
validity (Singh, et al. 1994; Fowler, et al. 2005), and may show that the turning involved 
in the ISWT protocol has a small impact on V’O2 max prediction or METs estimates.  
 
This study supported the guidelines of ASCM (2007) regarding METS performed 
during flat walking in healthy people. When the performance in METs from the ISWT 
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between cardiac patients and healthy adults, statistical differences were seen between 
both test's METs scores. The MET values achieved at maximal and submaximal 
walking speeds were significantly higher than those achieved by healthy adults 
(p<.001). Several factors may explain this difference in METS achieved by both 
populations, such as differences in body weight, fatigue, environmental (test venue), 
low cardiorespiratory capacity, medication and co-morbidities affecting cardiac 
patients.  
 
This study supported the referenced METS given by the ACSM (2007) for healthy 
people performing the flat walk, and showed that the greater values in METS achieved 
by cardiac patients didn't allow a true comparison with estimated METs obtained in 
healthy people. They concluded that while further studies are needed to establish 
estimated METs at different stage speeds of the ISWT in cardiac patients, that the 
shuttle walk test is a valid test to be used in cardiac patients for cardiorespiratory 
capacity assessment. 
        
2.3. Conclusion 
 
Exercise-based CR programmes (exercise-only CR and comprehensive-CR) in CHD 
patients is an effective treatment for preventing cardiac mortality, morbidity, all cause 
of death and may improve quality of life. It is thought that CR is an effective therapy 
due to its positive impact on reducing risk factors for CVD (strong evidence for 
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hypertension, smoking and total cholesterol) and due to the improvement in 
cardiorespiratory capacity due to exercise in cardiac patients. 
 
Cardiorespiratory capacity is an important outcome in exercise-CR programmes. 
Measuring cardiorespiratory capacity enables decisions on diagnosis, prognosis, 
treatment effect and exercise prescription of cardiac patients, based on objective 
measures. Field tests are practical and simple to use in clinical or community settings 
in the absence of laboratories tests in all phases of Cardiac Rehabilitation.   
 
The field test ISWT has shown high acceptability and practicability since the first time 
that it was applied in chronic stable pulmonary patients in a clinical setting. The first 
reliability studies measured in the short term (less than a week time) show that a 
practice walk is needed to achieve reliability as there is a learning effect caused by the 
performance between the first and second attempts. More recent studies have 
questioned the need for this first practice walk, due to its costly impact on clinical work. 
Furthermore, it could cause additional stress to the patients, showing no practicability, 
and no significant differences in the mean distance were witnessed. The long term 
reliability means there is no need for a practice walk, as demonstrated, the test is used 
in intervals of 6 to 8 weeks in the Cardiac Rehabilitation setting.  
 
The ISWT showed sensitivity to measure change in cardiorespiratory capacity due to 
the effect of Cardiac Rehabilitation, an average range of 100 m of improvement 
between studies was reported. 
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The ISWT has demonstrated to have good validity in measuring cardiorespiratory 
capacity. An early study on chronic pulmonary patients compared mean distance 
achieved with ܸ̇O2peak performance during a treadmill protocol (r=.88) due to the high 
correlation between ISWT and treadmill performance established in recent studies.  
However, this correlation can be improved if patient characteristics like age or 
anthropometric measures (high, weight) and comorbidities are taken into account, as 
witnessed in previous multivariate analyses on the 6MWT (Ingle, et al. 2006).  
 
When the performance in METs in the ISWT was compared in cardiac patients and 
healthy adults, statistical differences were seen between both group's METs scores. 
The METs achieved at maximal and submaximal speed were significant higher than 
the ones achieved by healthy adults. There is a need to further understand this very 
high oxygen consumption in CHD patients compared with healthy individuals. 
 
The ISWT showed diagnostic accuracy in predicting ܸ̇O2peak in heart failure and heart 
transplant patients, the distance achieve in ISWT being the strongest independent 
predictor of ܸ̇O2peak. From a distance achieved of less than <450 m/s it is possible to 
predict a peak ܸ̇O2peak of 14 ml.kg-1min-1. This distance has been supported as being 
the optimal cut point to prioritize patients for heart transplantation. The distance of 
>450 m/s achieved in ISWT had prognostic power in predicting event free survival 
after one year in heart failure patients. Despite this, more studies are needed to 
investigate the long term prognostic power of the ISWT in cardiac patients as studies 
done with treadmill protocol have worked towards (Joliffe, et al. 2002; Meyers, et al. 
2002) including when focusing on the 6 MWT in cardiac patients (Sakir, et al. 2007).   
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Research questions and justification for addressing them within this thesis are, 
therefore, as follows. 
  
Systematic reviews have concentrated on clinical outcomes to illustrate the efficacy of 
exercise based Cardiac Rehabilitation but none have examined whether CR results in 
changes in patients’ cardiorespiratory fitness. 
 
1. What evidence is there for changes in cardiorespiratory fitness of patients 
attending exercise-based Cardiac Rehabilitation? – the approach used to address this 
question will be a meta-analysis; 
 
Only absolute performance in the ISWT is interpreted not accounting for individual 
differences of cardiac patients performing the test,   
 
2. what are the predictors of performance in incremental shuttle walk test in 
cardiac patients? and base in this predictors will be possible to create percentile 
curves and normative values for the incremental shuttle walk test in cardiac patients?  
 
There are clear disparities in current estimates of oxygen cost in ISWT, 
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3. What is the energy cost of the ISWT? 
 
Little is known about what influences changes in fitness due to CR,  
 
3. what are the predictors of change in fitness due to CR, assessed by treadmill 
exercise test, and ISWT in cardiac patients?  
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Chapter 3.  Changes in Cardiorespiratory Fitness in CR Patients: A 
Meta-Analysis 
 
Abstract 
 
Objective: The improvement of cardiorespiratory fitness in patients due to Cardiac 
Rehabilitation (CR) is an important therapeutic outcome. There is plenty of evidence 
included in several meta-analyses focusing on the effectiveness of CR in reducing 
morbidity and mortality. The magnitude of gains in cardiorespiratory fitness produced 
by CR is not well known, including the factors which influence such gains. This chapter 
aims to quantify the changes in cardiorespiratory fitness due to CR, and understand 
which variables affect this changes. 
 
Methodology and results: A detailed literature search in changes in cardiorespiratory 
fitness in CR patients was made using electronic databases. The data collected was 
subjected to a random-effects meta-analysis, an effect size was produced to 
determine the aetiology of gains in cardiorespiratory fitness, and to determine potential 
sources of heterogeneity, analyses on subgroups were performed by Q statistics.  
 
A total of n=31 studies, containing n=48 groups (n=3827 participants) showed a mean 
improvement in fitness of 1.55 (95%CI: 1.21-1.89) MET’s, (p<0.001); equivalent to a 
standardised effect size of ES=0.97 (95% CI 0.80-1.13). Due to the high levels of 
heterogeneity shown by this value (Q=852, p<0,001), sub-group analyses on the effect 
size were performed. Improvements in fitness in patients were higher in cardiac 
programmes with more than 36 sessions and in studies where the Naughton Protocol 
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was used to assess patients, used as a modality of aerobic exercise or combined with 
resistance exercise. Age (young) and sex (males, and male-only exercise group) were 
some of the characteristics associated with the highest improvements in fitness. 
Programme (comprehensive or exercise-only), duration, study design, patients' 
primary diagnosis and patients' baseline fitness levels were unrelated to gains in 
fitness. 
 
Conclusions: This is the first meta-analysis to quantify the gains in cardiorespiratory 
fitness of patients attending exercise-based CR. The analysis identifies some of the 
characteristics (service or patients) that can influence the cardiorespiratory fitness 
gains in patients involved in CR.  
 
Service variables, such as including >36 sessions in the CR programme of aerobic or 
mixed aerobic and resistance exercise with a programme length of 12 weeks. The 
treadmill protocol used to assess cardiorespiratory fitness in patients had a major 
impact on the estimate of fitness improvement. Patient variables such as been young 
and male are shown to have greater impacts on fitness, those who may benefit more 
from CR are older, female patients, who have lower changes in fitness.  
 
Provision of exercise sessions for same sex groups and patient allocation based on 
age is recommended. This would help practitioners to differentiate between who 
achieves optimal increases in cardiorespiratory capacity in CR and who doesn't, 
improving exercise prescription in CR.    
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Key words:  Cardiorespiratory fitness; treadmill exercise test; predictors of change; 
cardiac patients; fitness improvements. 
 
 
3.1. Introduction 
 
CR is an effective therapeutic intervention for CHD patients, which reduces all cause 
mortality, cardiovascular mortality and morbidity (Oldridge, et al. 1988; O'Connor, et 
al. 1989; Jolliffe, et al. 2001; Taylor, et al. 2004; Conn, et al. 2009; Lee, et al. 1999). 
The effectiveness of CR in reducing patient mortality and morbidity can be explained 
in part by the positive effects that CR has in reducing modifiable risks factors for 
cardiovascular disease (Taylor, et al. 2006). 
 
One proposal is that CR may not just add years to life, but also life to years (Thompson, 
2009). Pharmacotherapy can effectively modify many CVD risk factors, rehabilitation 
based on exercise can also add to the improvement of functional capacity, mobility 
and patients independence, resulting in an increase in cardiorespiratory fitness (fitness 
from here in). The effectiveness of CR on the improvement in quality of life is 
independently associated with fitness improvements in cardiac patients (Lavie and 
Milani, 1997) and fitness levels are excellent tools with which to define prognostic cut 
points for future cardiovascular events (McAuley, et al. 2009; Sui, et al. 2007, Lyerly, 
et al. 2008). Gains in fitness achieved by patients in CR are closely, inversely, related 
to patient mortality and morbidity (Williams, et al. 2006; Blair, et al. 1995; Balady, et 
al. 1996; Gulati, et al. 2003; Myers, et al. 2002; Dorn, et al. 1999; Kavanagh, et al. 
2003). Levels of fitness gains are recognized to have clinical importance in cardiac 
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patients, however only limited studies have tried to synthesise such information (Conn, 
et al. 2009; Swain and Franklin, 2006).       
 
A recent systematic review (Conn, et al. 2009) showed an increase in the physical 
activity levels of a wide variety of cardiac patients. Changes in fitness were also 
reviewed in this study as a secondary outcome. This analysis was based in 
randomized controlled trials, and largely concentrated on the quantification of 
standardized differences between post-test groups. This design was used to ensure 
data quality and the authors excluded cohort and observational design studies. Such 
studies normally represent a more naturalistic approach to clinical practice. It would 
be an unethical study design to exclude cardiac patients from CR, due to the 
effectiveness of this therapy (Dusseldorp, et al. 1999); the increase in cohort-design 
studies is, therefore, both necessary and common. Conn, et al.'s (2009) meta-analysis 
was restricted in studies used due to inclusion criteria. A Subgroup analysis could not 
be used by the authors to determine which components of exercise (frequency, 
intensity, duration, and modality) determined the gains in fitness in cardiac patients. 
Nevertheless the effect size representing the change in physical activity was converted 
to energy expenditure (1984 Kcal·week-1). It was difficult to translate the estimated 
gains in fitness to a common language used normally as ܸ̇O2peak (ml·kg-1·min-1) or 
metabolic equivalents (MET’s). 
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3.2. Aims and hypothesis 
 
The present chapter aimed to quantify the overall gains in fitness reported in studies 
of exercise-based CR. By expressing fitness in commonly-used units (MET’s), results 
should have greater relevance for clinicians than those of previous studies reporting 
effect sizes. The secondary aim was to identify patient and programme characteristics 
associated with changes in fitness to provide guidance in designing CR programmes 
that maximize fitness gains for CR patients. 
 
3.3. Methods 
 
3.3.1. Search strategy 
 
The search was made independently by three authors, using PubMed, Ovid, Web of 
Science and The NIH library. Broad terms were used for the search: exercise, cardiac 
(or cardiovascular) rehabilitation, training, functional capacity, fitness 
(cardiorespiratory fitness), ܸ̇O2peak, ܸ̇O2max. Initially the search allowed us to gather 
7104 potential papers to include in the review. We aimed to include the most common 
‘’core’’ cardiovascular patient population in our analysis based on outpatient CR 
programmes. We produced a narrow search in terms of the paper's publish year and 
population age. Papers had a limit range (1970-2010) and population an age range 
(>18 years). The search included the Boolean operator ‘’NOT’’ in the search terms 
used: heart failure, home-based and waking programme. These options used in the 
search refined it to 4321 abstracts that were manually analysed for eligibility. Meta-
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analyses referring to other CR aspects and clinical guidance documents had their 
references section analysed in our search for finding further references (O'Connor, et 
al. 1989, Oldridge, et al. 1988; Taylor, et al. 2004, 2006; Williams, et al. 2006; Conn, 
et al. 2009; Dusseldorp, et al. 1999; Swain 2005). Our analysis only included primary 
research studies according to the criteria established in Table 3.1.            
 
The unsupervised or home-based intervention papers were excluded from analysis 
because of the great difficulty in assessing cardiac patients’ adherence or quantifying 
exercise dosage variables used in such programme modality. The evidence of the 
effectiveness of home-based CR in the reduction of mortality and morbidity is lacking 
(Taylor, et al. 2007). The incremental load-bearing inclusion as the only kind of 
assessment used in the studies is justified by an attempt to standardize the method 
used for fitness assessment. Cycle ergometer tests produced lower assessment 
values of ܸ̇O2peak. Field test are based in values estimation of MET’s or ܸ̇O2peak, which 
prediction equations used possess normally a large standard error of estimation 
(Morales, et al. 2000).  
 
These criterions did not include home-based intervention papers and included only 
assessments of fitness made by incremental load-bearing in order to restrict the data 
analysis to a more commonly used model of CR. This criterion has been used in past 
meta-analyses to help prove the efficacy of CR in reducing mortality, morbidity and 
overall risk factor reduction (Taylor, et al. 2004; Conn, et al. 2009; Lee, et al. 1999; 
Taylor, et al. 2006). The criteria for exclusion gave the present meta-analysis different 
characteristics to the only other meta-analysis published on this topic (Conn, et al. 
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2009) which included a bigger variety of CR modalities and included all available 
methods of fitness estimation. Non-randomized trials were purposely included in the 
present analysis. There were small differences in values from comparison of distal 
post-test values in control group versus treatment group, and pre-test versus post-test 
values in treatment group shown in previous analyses (Conn, et al. 2009). The search 
results revealed many studies without control groups in their design. These tended to 
be more like ‘’service evaluation’’ pieces of research done in natural settings and 
closer to the reality of health care (Blumenthal, et al. 1988; Dressendorfer, et al. 1995; 
Lavie and Milani, 1997). These trials had a high external validity, so were included in 
the study design and their characteristics included in the subgroup analysis.     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.1. Study Inclusion exclusion criteria 
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3.3.2.   Data extraction and treatment 
 
Means and standard deviations from the fitness assessment before and after CR were 
extracted from the studies that met the inclusion criteria. Most of the studies included 
METs as a measure of fitness, in studies that fitness results were given as oxygen 
consumption (ml·kg-1·min-1) this result was divided by 3.5 to calculate METs. The 
reported correlations between pre- and post-test data in CR studies were not reported 
in any studies, the magnitude of this relationship was estimated by using data from a 
CR programme at a local hospital.  After ethical approval, we analysed 149 patient 
data records which included the use of the Bruce Treadmill protocol before and after 
a standard CR programme. Significant improvements in ܸ̇O2peak (p<0.001) were 
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witnessed after using a repeated measures t-test, there was a correlation of r=0.535 
between pre- and post-test values. In our meta-analysis we used this correlation 
coefficient to correct for the use of paired values. The final analysis included a total of 
n=31 studies, producing n=48 independent groups of patients. The overall change in 
fitness as the mean difference between pre- versus post-test was reported as METs, 
as this is a common way to report and analyse the oxygen consumption data by 
researchers and clinicians in every day work. Random effects modelling were also 
used to report the effect size (ES) for standardised mean difference in fitness and to 
enable comparisons with previous studies. To determine potential sources of 
heterogeneity, analyses on subgroups were performed by Q statistics (Berlin, 1995)  
 
3.3.3.   Data coding for subgroup analyses 
 
Subgroup analyses were performed by the use of pre-selected moderator variables to 
understand the several causes of heterogeneity (Higgins, et al. 2002). From the 
analysis of subgroups it's possible to generate spurious findings, something strongly 
supported by previous papers (Higgins, et al. 2002; Davey Smith, et al. 1997). 
Therefore only a small number of subgroup analyses were performed by us, and the 
reason for being chosen was based potential causal mechanisms, magnitude of 
effects, and statistical significance shown within individual studies.  
 
The data was coded by developing two broad categories. Data related to the study 
design and CR programme design was coded first, patients' characteristic data was 
coded afterwards. Length of programme was coded in weeks, total number of sessions 
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included in each CR programme study, and exercise modality was coded as: aerobic, 
resistance or mixed. CR programmes were coded as comprehensive (including 
educational and/or behaviour change) or as being exercise-based only. The study 
design used in the analysis was coded as a cohort-study design or part of (randomised 
or non-randomised) trial including a control group. Treadmill protocols used for testing 
fitness pre- and post-test were coded by name and completed subgroup analysis in 
this category. The subgroup analysis of quantitative patient characteristics included 
age (Young, <50; Old 50-65 and Oldest, >65 years), baseline values of fitness (median 
split at >/<6.6 MET’s), sex of patient group (Males, Females or Mixed). We coded the 
primary reason for CR attendance (Revascularization, Post-myocardial infarction or 
Mixed). The subgroups and the way they were coded and cut-offs can be seen in Table 
3.2.  
 
It was not possible to create subgroups based on all the variables identified. Intensity 
of exercise prescription was a variable that was impossible to analyse due to the broad 
and often overlapping categories (e.g. 60-85% heart rate maximum) or poor quantified 
terms used (e.g. ‘symptom limited’ or ‘Borg scale’), which makes the data impossible 
to compare.  
 
 
3.4. Results 
 
The overall effect of CR on fitness levels was measured in metabolic equivalents 
(MET’s) as shown in Fig. 3.1. A mean difference in fitness between Pre- vs. Post-test 
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values of 1.55 (95%CI: 1.21 to 1.89) was calculated based on data from the (n=31) 
studies included in the analysis. An effect size (ES) =0.97 (95% CI 0.80 to 1.13) was 
calculated for the standardised mean difference between Pre- vs. Post-test using a 
random effects model. The difference was statistically significant (p<0.001), but also 
highly heterogeneous (Q=852, p<0.001). A forest plot visual analysis found that four 
groups representing four different studies (Miller, et al. 1984; Dressendorfer, et al. 
1995; Brubaker, et al. 1996; Arya, et al. 2005) had mean effects larger than expected 
(>2SD higher). Removal of these groups somewhat lowered the mean standardized 
difference (ES=0.80 95% CI 0.63 to 0.94). The value obtained was still statistically 
significant (p<0.001) and the degree of statistical heterogeneity remained high 
(Q=591, p<0.001). These groups were reintroduced into the study prior to subgroup 
analysis, as they had no common nor distinguishing characteristics.        
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Fig. 3.1. Forest plot for mean point estimate of change in fitness due to CR.
 
Legend: Points are mean points estimate (squares) with upper and lower 95% confidence intervals for the difference between 
pre-and post- CR measures of cardiorespiratory fitness (in metabolic equivalents). The overall mean point estimate (± 95%CI) is 
based on a random effects model.  (Miller, et al. 1984, Williams, et al. 1985); (Blumenthal, et al. 1988, Blumenthal, et al. 
1990);(Ades and Grunvald 1990); (Blumenthal, et al. 1990; Lavie, et al. 1993); (Ades, et al. 1995); (Dressendorfer, et al. 1995, 
Lavie and Milani 1995); (Brubaker, et al. 1996); (Balady, et al. 1996); (Wosornu, et al. 1996); (Shiran, et al. 1997); (Lavie and 
Milani 1997); (Nieuwland, et al. 1998); (Carlson, et al. 2000); (Belardinelli, et al. 2001); (Hao, et al. 2002 ); (Vonder-Muhll, et al. 
2002); (Gordon, et al. 2002); (Seki, et al. 2003); (Hevey, et al. 2003); (Lear, et al. 2003); (Milani, et al. 2004); (Arya, et al. 2005); 
(Adams, et al. 2008); (Seki, et al. 2008); (Milani and Lavie 2009); (Kosydar-Piechna, et al. 2010); (Shabani, et al. 2010); (Onishi, 
et al. 2010). 
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3.4.1. Subgroup analyses: test for heterogeneity 
  
Significant differences in between-group heterogeneity were seen in some subgroup 
analysis of programme design characteristics (Table 3.2). However, the overall 
programme length of the studies (>/< 12 weeks) didn’t influenced changes in fitness. 
The number of exercise sessions didn’t show statistically significant differences. 
Although programmes that included more than 36> (small number of studies k=5) 
sessions showed greater fitness gains than the studies that included 36 or <36 
sessions. The two last groups showed a similar effect size for change in fitness. The 
use of aerobic or mixed exercise modalities had a similar effect in influencing fitness 
changes, both showing significance (p=0.024), prescribed resistance exercise only 
programme (few studies k=2) didn’t have any effect on fitness. There were no 
statistical differences between comprehensive and exercise-only based CR 
programmes in improving fitness; however, it was possible to observe a tendency in 
effectiveness towards exercise-only CR. Study design (cohort or trial studies) had no 
significant effect in influencing fitness changes in our analysis. Programmes that used 
the Naughton protocol for fitness assessment had bigger improvements in fitness than 
in studies using Bruce, Balke or own reported protocol used in the studies. The studies 
that did not report the incremental design used in the assessment showed the small 
changes in fitness. Larger gains were seen in male groups and in the youngest age 
group, compared with women or mixed-sex groups and with the other age groups in 
the analysis. Analysis of the primary diagnosis subgroup showed no significant 
differences in between-group heterogeneity, although patients that suffered an MI 
possessed higher fitness gains when compared with other diagnoses. This subgroup 
analysis produced no significant results due to the small number of studies in the group 
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that had only post MI patients (k=5). When analysing the groups possessing low or 
high baseline fitness measures no significant differences were found relating to 
influence on fitness gains.   
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Table 3.2. Subgroup analysis for moderators of fitness gains expressed as standardised mean difference. 
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Legend: Duration of programme: as reported in manuscript 3 months assumed to be equal to 12 weeks. Number of exercise sessions: total 
reported in study (not the number actually attended). Exercise modality: aerobic — described as continuous exercise e.g. cycle ergometer, 
treadmill walking (home walking programmes excluded). Treadmill protocol: as given except ‘own’ — where authors described a highly modified 
or bespoke protocol with enough detail to replicate; ‘Not given’ — authors described using progressive/incremental exercise but did not provide 
enough detail to replicate. Study design: all values calculated as within-group, pre- vs. most distal post-test value, cohort describes studies in 
which not control group was used. Trial describes studies in which a waiting list, volunteer (selective) or random group of patients acted as 
controls. Sex — the characteristics of the group in which exercise training took place. Primary diagnosis — the reason given for patients attending 
CR. MI — myocardial infarction, revascularisation included coronary angioplasty procedures and coronary artery bypass grafting. Where 
emergency revascularisation took place following MI patients are classed as MI. Mixed—includes patient groups with mixed revascularisation 
and MI classifications as well as valvuloplasty and angina patients. Baseline fitness is maximal capacity derived from pre- rehabilitation treadmill 
testing grouped according to median split. Note; k values may not always sum to 48 due to missing data in some study
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3.4.2. Publication bias 
 
Funnel plots of precision (standard error) against effect size (standard difference in 
mean) are shown in Figure 3.2. Studies used in the analysis are shown in open circles 
and closed circles represent imputed studies. The strong evidence for publication bias 
in pre- versus post- rehabilitation improvement in fitness is evident in the asymmetry 
of the plot and clustering of imputed points provided.      
 
Figure 3.2. Funnel plot of precision by standard difference in means.
 
Legend: Open circles represent studies included in the meta-analysis. Closed circles are 
imputed values demonstrating the significant publication bias in studies analysed. 
 
3.5. Discussion 
 
CR (CR) is established as an effective therapy to reduce mortality and morbidity in 
patients suffering from several cardiovascular diseases (O'Connor, et al. 1989; 
Oldridge, et al. 1988; Jolliffe, et al. 2001; Taylor, et al. 2004; Conn, et al. 2009). 
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Exercise-only CR is the type of CR on which the early meta-analyses were based on, 
showing the effectiveness of the therapy. There has been, however, an increase in 
comprehensive CR programmes, but exercise training is a core component that 
remains a mainstay in overall CR programmes (NZGG 2002; BACR 2007; Thomas, et 
al. 2007; SIGN 2002; Balady, et al. 2007; Corra, et al. 2010; Corra, et al. 2007). 
 
The increase of cardiorespiratory fitness should be an outcome of CR (Balady, et al. 
2007; Corra, et al. 2010), and probably an explanation of the mechanism by which CR 
has a positive impact and influence on health status. The reduction of the risk factors 
for cardiovascular disease in patients, are also an explanation for the effectiveness of 
CR (Lee, et al. 1999; Taylor, et al. 2004, Taylor, et al. 2006).  
 
CR programmes are effective in increasing patients’ fitness levels, as discussed 
previously (Swain, 2005) and an estimate of effect size has been previously published 
(Conn, et al. 2009). A lack of detail in trials focusing on increased fitness due to CR, 
made it difficult until now to fully explore variables that potentially explain the large 
inter-individual and inter-study differences in changes in cardiorespiratory fitness. 
Conn et al.'s (2009) study design criteria (a controlled trial or quasi experimental study) 
was very restricted in studies included, showing a lack of depth of analysis. Due to the 
proven effectiveness of CR programmes, the authors noted that is not possible to 
randomly assign patients to a control condition (Dusseldorp, et al., 1999).      
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This chapter aimed to produce an estimate of the improvements in fitness that 
researchers and clinicians can expect to observe in patients that complete an 
exercise-based CR programme. It also aimed to identify the characteristics of CR 
programmes and patients that can influence the magnitude of fitness gains. To 
achieve these aims, it was necessary to specially modify the design of the analysis so 
it could be built on existing research and reviews in this field. The analysis was created 
using three criteria. 
 
First, fitness data was presented in metabolic equivalents (MET’s), as this measure is 
well-accepted and easily understood by researchers and clinicians. This metric is well 
used across all different exercise modalities and all groups of cardiac patients. 
Researchers and clinicians use it to describe cardiorespiratory capacity and work rate 
in everyday tasks such as risk stratification and exercise prescription (Balady, et al 
1996; Balady, et al. 2007; Ades, et al. 2006). 
 
Second, cohort-studies were included in the analysis which was not limited to 
randomised control trials. This option allowed for the analysis of more data from many 
more study groups (k=48) compred with previous meta-analyses (K=28) (Conn, et al. 
2009). A limitation of our study may be the design used resulting in an overestimation 
of the mean point of CR effectiveness. So to control the inflation factor in the final data 
result, we took the step and calculated a within-group correlation coefficient from our 
own empirical data and included this correlation in the analysis.      
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Third, in all our analyses we used random effects models and performed nine mixed-
effects subgroup analyses, in an attempt to define the source of the expected 
heterogeneity of improvements in fitness. When the data being analysed is supposed 
to be heterogeneous, as interventions by exercise have been in the past (Conn, et al. 
2009; Swain 2005), the use of random effect models is recommended (Berlin, 1995). 
 
Most meta-analyses have an expected product heterogeneity (Higgins, et al. 2002) 
and so, researchers, in their analysis, use a pre-planned subgroup analysis to define 
and understand the source of the data heterogeneity (Davey, et al. 1997). Conn et al. 
(2009) didn’t include a subgroup analysis, this was due to what they described as 
‘’scan data’’ in the research area. Their stringent study inclusion criteria could explain 
this lack of inclusion. A CR programme design should have all the elements for 
exercise dose prescription (frequency, exercise, intensity and modality), and patient 
characteristics (sex, age and condition), understanding which may influence fitness 
improvements may be very valuable. 
 
3.5.1. Discussion of results 
 
In our analysis of studies on CR programmes, we included 3827 patients and we 
created 48 subgroups from 31 published studies. Our results showed an increase in 
fitness of more than one and a half metabolic equivalents (1.55 CI 1.21-1.89 MET’s) 
due to CR programmes. This increase is impressive and clinically important, providing 
further evidence of the effectiveness of using CR as a therapeutic approach to achieve 
higher levels of fitness, lower mortality and morbidity, and also increase quality of life. 
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When the data was converted from MET’s to ܸ̇O2peak, it showed that patients taking 
part in a CR programme can expect increases in fitness of 5.4 (95%CI: 1.21-1.89) 
ml.kg-1min-1. This measure represents the body's ability to use oxygen, commonly 
known as functional capacity, aerobic capacity, cardiorespiratory fitness or simply 
fitness, these measures are predictive of mortality and morbidity in the general 
population (Sui, et al. 2007; Gulati, et al. 2003; Myers, et al. 2002) and also in cardiac 
patients (Myers, et al. 2002; Dorn, et al. 1999; Kavanagh, et al. 2003; Vanhees, et al. 
1995).  
 
These studies show us the cross-sectional associations between fitness and mortality, 
others studies have demonstrated the degree of impact that fitness gains have on 
mortality due to CR programmes. Kavanagh, et al. (2006) demonstrated that each 
increase of 1 ml·kg-1·min-1 in ܸ̇O2peak was related to a 10% reduction in cardiac 
mortality. Vanhess et al. (1995) demonstrated that each increase of 1% in ܸ̇O2peak was 
related to a 2% reduction in mortality. Myers et al., (2002) showed that a 1 MET 
increase in fitness was related to a 12% reduction in mortality, also Dorn, et al. (1999) 
showed that a 1 MET increase was related to a 10% reduction in mortality in male MI 
patients. In our present analysis the improvement in fitness shown (1.55 CI 1.21-1.89 
MET’s) could represent a reduction in mortality ranging from 16% (Myers, et al. 2002) 
to 54% (Kavanagh, et al. 2003). By estimating the average in the four studies 
mentioned (Myers et al., 2002; Dorn et al., 1999; Kavanagh, et al. 2003; Vanhess, et 
al. 1995) we witnessed an average lowering of mortality of 32%. This reality 
demonstrated that our study was similar in values to what was shown in previous meta-
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analyses on CR programmes' effect on patient mortality rates (O’Connor, et al. 1999; 
Oldridge, et al. 1998; Jolliffe, et al 2001; Taylor, et al. 2004; Conn, et al. 2009). 
 
Conn et al. (2009) meta-analysed various intervention effects of physical activity in 
cardiac patients, with an estimate effect size calculated for gains in fitness. It's 
important to highlight differences between this study and ours. Primarily Conn et al., 
(2009) studied physical activity. The comparable effect size for their primary outcome; 
gains in fitness due to physical activity was ES=0.49 (random effect models; pre- vs 
post-test values). When physical activity was converted to energy expenditure, the 
study found there was an increase of 1984 Kcal per week expenditure due to CR 
programmes. However, their effect size shown for fitness was not converted for any 
other metric.  
 
This meta-analysis (Conn et al, 2009), had very restrictive inclusion criteria for the 
studies used in their analyses. Only randomised control trials were included, which 
limited their analysis and may have biased their results away from more realistic CR 
studies as those conducted were part of service evaluations, audits or as staff-led 
research in existing CR programmes. In these studies, it wouldn’t be possible or ethical 
to withhold or delay CR to patients by recruiting them to be part of a control group. 
Conn et al, (2009) in their study showed a very restricted criterion concerning the 
studies included although the patient criteria was broad in terms of definition, with very 
diverse patients included those at risk of cardiovascular disease (CVD), intermittent 
claudication patients, angina patients, hypertensive patients and patients suffering 
from advanced heart failure phases. In the international studies used in the analysis 
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only few groups of cardiac patients were offered outpatient CR programmes unlike 
those included in our study (NZCC, 2002; BACR, 2007; Thomas et al., 2007; SIGN, 
2002; Balady et al., 2007; Corra et al., 2010; Corra et al., 2007). Our meta-analysis 
had a more broad criteria for study design, and patients included were only core CR 
patients including: MI-suffers, elective and emergency revascularization recipients and 
valvuloplasty patients. Our criterion of having fitness as our primary outcome and the 
inclusion of a subgroup analysis makes both meta-analyses very different from each 
other.       
 
There are two generalized models of CR programmes that have been investigated 
referenced in the literature, both including a component of exercise training. A 
comprehensive CR programme includes, in addition to the exercise element, a 
component of patient education or behaviour change (such as smoking), when 
compared with exercise-only CR programmes. This kind of CR approach seems to be 
less effective in lowering cardiac and all-cause of mortality (Joliffe, et al. 2001; 
Thompson, et al. 2003). 
 
The existence of different models of CR programmes (comprehensive or exercise 
only) is just one of many examples of differences seen in delivery of CR programmes 
that reflects the heterogeneity seen between CR programmes. Existing guidelines for 
CR programmes are available across much of the developed world such as the U.S. 
(Thomas, et al. 2007) and Europe (Piepoli, et al. 2010). However, some variation in 
written guidance, local understanding of such guidance and financial restrictions 
shows us that CR programmes could be more heterogeneous than first thought, when 
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compared for instance with pharmacological intervention. Understanding this reality of 
difference between CR programmes, we assumed and expected heterogeneity in our 
data (which was confirm Q=852, p< 0.001) this being the reason why a sub-group 
analysis was performed. 
 
3.5.2. Subgroup analyses: exploring the heterogeneity in response to CR 
 
The large variation in individual response to exercise training, when submitted to a 
standardized and controlled exercise training programme is well known. The main 
cause of this heterogeneity in results is the pre-training initial values of the individual 
that are taken in account, such as risk factors or ܸ̇O2peak.  Increases ranging from no 
gain to 100% in ܸ̇O2peak in large groups of sedentary subjects is reported. The more 
sedentary an individual is, the more impact and response they will have to the exercise 
programme, showing increased fitness levels (Bouchard and Rankinen 2001; Swain, 
2005). The prescription of exercise is also based on the variability of factors that define 
the dose of exercise applied to the individual (Intensity, Volume, Frequency and 
Modality used in sessions, as Length of exercise programme). This variability in 
exercise prescription and the effect that has on individuals response, is also a cause 
of heterogeneity in results. To our knowledge the causes of heterogeneity in results 
had never been investigated previously, only an estimate of CR impact on fitness had 
been completed until now (Conn, et al. 2009).  
Exercise programmes should aim to improve the ܸ̇O2peak of subjects as much as 
possible, as high levels of fitness are protective of mortality and morbidity in primary 
and secondary prevention. A 2005 study manipulated the intensity at different levels 
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and the duration (volume) of the activity was controlled to ensure the same energy 
expenditure was achieved. It was reported that high levels of intensity at vigorous 
intensity exercise, above 60%>ܸ̇O2peak when compared with moderate exercise 
intensity or lower intensities, were more effective in improving individual aerobic fitness 
(Swain, 2005).  
 
A minimal threshold of 45% of ܸ̇O2peak exercise training is defined as effective in 
improving fitness in subjects with very low fitness levels (Swain and Franklin 2002). In 
a more recent review (Swain and Franklin, 2006) it is suggested that vigorous exercise 
at intensity of 6> METS is more cardio-protective than lower intensities, resulting in a 
higher impact on diastolic blood pressure, glucose control, ܸ̇O2peak levels and lowering 
the risk of CHD events in the subject. The high intensity had no influence on systolic 
blood pressure and blood lipid profile or body fat loss. This cut point of vigorous 
exercise Intensity of 6 METs had been associated before with lower risk of all-cause 
mortality in the Harvard Alumni Health study (Sesso, et al. 2000) as vigorous exercise 
has been related with reduced risk of death by CVD (Yu, et al. 2003) and future risk of 
CHD events. Intensity influence is independent of the hours spent on activity 
(Tanasescu, et al. 2002).  
 
In exercise prescription of intensity, the exercise principle of overload (stress greater 
than normally encountered) applied as progression of intensity over time is 
fundamental for the patients to be able to achieve high levels of exercise work and 
intensity. Exercising at high intensities is important for subjects who are already 
relatively fit. Subjects with very low levels of fitness will need to progress from low, 
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moderate to high intensities over time. The minimum suggested achievement during 
the exercise programme, is an effort of 6 > METS (Swain and Franklin, 2006).  
 
Exercise performed at a higher intensity produced greater gains in ܸ̇O2peak, even when 
the volume is increased to match the energy cost performed at lower intensity exercise 
or is maintained at a constant. Intensity is more determinant than volume in exercise 
prescription for obtaining optimal gains in V’o2peak (Swain, 2005; Gormely, et al. 2008). 
In a review (Swain, 2005) studies using interval exercise training of 3-5 minute bouts 
at ܸ̇O2peak in exercise sessions, seemed to be more effective in improving ܸ̇O2peak than 
continuous exercise training. Interval training has also been shown to be effective in 
increasing fitness and cardiac function in lower functioning patients suffering from 
heart failure (Tomczak, et al. 2011).  
 
In cardiac patients in general, continuous exercise has proven to be effective in 
lowering all cause and cardiac causes death (O’Connor, et al. 1999; Oldridge, et al. 
1998; Jolliffe, et al. 2001), although high interval intensity training tends to be used 
more often in patients submitted to CR. A low risk cardiac group with high levels of 
fitness (>9 MET’s) were submitted to high intensity interval training (2min 40% ܸ̇O2peak, 
2 min 90% ܸ̇O2peak) in comparison with a continuous exercise (65% ܸ̇O2peak) training 
design.  Both types of exercise training had similar effects on ܸ̇O2peak gains, although 
interval training increased greater tolerance to anaerobic exercise or anaerobic 
tolerance. Strenuous activities are presented in everyday life, with the authors 
suggesting that this will have additional health benefits, without increasing the risk of 
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hazards occurring in exercise sessions, something well tolerated in CHD stable 
patients. Using high intensity interval training, it is suggested that in CR short exercise/ 
recovery is well tolerated, enabling increased exercise adherence by patients than 
exercise at moderate intensity in continuous mode. It’s suggested that passive 
recovery is preferred by the patients when exercising. The high interval intensity 
training (IIT) compared with continuous training produced a higher % of ܸ̇O2peak 
achieved and maintained during exercise and had beneficial effects in ventricular 
function and endothelial function and quality of life. Consequently, it is suggested by 
the authors that IIT has a greater benefit compared to the continuous normal mode 
used. It's suggested some caution is taken when utilising this type of exercise after an 
acute coronary syndrome, it is recommended to start with moderate intensity intervals 
and then progress in intensity (Warburton, et al. 2005; Guiraud, et al. 2009, 2011). In 
the analysis of the studies included in our study it was impossible to investigate the 
design of exercise aerobic intensity used, as this was not reported, therefore proving 
difficult to assess the impact of this variable in gains in fitness due to CR.  
 
The differences seen in intensity exercise prescription may influence to a large degree 
the heterogeneity seen in our analysis. This variance in intensity of training reported 
in various studies (%ܸ̇O2max, % ܸ̇O2peak, %HRmax, RPE scores or being ‘’symptom 
limited’’) was associated with a wide range and overlapping reported training intensity 
sometimes (50-85% ܸ̇O2peak), this turned subgroup analyses of this exercise variable 
impossible to determine the effect in changes fitness of subjects. 
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Intensity is known to be the principal determinant of the ability of exercise prescription 
to increase ܸ̇O2peak and improve health outcomes in healthy individuals (Swain and 
Franklin, 2006; Swain, 2005; Gormeley, 2008; Tanasesco, et al. 2002; Lee and 
Paffenbarger,  2000; Yu, 2003) and CHD patients (Swain and Franklin, 2002; 
Warburton et al., 2005; Tomczak, et al. 2011; Warburton, et al. 2005; Guiraud, et al. 
2009, 2011), although there are other variables capable of influencing fitness gains in 
patients due to CR. The next section in the chapter discusses all of our subgroup 
analyses systematically, based on our choice for subgroup selection, results 
explanation and potential explanations for the findings and limitations. 
 
3.5.2.1. Programme duration 
 
In the studies included in the analysis, the duration of programmes was from four 
weeks to twelve months. Exercise programme duration normally shows a positive 
relationship with increases in fitness, although in unfit individuals such as CHD 
patients, most of the gains in fitness are observed in the first 4 to 12 weeks of a training 
programme. (Miller, et al. 1984; Soleimani, et al. 2009; Wright, et al. 2002).  Twelve 
weeks, in our analysis, was both the median and modal value for the subgroup 
duration, making this the reference value for CR programme duration supported by 
guidelines in U.S. (Thomas, et al. 2007), U.K. (SIGN, 2002) or Europe (Piepoli, et al. 
2010). Most programmes included in the analysis were ≤12 weeks, studies including 
more than 12> weeks (including 11 studies) showed a slight, non significant increase 
in cardiorespiratory fitness. 
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The heterogeneity was significant within-groups, and seen in both subgroups. The 
results agree with studies that have compared different lengths, 8 weeks to 12 months 
durations in CR programmes, showing just a slight increase or no increase following 
initial gains. (Ades, et al. 1995; Seki, et al. 2003). In a study when the fitness response 
was observed in a programme of CR with a 26 week duration (6 months) with a number 
of 64 exercise sessions, the significant change in fitness was seen between 3 and 11 
weeks with 24 exercise sessions prescribed in training (Miller, et al. 1984).  
 
A study by Heritage, et al. (2010) was performed to understand the effect of three 
months of comprehensive CR programme duration in community using patients' views 
and opinions. This included if the length of programme was enough and if it had a 
positive impact on their lifestyles. The assessment was made using questionnaires at 
end of CR programme and at a follow up of 3 to 6 months after.  The results show that 
90% of individuals rated the programme good to excellent with the same scores seen 
at 3 and 6 moths follow up. The authors suggested 3 months of CR programme was 
the correct duration, being sufficiently long as it was highly rated by the participants 
(Heritage, et al. 2010).  In a study done by Reid, et al. (2005) the same number of 
sessions was maintained, and two different durations of CR programme were 
analysed. In a three months duration against 12 months, the analysis investigated the 
influence and impact of programme duration in physical capacity variables, risk 
factors, health-related quality of life, depressive symptoms, and cost of CR service to 
the cardiac health care system. There were no different outcomes at 12 or 24 months 
in the results and the cost of the two services was equal. The authors concluded that 
both types of duration had the same beneficial effects in CHD patients (Reid et al., 
2005). The suggested 3 month duration of CR programme seems to be practical and 
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effective but as a component of exercise prescription is a limiting variable to be 
analysed alone. The duration effect is influenced by the other components of exercise 
prescription that all define dose of exercise applied. For a better assessment of the 
effect of exercise dose on CHD patients’ fitness a subgroup was created for the total 
number of exercise sessions prescribed in CR programmes.   
 
3.5.2.2. Number of exercise sessions 
 
The CR programmes in our analysis showed a wide range of exercise sessions 
prescribed (from 4 to 144). The total number of exercise sessions represent a good 
analyse of the exercise dose used in each programme, and we hypothesised that more 
sessions would result in higher fitness gains. This variable had a common mode and 
median value (n=36) for the number of exercise sessions prescribed. This represents 
the reality of CR programmes which generally consist of 3 weekly sessions over 12 
weeks. In our analysis CR programmes of >36 sessions resulted in higher gains in 
patients’ fitness than when prescribed a lower number of sessions. No differences 
were found between groups of patients exercising for 36 sessions or <36 sessions, 
although this last group shows the lower change in fitness due to CR in the analyses. 
Our analysis suggests that 36 sessions is enough to increase fitness levels in a CR 
programme close to the overall mean difference, but additional benefit could be seen 
if more sessions were added to the CR programme. In our analysis there was only a 
small number of studies with more than 36 sessions (n=5), this was probably due to 
potential cost implications and the burden placed on the patient. It's important to 
understand the potential benefit of exercise prescription in CR of more than 36 
sessions in cardiac patients and their fitness levels.   
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The increased number of CR sessions in our analysis in general was associated with 
higher fitness gains in patients; this dose-response relationship is seen in several 
studies focusing on CR programmes. The fitness response to exercise is seen in a 
study in a programme of CR with a 26 week duration (6 months) with a total number 
of 64 exercise sessions. When patients have their fitness assessed at the end of the 
programme they have higher fitness levels compared with the first week and at the 
eleven week (24 exercise sessions prescribed for training) control test (Miller, et al. 
1984).  Another study investigated the impact of 5, 10 and 24 sessions of exercise 
prescription during 8 weeks of CR on the fitness of CHD patients. The study showed 
an improvement in exercise capacity correlated with the number of exercise sessions 
prescribed (Soleimani, et al. 2009).  In a study (Reid, et al. 2005) with a total of 33 
sessions and a duration of 3 months, there was a positive influence and impact on 
exercise variables, risk factors, health-related quality of life, depressive symptoms, 
and reasonable cost of CR service to cardiac health care system. This study supports 
the optimal number of CR sessions defined in our analysis. 
 
We know that shorter CR programmes can also be effective in increasing fitness levels 
(Wright, et al. 2002). This study focused on shorter CR in CABG patients of 6 weeks 
in length, 1 session a week, circuit based with a low intensity progressive design and 
randomized for either CR or exercise alone. There were no differences relating to 
exercise capacity between groups, both significantly increasing in fitness levels, 
although the CR group had more benefits in terms of cardiac and pulmonary function 
(Wright, et al. 2002).  There were limitations in our analysis, the group defined as <36 
sessions presented a large variance (4-28 sessions), making it impossible to identify 
100 
 
the minimum dose of exercise capable of stimulating change in fitness for those 
involved in CR programmes. This should be taken in account in future research as 
shorter programmes possess lower cost and may promote better adherence. 
 
3.5.2.3. Exercise modality 
 
The mode of exercise used in training sessions will influence physiological adaptations 
and physical capacity stimulated by exercise. In our analysis changes in 
cardiorespiratory capacity were analysed, representing changes in peak oxygen 
uptake. Aerobic endurance exercise is the modality of training specific to 
improvements in cardiorespiratory capacity.  Most studies in to the effects of exercise 
training on CHD patients, use the aerobic exercise (O’Connor, et al. 1999; Oldridge, 
et al. 1998; Jolliffe, et al. 2001; Taylor, et al. 2004; Conn, et al. 2009; Swain and 
Franklin, 2006; Swain, 2005; Miller, et al. 1984; Swain and Franklin, 2002; Gormeley, 
et al. 2008; Tanasesco, et al. 2002; Lee and Paffenbarger, 2000; Warburton, et al. 
2005; Guiraud; et al. 2009, 2010; Tomczak, et al. 2011; Carnethon, 2009; Soleimani, 
et al. 2009; Wright, et al. 2002; Reid, et al. 2005). It appears logical that this type of 
exercise training will be effective and produce large gains in fitness in patients due to 
CR programmes.  
 
The results of our study support the assumption made in favour of aerobic exercise in 
its effectiveness in improving fitness levels. The resistance exercise group, showed 
no significant changes in fitness improvement. This group had only a small number of 
studies (n=2), therefore, some caution should be taken before drawing conclusions 
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concerning the use of only resistance exercise training in CHD patients. Resistance 
exercise in combination with aerobic training has been used in different patients such 
as those with metabolic syndrome (Bateman, et al. 2011) or heart failure (Meyer, 2006; 
Maiorana, et al. 2000; Beckers, et al. 2008). The group of CR programmes that used 
aerobic endurance exercise in combination with resistance exercise (mixed group) had 
identical gains in fitness levels to the aerobic group. The results for gains in fitness 
produced by the combination of endurance and resistance exercise supports the idea 
that further improvements in fitness can be obtained by adding resistance exercise to 
prescribed aerobic exercise within the same exercise session.  
 
Baum, et al. (2009) investigated strength capacity in cardiac patients and showed a 
natural decline in strength levels with increased age. This decline was observed in 
superior members as inferior body musculature. When compared with healthy 
controls, cardiac patients’ leg strength was inferior, but no difference in arm strength 
existed. There was a qualitative difference between leg and arm strength in cardiac 
patients.  Patients with low levels of fitness were related to lower levels of strength too 
(Baum, et al. 2009). These findings were supported by another study where low fitness 
levels in CHD patients was associated with decreased strength capacity and 
fatigability in two major leg muscles (quadriceps and hamstrings) (Ghroubia, et al. 
2007). This decrease in leg strength in cardiac patients is not related to the disease 
and does not represent any pathological skeletal muscle metabolism. Instead, it is a 
consequence of inactivity and low issue of leg muscle strength. It’s suggested that 
resistance exercise is used in CR programmes to improve leg muscle strength as they 
are essential to cope with everyday activities and to perform vigorous aerobic exercise 
(Ghroubi et al., 2007; Baum, et al. 2009). Resistance training alone has demonstrated 
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its importance in cardiac patients. It has been shown to have a positive impact on 
some risk factors for CHD (Braith and Stewart 2006) and produces higher physical 
capacity levels, as it stimulates beyond other activities, such as aerobic endurance, 
balance, coordination and flexibility (Brochu, et al. 2002; Ades, et al. 2003; Ades, et 
al. 2005). The combination of aerobic endurance with resistance exercise has been 
supported in the guidelines for CHD patients (Thomas, et al. 2007; Piepoli, et al. 2010). 
 
Our results show the importance of the use of combined aerobic with resistance 
exercise training in CR programmes. There is some evidence to support our findings. 
A study with randomized CHD patients (16 men) performing aerobic exercise or 
aerobic exercise combined with resistance exercise, measured the impact of both 
training programmes in the leg muscular fatigue and fitness levels. The authors 
concluded that combined aerobic with resistance exercise training was superior to 
aerobic training. The combination was more effective in improving exercise tolerance, 
decreasing fatigue in leg muscles and also correcting some neuromuscular alterations 
(Gayda, et al. 2009). A similar study was replicated in 92 women with CHD doing both 
types of exercise programme for 6 months. It showed similar gains in fitness for both 
programmes, although there was a significant difference in physical quality of life 
assessed at one year follow-up in favour of the combined endurance-resistance 
exercise training programme (Heather, at al. 2007). Another study included 70 male 
CHD patients doing a CR programme based on combined aerobic-resistance exercise 
for 12 weeks, resulting in a positive impact in fitness levels. There was no improvement 
seen in the leg muscle volume of patients principally in patients with low baseline leg 
muscle volume, although strength capacity was improved (Kida, et al. 2006, 2008).  
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It can be concluded that a combination of both modalities (aerobic endurance exercise 
combined with resistance exercise) can improve fitness levels and reverse the lack of 
strength in leg musculature seen in cardiac patients. Using both modalities is more 
appealing and showed more diversity in the CR exercise programme, resulting maybe 
in a better adherence to programmes compared with single modality CR programmes. 
Few studies showed results of adherence, making it impossible to comment on that 
point. 
 
3.5.2.4. Comprehensive versus exercise-only CR programmes 
 
Meta-analyses have shown differences between these two main types of CR 
programmes in patient survival (Jolliffe, et al. 2001; Taylor, et al. 2004), or no 
differences at all (Heran, et al. 2011; Clark, et al. 2005}. Our choice of subgroup 
analysis was determined by this fact. Survival data in both programmes was analysed 
due to the strong documented relationship between gains in fitness and mortality.  
 
In our analysis we had as a hypothesis that exercise-only programmes would have a 
bigger effect on improvements in fitness. In our analysis no significant difference in 
between-group heterogeneity was found, although exercise-only programmes showed 
a trend towards larger gains than comprehensive-exercise programmes. Exercise only 
programmes were associated with lower mortality rates than comprehensive-exercise 
programmes. Exercise-only programmes have been found to reduce some 
behavioural risk factors like smoking; on which there is some rather counterintuitive 
evidence (Taylor, et al. 2004). A study showed that having a smoking habit assessed 
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during hospitalization and being referred to CR 6 months later, is a good predictor of 
smoking cessation (Dawood, 2008). Psychological interventions may be less effective 
when used in CR programmes (Rees, et al. 2004).  
 
The educational interventions in CHD patients showed no influence on all-cause 
mortality, cardiac morbidity, revascularization or hospitalization (Brown, et al. 2011; 
Whalley, et al. 2011; Rees, et al. 2004). Women were randomly assigned to a normal 
CR programme, exercising for three sessions/week for twelve weeks, combined with 
10 educational sessions. The other group undertook the normal CR programme with 
the addition of a specific programme tailored for women based on motivational 
interviewing, guided by the trans-theoretical model (TTM) of behaviour change. This 
last intervention had significantly improved global quality of life (QOL), improved health 
perception, vitality, social function when compared to the normal CR  control group, 
improving health behaviours may therefore increase adherence to exercise 
programmes (Beckie and Beckstead 2010, 2011; Rolfe, et al. 2010; Beckie, et al. 
2011; Grace, et al. 2010)     
 
Low fitness is an important risk factor for CHD and mortality. From the improvements 
in fitness and the relationship with lowering mortality in CHD patients and the result 
seen in our analysis of an obvious trend to higher fitness gains in exercise only-CR 
programmes, we recommend that the main aim of CR programmes should be focused 
on the delivery of the exercise sessions. Additional psychological or educational input 
into programmes had no or low benefit for patients. In our analyses the way the 
comprehensive-exercise CR was described in the literature was poor, limiting our 
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analysis. Studies presented few details of the interventions done, it was not explained 
if educational sessions were in addition to the exercise component of CR or whether 
they displaced exercise sessions. Very little was reported on the length of sessions 
provided and there was no data on the attendance of the patients to these sessions. 
 
3.5.2.5. Treadmill protocol 
 
The modality of testing can affect the result of any fitness test, something that is well 
documented. This was the reason why our choice was limited to incremental treadmill 
test protocols. In our study analysis the reported protocols used to assess CHD 
patients fitness were varied. In most of the studies the authors gave enough 
information and description to replicate the protocol used, six studies reported that in 
their assessment an ‘incremental test’ was used. These studies formed a subgroup 
(not specified protocol) as they were a rather homogeneous subgroup of studies where 
the authors conceived and used their protocols (own protocol).  
 
In our analysis the changes seen in patient fitness from studies where the treadmill 
protocol used was not described, the change in fitness measured was far lower than 
the overall mean (ES=0.48; 95% CI 0.22-0.74 METs). This made it difficult to comment 
on this due to the lack of information revealed by the studies.  
 
The estimates made in other subgroups such as ‘’Balke’’ and Bruce’’ were similar, 
except for the studies using ‘’Naughton protocol’’ this subgroup presented the highest 
effect size change over the all the others subgroups and the overall mean difference 
106 
 
(ES=2.4, 95% CI 1.08-3.74 MET’s). It is recommended that caution is taken when 
gains in fitness are being compared and the studies use different protocols. Studies in 
the analysis that used Naughton protocol were normal in terms of duration, modality 
or patients factors which may have influenced increases in fitness, except including a 
large group of patients had larger increases (Arya, et al. 2005).  
 
In relation to these studies we can only speculate as to why the increase in fitness 
levels were so high, but one explanation for this could be that the Naughton protocols 
is designed with short stages and soft transitions between workloads, making it highly 
suitable for cardiac patients in comparison to Bruce, that is by far the most commonly-
reported protocol. In the studies using their own protocol (producing the second 
highest subgroup mean estimate) typically the design of the protocols had soft 
transitions and short stages, as seen in the Naughton protocol. These findings need 
further investigation to understand and define which protocol has the highest 
applicability, validity when assessing fitness levels in CHD patients involved in CR 
programmes.                
 
3.5.2.6. Study design: cohort versus Trial 
 
The study design cohort versus trial subgroup analysis was done with the intention of 
determining if trials of CR, being designed and implemented mainly by researchers, 
were able to produce different changes in fitness in comparison with other forms. Our 
analysis had the intention of discovering whether we were justified in combining data 
from a wide variety of study designs. It was hypothesised that trials might produce 
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highest gains in fitness levels (pre- versus post-test) due to the influence of higher 
patient adherence to the study, the expertise of the researchers, selective nature of 
study participants, possibly having higher motivation to CR programmes due to their 
knowledge of being involved in a trial study. 
 
No differences were found between the subgroup of two study designs. Effect sizes 
were almost identical and logically also very close to the overall mean value. These 
findings are similar to those of Conn, et al. (2009) who found that study funding status 
had no influence on changes in patients’ physical activity levels. In our analysis we 
were confident of not introducing any bias into our results by using both study designs. 
A limitation of the analysis was the subjective nature of subgroup allocation. A number 
of cohorts were identified (with no control group) that had been supported with funding 
and other studies were not easy to classify due to the poor nature of study description 
of purpose and recruitment of patients.  
 
3.5.2.7. Summary: programme-level moderators 
 
Is it suggested that some heterogeneity in fitness gains seen can be justified by the 
choice of different treadmill protocols between studies. There was a moderate 
modifying effect of exercise modality, where programmes of mixed-modality appear to 
be more effective, and a total exercise dose define of 36 sessions as being optimal. 
Programme length, being exercise-only base CR or comprehensive-CR, and if the 
programme was part of a trial or cohort design of research, had no significant effect in 
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fitness gains. However there are also differences at the level of the patient which may 
moderate changes in fitness observed. 
 
3.5.3. Patient-level subgroups analysis 
 
3.5.3.1. Sex 
 
Epidemiological and clinical studies show that genders have differences in terms of 
CVD clinical profiles such as prevalence, presentation (symptoms and age of onset), 
and disease outcomes and disease management, although little information is 
available to explain how this happens, and why CVD affects different genders.  CVD 
is prevalent in both genders and is the leading cause of death worldwide in both 
genders. Women possess a lower CVD mortality rate than men, although CVD is the 
biggest killer of adult women in most developed countries, with increased risk 
particularly in the over 50s age group. In last decade the CHD mortality in men has 
been declining in contrast with women's CHD mortality rate which has been stable. 
(Mikhail, et al. 2005; Pilote, et al. 2007). 
 
Risk factors in women increases their risk of CVD events compared with men. CVD 
mortality rates are higher than men in women suffering from diabetes and 
hypertension. After an acute CVD event women with atrial fibrillation have greater risk 
of stroke than men with the same conditions (Pilote, et al. 2007).They are less likely 
to achieve optimal targets for blood pressure, glucose levels, and lipid values, and less 
likely to achieve good CVD management (Reibis, et al. 2009).  Woman possess more 
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co-morbidity factors such as diabetes mellitus, hypertension, hypercholesterolaemia, 
peripheral vascular disease, and heart failure (Mikhail, et al. 2005), and suffer more 
from depression which presents an additional independent risk for CVD (Möller-
Leimkühler, 2007).  
 
Woman also suffer more severe outcomes than men, and a higher mortality rate is 
seen in young women one year after an acute coronary event, which can be explained 
by the increased risk of death during the first days of hospitalization (Simon, et al. 
2006). The mortality in woman undergoing revascularization is also higher than men 
with worse outcomes and more risks (Mikail, et al. 2005; Vaccarino and Koch, 2003). 
Beyond these unexplained sex related factors, differences in CVD outcomes in women 
remains largely unknown. There are other factors towards CVD behaviour between 
men and women that may help to explain and influence these differences in genders, 
such as cultural, psychosocial and socio-economic status (Pilote, et al. 2007).  
 
Genders may also respond and benefit in different ways from CR programmes. 
Women's referral to CR is lower compared to men, despite being the same age and 
being submitted to the same clinical procedures. Women are less likely to be 
instructed on secondary prevention strategies and referred to CR by their clinicians or 
health carers. In CR women tend to be older with a greater cardiovascular burden, 
enrolling in CR at later stages of severity of their CHD disease, normally after valvular 
surgery or heart failure. Their rehabilitation process is also longer and more 
complicated (De Feo, et al. 2011; Caulin-Glaser, et al. 2001). Men tend to have better 
CR programme adherence, whilst women also participate less after being referred or 
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dropping out (Tardivel, 1998; Ginzel, 1996; Yohannes, et al. 2007; Jackson, et al. 
2005). Women have several barriers to CR, such as: less social support, 
transportation, family responsibilities, lack of CR awareness, seeing exercise as tiring 
and painful, and due to their co-morbidities. Psychosocial factors such as depression 
inhibition and anxiety are more prevalent in women as a barrier (Grace, et al. 2009; 
Cooper, et al. 2002; Barth, et al. 2009; Dunlay, et al. 2009). Some recent studies report 
that gender tailored CR programmes may improve attendance and adherence, such 
as the use of motivational interviews in combination with exercise CR programmes in 
women (Beckie, et al. 2009; Beckie and Beckstead 2009, 2010; Grace, et al. 2010).    
 
There is a well-documented gender-bias in CR in favour of men, who are refereed to 
CR more than women, and there is and under representation of women in the research 
done in CVD (De Feo, et al. 2011; Caulin-Glaser, et al. 2001; Schuster and Waldron 
1991). This bias towards men was confirmed in our study analysis. This bias maybe 
be explained historically due to CVD being more predominant in men, besides being 
the biggest killer in both genders. We had just three female-only groups versus 19 
male-only groups. This small number of groups makes the analysis of the results more 
difficult and significant between-group heterogeneity was seen.  
 
Higher gains in fitness were achieved by males compared with females although the 
difference in gains in fitness between men-only groups compared with mix-groups was 
even higher. These results were surprising as the mixed-groups were composed 
mainly by males. The analysis of group gender composition from previous reports 
found that in CR programmes 25% of the participants were women (Conn, et al. 2010; 
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Mikail et al., 2005). This tendency of higher gains in only one gender exercise group 
may cause difficulties in implementing CR exercise sessions composed of mixed-
groups. Given the group-exercise nature of most CR exercise programmes the male 
behaviour toward mix-groups, show that men were not exercising at the same intensity 
and working less when exercising together with women. It’s been hypothesised that 
men became overwhelmed in the presence of women, tending to feel shy and less 
confident to fully engage in CR exercise programmes (Yohannes, et al. 2007).  
 
We hypothesised that male-only groups would provide a more competitive, ambient 
exercise session in which men engaged strongly with CR exercise sessions, working 
harder. A limitation in our analysis was that, whilst of interest, it had little clinical 
significance except to suggest that if possible, patients may benefit more by exercising 
in same sex CR exercise sessions. If this is of practical application in everyday clinical 
work, due to financial, special or temporal limitations are apparent. 
 
3.5.3.2. Patient age 
 
Like sex, patient age is a non-modifiable risk factor.  Age has an impact on cardiac 
function and structure; the heart becomes more hypertrophic and hyporesponsive to 
sympathetic (but not parasympathetic) stimuli. Exercise induced cardiac 
responsiveness is also blunted in older patients.  Age is associated with a decline in 
peak aerobic capacity (ܸ̇O2peak, heart rate, ejection fraction and cardiac output 
responses to supine exercise in healthy men). These changes in cardiac function can 
be improved by long term exercise training adaptations and the effect they have on 
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cardiac function. Lack of physical activity is a greater risk factor in older patients for 
chronic disease and disability, with exercise having potentially important implications 
on increasing health benefits in this population (Stratton, et al. 1994; Ferrari, et al. 
2003; Fleg, et al. 2005; Heckman and McKelvie, 2008).  
In patients older than 65 when submitted to CR programmes its shown that physical 
capacity, quality of life and body strength are increased, regardless of the presence 
co-morbidities. Older patients in response to aerobic exercise, have greater 
improvements in sub-maximal endurance capacity in comparison with more modest 
gains in ܸ̇O2peak. It’s known that older patients have lower adherence, and are less 
likely to be referred by physicians to CR exercise programmes (Ades, et al. 1993; 
Audelin, et al. 2008; Ståhle, et al. 1999; Simpson, et al. 2005, Lavie and Milani, 2004; 
Marchionni, et al. 2003; Williams, et al. 1985; Listerman, et al. 2011) 
 
The present results show significantly greater fitness gains in younger patients 
compared with older or the oldest group of patients. These results are in agreement 
with the available literature (Williams, et al. 1985; Ades and Grunvald, 1990). The 
different significant results between age subgroups may be explained by a reduction 
in physiological adaptability in the oldest patients, in which the fitness gains were less 
than half those of younger patients. This may serve as a recommendation for 
practitioners in setting goals for patients, with lower expected gains in fitness in older 
patients, when fitness is shown in absolute terms, as in our analysis. If the gains in 
fitness levels were shown in relative percentage gains, the changes observed in older 
patients may be equal or even higher that of younger patients due to lower baseline 
fitness values. 
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3.5.3.3. Baseline fitness values 
 
Individuals showed a different pattern of change in fitness which is related to their 
initial fitness values. Individuals with low initial values had greater increases in fitness, 
due to exercise training programmes; this is referred to in literature as the law of initial 
values.  Statistically, this phenomena represents regression to the population mean 
and is well document in the exercise physiology literature (Bouchard and Rankinen, 
2001) and has been seen in patients attending CR programmes (Sakuragi, et al. 
2003). In this analysis patients were divided in two groups according to their baseline 
fitness values to test the hypothesis that those with lower baseline fitness would enjoy 
bigger gains in fitness. The results did not support this hypothesis however, as there 
was almost no between-group difference in fitness gains. The similarities seen, may 
be due to the fact that effective exercise prescription in CR programmes at individual 
level was reported in most studies. Exercising at individual level capacity, patients 
were able to exercise at similar relative exercise intensities thereby achieving similar 
improvements in fitness levels. While this result is encouraging, the subgroup analysis 
itself is limited as this one is focused on the arbitrary number of 6.6 MET’s, determined 
simply by median split, which limited our findings to patients with more varied baseline 
fitness values 
 
3.5.3.4. Primary diagnosis 
 
The analysis was completed and showed a trend towards greater improvements in 
fitness in the post-MI patient subgroup in comparison with those being rehabilitated 
for revascularisation or other reasons. The between-group heterogeneity was not 
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significant. The small number of studies in each specific subgroup made the 
interpretation difficult. This is a limitation of the analysis and is mostly due to the 
subgroup mixed-patient nature of studies that simply reflects the wide range of 
different patients referred and able to take part in CR programmes. 
 
3.5.3.5. Summary: patient-level moderators 
 
In summary of the results found, despite a big degree of heterogeneity between 
studies, increases in fitness levels were only significantly moderated differently by 
patients’ sex (being male) and age (being younger).  We recommend to practitioners 
to take note of these non-modifiable factors when implementing and designing CR 
programmes as it is suggested that younger male patients may particularly benefit 
from exercising in groups separated according to sex, enabling patients who can, to 
exercise in a more vigorous manner to promote optimal fitness levels.  
 
3.6. Conclusions and limitations 
 
Previous meta-analyses have confirmed the CR efficacy, used as a treatment to 
reduce patient mortality and morbidity. CR programmes possess this influence in 
mortality and morbidity due to modification, reduction of CHD risk factors and by the 
influence in improvement of cardiorespiratory fitness levels. High levels of 
cardiorespiratory fitness due to exercise training in CR programmes are associated 
with lower risk of cardiovascular mortality and morbidity.  A previous meta-analysis 
(Conn, et al. 2009), including a wide range of interventions aimed at improving physical 
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capacity in CHD patients, showed that programme variables such as more contact 
time with practitioners, more time exposed to exercise sessions and fitness testing 
were associated with higher levels of physical activity. Cardiorespiratory fitness is a 
more powerful predictor of health than physical activity, but Conn, et al.'s (2009), meta-
analysis did not investigate factors that were related to fitness increases as they did 
for physical activity. Despite the inherent aim of CR to improve cardiorespiratory 
fitness and the direct relationship that cardiorespiratory fitness has with different 
outcomes (Lee et al., 1999; Myers et al., 2002; Dorn, et al. 1999; Vanhees, et al. 1995) 
no study has systematically analysed the factors that may modulate cardiorespiratory 
fitness improvements. 
 
This is the first detailed evaluation of changes in cardiorespiratory fitness in patients 
undertaking exercise-based CR programmes and suggests patients may expect a 1.5 
MET improvement in cardiorespiratory fitness. The increase seen in our analysis can 
represent a 16-54% reduction in cardiac mortality, depending on the estimation 
techniques used (Myers, et al. 2002; Kavanagh, et al. 2003). The studies included in 
our meta-analysis which were used to provide the mean estimate were, however, 
highly heterogeneous. It was observed in our analysis that CR programmes had 
variables able to promote optimal stimulus and higher changes in cardiorespiratory 
fitness, such as including >36 sessions in the CR programme of aerobic or mixed 
aerobic and resistance exercise with a programme length of 12 weeks period. No 
evidence was found suggesting that longer CR programmes had additional benefits to 
patients, and no evidence for combining exercise training with patient education 
(comprehensive CR) and improvements in cardiorespiratory fitness levels. Our results 
seen from a more scientific perspective, showed that a treadmill protocol used to 
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assess cardiorespiratory fitness in patients had a major impact on the estimation of 
fitness improvement and, it is suggested that should be employed when comparing 
studies which have used different testing protocols.  
 
Young patients and those who are male had bigger increases in fitness, and may 
benefit more from CR than older, female patients, who had lower changes in fitness. 
It is recommended that there is provision of exercise sessions for same sex groups 
and that patients should be allocated according to their age. This would help patients 
achieve optimal increases in cardiorespiratory capacity.    
 
Our study found strong evidence of systematic publication bias, whereby significant 
findings from bigger studies were substantially more likely to have been published. 
The conclusions drawn from this meta-analysis are limited due to the inclusion of non-
randomized and cohort-based study designs, although the inclusion of these studies 
allowed us to perform subgroup analyses which identified some moderators of the 
response of cardiorespiratory fitness to exercise-based CR. 
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Chapter 4. Centile Curves and Normative Values for the Incremental Shuttle 
Walk Test at Entry to Outpatient Cardiac Rehabilitation. 
 
Abstract 
 
Objective: The Incremental Shuttle-Walk Test (ISWT) is used in Cardiac 
Rehabilitation (CR) to predict cardiorespiratory fitness. However, ܸ̇O2peak accounts for 
only 63% of the variance in test performance; and non-clinical variables (Height, BMI) 
may account for ~20% of variance in performance. The aim of this study was to identify 
additional predictors of ISWT performance, and produce centile curves and normative 
data of performance in ISWT in cardiac patients, as a cross-validation of the predictive 
power of the regression equation in the healthy population, to predict actual cardiac 
patients’ performance in ISWT. 
  
Methodology and results: 548 patients with clinically stable cardiovascular disease 
from four outpatient CR programmes completed the ISWT at entry to rehabilitation. 
We collected anthropometric and demographic data to identify predictors of test 
performance. Primary predictive variables were then used to produce normative 
values and centile curves of test performance.  
 
Age and sex were the strongest predictors of performance. Men walked 113 m (β= 
112.58 m; 95%CI 85.64 to 139.51) more than women. There was an age-related 
decline of 6.4 m (β=-6.36 m; 95%CI -7.78 to -4.95) and 5 m (β= -4.9; 95%CI -6.5 to -
3.3) per year in males and females respectively. Male performance (m) was also 
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influenced by height, BMI, presence of diabetes ~25% (R2=.25), diabetes and height 
also predicted ~28% (R2=.28) of female performance. Construction of centile curves 
confirmed a broadly linear reduction in expected ISWT values in males (25-85 years) 
but a more curvilinear trend in females.  All prediction models correlated positively with 
actual cardiac patient data from the ISWT, although correlations were very low in 
strength (r<4). 
 
Conclusions: These age and sex-stratified normative values may help practitioners 
to more accurately interpret individual performance at entry to CR. Improving exercise 
prescription and assessing change in cardiorespiratory capacity as patients fast track 
to community based CR.  Regression equations based on a healthy population have 
little or no clinical utility in cardiac patients. 
 
Key words:  Cardiorespiratory fitness; Incremental shuttle walk test; Predictors; 
Cardiac patients, Centiles curves, Normative data. 
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4.1. Introduction 
  
Functional capacity is an important outcome measure in primary and secondary 
prevention of coronary heart disease (CHD); it provides prognosis for future CHD 
events and mortality (Piepoli, et al. (2010). The Incremental Shuttle Walk Test (ISWT) 
may be used to predict cardiorespiratory capacity (Fowler and Singh, 2005), although 
the accuracy of any estimation of cardiorespiratory capacity is of some doubt (Woolf-
May and Ferrett, 2008; Almodhy, et al. 2014). The test may also aid exercise 
prescription (Fowler, 2000; Woolf-May and Ferrett, 2008), and can be used to track 
changes in cardiorespiratory capacity and assess programme efficacy (Woolf-May 
and Ferrett 2008; Almodhy, et al. 2012; Sandercock,et al. 2012). The test is 
recommended for use in CR programmes in UK, by the department of health (SIGN 
2002; BACPR 2012)  
 
The ISWT is measured in meters, this absolute outcome value is used in clinical 
practice to classify cardiac patient performance (exercise capacity) at entry into CR 
programmes. ISWT performance is not dependent solely on the patient’s 
cardiorespiratory capacity. Fowler and Singh (2005) found that 63% of the variance in 
ISWT performance in cardiac patients was explained by cardiorespiratory capacity, 
but this univariate regression did not facilitate the assessment of alternative 
performance predictors identified elsewhere in cardiac patients such as height and 
BMI (Pepera, et al. 2013).  
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Much of the variance in ISWT test performance may be due to non-modifiable factors 
such as a patient's sex and age (demographic characteristics) or anthropometric 
characteristics (such as height, weight, BMI), indicated by multivariate analysis of test 
performance in pulmonary-disease patients (Luxton, et al. 2008) and healthy 
individuals (Dourado, et al. 2011; Jurgensen, et al. 2011; Probst, et al. 2012; Dourado, 
et al. 2013; Harrison, et al. 2013).  
 
Age, sex and weight, as predictors of ISWT were never identified in ISWT performance 
in cardiac patients. Understanding the variables that modify performance in patients 
(such as demographic and anthropometric), allows a more accurate interpretation of 
the absolute performance in the ISWT in cardiac patients according to their different 
individual characteristics. This can then improve clinical practice and decisions, e.g. 
physiological tests mediated significantly by age and sex, normative reference data 
may improve test interpretation (Cole, et al. 1995; WHO, 2006; Sandercock, et. al. 
2012). In our study we attempted to quantify cardiac patients' ISWT absolute 
performance against centile curves and additionally we compare performance in 
meters in ISWT against the best predictors of ISWT. 
 
Recent studies in the healthy population purport to provide normative ISWT data in 
healthy individuals. These authors also explored the applicability of such normative 
ISWT data in clinical populations (Dourado, et al. 2011, 2013; Jurgensen, et al. 2011; 
Probst, et al. 2011; Harrison, et al. 2013). These studies actually provided equations 
which can predict ISWT performance in healthy individuals. Such predictions 
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developed in healthy cohorts are useful, as they work as a standard reference against 
which performance of patients can be compared. 
 
Such equations may be used to interpret CR patients' ISWT performance by 
estimating values as if the patient were healthy, and expressing actual performance 
as a percentage, as practised in the 6 min walk test (Enright and Sherrill 1998). These 
reference equations in healthy individuals (Dourado, et al. 2011, 2013; Jurgensen, et 
al. 2011; Probst, et al. 2011; Harrison, et al. 2013) (Table 4.1) were never applied to 
clinical populations, such studies should ideally have validated their models by 
comparing predicted values with actual test performance in a clinical population. 
Unfortunately, no studies to date have attempted to do this. 
 
In our study we intended to test the clinical utility of such equations. Any such equation 
must however be of clinical utility, and be practical to apply to cardiac patients in order 
to meet certain criteria for standard procedure of cross-validation:  
 
- We expected differences as they were different populations, healthy individuals 
walk much further than cardiac patients, e.g. the healthy population walks on 
average 500 to 850 m in the ISWT (Jurgensen, et al. 2011; Probst, et al. 2011) 
compared to 350 m walked by cardiac patients (Pepera, et al. 2013);   
 
- The equation should account for a credible amount of variance in the outcome 
measure of interest. However, as most of the variability in ISWT performance 
134 
 
is dependent from cardiorespiratory fitness, we expected a low (<40%) 
proportion of variance to be accounted for;  
 
- Any predictor variables used in these equations should be simple, objective 
measurements; 
 
- There should be some similarities in the variables used in the prediction 
equation and those known to predict performance in the clinical population in 
which the equation will be used (in this case cardiac patients) 
 
- When applied to a clinical population, the predicted values should correlate well 
with actual patient values (r>.5) – this process is called cross-validation.  
 
The present chapter was not intended to predicted ISWT performance by developing 
yet another regression equation. Instead the primary aim was to quantify absolute 
ISWT performance in cardiac patients, and develop centile curves based on the 
strongest predictors of ISWT performance, and test the predictive power of regression 
equation in the healthy population to predict our actual cardiac patient data.
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Table 4.1. Reference equation to predict performance in meters in Healthy 
Studies Reference equations for ISWT S.E.E. R2 
Jurgensen, et al. 
2011 
    = 374.004 - (6.782 x Age) – (2.328 x Weight) + (3.865 x Height) + (115.937 x Gender) 114.7 m 50.3% 
Probst, et al. 2011     = 1449.701 – (11.755 x Age) + (241.897 x Gender) – (5.686 x BMI) 167.8 m 71.0% 
Dourado, et al. 2011 1. = 34.608 – (4.384 x Age) – (2.949 x Weight) + (553.336 x Height) + (114.387 x Gender) 
2.= −243.867 − (2.833 x Age) − (3.259 x Weight) + (575.101 x Height) + (6.321 x Grip Strength)  
79.4 m 
74.6 m 
64.9% 
69.0% 
Dourado, et al. 2013 1.= 347.7 - (7.2 x Age) – (3.0 x Weight) + (472.3 x Height) + (137.2 x Gender) 
2.= 223.7 – (5.8 x Age) – (3.2 x Weight) + (421.3 x Height) + (62.1 x Gender) + (4.8 x Grip Strength) 
3.= -54.6 – (5.8 x Age) + (-4.3 x Weight) + (666 x Height) + (75.3 x Gender) + (2.1 x Lean Body Mass) + (0.64 
x Total Body Fat) 
- 
- 
- 
 
65.0% 
73.0% 
68% 
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Harrison, et al. 2013 = ISWT distance predicted = 603.35 + (61.87 × Forced expiratory volume in 1 second (FEV1) + (6.96 × 
Quadriceps maximal voluntary contraction) + (9.18 × Duke Activity Status Index) − (13.14 × BMI) − (4.01 × 
age) 
220 m 50.4% 
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4.2. Aims and hypothesis 
 
The primary aim of this chapter was to identify non-modifiable predictors of ISWT 
performance at entry to outpatient CR (pre-CR) and to produce reference values and 
centile curves based on actual performance. A secondary aim was to test the utility of 
published regression equations developed in healthy populations by cross-validating 
predicted values with actual ISWT performance in CR patients. 
 
4.3. Methods  
 
4.3.1. Participants 
 
We accessed clinical records of n=547 (415 males) (76% male) patients (63.1 ± 11.3 
years) who completed outpatient CR at four UK hospitals: (Greater London, Essex, 
Cumbria and Middlesex) and extracted clinical data and details of 10m ISWT 
performance at entry to rehabilitation. Table 4.2 gives the clinical characteristics and 
baseline measurements, diagnosis and reasons for attending CR.  
 
 
 
 
 
 
138 
 
Table 4.2. Descriptive Characteristics of Cohorts  
 
4.3.2. Procedures and Data Collection 
  
Data was collected at four hospitals that reported delivering comprehensive CR and 
routinely using the ISWT in accordance with the national guidance. The ethical 
approval for this study was obtained by Integrated Research Application Service (REC 
reference: 09/H0305/102) and approval to assess patient records by the National 
Information Governance Bureau (Request: ECC 1-04(e)/2010).  
 
Clinical Characteristics and Baseline Measurements                            Mean (SD) 
Number of patients                                                                                            547 
Age (years)                                                                                                    63.1 (± 11.3)  
Gender                                                                                                        M: 415 ; F:132 
Height (cm)                                                                                                   170.6  (± 8.7) 
Weight (Kg)                                                                                                    81.5 (± 17.3) 
Body mass Index (kg/m2)                                                                                27.8 (± 5.2) 
Diabetes                                                                                                            153 (28%)                   
Smoking                                                                                                         140 (25.6%) 
Primary Diagnosis 
MI                                                                                                                   375 (68.6%) 
CHD                                                                                                               119 (21.8%) 
Other                                                                                                                 53 (9.6%) 
Primary Treatment 
CABG                                                                                                             263 (48.1%) 
PCI                                                                                                                 230 (42.1%) 
Valvuloplasty                                                                                                      36 (6.6%) 
None                                                                                                                18 (3.3%) 
CHD, coronary heart disease; MI, myocardial infarction; Others: valve, cardiac arrest, 
arrhythmia, ACS and even others; CABG: coronary artery bypass surgery; PCI: 
percutaneous coronary intervention.  
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4.3.3. Statistical Analysis 
  
We used a univariate linear regression to identify predictors of ISWT performance in 
the population as a whole, and used an independent t-test to describe the difference 
in male and female test performance. After differences were affirmed, we performed 
stepwise multiple regressions to determine significant predictors of ISWT performance 
in males and females. We assessed predictors for co linearity; defined as variance 
inflation factor >4.0 (Rogerson, 2001). Statistical significance was set at p<0.05 and 
all analyses were performed using SPSS 19.0 (SPSS, an IBM Company, Armon, NY). 
 
We constructed centile curves for distance walked during the ISWT for males and 
females using the Generalized Additive Models for Location, Scale and Shape 
(GAMLSS) (Rigby and Stasinopoulos, 2006). GAMLSS models are part as a package 
included in the statistical software R (R Development Core Team 2011) and this 
statistic have been used by the World Health Organisation Multicentre Growth 
Reference Study Group (WHO, 2006). 
 
We tested the power of the regression equations developed for healthy individuals, 
and one equation for cardiac patients (table1) to generate predicted values of 
performance in our cohort. We use a paired t-test to examine mean differences, and 
the Pearson Product Moment Correlation to examine the relationship between 
predicted and actual values of ISWT performance in cardiac patients. 
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4.4. Results 
 
Overall ISWT performance ranged from 75 to 1145 m, (mean: 365 ± 164 m). Age was 
the strongest predictor (β=-5.95, 95%CI: -7.1 to -4.8) followed by sex (β=-112.6 m 
(95%CI -139.51 to -85.64)]. Independent t-tests verified that males (395±165 m) 
walked significantly further (t=8.081, p<0.0001) than females (269 ±118 m), so we 
performed all further analyses separately by sex.  
 
Preliminary analysis of the whole data set confirmed sex was retained as a significant 
predictor of ISWT performance in all initial multivariate models. We therefore, analysed 
males and females separately. Results of multivariate regression models created for 
males and females are given in table 4.3. In these sex-specific regressions, age 
remained the best predictor of ISWT performance, explaining 16% and 17% in men 
and women respectively. Additional predictors were height, BMI and (Presence=1 or 
Absence=0 of) diabetes. None of these variables explained >5% additional variance 
in males but diabetes did explain an additional 7.9% variance in female performance. 
Overall variance explained in each model was 25% for men, and 28% in women; the 
majority of which was accounted for by patients’ age.  
 
 
 
 
141 
 
Table 4.3. Predictors of ISWT in Males and Females 
Predictors in males β  R2     S.E.E (m) 
Age (years) β= -5.9 m (95%CI -7.1 to -4.6)  .156 152 
Height (cm) β=  5.0 m  (95%CI 3.1 to  6.8)  .208 148 
BMI (kg/m2) β= -5.1 m (95%CI -7.9 to -2.2)  .235 145 
Diabetes 
(Yes=1/No=0) 
β= -48.7 m (95%CI -17.3 to -
80.2) 
.252 144 
Model prediction R2=  .25  
Predictors in females         Β R2   S.E.E (m) 
Age (years) β= -4.8 m (95%CI -6.3 to -3.3) .174 108 
Diabetes 
(Yes=1/No=0) 
β= -80 m (95%CI -39.5 to -
120.5) 
.253 103 
Height (cm) β=  2.8 m  (95%CI 0.11 to 5.5) .277 102 
Model prediction R2=  .28  
 
4.4.1. Normative Data and Centile Curves 
 
Tables 4.4 and 4.5 give the normative values for ISWT performance at the 3rd, 10th, 
25th, 50th, 75th, 90th and 97th centiles in male and female CR patients. Figures 4.1 and 
4.2 provide smoothed centile curves of the same data. There was a negative 
relationship between age and ISWT performance at all centile values in both sexes. 
The median expected value for the youngest patients was more than double that of 
the oldest in males and females. Male ISWT values were higher than female values 
across the age range (25-85 years). There was still, however, a two-fold difference in 
expected values between the 3rd and the 97th percentile in both sexes and at all ages. 
Distances walked (3rd – 97th percentile) varied on average by 628 (868 to 371) m in 
males and ~454 (634 to 300) m in females. The overall variance tended to decrease 
with age in both sexes.  
 
142 
 
In males, the relationship was broadly linear across the age range (25-85 years) for 
which centiles were constructed. The median ISWT performance of females was more 
curvilinear with a steeper decrease in younger women (25-60 years) followed by a 
gentler, more linear decrease from 60 years of age onwards. 
 
Table 4.4. Centile Values for Total Shuttles Walked by Males Aged 25–85 Years 
Age C3 C10 C25 C50 C75 C90 C97 Mean SD 
25 277 413 413 609 699 860 1145 635 237 
30 256 381 492 579 676 833 1092 603 221 
35 236 351 458 549 651 803 1036 571 208 
40 217 322 424 519 625 771 978 539 196 
45 199 295 392 489 597 735 918 507 186 
50 182 269 361 459 569 698 858 475 176 
55 166 245 331 429 539 658 798 444 166 
60 150 221 302 399 507 618 739 412 156 
65 135 199 274 369 475 575 680 380 146 
70 120 178 247 339 441 532 621 349 136 
75 106 157 221 309 406 488 564 317 126 
80 93 137 196 279 370 443 507 286 116 
85 79 118 171 250 333 397 450 254 105 
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Figure 4.1. Centile Curves for Total Shuttles Walked by Males Aged 25–85 Years. 
 
 
Table 4.5. Centile Values for Total Shuttles Walked for Females Aged 25–85 Years 
Age C3 C10 C25 C50 C75 C90 C97 Mean SD 
25 150 263 384 507 616 704 784 495 168 
30 132 237 349 466 570 655 732 455 159 
35 116 214 318 428 527 609 684 455 150 
40 103 193 290 393 487 567 640 386 143 
45 93 175 265 361 451 527 600 356 134 
50 85 160 242 332 417 491 562 329 126 
55 79 148 222 305 386 458 528 304 119 
60 77 138 205 281 358 427 496 282 111 
65 76 130 189 259 332 399 467 263 104 
70 77 123 176 239 308 373 441 245 97 
75 77 117 163 221 286 349 417 228 90 
80 77 111 151 204 265 327 395 213 85 
85 75 104 140 189 246 307 375 199 81 
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Figure 4.2. Centile Curves for Total Shuttles Walked in Females Aged 25–85 Years. 
 
4.4.2.  Cross-validation of Prediction Equations Developed in Healthy 
Populations 
   
Paired t-tests verified that all equations developed in healthy individuals (Table1) 
significantly overestimated ISWT performance in CR patients. The only equation that 
produced an estimate of performance not significantly different from actual values was 
Pepera, et al. (2013) equation, in Table 1, and only when applied to women.  
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All prediction models correlated positively with our data. In men the highest correlation 
between predicted and actual values came from the equations featured in Jurgensen, 
et al. (2011) (r= .376), and Probst, et al. (2011) (r=.388) (Figure 3). The closest 
correlations between predicted and actual values in women were also those of Probst, 
et al. (2011) (r= .360) and Jurgensen, et al. (2011) (r= .324) (Figure 4). All the other 
models correlated under r= .3 with our data in men and women. 
 
Figure 4.3. Predictive Values from Jurgensen vs Actual Data   
 
 
Figure 4.4 Predictive Values from Probst vs Actual Data   
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4.5. Discussion  
 
The aim of this study was to aid the interpretation of functional capacity measurements 
made using the ISWT by considering the role of non-modifiable variables which may 
influence performance in cardiac patients. We presented reference values for the 
Incremental Shuttle-Walking Test (ISWT) in patients at entry to outpatient CR.  
 
We confirmed that age and sex accounted for ~25% of variance in test performance 
and that males walked significantly further than females at all ages. In males, the 
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median expected distance walked decreased by 59%; from 609 m at 25 years to 250 
m at 85 years. The median distance female patients walked dropped by 62%; from 
507 m at 25 years to 189 m at 85 years. Based on only the variance in test performance 
associated with age and sex – there was >300% variation in the distance walked 
between the youngest male and oldest female patients tested. While a large variation 
evident at each age in both sexes is likely due to differences in cardiorespiratory fitness 
(Fowler and Singh, 2005), such massive age- and sex-related variation suggests that 
reporting and interpreting ISWT performance simply as distance walked is 
problematic. These centile curves provide the first set of reference values in cardiac 
patients; which may allow practitioners to make meaningful age- and sex-referenced 
interpretation of ISWT performance at entry to outpatient CR.  
 
The prediction models developed in the healthy population correlated poorly with our 
data (r<.4), and the predictors in regression equations reported are different than 
actual cardiac patients, they are of no use in clinical practice to predict ISWT 
performance in cardiac patients. 
 
4.5.1. Predictors of ISWT Performance 
 
Identification of age and sex as ISWT predictors was in agreement with studies on 
COPD patients (Luxton, et al. 2008) and healthy individuals (Dourado, et al. 2011; 
Jurgensen, et al. 2011; Probst, et al. 2012; Dourado, et al. 2013). The greater distance 
walked by males (126 m (95% CI: 100-151 m) further than females) was expected and 
of similar magnitude (110 m) to the mean of a previous study on cardiac patients 
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(Pepera, et al. 2013). In healthy individuals differences as great as 163 m (Jurgensen, 
et al. 2011), 183 m (Dourado, et al. 2011) and even 290 m (Probst, et al. 2012) have 
been reported, but it should be noted that these healthy individuals walked a much 
greater overall distance during the ISWT than the present sample of CR patients.  
 
Sex-related differences in walking performance are likely due to higher absolute 
cardiorespiratory capacity, greater muscle strength and mass in males or also simply 
because they are taller than females on average and have greater stride length. 
Pepera et al. (2013) reported that stride length was the most powerful predictor of 
ISWT performance in cardiac patients; but that this dynamic measure was not routinely 
used in clinical practice. Pepera et al. (2013) found height (as a proxy for stride length) 
could predict 17% of variance in ISWT performance in a mixed-sex sample of cardiac 
patients. Conversely, height was only a very minor predictor of ISWT performance 
(2.4% in females and 5.2% in males) in the present study due probably to separate 
analyses by sex.  
 
BMI predicted 2.7% of variance in male’s ISWT performance and was negatively 
associated with test performance as has been reported in cardiac patients (Pepera, et 
al. 2013), as it has been in healthy individuals (Probst, et al. 2012).  This is mostly 
because BMI is a measure of adiposity and greater body mass (especially fat mass) 
which increases the energy cost of walking.  
Diabetes explained only 1.7% of the variance in test performance in males but was 
more important (7.9% variance) in females despite both a smaller sample size and 
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lower incidence of diabetes in women (26%) compared to men (28%). Diagnostics 
showed no co linearity between diabetes and any of the potential predictors. This is a 
novel finding as diabetic status has been assessed in other studies. Diabetic women 
walked on average 80 m less than those without the condition. This suggests clinicians 
should take the presence of diabetes into consideration when interpreting ISWT 
performance, as the impact value of this magnitude is reported as 'mean change' in 
CR programs. Ideally we would like to create curves at least for females with and 
without diabetes, with more research needed. 
 
We explained ~25 to 28% of the variance in sexes performing the ISWT by non-
modifiable variables. The main source of variance in ISWT performance is 
cardiorespiratory capacity, explaining 63% of the variance (Fowler and Singh 2005). 
Diagnosis, treatment, medication and time from event to CR, waist circumference, 
blood pressure and smoking were not significantly related with ISWT performance in 
CHD patients as reported previously (Pepera, et al. 2010; Pepera, et al. 2013).  
 
4.5.2. Cross-validation of Prediction Equations Developed in Healthy 
Populations.   
 
The studies done in healthy participants with a similar mean population age (Dourado, 
et al. 2011, 2013; Jurgensen, et al. 2011; Probst, et al. 2011; Harrison, et al. 2013) 
acknowledge the utility of ISWT in clinical practice, and claimed the utility of their 
prediction models in predicting performance in clinical populations, although they 
developed their studies only in healthy populations, reporting no justification for such 
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claiming. Such studies should ideally have validated their models by comparing 
predicted values with actual test performance in a clinical population. Unfortunately, 
such analysis were not done in the available literature (Dourado, et al. 2011, 2013; 
Jurgensen, et al. 2011; Probst, et al. 2011; Harrison, et al. 2013). 
 
4.5.2.1. Mean Differences in Predicted and Actual Values 
 
The application of all prediction equations developed in the healthy population 
(Dourado, et al. 2011; 2013; Jurgensen, et al. 2011; Probst, et al. 2011; Harrison, et 
al. 2013), reported in Table 4.1, in actual patient values, significantly overestimated 
their performance. All the studies (Dourado, et al. 2011; 2013; Jurgensen, et al. 2011; 
Probst, et al. 2011; Harrison, et al. 2013) reported higher mean ISWT performance 
than the patient values observed, e.g. the healthy participants walked on average 500 
to 850 m in ISWT (Jurgensen, et al. 2011; Probst, et al. 2011) compared with a mean 
of 365 ± 164 m achieved in cardiac patients. Healthy population mean values of 
performance were higher than actual patients, this is expected as CHD patients have 
cardiorespiratory impairments and are more likely to have several co-morbidities. 
Overestimation of actual values does not necessarily invalidate any equation, as 
predicted values can be used as a health reference value point, and to express actual 
performance as a percentage, as practised in the 6 min walk test (Enright and Sherrill, 
1998). 
 
When we used both sexes of our cohort and predicted their performance using 
equations from past research (Jurgensen, et al. 2011) (Probst, et al. 2011) (table 4.6) 
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there was a gross overestimation in predicted performance in cardiac patients. In 
Jurgensen, et al. (2011) and Probst, et al. (2011) equations for the prediction of 
performance in ISWT ranged in the men and women from 223 m (67%) to 465 m 
(140%) and 60 m (19%) to 181 m (50%) respectively.  
 
Table 4.6 Prediction of ISWT Performance Using Patient Data as an Example 
Actual 
patient 
Age 
(years) 
Weight 
(kg) 
BMI 
(Kg/m2) 
Height 
(cm) 
ISWT 
(meters) 
Jurgensen 
(m) 
Probst 
(m) 
Man 63 74 27.5 171.5 330 553 ± 115 795± 115 
Female 63 80.5 29.6 173.2 360 429 ± 168 541± 168 
 
4.5.2.2. Accounting for Variance in Equations Developed in the Healthy 
Population  
 
Regression equations based on the healthy population performing the ISWT 
(Dourado, et al. 2011; 2013; Jurgensen, et al. 2011; Probst, et al. 2011; Harrison, et 
al. 2013) (table 1) explained 50% to 71% of the variance in performance. This is bad, 
as most of the variance in actual cardiac patient values is based on cardiorespiratory 
capacity. This compares favourably with the 25% to 28% of variance explained in our 
cohorts of male and female cardiac patients. The high proportion of variance explained 
by demographic and geographical variables in regression equations based on the 
healthy population is surprising as the most powerful predictor of ISWT performance 
should be the cardiorespiratory capacity of an individual or population. This suggests 
that either the ISWT is a poor measure of cardiorespiratory capacity in healthy 
individuals or that adding cardiorespiratory capacity would alter the predictors of ISWT 
performance. 
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4.5.2.3. Simplicity of Predictor Variables Used in Regression Equations. 
 
Using complex, clinical variables to predict the relatively simple ISWT test outcome 
(distance walked) in actual patient values is of little use, even if a very powerful 
prediction equation was developed. This is because predictors should be simple 
measures that are easy to obtain in clinical practice. There are some simple 
applications of the regression equation used e.g. in healthy individuals. Adding more 
clinical measures (Hand grip, %Lean body mass, %Total body fat; or forced expiratory 
volume in 1 second, quadriceps maximal voluntary contraction, and Duke Activity 
Status Index) to their prediction models didn’t increase predictive power in ISWT 
performance (Dourado, et al. 2011, 2013; Harrion, et al., 2013), as expected. 
Predictors used in regression equations should be simple and easy to obtain in clinical 
practise as reported in regression equations by Jurgensen, et al. (2011), Probst, et al. 
(2011) and equation one in Dourado, et al. (2011, 2013), Table 4.1.  
Dourado, et al.'s (2011), equation two, equation two and three from Dourado, et al. 
(2013); and Harrion, et al.'s (2013) equations based on healthy individuals were 
excluded from the cross validation procedure as the predictors were too complex to 
use in clinical practice. 
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4.5.2.4. Similarity in Predictor Variables: Healthy Versus Cardiac Patients. 
 
In order to be of useful, equations should include similar variables. In the case of 
predicting ISWT performance in CR patients, the presence of co-morbidities (such as 
diabetes) or clinical characteristics (size or site of MI) and low cardiorespiratory 
capacity would challenge the validity of equations based on development populations 
in which these characteristics are not present. Such systematic differences will simply 
produce gross overestimates of the performance in our cardiac patients. 
 
No other regression equation (Jurgensen, et al. 2011; Probst, et al. 2011) differed in 
predictors reported in men and women, as actual cardiac patients: 
  
Equation 4.x Predictors of ISWT in Male Cardiac Patients. 
- ISWT = -45.154 - (5.9 x Age) + (5.0 x Height) - (5.1 x BMI) - [48.7 x Diabetes 
(1), no Diabetes (0)]; S.E.E. = 144.1 m; 
 
Equation 4.x Predictors of ISWT in Female Cardiac Patients. 
- ISWT = -11.924 - (4.8 x Age) - [80 x Diabetes (1), no Diabetes (0)] + (2.8 x 
Height); S.E.E. = 101.6 m. 
  
Similar predictors were found between actual cardiac patients and healthy individuals. 
Sex and age were the primary predictors of ISWT performance in cardiac patients. 
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Age was also the most powerful variable in all regression equations based on healthy 
populations and to a lesser extent gender had also had a powerful effect (Dourado, et 
al. 2011; 2013; Jurgensen, et al. 2011; Probst, et al. 2011). Weight was not reported 
as a predictor in actual patients, as reported in regression equations based on healthy 
individuals (Dourado, et al. 2011; 2013; Jurgensen, et al. 2011). BMI was a predictor 
in actual patients also reported by Probst, et al. (2011), and height too was a predictor, 
as reported by Dourado, et al. (2011; 2013); Jurgensen, et al. (2011) 
 
In Jurgensen, et al.’s (2011) equation the predictors Age, Height, Gender, were the 
same reported in actual patients, they also accounted for the same magnitude and 
direction, than actual patients. The predictors were the same between genders which 
differs from actual cardiac patients.  
 
In Probst, et al. (2011) proposed an equation that included Age, Sex and BMI as the 
same predictors as actual patients. The predictors were the same between genders 
which differs from actual cardiac patients. BMI was a predictor in male patients. BMI 
was not a predictor in female cardiac patients. Predictors also accounted for the same 
direction, although gender had double the magnitude than actual patients. 
 
In Dourado et al. (2011, 2013) Age, Height, Gender were the same predictors as in 
actual patients. The predictors were the same between genders which differs from 
actual cardiac patients. Predictors also accounted for the same direction, although 
height was hugely increased in magnitude, compared with actual patients. 
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4.5.2.5. Correlation of Predicted Values in Actual Patients by Healthy 
Population Equations Versus Actual Patient Values 
 
When examining the ability of the regression models based on healthy individuals 
(Dourado, et al. 2011; 2013; Jurgensen, et al. 2011; Probst, et al. 2011) (Table 4.1) in 
predicting patients' actual performance during the ISWT, the two equations that 
produced estimates that correlated best with actual patient values were Jurgensen, et 
al. (2011) and Probst, et al. (2011). Jurgensen’s equation produced estimates that 
correlated weakly with actual values (Table 4.4) for men (r=.388), and women (r=.376). 
Broadly similar correlations were found between estimates based on Probst’s equation 
and actual values (Table 4.5) in male (r=.324) and female (r=.360) CR patients.  
 
These correlations were all weak and figures 4 and 5 showed that actual test values 
varied greatly for patients in any predicted performance (Jurgensen, et al. 2011; and 
Probst, et al. 2011). The low correlations (r<.4) between predicted and actual values 
suggest neither equations developed in healthy individuals holds the necessary 
predictive power for use in patients entering CR. 
 
The numerous studies claiming to provide reference data for ISWT in cardiac patients 
are collectively flawed. None of these studies provided a justification for developing 
prediction equations in using healthy subjects. The studies claimed their predictions 
may be ‘useful’ in cardiac patients although none of them followed the standard 
procedure of cross-validation (Dourado, et al. 2011; 2013; Jurgensen, et al. 2011; 
Probst, et al. 2011; Harrison, et al. 2013), Table 4.7. 
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Predicting ISWT performance in cardiac patients from regression equations developed 
in healthy populations (Jurgensen, et al. 2011; Probst, et al. 2012) does not seem 
feasible. Their prediction of actual patient performance in ISWT correlated weakly 
(r<4) with actual patient performance. The predictors found are different in genders in 
actual cardiac patients whereas they were equal between genders in the healthy 
population. The same predictors in regression equations in the healthy population had 
different a magnitude and strength of prediction than in actual patients. Regression 
equations based on the healthy population had little or no clinical utility as claimed by 
the authors of such studies, so it is important to provide population-specific reference 
data. 
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Table 4.7. Comparison of Reference Equations in Healthy and Actual Cardiac 
Patients  
Studies Jurgensen, et al. 
2011 
Probst, et al. 
2011 
Dourado, et al. 
2011 
Dourado, et al. 
2013 
Harrison, et al. 
2013 
1- Explanation of  amount 
of variation  
-Very High, 50.3% -Very High, 71.% -Equation 1- Very 
High, 64.9% 
-Equation 2- Very 
High 69.0% 
-Equation 1- Very 
High, 65.% 
-Equation 2- Very 
High, 65.% 
 
-Equation 3- Very 
High, 65.% 
-Very High, 50.3% 
2- Simplicity of  predictors -Yes -Yes -Equation 1- Yes 
-Equation 2- 
Complex 
-Equation 1- Yes 
-Equation 2- 
Complex 
-Equation 3- No 
-Complex 
4- Similar Predictors   
(same magnitude and 
direction) 
-Same direction 
and magnitude 
-Same direction 
different 
magnitude 
-Equation 1- 
Same direction 
different 
magnitude 
-Equation 2- No 
similar 
-Equation 1- 
Same direction 
different 
magnitude 
 -Equation 2- No 
similar    
-Equation 3- No 
similar 
-No similar 
5-Correlation, with actual 
patients 
-r=.388 -r=.376 -Equation 1- 
r=.245 
-Equation 1- 
r=.249 
----------- 
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4.5.3. Current Clinical Application of ISWT Performance 
  
The ISWT is sometimes used as an estimate of cardiorespiratory fitness, which 
explains ~62% of the variance in distance walked (Fowler and Singh, 2005). As stated 
above, we can assume cardiorespiratory fitness explains much of the variance in 
distance walked (3rd – 97th percentile) evident at all ages in both sexes. The ISWT is 
more commonly reported simply as distance walked (Fowler and Singh, 2005) which 
is clearly problematic given the expected variation in performance due to non-
modifiable factors (figures 1 and 2). 
 
The ISWT is also used to classify patients as either high or moderate/low risk based 
on achieving a criterion-related performance deemed equivalent to 5 METs (SIGN 
2002) but there is some debate as to the distance walked during the ISWT which is 
equivalent to 5 METs (Fowler and Singh, 2005; Woolf-may and De Ferret, 2008;  
Almodhy, et al 2014). The significant age- and sex-related variance shown in our study 
suggests the use of a universal cut-point may be problematic. Regardless of 
cardiorespiratory fitness any single cut-off for all ages and both sexes will clearly 
favour younger, male patients and simply cannot account for the expected difference 
in patients’ ISWT performance.  
 
For example, to exceed the proposed 5 MET cut-off, all patients need to walk 
approximately 420 m (Fowler and Singh, 2005). Our data showed that this distance is 
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within the lower part of the expected range for a 50 year old male (~25th percentile) 
but that an 80 year-old female would need to perform above the 90th percentile for 
age and sex to meet this criterion. The average 50 year old male is, therefore, more 
than seven times more likely to meet this criterion. Put simply, absolute (distance 
walked) cut-offs classify patients more by their age and sex than their cardiorespiratory 
fitness. 
 
4.5.4. Clinical Application of ISWT Performance with Reference Values 
 
The ISWT is used to provide information and feedback to patients on exercise capacity 
and improvements in fitness due to CR. Given the large variation in expected values 
(due to age and sex) we believe the centile curves presented here can provide a more 
meaningful and individualised interpretation of ISWT performance.   
 
For example, at entry to CR, 80 year old female patients typically walk between 77 m 
and 395 m during initial assessment by ISWT. By comparison, 50 year old males 
typically walk much further (between 182 and 858 m). An absolute ISWT distance of 
200 m would place a 50 year old male below the 5th percentile for age and sex; 
possibly indicating very low cardiorespiratory fitness, presence of significant co-
morbidities or low test effort. Conversely, the same (200 m) absolute distance 
suggests an above-average performance for an 80 year old female patient. This 
above-average performance by the 80 year old female patient suggests that she might 
expect lesser improvement in ISWT performance due the law of initial values. 
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Conversely practitioners might expect much greater improvement in ISWT 
performance in the 50 year male patient.  
 
The law of initial values suggests the largest improvements are seen in those with the 
lowest initial test scores. In the example male patient, the reference values may have 
aided goal-setting, such as aiming to attain a distance around the 50th percentile. In 
the female patient, however, a suitable goal might have been to maintain the same 
distance or to make a very small improvement. Test interpretation based on reference 
values may better-inform initial exercise prescription, improve application and 
individualization of exercise progression as well as inform practitioners and patients 
about the degree of improvement expected due to CR.  
 
The ISWT has been successfully used to ‘triage’ patients more accurately at entry to 
outpatient CR; by identifying individuals to be ‘fast tracked’ to community rehabilitation 
(Robinson, 2011). The distances walked by the 60 year old patients in this study were 
620 m which is equal to around the 90th percentile for men and well above the 97th for 
women in our population. The successfully fast-tracked patients are a minority and 
clearly not typical of patients entering CR. Interpretation of ISWT against an absolute 
distance will, however, create a preference for younger, male patients to meet any 
such potential fast-track criteria. The present data shows a 40 year old male is about 
3 times more likely to meet this 620 m criterion cut-off than a 70 year old female.   
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We suggest practitioners could make more meaningful interpretation of test scores 
when combined with these reference data. Such a practice may aid clinical decision 
making, improve patient understanding, and goal setting for fast track at entry to 
outpatient CR or back referral to inpatient CR 
 
4.5.5. Study Limitations 
 
Our sample is typical of CR patients in England but may not be reflective of the 
intentional population. Given the potential clinical importance of diabetes in 
(particularly female’s) ISWT test performance we would ideally have created curves 
separately for diabetic patients. Sample size prevented this but future research should 
assess the potential impact of diabetes on exercise test performance in cardiac 
patients.  
 
The percentile values in each gender at all ages were disparate, representing the 
potential changes in ISWT performance is which are, most likely, dependent on 
cardiorespiratory fitness. Our present study goes some way to explaining the source 
of the remaining 35% of variance in CHD patients’ test performance. Concurrent 
analysis of non-modifiable predictors identified here as well as cardiovascular fitness 
might explain a still greater proportion of test variance. To date, no large-scale 
multivariate analysis combining non-modifiable predictors and direct assessment of 
oxygen consumption has been performed in cardiac patients. If the ISWT is to remain 
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in use as an estimate of cardiorespiratory fitness such a study is warranted to confirm 
the relative importance of all potential predictors.   
 
These reference values provide only expected walking distances for patients entering 
CR and we cannot provide (or suggest) a clinical cut-off for ‘good’ or ‘poor’ test 
performance; such a threshold and factors which can predict changes in performance 
should be identified. Ultimately, differences in mortality and morbidity according to 
initial ISWT performance and improvements due to CR will be needed to produce valid 
clinical cut-offs of performance. Our data was gained from sequential patient records 
and while they are similar to other studies, they are lower than values from studies 
which recruited patients as volunteers and are, therefore, difficult to compare. To 
improve exercise prescription, predictors of change in ISWT performance should be 
identified. 
 
4.6. Conclusion 
  
We have provided the first reference data for the incremental shuttle-walking test 
(ISWT) in patients at entry to CR. Distance walked on the ISWT varied greatly due to 
non-modifiable patient characteristics; particularly age and sex. We propose that 
clinicians may better-interpret ISWT performance by comparing absolute (distance 
walked) values with the age- and sex-specific reference values presented here. This 
practice may provide a more meaningful and individualised assessment of patients’ 
functional capacity, exercise prescription, and magnitude of change in 
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cardiorespiratory fitness expected at entry to CR programs. This may help ‘triage’ 
patients by better interpreting ISWT performance taking into account a patient's age 
and sex at entry to outpatient CR and potentially identifying individuals who can be 
‘fast tracked’. Regression equations based on the healthy population have little or no 
clinical utility in cardiac patients. 
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Chapter 5. Oxygen costs of the Incremental Shuttle Walk Test in cardiac 
rehabilitation participants; an historical and contemporary analysis 
 
 
Abstract 
 
Objective: The Incremental Shuttle Walk Test (ISWT) has become a standardized 
assessment for cardiac rehabilitation (CR). Three studies have reported the oxygen 
costs (VO2)/metabolic equivalents (METs) of the ISWT. In spite of classic 
representations from these studies graphically showing curvilinear VO2 responses to 
incremented walking speeds, linear regression techniques (also used by the ACSM) 
have been used to estimate VO2.  
 
Two main aims: i. to resolve currently reported discrepancies in the ISWT VO2-walking 
speed relationship and ii. to derive an appropriate VO2 vs walking speed regression 
equation.  
 
Methodology and results: VO2 was measured continuously during an ISWT in 32 
cardiac rehabilitation and 30 age-matched controls  
 
Both the CR and control group VO2 responses were curvilinear in nature. For the CR 
group VO2 = 4.5e0.37 x walking speed (mph).  
 
Conclusions: CR vs control participants had a VO2 up to 30% greater at the higher 
ISWT stages. The curvilinear nature of the VO2 responses during the ISWT concur 
with classic studies performed for over 100 years. VO2 estimates for walking, based 
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on linear regression techniques, are currently being incorrectly recommended and this 
study provides a resolve of this matter when the ISWT is used in CR populations. 
 
5.1 Introduction 
 
 
Direct measurements of maximal oxygen consumption (ܸ̇O2max) and estimates of peak 
oxygen consumption (ܸ̇O2peak) obtained from exercise tests provide valuable 
information for decision making in cardiac rehabilitation, including patient risk 
stratification (AACVPR 2013; ACSM 2013; BACPR 2014). The gold-standard 
measurement for assessing ܸ̇O2max is maximal incremental exercise testing by 
treadmill or cycle ergometry.  
 
The Incremental Shuttle-Walking Test (ISWT) was originally developed to assess 
functional capacity of patients’ chronic obstructive pulmonary disease (Singh, et al. 
1992;  Parreira, et al. 2014) but has been adopted to assess cardiorespiratory fitness 
in patients with cardiovascular disease attending exercise-based rehabilitation (Tobin 
1999; Jolly, et al. 2008; BACPR 2014; NACR 2014). In the absence of Gold-Standard 
assessments, the ISWT has become widely used in cardiac rehabilitation (Brodie, et 
al. 2006).  
 
The ISWT can provide practical valuable information for physical activity guidance and 
exercise prescription, along with more traditional information for evaluating changes 
in exercise capacity as an outcome measure for individual patients or whole service 
delivery (Sandercock, et al. 2013; Almodhy, et al. 2014). In the absence of direct 
measures of ܸ̇O2 values during the ISWT, clinicians tend to rely on ܸ̇O2 estimates, 
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usually derived from a linear regression equation recommended by the American 
College of Sports Medicine (ACSM) (ACSM 2013). 
 
To date, only three studies (summarized in Figure 1) have reported the oxygen cost 
(ܸ̇O2 in [ml∙kg-1∙min-1] or metabolic equivalents [METs]) for individual stages of the 
ISWT in cardiac populations or age-matched controls (Woolf-May and Ferrett, 2008; 
Woolf-May and Meadows 2013; Almodhy, et al. 2014). The data from these studies 
make it possible to compare measured ܸ̇O2 values with ܸ̇O2 estimates from the ACSM 
equation (ACSM 2013). In all cases the values reported in both the healthy populations 
were greater than those estimated by the ACSM. Underestimation was even greater 
in cardiac patients’. 
 
The first study (Woolf-May and Ferrett, 2008) reported ܸ̇O2 values for cardiac patients 
up to 40% greater than estimated by ACSM during the initial test stages of the ISWT 
and up to 90% greater during the latter stages. In comparison to age-matched healthy 
individuals, the measured ܸ̇O2 of cardiac patients was 26% and 47% greater at the 
lower and upper stages, respectively.  
 
The second study from this same group (Woolf-May and Meadows 2013), reported 
recorded ܸ̇O2 values during the ISWT similar to ACSM estimates at stages 1 to 5. The 
values then increased in a curvilinear fashion until being 20% greater than estimated 
by the ACSM equation at stage-9; far less than the 90% difference previously reported 
in a similar population. Also contrary to their former study, the ܸ̇O2 values differed very 
little between cardiac rehabilitation participants and age-matched controls. Such 
inconsistencies without any comment from the same group of researchers means that 
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cardiac rehabilitation professionals are currently faced with some confusion over 
estimating the oxygen costs of the ISWT whether for the purpose of exercise 
prescription or risk stratification. 
 
An initial step towards resolving these inconsistencies was undertaken as pilot work 
during the early stages of this thesis; (Almodhy, et al. 2014). We undertook a small 
(n=8) pilot study in cardiac patients.  We found ܸ̇O2 that fell between those reported 
previously by Woolf-May, et al (2008) and those of Woolf-May, et al. (2013). The study 
also demonstrated that ܸ̇O2 responses to the ISWT were fundamentally different to 
those of treadmill exercise; the gold standard method of assessing VO2peak in cardiac 
patients and the reference standard for the ACSM equations.  
 
Another area of concern with the extant descriptions of the ISWT’s oxygen cost 
reported by Woolf-May et al., are the authors’ interpretations of recorded data and the 
application of the ACSM estimation equations; both assume a linear relationship 
between increments in walking speed and ܸ̇O2 (Woolf-May and Ferrett, 2008; Woolf-
May and Meadows, 2013). This assumption is contrary to the accepted findings of 
numerous studies (Passmore and Durnin, 1955) (Margaria, et al. 1963, Menier and 
Pugh, 1968)  dating as far back as 1912 (Douglas and Haldane, 1912), which 
consistently report a curvilinear increase in ܸ̇O2 in response to increased walking 
speed. 
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Figure 5.1 Oxygen cost of the Incremental Shuttle Walk Test (ISWT) in cardiac 
rehabilitation participants and age-match healthy controls 
 
 
 
 
Just as the historical data have shown, upon simple visual examination of the more 
recent ISWT data (Figure 5.1), there is clearly a curvilinear relationship between ܸ̇O2 
and walking speed. The curvilinearity of these values is made very apparent when the 
linear ACSM equation (ACSM 2013) is plotted as a reference line. The responses of 
heart rate (HR) and ratings of perceived exertion (RPE) reported by Woolf-May and 
Meadows (2013) (Woolf-May and Meadows, 2013) also demonstrated clear and 
corresponding curvilinear patterns, confirming the traditional assumption that these 
measures are strong correlates of measured ܸ̇O2. The ܸ̇O2 values in Figure 1 for the 
ISWT have been reported from stages 1 to 9. Stages 10 to 12 have not been included 
because these represent speeds for running (4.7 – 5.0 mi.h-1 or 7.5 – 8.0 km.h-1), 
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which traditionally have been shown to have a linear relationship with ܸ̇O2 (Falls and 
Humphrey, 1976).  
 
The disparity of findings between studies, the potentially flawed assumption of a linear 
relationship and the inadequacy of prediction equation to estimate the ISWT’s oxygen 
cost are problematic. Further data are needed to promote confidence in cardiac 
rehabilitation professionals when wishing to apply assumptions of the ܸ̇O2 values in 
patients who have been assessed with the ISWT. 
 
5.2. Aims 
 
 
The aims of this study have therefore been two-fold: i. to determine if ܸ̇O2 responds in 
a linear or curvilinear manner to increases in walking speeds during the ISWT and ii: 
to resolve current discrepancies in reported values for the oxygen cost of commonly-
completed stages of the ISWT in cardiac patients. 
 
5.3. Methods 
  
 
5.3.1. Participants 
 
 
Following ethical approval from, cardiac rehabilitation participants from two 
community-based cardiac rehabilitation programs both of which adhered to national 
standards of service delivery (BACPR, Buckley et al. 2013) were recruited via open 
invitations to any patient diagnosed with and being treated for cardiac disease as per 
national guidelines (NICE 2013). Inclusion criteria were based on standard eligibility 
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for a UK cardiac rehabilitation service (BACPR 2012). Patients were excluded from 
participating for the following reasons: an auditory impairment which did not allow them 
to hear the audio shuttle-pacing bleeps of the ISWT; cognitive impairment which 
prevented them from understanding how to perform the test or comprehend 
instructions to remain in independent control of their walking pace; a diagnosis of heart 
failure or chronic obstructive pulmonary disease which would affect normal pulmonary 
responses to exertion; or a significant neuro-musculoskeletal or vascular condition 
which impaired them from being able to safely perform and complete at least five 
stages of the ISWT whilst comfortably tolerating walking up to a steady vigorous pace.  
Age-matched controls were recruited, under the same exclusion criteria as the CHD 
patients, from people already attending the same community center either for personal 
health-promoting exercise or as participants from their local primary-care Exercise 
Referral program who had been referred for an elevated risk of cardiometabolic 
disease. 
 
For 85% power, a ܸ̇O2 of 1.75 ml.kg-1.min-1 was determined to represent a clinically 
important difference in oxygen cost, based on our pilot data (Almodhy, et al. 2014). In 
conjunction with this clinical significance and where participants were assumed to 
have enough fitness to complete five stages at an estimated ܸ̇O2  of 14 ml.kg-1.min-1, 
30 participants per group were deemed suitable for achieving the effect-size of at least 
10% and an alpha of p< 0.05 and β=0.8. 
 
5.3.2. Procedures 
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Prior to testing, all participants were health screened for clearance to perform 
moderate to vigorous exercise by way of standardized procedures (BACPR 2014, 
ACPICR 2015), which were employed by qualified cardiac rehabilitation staff. 
Measurements included resting heart rate, blood pressure, height, age and body 
mass, where all of these were also required for measuring the cardiopulmonary gas 
exchange. 
 
All participants performed the recommended ISWT practice test (Singh, et al. 1992, 
Jolly, et al. 2008), which also included familiarization in wearing the respiratory face-
mask though not connected to the gas analysis system. Participants then rested for 
the required 30 min before performing the actual data collection test. The test end-
point, in keeping with current recommendations (SIGN 2002, ACPICR 2015) was the 
attainment of 75% of heart rate reserve (~80-85% HRmax) and/or an RPE of 14-15 
on Borg’s scale(Borg 1998).  During the ISWT, cardiopulmonary gas exchange was 
measured continuously via a portable gas analysis system (K4b2 Mobile Breath by 
Breath Metabolic System, COSMED Rome, Italy). The expired air and gas 
concentrations were measured via a pneumotach connected to the face-mask (Hans 
Rudolph Ltd, USA.). The system was calibrated for each participant using known 
concentrations of oxygen and carbon dioxide and a three-liter syringe to calibrate for 
the volume of pulmonary air exchanged. Heart rate was measured using a Polar chest 
strap telemetry system (Polar Ltd., Kempele, Finland). For data analyses, the average 
ܸ̇O2, heart rate and RPE captured in the last 15 seconds of each of the one-minute 
stages was recorded and entered into the statistical analyses computer software 
package (SPSS for Windows, version 20). 
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Ethical approval: “All procedures performed in studies involving human participants 
were in accordance with the ethical standards of the institutional and/or national 
research committee and with the 1964 Helsinki declaration and its later amendments 
or comparable ethical standards.” 
 
5.3.3. Data analyses 
 
Descriptive data are shown in table 5.1.  Independent t-tests were performed to 
compare data between the cardiac group and the aged matched controls.  
 
Using the curve estimation function in SPSS, we compared whether linear or 
exponential regression models explained more of the variance in ܸ̇O2 according to 
ISWT stage. One-sample t-tests were used compare measured MET values with 
group-mean values from previous studies. 
 
5.4. Results 
 
Thirty-two cardiac rehabilitation participants and 30 age-matched controls completed 
the ISWT to Stage-5 or higher. Group comparisons are summarized in Tables 5.1 and 
5.2.  
 
 
 
 
 
 
 
 
 175
 
 
 
 
Table 5.1 Descriptive characteristics of participants (mean ±SD)  
  
Cardiac group 
 
Age-matched controls 
N 32 30 
Sex (male) 18  (56%)  11 (35%)  
Age (years) 64.5 (±7.8) 63.4 (±8.6) 
Height (cm) 173.1 (±8.2) 168.8 (±7.1)* 
Mass (kg) 85.4 (±11.2) 78.7 (±16.9) 
Body mass index (kg/m2) 28.6 (±3.2) 27.6 (±5.2) 
Walking distance - meters:   
Male  
Female 
Total 
548 (±183)  
464 (±152)  
512 (±173) 
687 (±158) ** 
650 (±192) ** 
664 (±179) ** 
 
Age-matched controls walked 152 m further (p<0.001) than cardiac patients (Table 2) 
and this difference remained when participants were divided into sub-groups of males 
and females. 
 
 
 
 
Table 5.2. Participants’ clinical characteristics and treatments. 
 
Cardiac group 
 
N 
 
Age-matched controls  
 
N 
Angina 3 Hypertension  4 
Myocardial infarction 7 Orthopedic 5 
Angioplasty 8 Obese  3 
Coronary bypass 9 Smoking 2 
Others 5 Others 
Nothing reported  
3 
13 
CHD others: atrial fibrillation; dilated cardiomyopathy; pacemaker; valve replacement. Age-matched controls others: stroke; 
chronic fatigue; diabetes control versus cardiac group *p = .032 , **p < .001  
 
 
5.4.1. Oxygen cost of ISWT in cardiac patients and age-matched controls. 
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Within the control group, a subgroup analysis was performed between those with 
identified health conditions (n = 17) and those without (n = 13). There was no 
difference in the oxygen cost of walking in these two groups at any stage, which 
allowed the data to be pooled into one complete control group (n=30). Analyses of the 
data was capped at ISWT Stage-9 so as to focus on the evaluation just for walking; all 
participants who proceeded onto to Stage-10 or higher had to run, which is 
commensurate with a similar walk-run threshold reported in classic studies (Falls and 
Humphrey 1976).   
 
 
Table 5.3 Oxygen cost of ISWT in cardiac patients versus healthy, age-matched 
controls mean: difference in MET’s  
 
 
 
 
 
 
 
 
 
 
 
 
ISWT 
Stage 
Walking Speed 
(mph) 
Sample Size 
(Cardiac:Healthy) 
Mean 
difference 
95%CI 
1 
 
1.12 32:30 -0.2 -4.4 to -0.1 
2 
 
1.50 32:30 0.1 -1.5 to 0.4 
3 
 
1.88 32:30 0.4 0.1 to 0.7 
4 
 
2.26 32:30 0.6 0.2 to 0.9 
5 
 
2.64 32:30 0.6 0.2 to 1.0 
6 
 
3.02 27:30 0.7 0.2 to 1.2 
7 
 
3.40 21:30 1.0 0.4 to 1.5 
8 
 
3.78 17:30 1.3 0.6 to 2.1 
9 
 
4.16 11:30 1.9 0.9 to 3.0 
10 
 
4.54 0:30 5.5 4.2 to 6.8 
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5.4.2. Comparison of Linear versus Curvilinear Models to Describe Oxygen 
Cost of ISWT. 
 
In healthy individuals the exponential and the linear model explain both at same level 
the oxygen consumption in performing the ISWT. The linear model (y= 0.47 + 2.75 x 
m/s) had an R2=.989 and the exponential model (y=1.435e.743 x m/s) had an R2=.988.  
In cardiac patients, linear regression did not adequately describe the response and 
the best model to describe the oxygen consumption when performing the ISWT was 
exponential (y= 1.138e1.138 x m/s) with a R2= .962.  
 
Figure 5.2. Comparison of oxygen cost of ISWT estimated from ACSM equation 
(linear) with measured values in cardiac patients (exponential) and age-matched 
controls (linear or exponential) 
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5.4.3. Conversion to metabolic equivalents (METs) for cardiac groups 
 
 
For the purposes of practically applying this information in monitoring or guiding 
exercise intensity in cardiac rehabilitation, Table 5.4 summarizes the oxygen cost in 
units of METs at each ISWT stage. These values are based on the assumption that 1-
MET equals a ܸ̇O2 of 3.5 ml·kg-1·min-1 (Ainsworth, Haskell et al. 2011). MET values 
from Almodhy et al. (2014) agree most closely with this current study where the mean 
difference for Stages 1 to 8 is 0.2 METs (range 0.1 – 0.4 METs). At Stage-9 the values 
differed by 0.7 METs.  
 
Compared with this current study, Table 5.4 shows that the Woolf-May and Meadows 
(2013) cardiac participant values were lower at all stages; 0.6 METs lower at Stage-2, 
increasing to 1.7 METs lower at Stage-8 and 2.6 METs at Stage-9. In comparing this 
current study’s values to the original study on METs by Woolf-May and Ferrett (2008), 
this range of differences was of a similar magnitude to Woolf-May and Ferrett (2008) 
but these values were systematically greater across the nine ISWT stages ranging in 
difference by 0.8 to 2.0 METs, respectively. 
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Table 5.4 Metabolic equivalents (METs) derived from the oxygen costs of the Incremental Shuttle-Walking Test in cardiac 
rehabilitation participants; current findings compared with previous studies. 
 
 
ISWT Stage  1 2 3 4 5 6 7 8 9 
ISWT walking speed 
mph (m·min-1) 
1.1 
(54.5) 
1.5 
(40.0) 
1.9 
(31.6) 
2.3 
(26.5) 
2.6 
(22.7) 
3.0 
(20.0) 
3.4 
(17.6) 
3.8 
(15.8) 
4.2 
(14.3) 
 
METs Cardiac Groups  
Mean  + SD (n) 
 
1.7 + 0.4 
(n=32) 
2.5 + 0.5 
(n=32) 
3.2 + 0.6 
(n=32) 
3.7 + 0.7 
(n=32) 
4.2 + 0.9 
(n=32) 
4.8 + 1.0 
(n=27) 
5.5 + 1.0 
(n=21) 
6.3 + 1.3 
(n=17) 
7.6 + 1.7 
(n=11) 
 
Almodhy et al (2014) 
 
2.0 2.7 3.1 3.6 4.0 4.4 5.3 6.1 6.9 
Woolf-May &  
Meadows (2013 ) 0.7 2.1 2.6 2.9 3.1 3.6 4.2 4.6 5.1 
Woolf-May & 
 Ferret (2008 ) 2.5 3.8 4.3 4.8 5.5 6.3 7.5 8 8.2 
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5.5. Discussion 
 
The ISWT is widely used during patient assessment at entry to and exit from outpatient 
cardiac rehabilitation. This most recent study on the oxygen costs of walking during 
the ISWT in cardiac rehabilitation patients provides the first comprehensive 
comparison of a new data set with data from similar studies. We believe this is the first 
critique of such studies against the historical background of classic studies on the 
energy costs of walking.  
 
The present data demonstrate that the oxygen cost of over-ground walking responds 
as a positively accelerating (curvilinear) function of speed which is independent of: 
testing protocol, participant age and clinical status. In light of this finding from our data 
alone or when combined with findings from extant studies which have reported this 
phenomenon for over a century, it is surprising that the ACSM continues to 
recommend the use of a linear regression equation to predict oxygen cost of walking 
(ACSM 2013). Such existing linear equations clearly and consistently underestimate 
VO2 for walking speeds >2 mi·h-1 (>3 km·h-1)   
 
From a clinically significant effect-size perspective, however, the values were close to 
those of the pilot study. (Almodhy, et al. 2014), which supports confidence in the 
recommended regression equation (Table 5.4) to be used by cardiac rehabilitation 
professionals. 
 
The first study in this area (Woolf-May and Ferrett, 2008), reported much higher VO2 
values in cardiac participants when compared with data from all the other measures 
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of cardiac groups (including this current study). It would now seem that their values 
appear systematically inflated from some potential anomaly in their measurements.  
 
A general pattern now appearing from the four data sets of comparing the VO2 in 
cardiac participants to age-matched controls during the ISWT is that most cardiac 
participants require an oxygen uptake of up to 30% more than age-matched controls, 
which is mainly found in the final three walking stages assessed (7, 8, 9). 
 
The limitation in economy and higher oxygen consumption to exercise seen in CHD 
doesn’t seem to be cause by any locomotion dysfunction, as motor pattern in ISWT 
performance was similar in age-match control, when performance was simply 
observed. The arteriosclerosis progression to CHD, promotes structural and metabolic 
dysfunction of the all cardiovascular system. Differences between CHD patients and 
age-matched control in the structure and metabolism of heart, peripheral circulation 
system and skeletal muscles, can be the cause and the explanation, for higher and 
less economical oxygen consumption in CHD patients when compared with age-match 
control, for same exercise intensity. CHD patients have limited endurance (aerobic) 
exercise performance. Heart is dysfunctional by the loss of the myocardial 
performance, resulting in poor increasing of cardiac output response to exercise 
intensity, leading to skeletal muscle hypoperfusion and lactic acidosis, causing fatigue 
and exercise intolerance. The limited response of the myocardial performance to the 
progressive oxygen demands in skeletal muscle exercising, seems to be the major 
limitation in CHD patients to exercise performance, still this lost in myocardial function 
doesn’t fully explain the higher oxygen consumption by CHD patients compared with 
age-match control exercising at same intensity.  
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Skeletal muscle metabolism and structure dysfunction main explain further differences 
in oxygen consumption between cohorts in this study. Chronic diseases such as 
chronic pulmonary, renal disease, heart failure, have higher impact, and worsening of 
sarcopenia which is represented with loss of skeletal muscle strength and muscle 
mass with advancing age (decreased motor units, growth hormones, insulin-like 
growth factors, and impaired mitochondrial function) (Zizola and Schulz 2013). This is 
also seen in CHD patients (Ghroubi, et al. 2007). Chronic inflammation developed in 
heart failure, release inflammatory mediators into the circulation that further activate 
systemic inflammation, promoting muscle atrophy, fatty infiltration and decreased 
oxidative enzyme levels, what reduced oxidative metabolism with an earlier shift to 
glycolytic metabolism. Is also seen an alteration of fibre composition with an increased 
number of Type II fibers (anaerobic, glycolytic) as compared to Type I (aerobic, 
oxidative) (Zizola and Schulze 2013). Fibre shift has been found to happen also in 
COPD patients (Gosker, et al. 2007; Vogiatzis, et al. 2011; Maddocks, et al. 2014). 
This may be an explanation also for the abnormally low peripheral oxygen extraction 
during exercise seen in Heart failure patients. These peripheral mechanisms are also 
the cause of exercise endurance intolerance in heart failure (Dhakal, et al. 2015; 
Upadhya, et al. 2015). The explanation to the higher oxygen consumption, and the 
lake on oxygen economy by CHD patients compared with age-match control 
exercising at same intensity, can be due to skeletal muscles inefficiency in using 
oxygen, as described in heart failure and COPD patients. There is a need for further 
research in muscle dysfunction, as explaining the full extent changes in muscle 
structure, function, and metabolism, in CHD patients. 
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Chapter 4 and our previous work (Pepera, et al. 2013) explored anthropometric factors 
of height, body mass and body mass index, which can influence ISWT performance 
but they did not directly measure ܸ̇O2.  Taller individuals were found to perform better, 
and this relationship increased in strength at higher speeds. In this current study 
however, the cardiac group were significantly taller (Table 5.1) and yet were still less 
economical in ܸ ̇ O2 than the control group; and there was no between-group differences 
in body mass index. 
 
Another phenomenon, which is not accounted for in all the ISWT data sets thus far, is 
that the ISWT stages are only one-minute in duration. In healthy individuals exercising 
at a constant intensity, a duration of between 40 and 60 s is required for VO2 to rise to 
a submaximal constant, where in patients with cardiovascular disease this can take 
up to 90 s (Koike, et al. 1998; Tajima, et al. 2009). Under beta-blockade, which is 
standard treatment for patients with ischemic heart disease or heart failure, the VO2 
kinetics are also slowed (Dodd, et al. 1988; Kowalchuk and Hughson, 1990). In all 
these cases affected by disease or medication, or both, the ܸ̇O2values during the one-
minute stages of the ISWT should theoretically be diminished in cardiac patients; 
therefore the differences in cardiac versus healthy controls could potentially be even 
greater than what is currently being reported. Future studies in comparing ܸ ̇ O2between 
cardiac and healthy controls at a point after the ܸ̇O2-slow component (Poole and 
Jones, 2012) are required to determine a possible correction factor if practitioners wish 
to transpose exercise intensity information from the ISWT in to steady-state exercise 
prescriptions. 
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5.5.1. Potential Impact of Findings on Use and Interpretation of the ISWT in 
Cardiac Rehabilitation Patients 
 
It is clear that the ACSM equations should not be used to estimate oxygen cost of the 
ISWT and this recommendation also looks likely to be extended to walking speed in 
all adult populations.  The acceptance of linear predictions of oxygen costs means the 
estimates of improvement in VO2 in patients attending cardiac rehabilitation following 
an ISWT could be underestimated.  
 
5.6. Conclusion 
 
In light of historical studies on the oxygen costs of walking and then comparing and 
critiquing the current results and those of previous similar studies on the ISWT, there 
is further confirmation of the curvilinear nature of VO2 as a function of walking speed. 
During the ISWT, it appears that cardiac rehabilitation participants have a VO2 up to 
30% higher than age-matched controls. Together, these findings suggest studies may 
have underestimated the VO2 of cardiac patients as well as improvements in VO2 
following a program of exercise-based cardiac rehabilitation. In estimating VO2 from 
the walking speeds of the ISWT in cardiac rehabilitation participants, the following 
median equation has been derived: VO2 = 4.5e0.37· walking speed (mph). 
 
Future work is required to make similar evaluations in other populations, which use 
the ISWT as an outcome measure and physical activity intensity guidance. In more 
accurately achieving the transposition of the relationship between walking speed and 
VO2 (METs) during the ISWT to physical activity guidance, a correction factor may be 
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required to accommodate the limited oxygen kinetics information that coincides with 
only one-minute stages of the ISWT. 
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 Chapter 6- Predictors of change in exercise capacity in ISWT and 
 incremental treadmill test in cardiac patients 
 
Abstract 
 
Objective: Identifying characteristics of the exercise-based CR program itself which 
are associated with improved or worsened changes in fitness, as identifying both 
modifiable and non-modifiable individual characteristics which influence patients’ 
fitness response to exercise training can aid goal setting, prescription and evaluating 
exercise prescriptions, as well as modifying and improving program delivery to 
maximise potential gains in fitness for patients. 
 
Methodology and results: Five hundred and forty eight patients with clinically stable 
cardiovascular disease from four outpatient cardiac rehabilitation programs completed 
ISWT performance at entry to rehabilitation, and 53 MI patients where changes were 
assessed by treadmill. 
 
There was a significant ISWT change in performance due to CR in male (111 m 
95%CI: 100 to 122. M, t=19.9, p<0001) and female (80, 95%CI: 67 to 94 m, t=11.8 
p<0001) patients. We analysed males and females separately. Young patients, those 
who are male and have a longer time between event and pre-test CR, had a lower 
performance in pre-CR test, have bigger increases in changes in performance in 
exercise tests, may benefit more from CR than older patients, those with a high pre-
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test performance, female patients with a high waist circumference and smoking habits, 
who have lower changes in exercise test performance. 
 
Patients who were older, had a higher baseline ETT performance and those taking 
diuretics had smaller improvements in ETT performance. Attending more exercise 
sessions was associated with a larger change in ETT performance from baseline to 
retest at the end of their CR programmes.  
 
Conclusion: It is recommended CR exercise should be provided in same sex and age 
sessions. The dose of exercise should be increased in women and elderly patients if 
exercising in mixed-CR groups. In sex/age-tailored CR groups, patients with low 
baseline fitness and a high waist circumference, who are smokers, should have a 
higher dose of exercise than others. Patients with high baseline fitness can be fast-
tracked to CR community bases. Further investigation is needed to understand the 
right dose of exercise according to patients’ individual characteristics and needs.  
 
Key words:  Exercise capacity; incremental shuttle walk test; treadmill exercise test; 
predictors of change; cardiac patients; fitness improvements. 
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6. Introduction  
 
Cardiac Rehabilitation programs (CR) are effective in improving cardiorespiratory 
fitness (fitness), the meta-analysis in Chapter 3 (Sandercock, et al. 2011) 
demonstrated a gain of 1.55 (95% confidence intervals [CI]: 1.21–1.89) metabolic 
equivalent (MET) improvements in the cardiorespiratory fitness (CRF) assessed by 
Exercise Treadmill Test (ETT) of patients undertaking exercise-based CR 
programmes. A magnitude of change of ~ 100 metres in mean distance in performance 
of ISWT due to exercise-based CR programmes has been reported in several studies 
(Arnott, 1997; Tobin and Thow, 1999; Fowler and Singh, 2005; Arnold, et al. 2007; 
Sandercock, et al. 2007; Almodhy, et al. 2012; Sandercock, et al. 2012).  
 
Gains in fitness achieved by patients in CR are closely, inversely, related to patient 
mortality and morbidity, and evidence is strong and abundant (Williams,et al. 2006; 
Blair, et al. 1995; Gulati, et al. 2003. These studies show us the cross-sectional 
associations between fitness and mortality, others studies have demonstrated the 
degree of impact that fitness gains have on mortality due to CR programmes (Myers, 
et al. 2002; Dorn, et al. 1999; Kavanagh, et al. 2003; Vanhees, et al. 1995, Keteyian, 
et al. 2008) 
 
CR is effective in increasing changes in fitness (ΔFitness) in all patients (females and 
males), and in all age groups (young < 65 years, elderly-young 65-75 years or elderly 
>75), however changes in fitness are not of the same magnitude in all patients (Ades, 
2001; Lavie and Milani, 2004; Audelin, et al. 2008). The degree of ΔFitness due to an 
exercise-based CR program depends on patients’ individual non-modifiable 
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characteristics such as age and gender, as reported in Chapter 3 (Sandercock, et al. 
2011).  
 
The impact of age on ΔFitness assessed by ETT, has been reported previously with 
abundance in literature, where some studies reveal no significant differences in age 
groups on ΔFitness (Balady, et al. 1996; Lavie, et al. 1993; Lavie, et al. 1995), others 
report that older patients have higher ΔFitness than younger patients (Ades and 
Grunvald, 1990; Ades, et al. 1993; Lavie and Milani, 1996; Lavie and Milani, 1995).  
 
Higher ΔFitness in younger compared with elderly CHD patients have been fully 
reported in more recent studies, where they were assessed by ETT, (Williams, et al. 
1985; Lavie and Milani, 2001; Sandercock, et al. 2011; McKee, et al. 2013, St. Clair, 
et al. 2014; Beckie, et al. 2013) by cycle ergometer test (Marchionni, et al. 2003); or 6 
m walk test (Maniar, et al. 2009; Listerman, et al. 2011). In ISWT no predictors of 
change in performance have been assessed yet, only older age associated with less 
change in performance in cardiac patients (Almodhy, et al. 2012).  
 
The same magnitude of ΔFitness between genders has been reported (Balady, et al. 
1996); (Lavie and Milani, 1997), however differences according to genders have also 
been reported recently, females have less ΔFitness than males (Mckee, 2008; 
Sandercock, et al. 2011; Savage, et al. 2008; St. Clair, et al. 2014). 
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The degree of ΔFitness due to an exercise-based CR programme depends also on 
patients’ individual modifiable characteristics.  High baseline fitness with high patients’ 
initial test score at entry at CR is negatively associated with ΔFitness. This fact has 
been shown (Beckie, et al. 2013; Mckee 2008; Lavie and Milani, 1994; Ballady, et al 
1996; McKee, et al. 2008, 2013) and at 6 months follow-up from CR (Pierson, et al. 
2004). A negative influence on ΔFitness was seen previously by waist circumference 
(Beckie, et al. 2013), BMI (Lavie and Milani, 1996) and the presence of diabetes (Milani 
and Lavie, 1994; Milani and Lavie, 1996; Savage, et al. 2008), low hand grip strength 
(Savage, et al. 2008), smoking (Weinberger, et al. 2014), BMI and smoking status at 
6 month follow-up (Lee, et al. 2002).  
 
Chapter 3 identified some of the characteristics of the clinical service that can also 
influence the ΔFitness in patients involved in CR. Programmes had variables able to 
promote optimal stimulus and higher ΔFitness, such as including n≥36 sessions in the 
cardiac rehabilitation programme of aerobic, or mixed aerobic, and resistance exercise 
with a programme length of 12 weeks. No evidence of additional benefits to patients 
was found for longer cardiac rehabilitation programmes, and no evidence for 
combining exercise training with patient education (comprehensive cardiac 
rehabilitation), and improvements in ΔFitness. ETT protocol used to assess ΔFitness 
in patients has a major impact on the estimate of ΔFitness and it is difficult to compare 
studies which use different testing protocols. 
    
The ability to predict changes in exercise from performance in different types of testing 
of a (ISWT or Exercise Treadmill test) is a practical clinical necessity to better prescribe 
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the dose of exercise and evaluate the exercise prescription, and to better tailor CR 
programmes according to patients’ individual differences and needs. 
 
6.1. Aims and hypothesis 
 
Just as variables other than cardiorespiratory fitness are unlikely to account for the 
majority of variance observed in the ISWT performance, there is little value in 
attempting to create accurate predictive models of ΔFitness. The aim of this chapter 
is to identify non-modifiable and modifiable predictors of change in ISWT for the first 
time, and discriminate further predictors of change in performance assessed by 
Exercise Treadmill Test performance in post-outpatient CR patients (post-CR). 
 
6.2. Methods  
 
6.2.1. Participants 
 
We accessed clinical records of n=547 (415 males) (76% male) patients (63.1 ± 11.3 
years) who completed outpatient cardiac rehabilitation at four UK hospitals: (In Greater 
London, Essex, Cumbria and Middlesex) and extracted clinical data and details of 10 
m ISWT performance at exit from rehabilitation. Table 4.2 gives the clinical 
characteristics and baseline measurements, diagnosis and reasons for attending CR 
of cohorts, presented in chapter 4. 
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We accessed clinical records of n=51 (44 males) (86% male) patients (63.1 ± 11.3 
years) who completed outpatient cardiac rehabilitation (from May 2011 to November 
2012 at the Centro Hospitalar de Vila Nova de Gaia/Espinho, Portugal), and extracted 
clinical data and details of Exercise Treadmill Test performance at exit from 
rehabilitation. Those aged ≥18 years, men and women, referred to the Hospital 
Cardiology Department after an acute MI. Exclusion criteria included the presence of 
uncontrolled cardiac arrhythmias, unstable angina pectoris, uncontrolled 
hypertension, significant valvular disease, diagnosis of heart failure, uncontrolled 
metabolic disease (e.g. uncontrolled diabetes and thyroid disease), presence of 
pulmonary and renal comorbidities, conditions limiting participation in exercise training 
(e.g. peripheral artery disease, orthopaedic limitations, and musculoskeletal disorder), 
abnormal hemodynamic responses, myocardial ischemia, and/or severe ventricular 
arrhythmias during baseline exercise testing. Table 6.2 gives the clinical 
characteristics and baseline measurements, diagnosis and reasons for attending CR 
of cohorts.  
 
6.2.2. Procedures and data collection 
 
Data collecting and ethical approval for this study was the same as presented in 
Chapter 4 for the ISWT cohort.  The ISWT cohort had a core component of supervised 
exercise training and some aspect of formal patient education or counselling on 
lifestyle change. The services used mixed circuit-based (aerobic and resistance) 
exercise training sessions of 60 min duration, including a 15 min warm-up and cool-
down performed at the beginning and end (SIGN 2002). The CR programmes were 6 
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to 8 weeks long, and based on one exercise session a week on average. Our median 
time from event to ISWT was 53 days.  
 
Data for the ETT group was collected at one hospital which reported delivering 
comprehensive CR and routinely using the Exercise Treadmill Test in accordance with 
national guidance. The ethical approval for this study was obtained by the Hospital 
Ethics Committee (reference 627/2010). All procedures were conducted according to 
the Declaration of Helsinki, and the trial has been registered at ClinicalTrials.gov 
(NCT01432639). 
 
Every patient who agreed to participate in the study provided a written informed 
consent. In brief, 4 weeks after an acute MI, consenting patients were assigned to an 
exercise-based CR exercise training, based on 3 supervised exercise sessions per 
week for 8 weeks (10 minutes of warm-up, 30 minutes of aerobic exercise on a cycle 
ergometer or treadmill at 70%-85% of maximal heart rate achieved in the exercise test 
and 10 minutes of cool-down). During the exercise sessions, the participant’s heart 
rate was continuously monitored by electrocardiogram, and levels of exertion were 
assessed with the Borg scale. In addition, these patients were also under the usual 
medical care and follow-up (e.g. regular appointments with a cardiologist and 
optimised medication). 
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6.2.3. Statistical analysis  
 
Pearson Product Moment Correlation was used to examine the relationship of possible 
and logical predictors, with performance measured in both types of assessment, ISWT 
and Exercise Treadmill Test (ETT). Predictors of change in ISWT and ETT 
performance were identifed in the population as a whole, and an independent t-test 
was used to describe the difference in male and female test performance in the data 
from the cohort assessed by ISWT, as the data from the cohort assed by ETT did not 
have a sufficient number of females to discriminate between sexes.  
 
After differences were affirmed, we performed enter multiple regressions to determine 
significant predictors of change in performance in the ETT group, and in the ISWT 
group by males and females. We assessed predictors for collinearity; defined as 
variance inflation factor >4.0 (Rogerson 2001). Statistical significance was set at 
p<0.05 and all analyses were performed using SPSS 19.0 (SPSS, an IBM Company, 
Armon, NY). 
 
6.3. Results 
 
6.3.1. Cohort performance assessed by ISWT  
 
There was an overall ISWT change in performance due to CR, 365 ±164 m in pre-CR 
and 468 ±194 m in post-CR. Independent t-tests verified a significant difference of 
change in performance 104 ±107 m (95%CI 94.7 to 112.7, t=22.7, p<0001).  
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There was a significant ISWT change in performance due to CR in both sexes. 
Independent t-tests showed a significantly (t=19.9, p<0001) greater change in 
performance in males (111 95%CI 100 to 122 m), than females (80 ±79 95%CI 67 to 
94 m). 
 
We analysed males and females separately.  Results of multivariate regression (Enter 
Method) are given in table 6.1 with predictors given in order of magnitude. Age was 
the best predictor of change in ISWT performance in males. Time from event to pre-
test (days) predicted more changes, and higher pre-rehabilitation distance achieve in 
ISWT was a predictor of less change in ISWT performance. However, this model 
explained only 7.8% of variance for change in ISWT performance in men. 
 
Age also predicted change in females but was less powerful than baseline ISWT 
performance. Waist circumference and smoking were both negatively associated with 
change in ISWT performance. This model explained 28% of the overall variance 
observed for change in ISWT performance in women. 
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Table 6.1. Predictors of change in ISWT performance due to CR 
Predictors in males β  R2  S.E.E 
(m) 
Age (years) β= -2.91 m (95%CI -4.1 to -1.7)    
Event to CR (days) β=  1.43 m  (95%CI 3.1 to  6.8)  .078 111 
Baseline ISWT (m) β= -0.10 m (95%CI -1.72 to -0.25)    
  
Predictors in females         Β R2   S.E.E 
(m) 
Baseline ISWT (m) β= -0.19 m  (95%CI -0.30 to -0.10)   
Age (years) β= -1.83 m  (95%CI -2.9 to -.74)   
Waist circumference (cm) β= -0.42 m  (95%CI -0.7 to -.11) .288 61 
Smoking β=  -31.6 m  (95%CI -61.3 to -1.8) 
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6.3.2. Cohort performance assessed by ETT 
 
Table 6.2. Descriptive characteristics of Cohort assessed by ETT   
 
ETT performance improved from 514.5 ±148.8 s pre-CR to 600.5 ±160.3 s at post-CR. 
Paired t-test showed the mean difference in ETT performance 85.9 95%CI: 64.0 to 
107.8) was statistically significant, (t=7.89, p<0001). 
 
Results of the enter multivariate regression model is given in table 6.3. Patients who 
were older, had a higher baseline ETT performance and those taking diuretics had 
smaller improvements in ETT performance. Attending more exercise sessions was 
associated with a larger change in ETT performance from baseline to retest at the end 
of their CR programmes.  
Clinical characteristics and baseline measurements                            Mean (SD) 
Number of patients                                                                                            51 
Age (years)                                                                                                    55.4 (± 3.4)  
Gender (males)                                                                                              44 (86.3%) 
Height (cm)                                                                                                 167.8  (± 8.6) 
Weight (Kg)                                                                                                  76.7 (± 10.8) 
Body Mass Index (kg/m2)                                                                              27.3 (± 3.8) 
Diabetes                                                                                                           11 (21.6%)                                                                                         
Smoking                                                                                                           24 (47.1%) 
MI                                                                                                                       51 (100%) 
CABG                                                                                                               48 (94.1%) 
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Table 6.3. Predictors of change in ETT performance due to CR 
Predictors of change β  R2     S.E.E (s) 
Age (years) β=  -3.29  (95%CI -5.4 to -1.1)    
Baseline ETT (s) β=  -.205   (95%CI -.36 to - .04)  0.31 67.2 
Diuretics β=  -.73.1  (95%CI -137 to -8.4)    
Number of CR 
sessions 
β=    6.82  (95%CI  7.4 to 12.9)   
Legend: ETT – exercise tolerance test. Diuretics (Y/N) Number of CR sessions (out of 
maximum value of 24) 
 
6.4. Discussion  
 
The National Audit of Cardiac Rehabilitation (NACR) shows UK programmes cater for 
a wide age-range of patients of both sexes who may present with numerous clinical 
diagnoses and any number of comorbidities (Doherty 2014). As would be expected in 
such a varied population, patients’ ISWT performance is highly heterogeneous when 
assessed at the start of cardiac rehabilitation (Arnold, et al. 2007; Sandercock, et al. 
2007; Sandercock, et al. 2012; Sandercock, et al. 2013) and the same is expected at 
exit of CR programmes. Despite evidence that performance differs by age and sex in 
healthy adults (Jurgensen, Antunes et al. 2011; Probst, Hernandes et al. 2012; 
Harrison, Greening et al. 2013), and supported by the findings of chapter 4 in 
predictors of performance in ISWT in cardiac patients, although there are no reference 
predictors to explain the heterogeneity seen in changes in performance in ISWT due 
to CR. 
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The aim of this study was to aid interpretation of changes in performance in CHD 
patients due to CR programmes, in exercise capacity measurements, in two different 
cohorts, one using the ISWT and other a Modified Bruce Treadmill Protocol Exercise 
Tolerance Test (ETT). Both cohorts analysed by us had significant improvements in 
exercise capacity in a post-CR test. The performance of Old patients and patients with 
higher baseline performance increases less due to CR. Age and Baseline performance 
are strong predictors of change in both genders in the ISWT cohort and ETT cohort.  
In ISWT cohort males who wait less than 12 weeks to start CR after an event, females 
with a bigger waist circumference and who smoke, were both negatively associated 
with change in ISWT performance. In the ETT cohort, those taking diuretics had 
smaller improvements in ETT performance, and those attending less exercise 
sessions. 
 
6.4.1. Predictors of change in performance  
 
6.4.1.1. Non-modifiable predictors  
 
6.4.1.1.1. Gender 
 
This study was able to discriminate predictors of change in performance of ISWT 
according to sexes. The performance of males changes more than that of women. 
This effect in sexes on the magnitude of changes assessed by ETT has been reported 
before by us in chapter 3 and elsewhere (St. Clair, et al. 2014; Mckee, 2008; 
Sandercock, et al. 2011; Savage, et al. 2008). Sex was not a predictor of change in 
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performance assessed by ETT in our cohort, maybe due to the inclusion of only 7 
women in the cohort of 51 patients assessed, not possessing enough power of 
analysis to discriminate differences between sexes.  
 
There are no physiological reasons that justify males having more adaptation in 
exercise capacity due to CR than females, as seen in our findings in changes in 
performance assessed by ISWT. However, as discussed in chapter 3, more deep 
epidemiological and clinical studies report that women have worse CVD clinical profile 
as prevalence, worse presentation (symptoms and age of onset), worse disease 
outcomes, and worse disease management and rehabilitation, possessing more 
comorbidities, although not much is known why CVD affects genders differently 
(Mikhail 2005; Pilote, et al. 2007).  
 
Women with CHD also have adverse psychosocial profiles, poor attendance at CR 
programmes, and specific gender biopsychosocial barriers to CR than men, as 
discussed in chapter 3 already and elsewhere (Beckie, et al. 2009). Randomised 
studies in females completing a tailored programme that included motivational 
interviewing guided by the Trans-theoretical Model (TTM) of behaviour change, and 
delivered with a motivational interviewing counselling style, compared with females in 
a mixed-gender CR programme under the same exercise prescription, revealed that 
the CR programme tailored for women significantly improved global QOL (Beckie and 
Beckstead, 2010), improved general health perceptions that contribute to healthy 
behaviours, social functioning, and mental health (Beckie and Beckstead, 2011), such 
as reduced depressive symptoms (Beckie, et al. 2011), increasing exercise 
attendance by 4 sessions and education sessions attendance by 31% (Beckie and 
 204
Beckstead, 2010). There are several reasons that may justify less responsiveness in 
ΔFitness due to CR in females then males.   
 
Low level of baseline fitness is another factor associated with disability in females, 
reported in all studies that assessed changes in performance due to CR by ETT that 
discriminate genders in results  (St. Clair, et al. 2014; Balady, et al. 1996; Lavie and 
Milani, 1997, Mckee, 2008; Sandercock, et al. 2011; Ades,  et al. 2006) and in ISWT 
(Jurgensen, et al. 2011; Probst, et al. 2012; Harrison, et al. 2013), and supported by 
the findings of chapter 4 on predictors of performance in ISWT in cardiac patients.  
 
When optimal clinical care and optimal conditions of a comprehensive-CR programme 
are established, similar changes in fitness in both genders due to the same CR 
programme have been reported (Balady, et al. 1996), and 1.4 and 1.6 METs change 
in fitness reported in females exercising in mixed-gender CR (Lavie and Milani, 1997; 
Beckie, et al. 2013), being of the same magnitude of what is expected in CHD patients 
responsiveness in fitness due to an exercise-based CR, as found in chapter 3 
(Sandercock, et al. 2011). In chapter 3 (Sandercock, et al. 2011) women have higher 
ΔFitness when exercising in female-only CR compared with females exercising in 
mixed-gender CR.  
 
Chapter 3 (Sandercock, et al. 2011) reports that males had higher gains in fitness 
exercising in gender-specific CR, than in mixed-gender CR, or female-only CR. Higher 
gains in fitness in male-only CR may be an effect of their competitive nature within the 
group session, making them exercise harder. When males exercise in a mixed-gender 
CR programme, they may feel distracted, and overwhelmed in the presence of 
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females, or tending to feel shy and less confident, not fully engaging in CR exercise 
programme (Yohannes, et al. 2007).  Females were more likely than males to describe 
that they limited activities to be “safe for their heart” (Audelin, et al. 2008). 
 
Real CR programmes as in our study, presented in other literature (St. Clair, et al. 
2014; Mckee, 2008; Savage, et al. 2008), or in a bigger view given by a meta-analysis 
done in chapter 3 (Sandercock, et al. 2011), reveal that CR in males increases more 
than females, which leads to the conclusion that tailoring exercise by gender will 
optimize ΔFitness outcomes in CR. These findings are important for practitioners in 
setting goals for patients, they should expect lower ΔFitness in female patients, and 
lower baseline fitness.  
 
Based on the evidence, important implications for better service delivery (service 
design, better prescription of the dose of exercise, definition of CR goals, and 
evaluation of the exercise prescription) are concluded: that although CR should be 
tailored by sex, females exercising in mix-gender CR will benefit as much for CR as 
men in ΔFitness, if the dose of exercise (number of exercise sessions) is higher than 
males. Further research to determine the right dose of exercise is needed in both 
sexes as sexes also differ in baseline fitness.    
  
Further research is needed to understand why differences in genders are seen in the 
magnitude of responsiveness to CR programmes. Analysis should focus also on other 
factors towards CVD behaviour between males and females that may help to explain 
the influence of differences in genders, such as cultural, psychosocial and socio-
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economic status (Pilote, et al. 2007). This will help to better design out-patient hospital 
CR programmes with the intention of optimising fitness changes. 
 
6.4.1.1.2. Age  
 
Like sex, patients’ age is a non-modifiable predictor of ΔFitness. Age is a common 
predictor of change in performance in the ISWT cohort in both sexes, and also in the 
cohort assessed by ETT. The performance of old patients in exercise tests after CR 
changes less than that of younger patients, this finding was also reported in chapter 3 
(Sandercock, et al. 2011) and elsewhere (Williams, et al. 1985; Lavie and Milani, 2001, 
Sandercock, et al. 2011; McKee, et al. 2013; St. Clair, et al. 2014; Beckie, et al. 2013), 
by cycle ergometer test (Marchionni, et al. 2003); or 6 m walk test (Maniar, et al. 2009; 
Listerman, et al. 2011).  
 
Despite different findings elsewhere, where some studies reveal no significant 
differences in age groups’ effect on ΔFitness (Balady, et al. 1996; Lavie, et al. 1993; 
Lavie, et al. 1995), others report that older patients have higher ΔFitness than younger 
patients (Ades and Grunvald, 1990; Ades, et al. 1993; Lavie and Milani, 1996; Lavie 
and Milani, 1995).  
 
The fact that ageing has a negative effect on ΔFitness in CHD patients, as in our 
findings, can be also supported by previous literature which reports that elderly 
patients with CVD have very high rates of disability, as the consequence of CHD 
disease or pathology, higher recurrent coronary events, and higher health resources 
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use, than people without coronary heart disease. More advanced age (middle age 65-
75 years and older age patients 75> years), and especially female patients with clinical 
manifestations of angina pectoris or chronic heart failure are associated with the 
highest rates of disability. Older CHD patients suffer more from depression symptoms 
(Pinsky, et al. 1990, Ades, 2001, Rich, et al. 1992; Ades, et al. 2002; Lavie and Milani, 
2004; Audelin, et al. 2008) age is also a predictor of death in CHD patients (Rich, et 
al. 1992).  
 
Age has a negative impact on cardiac function (decline peak aerobic capacity), and 
structure as reported in chapter 3. Lack of physical activity is a higher risk factor in 
older patients for chronic disease and disability, and the cardiac responsiveness due 
to exercise based-CR is also blunted in older patients. (Stratton, et al. 1994, Heckman 
and McKelvie, 2008; Ferrari, et al. 2003; Fleg, et al. 2005). This may represent some 
reduction in physiological adaptability, particularly in the oldest patients, as a possible 
cause for less ΔFitness in elderly compared with younger patients in post-CR tests 
when submitted to the same exercise-based CR protocol. In chapter 3 (Sandercock, 
et al. 2011) the ΔFitness were less than half those of younger patients. Several factors 
can explain less ΔFitness in elderly patients. 
 
Other factors associated with disability in elderly are a low level of baseline fitness, 
reported in all studies that assessed changes in performance due to CR by ETT 
(Williams, et al. 1985; Lavie and Milani, 2001; Sandercock, et al. 2011; McKee, et al. 
2013; Marchionni, et al. 2003; Maniar, et al. 2009; Listerman, et al. 2011; Balady, et 
al. 1996; Lavie, et al. 1993; Lavie, et al. 1995, Ades and Grunvald, 1990; Ades, et al. 
1993; Lavie and Milani 1996; Lavie and Milani 1995; Ades, et al. 2006; St. Clair, et al. 
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2014), and in ISWT (Arnold, et al. 2007; Sandercock, et al. 2007; Sandercock, et al. 
2012; Sandercock, et al. 2013), and in ISWT (Jurgensen, et al. 2011; Probst, et al. 
2012; Harrison, et al. 2013), and also supported by the findings of chapter 4 in 
predictors of performance on ISWT in cardiac patients. 
 
These findings are important for practitioners in setting goals for patients, who should 
expect lower ΔFitness in older patients, and lower baseline fitness, when fitness is 
shown in absolute terms as in our analysis. If the ΔFitness levels were shown in 
relative percentage gains, the changes observed in older patients may be equal or 
even higher that of younger patients due to lower baseline fitness values. 
 
The findings of chapter 3 (Sandercock, et al. 2011), and those reported elsewhere 
(Williams, et al. 1985; Lavie and Milani, 2001; McKee, et al. 2013; (Marchionni, et al. 
2003; Maniar, et al. 2009; Listerman, et al. 2011; St. Clair, et al. 2014) leads us to the 
conclusion that tailoring exercise by age/sex tailored CR, will optimize ΔFitness 
outcomes in CR. It is not clear whether there is a need to stratify by group age (<65, 
65 to 75 and 75>) or just have a cut-off point for very elderly (65> or 75> years) where 
the intervention is most needed and mostly depends on the patients’ age group being 
treated.   
 
Based on the evidence, important implications for better service delivery (service 
design better prescription of the dose of exercise, setting fitness CR goals, and 
evaluation of the exercise prescription) are concluded, that exercise groups should be 
according to age group, in gender-tailored CR or when elderly patients exercising in 
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mixed CR, will benefit as much for CR than younger patients in ΔFitness, if the dose 
of exercise is higher than younger patients.      
 
6.4.1.2. Modifiable predictors 
 
6.4.1.2.1. Baseline fitness 
 
Better initial pre-CR test performance was associated with smaller gains in fitness in 
both sexes in the ISWT cohort, as in the ETT cohort. Baseline performance in the 
performance test at entry to CR has also been reported as a predictor of ΔFitness at 
CR exit assessed by ETT (Beckie, et al. 2013; Mckee 2008; Lavie and Milani, 1994; 
Ballady, et al 1996; McKee, et al. 2013). The more sedentary an individual is, the more 
impact and responsiveness he/she will have to the exercise programme and increase 
in ΔFitness. This finding was expected and represents the often reported phenomenon 
known as the law of initial values, or regression to the mean reported in Healthy 
(Bouchard and Rankinen, 2001) and CHD patients (Swain, 2005; Sakuragi, et al. 
2003).  
 
These findings are important for practitioners in setting goals for patients. Lower 
ΔFitness are expected in older patients, and in females, compared with young and 
male patients due to CR.  However, as we report above, based on our findings and 
elsewhere, the benefit in higher ΔFitness based on low baseline fitness should be 
interpreted based within age, and sex groups of CHD, e.g. females young patients 
with a low baseline will increase less than young males with low baseline fitness.  
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Based on the evidence, important implications for better service delivery (service 
design, better prescription of the dose of exercise, setting fitness CR goals, and 
evaluation of the exercise prescription), it is concluded that  patients possessing a 
higher baseline in mixed-CR, or gender-tailored CR, would benefit and optimise their 
higher ΔFitness, if their exercise programme is based on a lower dose of exercise than 
patients with lower baseline values at entry to CR, and can be fast-tracked for 
community CR. 
 
6.4.1.2.2. Diuretics medication 
 
In the CHD, patients on diuretics medication assessed by ETT have less ΔFitness, 
although these patients were older, and had a worst ejection fraction, revealing signs 
of heart failure. This predictor of ΔFitness has never been reported before in literature. 
In the ISWT cohort, there were no changes in performance among patients under this 
medication.  
 
If it is confirmed, this has important implications for better service delivery (service 
design, better prescription of the dose of exercise, and evaluation of the exercise 
prescription). When exercising in mixed-CR, sex/age-tailored CR programmes, 
patients on diuretics medication would benefit and optimise their higher ΔFitness, if 
their exercise programme is based on higher volumes of exercise, than patients not 
taking diuretics. 
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6.4.1.2.3. Time wait to CR 
 
Bigger changes in exercise performance are associated with male patients who had 
waited longer to begin CR (time from event to pre-CR test) in ISWT. This is the 
opposite of what would be expected, as a longer delay should lead to greater 
spontaneous recovery after event, although this effect is only seen in patients that wait 
up to 12 weeks, those that wait longer than 12 weeks had a lower baseline, they could 
become deconditioned while they wait longer, and also improve less than the patients 
starting CR up to 12 weeks after event. It is not expected as lower baseline is a 
predictor of higher ΔFitness. In the ETT cohort, the time from event to CR was the 
same in all patients making it impossible to determine the influence of time to CR in 
ΔFitness. Although such finding needs to be further investigated.  
 
If it is confirmed this has important implications for better service delivery in men 
patients mainly (service design, better prescription of the dose of exercise, and 
evaluation of the exercise prescription) as patients will benefit more from CR if they 
are enrolled at CR programmes after 12 weeks from event. 
 
6.4.1.2.4. Waist circumference  
 
In the ISWT cohort females with a bigger waist circumference (WC) are associated 
negatively with change in ISWT performance at CR exit, this fact has been reported in 
ΔFitness assessed by ETT (Beckie, et al. 2013). Although was not a predictor in males 
in ISWT cohort neither in ETT cohort. Waist circumference is a measure of central 
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adiposity. The combined effect of high central adiposity and low CRF is particularly 
significantly associated with increased mortality in CR (Goel, et al. 2011). WC has also 
been associated as the best anthropometric measure to determine the risk of CVD in 
men and woman of central adiposity (Pouliot, et al. 1994). Males with a high WC above 
102 cm and females above 88 cm are at high risk of a CHD (Balady, et al. 2007).   
 
Higher BMI has also been associated with less ΔFitness (Lavie and Milani, 1996). 
Obese CHD patients change less in ΔFitness than non-obese CHD patients. Obesity 
is an independent risk factor for CHD. In the USA at entry over 80% of patients are 
overweight and over 50% have metabolic syndrome. CR programmes normally do not 
include a weight loss component as a primary aim and weight loss outcomes in CR 
are not effective in the reduction of body weight, or only minimal weight loss occurs in 
CR programmes (Savage,  et al. 2000; Ades, et al. 2010). 
 
Different effective approaches and design of CR programmes have been developed 
to tackle and optimise the reduction of body weight in CR programmes, such as 
implementing weight changing behaviour counselling sessions in a CR setting, along 
with high energy expenditure exercise sessions (long duration), and with a high 
frequency of exercise sessions per week (mostly daily exercise sessions), and longer 
programmes lengths (12 weeks, 5 months, 12 months), with outpatient CR 
complemented with home-based CR. Higher ΔFitness are also associated with higher 
body weight reduction too (Savage, et al. 2000;  Ades, et al. 2009; Araya-Ramírez 
2010). Effective weight reduction in CHD patients was also reported by just increasing 
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exercise daily (12 months of continuous exercise) without any restriction in diet 
(Mertens, et al. 1998). 
 
Based on the evidence, important implications for better service delivery (service 
design, better prescription of the dose of exercise, and evaluation of the exercise 
prescription) are concluded. Patients with higher central obesity revealed by higher 
waist circumference or high BMI (BMI 25>kg/m2 Overweight, or 30> kg/m2 Obese) 
when exercising in mixed-CR, sex/age-tailored CR programmes, would benefit and 
optimize their higher ΔFitness, if their exercise programme is based on higher volumes 
of exercise (higher frequency, daily if possible, and long duration of exercise sessions 
per week) done in outpatient CR complemented with home-CR, as literature reports, 
than patients with lower WC and BMI at entry to CR. Although to optimise the right 
dose of exercise for these patients further research is needed.   
 
6.4.1.2.5. Smoking habit  
 
In ISWT, smoking was negatively associated with a change in ISWT performance in 
females, although smoking was not a predictor in men in either the ISWT cohort or in 
the ETT cohort. CHD patients that were smokers had lower ΔFitness at the end of CR 
compared with non-smokers, when assessed by ETT (Weinberger, et al. 2014).  
 
Smoking is a major risk factor for CHD morbidity and mortality, and is considered to 
be the most preventable cause of death in the world. Cigarette smoke contains more 
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than 4000 chemical substances, including nicotine and carbon monoxide (CO) that 
have harmful effects on cardiovascular function. These tobacco smoke ingredients 
cause an increase in oxidative stress that promotes endothelial damage and 
dysfunction, causing intravascular inflammation, which promotes the development of 
atherosclerosis from endothelial dysfunction to acute clinical events, the latter being 
largely thrombotic and CHD. (Ambrose and Barua, 2004; Csiszar, et al. 2009, 
Tomiyama, et al. 2010).  
 
Female smokers have higher risk of CVD than male smokers (Bolego, et al. 2002; 
Tan, et al. 2010; Wenger, 2003, Weinberger, et al. 2014) and higher CVD mortality 
than males (Eisner, et al. 2010; Mosca, et al. 2007; Mosca, et al. 2011). A recent meta-
analysis showed that female smokers demonstrated a 25% greater risk of coronary 
heart disease than male smokers after controlling for other CVD risk factors, reported 
in a meta-analysis (Huxley and Woodward, 2011).  
 
Continuing smoking after a cardiac event greatly increases mortality risk. Smoking 
cessation and participation in cardiac rehabilitation (CR) are effective in reducing 
morbidity and mortality, as improvements in endothelial function, which may mediate 
part of the reduced cardiovascular disease risk reported after smoking cessation. 
Hospital-based smoking cessation programmes, as well as referral to cardiac 
rehabilitation, were strongly associated with increased smoking cessation rates 
(Dawood, et al. 2008). However smoking status also predicted not attending CR and 
was a strong predictor of CR dropout (Johnson, et al. 2010; Gaalema, et al. 2015). 
Females have more adverse cardiovascular consequences from smoking, however 
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cessation of tobacco has greater cardiovascular benefits for women compared to men 
(Mercuro, et al. 2010). Smokers also have lower baseline fitness at entry to CR 
(Asthana, et al. 2012).  
 
These findings are important for practitioners in setting goals for smoker patients, 
lower ΔFitness should be expected in smoker patients, and most important in female 
smokers. Based on the evidence, important implications for better service delivery 
(service design, better prescription of the dose of exercise, setting fitness CR goals, 
and evaluation of the exercise prescription) are concluded, that smoker patients, most 
importantly female patients, when exercising in sex/aged-tailored CR or when 
exercising in mixed-CR, would benefit and optimise their higher ΔFitness, if their 
exercise programme is based on a higher dose of exercise, than non-smoker CHD 
patients. 
 
6.4.1.2.6. Number of Exercise Sessions 
 
The higher number of sessions (dose of exercise=number of sessions) has a positive 
influence on ΔFitness in the ETT cohort, being a predictor ΔFitness (exercise based 
CR based on 24 sessions). In ISWT the number of sessions is very low, from 6 to 8 
sessions, which may be a reason for not being a predictor in this cohort. The higher 
responsiveness on ΔFitness with a higher number of sessions was also reported in 
Chapter 3 (Sandercock, et al. 2011), CR programmes of >36 sessions resulted in 
higher gains in patients’ fitness than when exercising with a  lower number of sessions, 
the total number of  exercise sessions represents a good analysis of the exercise dose 
used in each programme, and more sessions will represent higher fitness gains, this 
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dose-response relationship is seen in several studies done in CR programmes (Miller, 
et al. 1984; Soleimani, et al. 2009, Reid, et al. 2006). Chapter 3 also revealed that 
there was no difference in ΔFitness in different CR programme lengths (less than 12 
weeks and more than 12 weeks). 
 
Twelve weeks in our analysis in chapter 3 was the both the median and modal values 
for the subgroup duration, this being the reference value for CR programmes duration 
supported by guidelines in U.S. (Thomas, et al. 2010), U.K. (SIGN, 2002) or Europe 
(Piepoli, et al. 2010). Most of the evidence of ΔFitness reported in the literature is 
based on a 12 week length programme of 36 sessions of comprehensive-CR 
programmes (Balady, et al. 1996; Lavie, et al. 1993; Lavie, et al. 1995; Ades and 
Grunvald, 1990; Ades, et al. 1993; Lavie and Milani, 1996; Lavie and Milani, 1995; 
Williams, et al. 1985; Lavie and Milani, 2001; Sandercock, et al. 2011; McKee, et al. 
2013;  St. Clair, et al. 2014; Beckie, et al. 2013; Marchionni, et al. 2003); or 6 m walk 
test (Maniar, et al. 2009; Listerman, et al. 2011; Almodhy, et al. 2012; Lavie and Milani, 
1997; Mckee, 2008; Sandercock, et al. 2011; Savage, et al. 2008; St. Clair, et al. 2014, 
Beckie, et al. 2013; Mckee, 2008; Lavie and Milani 1994; McKee, et al. 2008, 2013; 
Pierson, et al. 2004;. Beckie, et al. 2013; BMI (Milani and Lavie, 1994; Milani and 
Lavie, 1996; Savage, et al. 2008; Savage, et al. 2008; Lee, et al. 2002). In unfit 
individuals, such as CHD patients, most of the gains in fitness are observed in the first 
4 to 12 weeks of a training programme. (Miller, et al. 1984; Soleimani, et al. 2009; 
Wright, et al. 2002). 
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These findings are important for practitioners for designing CR programmes and in 
setting goals for patients, the most important is not so much the length of a CR 
programme, as reported by findings in chapter 3, but the number of exercise sessions 
performed by the patients, which can also increase in a longer programme depending 
on the exercise prescription, and group of patients’ needs, as e.g. women with high 
waist-circumference. The basic design is 12 weeks, 36 sessions, with a frequency of 
3 sessions a week. Programmes with this length can incorporate more sessions, the 
progression in the dose of exercise can increase from 3 to 7 sessions a week.  
 
Existing guidelines for CR programmes implementation are available over much of the 
developed world such as U.S. (Thomas, et al. 2007) and Europe (Piepoli, et al. 2010), 
UK (SIGN, 2002) although some variation in written guidance, in local understanding 
of such guidance and financial restrictions show us that CR programmes could be 
more heterogeneous than we might have thought, when compared for instance with 
pharmacological intervention. In the ETT cohort, the CR programme was based in 8 
weeks, 24 sessions in Portugal, and the ISWT cohort based on 6 to 8 weeks, 6 to 8 
sessions in the UK. Both programmes differ from the guidelines proposed. 
 
Based on the evidence important implications for better service delivery (service 
design, better prescription of the dose of exercise, setting fitness CR goals, and 
evaluation of the exercise prescription), and as discussed in above sections, it is 
concluded that the dose of exercise (1 to 7 sessions a week, in a 12 week length CR 
programme) should be according to the individuals’ needs and characteristics of each 
age-group and sex of CHD patients. Taking into consideration individual differences 
such as baseline fitness, waist-circumference, and smoking status, should predict if a 
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higher dose of exercise is needed or not. Further investigation is needed to determine 
the right dose of exercise for each group of patients.  
 
6.4.3. Summary and Applications of Chapter Findings 
 
Patients’ mean age (63 ±11 years) is slightly lower than the typical age (66-70 years) 
of patients reported nationally (Doherty, 2014). The mean age of male patients (62 
±13 years) was close to the national mean value of 66 years but the mean age of our 
female patients (63 ±17 years) was seven years lower than the national average. 
Given this age difference, and the smaller sample size the present reference values 
may be less generalisable for female CR patients than for males. The smaller sample 
of females is to be expected when accessing data from patient records. Nationally, 
men account for 70% of cardiac rehabilitation patients slightly lower than the 76% 
value in our sample. The proportion of white participants (79.5%) was similar to 
national data (80%).  Our median time from event to ISWT was 53 days. Post-MI 
patients typically start rehabilitation 40 days following treatment with PCI; patients 
receiving CABG start an average of 54 days after referral (Doherty, 2014). 
Comparable times for our sample were 42 days (for Post-MI, patients receiving PCI) 
and 63 days for CABG patients. Again, the both these figures are close to nationally 
reported values suggesting this was a broadly typical cohort of UK cardiac 
rehabilitation patients. In Portugal there is no National audit of CR programs. 
 
We confirm in our findings in chapter 4, that performance in ISWT at entry to CR 
programmes is mostly dependent on non-modifiable predictors such as age and 
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gender. Old, female patients have lower baseline fitness at CR entry. Some predictors 
of change in performance in ISWT between pre and post-CR are found in this chapter. 
Age and gender are the best non-modifiable predictors of change in performance in 
ISWT due to exercise-base CR. Older patients and females change less, or young 
patients and males change more in performance due to CR. This has several 
implications for the optimisation of CR service design, better dose of exercise, and 
evaluation of the exercise prescription. Leading us to the conclusion that CR should 
be tailored according to sex/age groups, dose of exercise should be increased in 
women and elderly patients. In sex/age-tailored CR groups, patients with low baseline 
fitness and high waist circumference, who smoke, should have a higher dose of 
exercise than others.    
 
6.4.5. Limitations 
 
It was impossible to compare between the ISWT cohort with a final outcome measured 
in metres, and the ETT cohort with an outcome in seconds. In this study it was also 
impossible to discriminate between variables of the service of CR in predicting change 
in performance at exit of CR in CHD patients assessed by ETT or ISWT, as reported 
in Chapter 3. The only variable assessed of the service was longer time from event to 
start of CR until 12 weeks in males in ISWT cohort, will predict higher ΔFitness, 
although further confirmation of this finding is needed. Different predictors such as 
diabetes and other comorbidities were also impossible to assess in our cohort. There 
was not enough information in the data to discriminate between differences in dose of 
exercise and changes in performance in the exercise tests.  
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There is a need to understand the effect of the different components of dose of 
exercise on the impact in changes in performance in ISWT and ETT due to CR in 
cardiac patients, such as the intensity of the exercise prescription. The exercise 
principle of overload (stress greater than normal encountered) applied in progression 
of intensity over time is fundamental to the patients to be able to achieve high levels 
of exercise work and intensity. Exercising at high intensities is important for subjects 
who are already relatively fit. Subjects with a very low level of fitness will need to 
progress from lower, moderate to high intensities in time (Swain and Franklin, 2006).  
Intensity is more of a determinant than volume in exercise prescription for obtaining 
optimal gains in V’o2peak (Swain, 2005; Gormeley, et al. 2008; Gormeley, et al. 2008; 
Warburton, et al. 2005; Guiraud, et al. 2009; Guiraud, et al. 2011).  
 
More studies are needed to understand the predictors of change in performance in 
cardiac patients due to CR programmes, and as seen in ISWT predictors of change 
further studies are needed to identify and confirm predictors according sexes. Taking 
into consideration individual differences such as sex, age, baseline fitness, waist-
circumference, and smoking status, should predict if a higher dose of exercise is 
needed or not. Further investigation is needed to understand the right dose of exercise 
according to patients individual characteristics and needs.  
  
6.5. Conclusion  
 
Identifying patient-level characteristics meaningfully associated with changes in 
fitness is useful in managing patient expectations, and setting them goals for changes 
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in fitness during CR. These findings are important for practitioners, having several 
implications in the optimisation of CR service design, better dose of exercise, and 
evaluation of the exercise prescription. The degree of change in fitness due to 
exercise-based CR programme depends on patients’ individual modifiable and non-
modifiable characteristics. We intend to explain for the first time the heterogeneity 
seen in changes in performance assessed by ISWT at exit of Cardiac rehabilitation.  
 
We recommend that CR should be tailored according to sex/age group. Sex/age- 
tailored CR including patients with high waist circumference, who smoke, should have 
a higher dose of exercise than others. Patients with high baseline fitness can be fast-
tracked to community CR programmes. Females and older patients exercising in 
mixed-CR should exercise in higher doses to benefit as much as young and male 
patients in cardiorespiratory fitness changes due to CR programmes. Further research 
is needed to clarify the right dose of exercise according to different patients 
characteristics and needs.    
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Thesis final summary 
 
 
The overarching aims of this thesis are to increase the benefits of CR (exercise-based 
Cardiac Rehabilitation), by improving assessment of patients’ exercise capacity, or 
cardiorespiratory capacity, and optimizing current delivery models. UK has an ageing 
population, being cardiovascular diseases one of the most commune diseases among 
elderly. The Department of Health and several National Health Institutions have 
endorsed outpatient- hospital CR guidelines and goals to service deliver, despite this 
multi efforts UK outpatient- hospital CR service deliver is insufficient, and suffer from 
NHS service cuts. There is also little National evidence produced to test the 
effectiveness of CR delivery models. The review of literature and Chapter 3 based in 
international studies summarise state of play at the start of this thesis, Chapters 4, 5, 
and 6 are studies based in UK data. In chapter 3 and 6, evidence produced helps to a 
better interpretation of changes in cardiorespiratory capacity, and predictors of change 
in performance assessed during CR. Chapter 4 and 5 evidence helps to improve the 
interpretation of the outcomes of the Incremental Shuttle-Walking Test (ISWT), what 
helps in a better and more accurate assessment of changes in performance, or 
cardiorespiratory fitness in patients participating in CR. The evidence produced will 
result in a better CR delivery models. 
  
There is a wealth of evidence that CR reduces all-cause and, cardiac mortality 
(Oldridge, et al. 1988; O'Connor, et al. 1989; Jolliffe, et al. 2001; Taylor, et al. 2004; 
Taylor, et al. 2006; Clark, et al. 2005; Heran, et al. 2011). Despite numerous 
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systematic reviews of CR; and exercise-based intervention; no review had concerned 
the simple matter of whether outpatient- hospital CR actually improved 
cardiorespiratory fitness (fitness). Gains in fitness achieved by patients in outpatient- 
hospital CR are closely, inversely, related to patient mortality and morbidity and the 
evidence for this is strong and abundant, changes in fitness reported in studies are 
heterogeneous, and none of studies have given a standard reference for change in 
fitness to be used in CR. In Chapter 3, the meta-analysis performed, provides an 
estimate of the magnitude and moderators of fitness gains. The increase in 
cardiorespiratory fitness found is clinically important, providing further evidence of the 
effectiveness of using CR as a therapeutic approach to achieve higher levels of fitness. 
Chapter 3 provides an international estimate of fitness gains, the reference of 
magnitude of change will result in a better CR delivery models Our review it also 
highlighted the stark lack of published evidence for UK CR, and the differences in 
exercise prescription practices seen in International studies compared with UK. 
 
Data from European and American studies form the basis of most meta-analyses. Like 
our own meta-analysis of studies evaluating changes in fitness due to CR (Chapter 3). 
The dose of exercise prescribed to CHD patients in European (Piepoli, et al. 2010) 
and American (Balady, et al. 2007) guidelines support a minimum of 3 sessions a 
week, for a minimum of 8 (24 exercise sessions) to 12 weeks (36 exercise sessions), 
progressing to 4 or 5 exercise sessions a week during the CR. The Department of 
Health recommendations for CR are based in lower doses of exercise prescribed. 
SIGN guidelines (SIGN 2002) support a minimal dose of 16 exercise sessions, in 8 
weeks, and NSF guidelines (DOH 2000) 12 sessions, in 6 weeks. It appeared 
questionable, therefore, as to whether UK CR programs could be as clinical effective 
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as those comprising the evidence base, due to their lower dose of exercise prescribed. 
It was clear that UK studies were need to support this affirmation, and to understand 
if the exercise prescription in UK CR programmes was actually beneficial in terms of 
patient outcomes. 
 
Given the lack of UK evidence we undertook a multi-centre study (Sandercock, et al. 
2012), in UK outpatient- hospital CR. A minimal dose of median of 8 (6 to 16 sessions) 
exercise sessions, which is close to minimum guidelines addressed, proves to elicit 
low gains in fitness (one third less) than international studies as reported in Chapter 
3. At this time RAMIT, a multi-centre trial done in UK CR with same levels of exercise 
dose prescribed as our multi-centre (6 to 8 weeks, exercising once or twice a week), 
found no significant benefits, at two-year follow-up (West, et al. 2012). This exercise 
under prescription represented in these recent multi-centres studies, which has also 
been highlighted in the past in National Surveys, seam to demonstrated the CR reality 
in UK, and may be the cause of the clinical treatment inefficacy. UK CR, should be set 
at the level of European, or American Guidelines which prove to be effective in care 
of CHD patients. There is some variance in fitness gains due to CR as reported in 
findings in Chapter 3, variance in fitness levels assessed at entry to CR are also 
expected, as confirmed by studies using the Gold-standard test, however no studies 
inform how to interpreter the ISWT performance in CHD patients. Chapter 4 aimed to 
identify factors associated with the performance of Incremental Shuttle-Walking Test 
(ISWT) in CHD patients at entry to CR. 
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The Gold-Standard test to assess cardiorespiratory fitness in CHD patients is the 
treadmill or cycle ergometer, evidence is strong for fitness levels assessed, minimal 
clinical improvement, and their relation with morbidity and mortality. There are also 
reference data to help a better interpretation of fitness results according with patients 
individual differences, at entry to CR. However, this equipment is expensive, needing 
specialized operators, not being widely available in CR services in UK do to NHS 
funding cuts, being the assessment of fitness normally made by the use of the ISWT. 
This field test is simply to use with no need of specialized operators, with no additional 
cost associated, besides the need of a radio, and CD with instructions, being endorsed 
to use in outpatient- hospital CR practices by National Health Guidelines. After closer 
scrutiny of the exiting evidence in the literateur review of this thesis, and current 
practice, we identified several limitations of the ISWT; the most widely-used test in UK 
CR. There is little evidence of clinical utility in terms of stratifying risk, prescribing 
exercise, assessment change of performance, and whole service delivery. There are 
no studies at all that link final outcome of the performance in the test, meters, and a 
minimal clinical change, with morbidity and mortality, as in the assessment by the 
Gold-Standard test. No reference data were available for the ISWT despite evidence 
of large inter-individual differences in performance at entry to CR.  
 
In Chapter 4 reference values and centile curves of ISWT performance in CHD 
patients at entry to CR were produced, based on the best individual patients’ 
characteristics identified as correlated of ISWT performance. This reference values 
and centile curves may aid clinical decision making, by providing a more meaningful 
and individualised assessment of patients’ functional and exercise capacity, better risk 
stratification, exercise prescription, goal setting, and magnitude of change in 
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cardiorespiratory fitness expected at entry in outpatient- hospital CR, as better 
assessment of goal setting achievement at exit of CR. Consequently, this may help 
‘triage’ patients by better interpreting ISWT performance, at entry to CR and potentially 
identifying individuals who can be ‘fast tracked’ to community CR or in exit of CR define 
who can be referred back. This will result in a better CR delivery models. Chapter 4 
explained that ISWT performance at entry to CR is heterogeneous, not only dependent 
on fitness, but also in individuals’ characteristics. Reviewing the literature, we found 
that a consensus on the estimated, and direct measure of ܸ̇O2peak (ml·kg-1·min-1) or 
metabolic equivalents METs) values from the ISWT was also lacking.  Chapter 5 
aimed to better define the ܸ̇O2peak (ml·kg-1·min-1) of the ISWT in the hope to produce a 
scientific consensus. We also reported stage-by-stage values for CHD patients as 
ܸ̇O2peak (ml·kg-1·min-1) and in METs, to enable use by clinicians and CR practitioners. 
 
Clinicians and health practitioners, really in ܸ̇O2peak (ml·kg-1·min-1) results or METs, 
given by the fitness assessment by the Gold-standard test, to prescribe exercise, risk 
stratify, and better assess the prognostic of CHD patients, as assessment of whole 
service delivery. Evidence for this in literateur is strong, and is the reason why Chapter 
3 review was based in the assessment of fitness by treadmill test, and results reported 
in METs. In UK only three studies have reported the ܸ̇O2peak (ml·kg-1·min-1) by stage for 
the ISWT in CHD patients or age-matched controls (Woolf-May and Ferrett 2008; 
Woolf-May and Meadows 2013; Almodhy, Beneke et al. 2014). These three studies 
report different results in ܸ̇O2peak (ml·kg-1·min-1) by CHD patients performing the ISWT, 
also the data from these studies report that ܸ̇O2peak (ml·kg-1·min-1) estimates from the 
ACSM equation (ACSM 2013), underestimates ܸ̇O2peak (ml·kg-1·min-1) in CHD patients’. 
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Such inconsistencies mean that cardiac rehabilitation professionals are currently 
faced with some confusion over estimating, and the real ܸ̇O2peak (ml·kg-1·min-1) of the 
ISWT whether for the purpose of exercise prescription or risk stratification, and 
prognostic of CHD patients.  
 
Chapter 5 resulted in the confirmation of the curvilinear nature of ܸ̇O2peak (ml·kg-1·min-
1) as a function of walking speed, as old studies reported; as opposed to the assume 
a linear relationship between increments in walking speed and ܸ̇O2peak (ml·kg-1·min-1), 
used by ACSM estimation equations that underestimate performance and 
improvement in ܸ̇O2peak (ml·kg-1·min-1) in patients attending outpatient- hospital CR. 
New values of ܸ̇O2peak (ml·kg-1·min-1) or METs in CHD patients performing the different 
stages of the ISWT were produced, clarifying the doubts emerged by past studies. 
Oxygen demands of the ISWT in CHD patients are as much as 30% higher than those 
of age-matched controls. Further research should try to understand why there is higher 
ܸ̇O2peak (ml·kg-1·min-1) in ISWT performance in CHD patients compared with healthy 
individuals, or why there is ܸ̇O2peak (ml·kg-1·min-1) differences for same exercise dose 
between CHD patients and healthy individuals. This new ܸ̇O2peak (ml·kg-1·min-1) or 
METs values produced will help in a better clinical practice, improving risk stratification 
and exercise prescription in CR, as better patients prognostic. This will result in a better 
CR delivery models. Chapter 4 and 5 findings improve the assessment of 
performance, and changes in performance. Chapter 4 revealed that performance in 
test at entry to CR among CHD patients is heterogeneous. Chapter 3 demonstrated 
the heterogeneity of response to exercise, evidenced by variation in treadmill test 
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performance at completion of CR. As few studies have examined differences in 
response to exercise training in CR patients this became the aim of chapter 6. 
.     
Chapter 6 identify further predictors of change in performance in ISWT, which are 
associated with improved or worsened changes in performance in patients attending 
CR. Individual non-modifiable characteristics as predictors confirm findings from 
chapter 3, female and older patients change less in performance. Patients individual 
modifiable characteristics were also confirmed as predictors, lower baseline 
performance, waist circumference, and status of smoking were associated with less 
change in performance in ISWT. Optimal CR service should be tailored according to 
sex/age group, although for cost service-efficacy is not wise to recommend. Patients 
with high baseline fitness can be fast-tracked to community CR. Females and older 
patients exercising in mixed-CR should exercise in higher doses to benefit as much 
as young and male patients in cardiorespiratory fitness changes due to outpatient- 
hospital CR. These findings will result in a better CR delivery models. Further research 
is needed to clarify the right dose of exercise according to different patients’ 
characteristics and needs. 
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Background/objectives: Improving patients' cardiorespiratory ﬁtness is an important therapeutic outcome in
cardiac rehabilitation. The ability of cardiac rehabilitation to reducemortality andmorbidity has been evidenced
through several meta-analyses. Whether cardiac rehabilitation can increase cardiorespiratory ﬁtness and which
factors may inﬂuence such gains are less well quantiﬁed.
Methods:We performed detailed literature searches of electronic databases and manually searched papers con-
cerning changes in cardiorespiratory ﬁtness in cardiac rehabilitation patients. We performed random-effects
meta-analysis of mean improvements in cardiorespiratory ﬁtness and subgroup analyses to determine potential
sources of heterogeneity.
Results: Data from 31 studies produced 48 groups (n=3827) with a mean improvement of 1.55 (95% CI 1.21–
1.89) METs, (pb0.001); equivalent to standardised effect size of ES=0.97 (95% CI 0.80–1.13). As this value
was highly heterogeneous (Q=852, pb0.001) we performed subgroup analyses on the effect size data. Gains
in ﬁtness were highest in patients receiving >36 exercise sessions in studies where ﬁtness was assessed using
the Naughton Protocol. Patient characteristics associated with the highest ﬁtness gains were age (being
young) and sex (being male training in a male-only exercise group). Changes in ﬁtness were unrelated to
programme type (comprehensive or exercise-only), duration or study design. There was no association with
patient's baseline ﬁtness levels.
Conclusion: This is the ﬁrst meta-analysis of changes in cardiovascular ﬁtness in cardiac rehabilitation patients
and shows clinically signiﬁcant improvements in a large sample of patients from a variety of rehabilitation
programmes. This analysis helps describe the characteristics of cardiac rehabilitation programmes which can
increase patients' cardiorespiratory ﬁtness.© 2011 Elsevier Ireland Ltd. All rights reserved.1. Introduction
There is an abundance of high quality evidence for the effectiveness
of cardiac rehabilitation as a therapeutic intervention to reduce all cause
mortality, cardiovascular mortality and morbidity [1–6]. Much of the
reduction in mortality and morbidity can be attributed to the positive
inﬂuence that cardiac rehabilitation can have on cardiovascular risk
factors such as smoking, hypertension and hypercholesterolemia [7].
In addition to adding years to the life of cardiac patients, it has also
been proposed that rehabilitation should add ‘life to years’ [8]. Whilst
pharmacotherapy can effectively modify many risk factors, exercise-
based rehabilitation can increase functional capacity, mobility and
independence by improving patients' cardiorespiratory ﬁtness (herein
ﬁtness). Increased ﬁtness is independently associated with improved
quality of life in cardiac patients [9] and ﬁtness is an excellent prognos-
tic marker for future cardiovascular events [10–12]. Increases in.
Ltd. All rights reserved.
l, Changes in cardiorespirator
8cardiorespiratory ﬁtness observed in patients during rehabilitation are
closely associated with the reported reductions in mortality and mor-
bidity [13–19]. Despite recognition of the clinical importance of ﬁtness
in cardiac patients, only limited attempts to synthesise the literature
in this have been made [5, 20].
Recently, Conn et al. [5] found a signiﬁcant improvement in phys-
ical activity levels of wide range of cardiac patients. The authors also
meta-analysed changes in ﬁtness as a secondary outcome. This analysis
largely concentrated on quantifying standardised differences between
post-test groups from randomised controlled trials. Whilst this
approach ensured data quality it excluded the type of cohort-design
and observational studies often performed in the more naturalistic
setting of clinical practice. The effectiveness of CR as a therapy makes
it unethical to withhold it from patients [21], making cohort-design
studies increasingly necessary and common. The inclusion criteria that
exercise testing be used as a behaviour change mechanism restricted
the available studies in the meta-analysis of Conn et al. [5]. These
authors were unable to perform subgroup analysis to determine
which features of exercise (frequency, intensity, duration, modality)
inﬂuenced changes in ﬁtness. Whilst the effect size for change iny ﬁtness in cardiac rehabilitation patients: A meta-analysis, Int J Car-
2 G. Sandercock et al. / International Journal of Cardiology xxx (2011) xxx–xxxphysical activity was insightfully converted to energy expenditure
(1984 kcal·week−1) there was no common-language estimate for
gains in ﬁtness such as in V⋅O2peak (ml·kg−1·min−1) or metabolic
equivalents (METs).
The aim of the present study was to determine the overall increase
in ﬁtness observed in CR studies expressed in easily interpreted units
(METs) which are potentially more useful to clinicians than standar-
dised effect sizes. The second aimwas to determine patient character-
istics and programme features including exercise dose information
associated with changes in ﬁtness. The latter aim was designed to
provide further guidance to clinicians in designing and reﬁning cardi-
ac rehabilitation provision to maximise patients' ﬁtness gains.
2. Methods
2.1. Search strategy
Three authors independently searched PubMed, Ovid, Web of Science and The NIH
library. Using broad search terms: exercise, cardiac (or cardiovascular) rehabilitation,
training, functional capacity, ﬁtness (cardiovascular ﬁtness), V⋅O2peak, V⋅O2max. Initial
results produced 7104 potential studies for review. Our aim was to perform an analysis
on outpatient cardiac rehabilitation programmes provided to the ‘core’ cardiovascular
patient population. To narrow the search terms we limited the date range (1970–2010)
and age range (>18 years) and included the Boolean operator ‘NOT’ with the search
terms: heart failure, home-based and walking programme. This yielded 4321 abstracts
which were manually scanned for eligibility. We also manually scanned the reference
sections of existing meta-analyses concerning other aspects of cardiac rehabilitation and
national clinical guidance documents [1, 2, 4, 5, 7, 13, 21, 22]. After removing reviews
and meta-analyses we included primary research studies which met the criteria outlined
in Table 1.
The exclusion of unsupervised or home-based interventions was justiﬁed due to
the gross difﬁculties in monitoring overall adherence to such programmes as well as
the difﬁculties in assessing exercise dose variables. Evidence for the efﬁcacy of
home-based CR as therapy to reduce mortality and morbidity is also lacking [23]. The
inclusion of only incremental load-bearing exercise testing was made in an attempt
to standardise the measurement of ﬁtness. Lower values are often obtained from
cycle ergometry and while ﬁeld tests can estimate MET or V⋅O2peak values, the predic-
tion equations used often have large standard errors of estimation [24]. These two
criteria were designed to restrict the analysis to the most commonly-provided model
of cardiac rehabilitation, similar to the criteria used in meta-analysis demonstrating
the efﬁcacy of CR in reducing mortality, morbidity and reducing risk factors [4, 7].
These exclusion criteria differentiate this study from the meta-analysis of Conn et al.
[5] which included highly varied models of CR provision and any available estimate
of ﬁtness [5]. We purposefully did not exclude non-randomised trials. Previous analysis
has shown little difference in values from comparisons of distal post-test values in
control versus treatment groups and pre- versus post-test values in treatment groups.
During searches we noticed that many studies did not have control groups as they
appeared to be ‘service evaluation’ type studies often performed in naturalisticTable 1
Study inclusion and exclusion criteria.
Inclusion criteria
1. Published 1970–December 2010.
2. English language publication or translation available.
3. Participants with diagnosis of cardiovascular disease for whom exercise-based
rehabilitation is internationally recommended: post-myocardial infarction, patients
receiving revascularisation therapy, valvular replacement recipients and those suf-
fering angina pectoris.
4. Intervention met our deﬁnition of cardiac rehabilitation. Supervised exercise
training as a hospital outpatient or in a structured setting in the local community
or at a residential centre.⁎
5. Experimental or quasi-experimental design (randomised controlled trial, non-
randomised trial or cohort observation).
6. Fitness assessed by weight bearing incremental test pre- and post-rehabilitation
and expressed as a unit which could be converted to Metabolic Equivalents (METs
Vo2peak or Vo2max in ml·kg−1·min−1 or l·min−1).⁎
7. Necessary data to compute mean change in exercise capacity (mean, SD, t-value,
F-value, p-value and sample size).
⁎Additional information: exclusion criteria.
4a -We excluded the following types of intervention; home-based exercise programmes
(supervised or unsupervised); telephone, internet or email based programmes, home
walking programmes, group walking programmes.
6a - We also excluded all non-weight bearing exercise tests (cycle ergometry) and did
not include ﬁeld tests of functional capacity such as timed walk tests, incremental
shuttle-walking test, step tests and non-exercise estimates of ﬁtness.
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diol (2011), doi:10.1016/j.ijcard.2011.11.068environments. Given the high potential external validity of such trials, we included
them whilst also including this particular element of study design in our subgroup
analyses.
2.2. Data extraction and treatment
From studies which met our inclusion criteria we extracted means and standard
deviations from exercise testing carried out before and after rehabilitation. In most
cases this was available as METs, and where not available, METswere calculated by divid-
ing reported oxygen consumption by 3.5. Given the paucity in reporting correlations
between pre- and post-test data in studies (no studies reported this), we estimated the
magnitude of this relationship using data from a local hospital. After ethical approval,
we examined the records of 149 patients who underwent the Bruce Treadmill Protocol
before and after a standard CR programme. A repeated measures t-test demonstrated a
signiﬁcant improvement in V⋅O2peak (pb0.001) and a correlation between pre- and post-
test scores of r=0.535. This correlation coefﬁcient was used in our meta-analysis. A
total of 31 studies yielding 48 independent groups of patients were included in the ﬁnal
analysis. We chose to represent the overall change in ﬁtness as the mean difference in
pre- versus post-test ﬁtness in METs, as this is readily understood by both researchers
and clinicians. We also used random effects modelling to report the effect size (ES) for
standardised mean difference in ﬁtness to allow comparison with previous studies. This
effect size was then used in subgroups analyses exploring heterogeneity.
2.3. Data coding for subgroup analysis
We performed subgroup analyses using pre-selected moderator variables to investi-
gate possible sources of heterogeneity [25]. The possibility of generating spurious ﬁndings
from subgroup analyses iswell documented [25, 26].We therefore performedonly a small
number of subgroup analyses; all subgroups themselves were determined a priori and
were based on potential causal mechanisms, magnitude of effects, and statistical signiﬁ-
cance in existing studies. Each subgroup analysis wasmethodologically or physiologically
justiﬁed and each grouping was agreed by all authors.
We developed two broad categories of data to be coded. We ﬁrst coded data relating
to the study design and CR programme design, then data regarding patient characteristics.
We coded length of the programme in weeks, the total number of exercise sessions per
programme and whether the exercise modality was: aerobic, resistance or mixed. We
coded whether the CR programme was comprehensive (included education and/or
behaviour change) or was exercise-only and whether the study was a cohort design or
part of a (randomised or non-randomised) trial involving a control group. Finally we
performed subgroup analyses based on treadmill protocol reported. Quantitative patient
characteristics codedwere age (young b50; old 50–65 and oldest >65 years) and baseline
level of ﬁtness (median split at >/b6.6 METs). We coded patient groups according to sex
(males, females or mixed). The primary reason for CR attendance was coded as Revascu-
larisation, Post-myocardial infarction (MI) or Mixed. Details of all subgroups and cut-offs
can be found in Table 2.
Despite potential mechanisms by which they might inﬂuence study outcomes, we
were unable to create satisfactory subgroups for several variables. Prescribed exercise
intensity was commonly given as broad and often overlapping categories (e.g. 60–85%
heart rate maximum) or using poorly quantiﬁed terms (e.g. ‘symptom limited’ or ‘Borg
Scale’).
3. Results
The overall effect for CR interventions of on ﬁtness measures in
metabolic equivalents (METs) is shown in Fig. 1. The 31 studies
yielded 48 separate groups which had a mean pre- vs. post-test differ-
ence in ﬁtness of 1.55 (95% CI 1.21–1.89) METs which was highly sig-
niﬁcant (pb0.001). Using a random effects model, the effect size for the
standardisedmeandifference in pre- vs. post-test ﬁtnesswas: ES=0.97
(95% CI 0.80–1.13). This difference was statistically signiﬁcant
(pb0.0001) butwas also, highly heterogeneous (Q=852, pb0.001). Vi-
sual inspection of the forest plot showed four groups from four different
studies [27–30] with larger than expected (>2SD higher) mean effects.
Removal of these groups reduced slightly themean standardised differ-
ence (ES=0.80; 95%CI 0.63–0.94). This value remained statistically sig-
niﬁcant (pb0.001) but also retained a large degree of statistical
heterogeneity (Q=591, pb0.001). We could identify no common fea-
tures of these groups and they were retained in all further analyses.
3.1. Subgroup analyses: tests for heterogeneity
There were a number of programme design characteristics which
showed signiﬁcant between-group heterogeneity (Table 2). Observed
changes in ﬁtness did not vary according to overall programme length
(>/≤12 weeks). There was no statistically signiﬁcant differencesy ﬁtness in cardiac rehabilitation patients: A meta-analysis, Int J Car-
Study name Difference in means and 95% CI
Difference Standard 
in means error
Miller et al. (1984) a 1.750 0.081
Miller et al. (1984) b 2.200 0.083
Williams et al. (1985) a 3.500 0.199
Williams et al. (1985) b 2.900 0.122
Williams et al. (1985) c 3.000 0.156
Williams et al. (1985) d 2.800 0.156
Blumenthal et al. (1988) a 0.890 0.284
Blumenthal et al. (1988) b 0.950 0.322
Ades & Grunvald (1990) a 1.290 0.326
Ades & Grunvald (1990) b 1.570 0.252
Blumenthal et al. (1990) a 1.370 0.217
0.320 0.991
602.0009.1a)3991(eivaL
532.0002.2b)3991(eivaL
Ades et al. (1995) a 0.860 0.244
Ades et al. (1995) b 1.090 0.443
Lavie & Milani (1995) a 2.300 0.153
Lavie & Milani (1995) b 2.400 0.318
Dressendorfer et al. (1995) 1.090 0.078
Brubaker et al. (1996) a 0.200 0.096
Brubaker et al. (1996) b 2.300 0.096
Balady et al. (1996) 2.900 0.133
Wosornu et al. (1996) (a) 1.400 0.244
Wosornu et al. (1996) (b) 0.700 0.242
Shiran et al. (1997) 1.500 0.347
Lavie & Milani (1997) 1.400 0.247
Nieuwland (1988) a 1.300 0.383
Nieuwland (1988) b 1.340 0.303
Carlson et al. (2000) 0.400 0.186
Belardinelli et al. (2001) 1.460 0.248
Hao et al. (2002) a 1.400 0.456
Hao et al. (2002) b 1.800 0.554
Hao et al. (2002) c 0.500 0.667
Vonder-Muhll et al. (2002) 1.100 0.213
Gordon et al. (2002) 0.450 0.336
Seki  et al. (2003) 0.080 0.159
Hevey et al. (2003) a 3.340 0.499
Hevey et al. (2003) b 2.920 0.431
342.0001.0)3002(.lateraeL
Milani et al. (2004) 0.430 0.099
111.0009.4)5002(.lateArya
Adams et al. (2008) 2.100 0.187
112.0015.0Seki et al. (2008) 
Milani & Lavie (2010) a 0.460 0.218
Milani & Lavie (2010) b 0.680 0.073
Kosydar-Piechna  et al. (2010) 0.500 0.239
Shabani et al. (2010) 3.000 0.260
Onishi et al. (2010) 0.250 0.143
1.550 0.175
-6.00 -3.00 0.00 3.00 6.00
desaercnIdesaerceD
Mean (95%CI) Change in Fitness (METs)
Blumenthal et al. (1990) b
Fig. 1. Forest plot for mean point estimate of change in ﬁtness due to cardiac rehabilitation. Legend: Points are mean point estimate (squares) with upper and lower 95% conﬁdence
intervals for the difference between pre- and post-cardiac rehabilitation measures of cardiorespiratory ﬁtness (in metabolic equivalents). The overall mean point estimate (±95%
CI) is based on a random effects model. Miller et al. [27]; Williams et al. [31]; Adams et al. [32]; Ades et al. [33]; Ades and Grunvald [34]; Arya et al. [30]; Balady et al. [16];
Blumenthal et al. [35,36]; Brubaker et al. [29]; Carlson et al. [37]; Dressendorfer et al. [38]; Gordon et al. [39]; Hao et al. [40]; Hevey et al. [41]; Kosydar-Piechna et al. [42]; Lavie
[43]; Lavie and Milani [44]; Milani et al. [45]; Milani and Lavie [46]; Lear et al. [47]; Wosornu et al. [48]; Shiran et al. [49]; Nieuwland et al. [50]; Ayra et al. [30]; Adams et al.
[32]; Seki et al. [51]; Seki et al. [52]; Milani and Lavie [45]; Shabani et al. [53]; Onishi et al. [54].
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(k=5) of programmes that did include >36 sessions reported much
larger gains in ﬁtness than those with exactly 36 or b36 session. The
effect size for change in ﬁtness in the latter two groups, was very sim-
ilar. Programmes comprising aerobic or mixed exercise modalities
were equally effective and signiﬁcantly (p=0.024) more so thanPlease cite this article as: Sandercock G, et al, Changes in cardiorespirator
diol (2011), doi:10.1016/j.ijcard.2011.11.068the few (k=2) which prescribed resistance exercise. Gains in ﬁtness
were not signiﬁcantly different between comprehensive cardiac reha-
bilitation exercise-only programmes despite a trend towards the
latter appearing more effective. There were no differences in ﬁtness
gains between studies grouped according to whether they were a
trial or a cohort study. Programmes which assessed ﬁtness using they ﬁtness in cardiac rehabilitation patients: A meta-analysis, Int J Car-
Table 2
Subgroup analysis for moderators of ﬁtness gains expressed as standardised mean difference.
Moderator Groups k Standardised
mean difference
95% CI P Between
group Q
P-value
(between)
Within
group Q
P-value
(within)
Study characteristic subgroups
Duration of programme ≤12 weeks 37 1.00 0.81–1.18 b0.001 204 b0.001
>12 weeks 11 0.89 0.51–1.27 b0.001 630 b0.001
0.2 .640
Number of exercise sessions b36 14 0.81 0.47–1.14 b0.001 158 b0.001
=36 26 0.98 0.77–1.20 b0.001 520 b0.001
>36 5 1.74 0.78–2.69 b0.001 116 b0.001
3.4 .183
Exercise modality Aerobic 19 1.04 0.67–1.40 b0.001 375 b0.001
Mixed 26 0.98 0.79–1.18 b0.001 462 b0.001
Resistance 2 0.33 0.11–0.78 0.140 2.1 0.152
7.4 .024
Programme type Comprehensive 28 0.83 0.65–1.03 b0.001 453 b0.001
Exercise-only 20 1.13 0.81–1.15 b0.001 328 b0.001
2.5 .117
Treadmill protocol Balke 6 0.70 0.49–0.92 b0.001 9.4 b0.001
Bruce 14 0.79 0.60–0.98 b0.001 114 b0.001
Naughton 5 2.41 1.08–3.74 b0.001 96.1 b0.001
Own 14 1.12 0.70–1.55 b0.001 330 b0.001
Not speciﬁed 8 0.48 0.22–0.74 b0.001 96.4 b0.001
12.1 b0.001
Study design Cohort 22 0.98 0.80–1.20 b0.001 260 b0.001
Trial 26 0.96 0.71–1.19 b0.001 450 b0.001
0.1 .740
Patient characteristic subgroups
Sex Females 3 0.92 0.08–1.76 b0.001 23.7 b0.001
Males 19 1.44 0.98–1.89 b0.001 429 b0.001
Mixed 21 0.65 0.48–0.62 b0.001 219 b0.001
10.1 .011
Age Young 17 1.45 1.00–1.90 b0.001 235 b0.001
Old 16 0.90 0.63–1.17 b0.001 143 b0.001
Oldest 15 0.64 0.42–0.79 b0.001 359 b0.001
13.5 b0.001
Primary diagnosis Post MI 5 2.08 0.87–3.30 b0.001 98.1 b0.001
Revascularisation 4 0.96 0.34–1.86 b0.001 33.2 b0.001
Mixed 38 0.86 0.69–1.04 b0.001 637 b0.001
3.8 .144
Baseline ﬁtness ≥6.6 METs 25 0.97 0.74–1.20 b0.001 403 b0.001
b6.6 METs 23 0.97 0.74–1.21 b0.001 445 b0.001
0.0 0.993
Legend: Duration of programme: as reported in manuscript 3 months assumed to be equal to 12 weeks. Number of exercise sessions: total reported in study (not the number actually
attended). Exercise modality: aerobic — described as continuous exercise e.g. cycle ergometry, treadmill walking (home walking programmes excluded). Treadmill protocol: as given
except ‘own’ — where authors described a highly modiﬁed or bespoke protocol with enough detail to replicate; ‘Not given’ — authors described using progressive/incremental
exercise but did not provide enough detail to replicate. Study design: all values calculated as within-group, pre- vs. most distal post-test value, cohort describes studies in which not con-
trol group was used. Trial describes studies in which a waiting list, volunteer (selective) or random group of patients acted as controls. Sex — the characteristics of the group in which
exercise training took place. Primary diagnosis — the reason given for patients attending CR. MI — myocardial infarction, revascularisation included coronary angioplasty procedures
and coronary artery bypass grafting.Where emergency revascularisation took place followingMI patients are classed asMI.Mixed— includes patient groupswithmixed revascularisation
andMI classiﬁcations aswell as valvuloplasty and angina patients. Baselineﬁtness ismaximal capacity derived frompre-rehabilitation treadmill testing grouped according tomedian split.
Note; k values may not always sum to 48 due to missing data in some studies.
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reported using the Bruce, Balke or their own protocols. The smallest
gains in ﬁtness were observed in studies which did not report the
exact nature of the incremental protocol they used.
Groups of male patients and those in the youngest age group
(b55 years) showed signiﬁcantly larger gains in ﬁtness than female
or mixed-sex patient groups and the two groups of older patients.
While there was no signiﬁcant between group heterogeneity in sub-
groups based on primary diagnosis, patients who had suffered an
MI, had much larger ﬁtness gains than those with other diagnoses.
This trend did not reach signiﬁcance due probably to the very small
number of groups (k=5) representing only post-MI patients. Pa-
tients' ﬁtness gains were very similar in groups based on low or
high baseline ﬁtness measures.
3.2. Publication bias
Funnel plots of precision (standard error) against effect size (stan-
dard difference in mean) were created. Fig. 2. Shows the studies in-
cluded in the present analysis in open circles with the imputedPlease cite this article as: Sandercock G, et al, Changes in cardiorespirator
diol (2011), doi:10.1016/j.ijcard.2011.11.068studies represented by closed circles. The asymmetry of the plot and
clustering of imputed points provide strong evidence for publication
bias in the pre- versus post-rehabilitation changes in ﬁtness.
4. Discussion
Cardiac rehabilitation is acknowledged as an effective intervention
to reduce mortality and morbidity in patients with variety of cardio-
vascular diseases [1–5]. The earliest meta-analysis on the topic exclu-
sively contained studies which only used exercise training as an
intervention and despite the increase in comprehensive CR pro-
grammes exercise training remains a mainstay of most rehabilitation
programmes [55–61].
It is agreed that increased cardiorespiratory ﬁtness is a desired
outcome of CR [59, 60] and probably represents the mechanism by
which CR exerts much of its positive inﬂuence on health [4, 7]. Sys-
tematic review [22] and meta-analysis [5] have both provided evi-
dence for the effectiveness of CR programmes as a means to increase
ﬁtness. A paucity of detailed randomised trials on the topic has, so far,
prohibited authors from fully exploring variables which might explainy ﬁtness in cardiac rehabilitation patients: A meta-analysis, Int J Car-
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Fig. 2. Funnel plot of precision by standard difference in means. Legend: Open circles
represent studies included in the meta-analysis. Closed circles are imputed values
demonstrating the signiﬁcant publication bias in studies analysed.
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ry ﬁtness gains. The lack of studies eligible formeta-analysis in the study
of Conn et al. [5] was due mostly to their inclusion criteria of study de-
sign: being a controlled trial or quasi-experimental study. As the authors
noted, the efﬁcacy of CR as a therapy means patients cannot always be
randomised to a control condition due to ethical constraints [21].
The aims of the present study were to describe more fully the gains
in ﬁtness researchers and clinicians might expect to observe in patients
undertaking CR programmes and to identify characteristics of CR pro-
grammes and patients which may modulate the magnitude of such
gains. We modiﬁed the design of this meta-analysis speciﬁcally to
meet these aims so that it could build on the existing research and
reviews in this area. This was achieved in three speciﬁc ways.
First, tomake the analysis easily understood to researchers and clini-
cians alike, we ﬁrst represented change in ﬁtness in well-accepted and
easily understood metric of metabolic equivalent (METs). This metric
is transferable across a number of exercise modalities and can be used
in all patient groups. It is used routinely by researchers to describe
aerobic exercise capacity and work rates as well as by clinicians in
everyday tasks like risk stratiﬁcation and exercise prescription [16, 59,
62].
Second, we included cohort studies in our analysis and did not limit
it to controlled trials. This allowed us to analyse data from many more
study groups (k=48) than in the only previous meta-analysis [5] on
this topic (k=28). An obvious limitation of this design is that it may
overestimate the mean point estimate of the intervention's effective-
ness. We therefore took the step of calculating a within-group correla-
tion coefﬁcient based on our own empirical data and entered this
correlation into the analysis to control for this inﬂation.
Third, we used random effects models in all analyses and undertook
nine mixed-effects subgroup analyses to investigate the source of the
expected heterogeneity of changes in ﬁtness. Random effects models
are recommended when the intervention being analysed is likely to
be heterogeneous [63] as exercise interventions have previously been
described [5, 22].
Heterogeneity is an expected product of most meta-analyses [25]
and as such, researchers should be prepared to undertake pre-planned
subgroup analyses to determine its sources [26]. Subgroup analyses
were deemed impossible by Conn et al. [5] due to what they described
as ‘scant data’ on the topic. This was most likely due probably to their
stringent study inclusion criteria. From a programme design perspec-
tive, details of which elements of CR (exercise frequency, intensity
and dose) or which patient characteristics (sex, age and condition)
may affect ﬁtness gains may be very valuable.
4.1. Discussion of results
The CR programmes and interventions evaluated comprised n=
3827 patients in 48 separate groups from 31 published studies. ThePlease cite this article as: Sandercock G, et al, Changes in cardiorespirator
diol (2011), doi:10.1016/j.ijcard.2011.11.068analysis showed that cardiac rehabilitation was associated with an
increase in ﬁtness of more than one and a half metabolic equivalents
(1.55; 95% CI 1.21–1.89 METs). This is an impressive and clinically
important increase and provides further evidence for the efﬁcacy of
CR as a therapeutic tool to increase exercise capacity, decreasemortality
and morbidity and to increase patients' quality of life.
Converting this value to V⋅O2peak, patients enrolled in CR pro-
grammes can expect their cardiorespiratory ﬁtness to improve by
an average of 5.4 (95% CI 4.2–6.6) ml·kg−1·min−1. Measures of the
body's ability to use oxygen, commonly referred to as functional ca-
pacity, aerobic capacity, cardiorespiratory ﬁtness or simply ﬁtness as
we have done are predictive ofmortality andmorbidity in both the gen-
eral population [12, 15, 17] and cardiac patients [17–19, 64].
In addition to cross-sectional associations between ﬁtness and mor-
tality, several studies have demonstrated the degree to which gains in
ﬁtness due to exercise programmes can reduce mortality. Kavanagh
et al. [19] found that each 1 ml·kg−1·min−1 gain in V⋅O2peak was asso-
ciated with a 10% reduction in cardiac mortality. Vanhees et al. [64]
found each 1% increase in V⋅O2peak was associated with a 2% reduction
in mortality. Myers et al. [17] found that a 1 MET increase in ﬁtness
was associated with a 12% decrease in mortality, whereas Dorn et al.
[18] found a 1 MET gain produced a 10% reduction in mortality in
male MI patients. The improvement shown in the present analysis
(1.55; 95% CI 1.21–1.89 METs) could, therefore, equate to reductions
in mortality anywhere from 16% [17] to 54% [19]. The average estimate
from all four of the above studies [17–19, 64], and using ourmean value
was 32%. This ﬁgure is broadly similar to the actual reductions in mor-
tality (20–30%) reported in previous meta-analyses of survival data
from CR patients [1–5] and summarised previously [65].
Conn et al. [66] recently meta-analysed the effects of various inter-
ventions on the physical activity of cardiac patients including an esti-
mate of the effect size for increases in ﬁtness. It is important to outline
how the present study differs from this existing work. First, Conn et
al. primarily studied physical activity. The comparable effect size for
their primary outcome was ES=0.49 (random effects model; pre-
versus post-test values). Converting physical activity to energy ex-
penditure, the authors suggested CR was associated with an addition-
al 1984 kcal per week expenditure. Their effect size for ﬁtness
(ES=0.43) was not, however, converted to any other metric. Conn et
al. had strict inclusion criteria which limited their analyses to trials
with a control group, and we feel this may have biased their results
away from more naturalistic CR studies such as those carried out as
part of service evaluations, audits or as staff-led research in existing
CR programmes. Under these circumstances it would be neither possi-
ble nor ethical to withhold or delay CR to patients by placing them in
control group. In contrast to their strict inclusion criteria for study de-
sign, Conn et al. employed a very broad deﬁnition of cardiac patients
which resulted in the analyses of patient groups as diverse as; those
‘at risk’ from CVD, intermittent claudication patients, angina patients,
hypertensive patients through to patients with advanced stages of
heart failure. Internationally, only a few of these patient groups are rou-
tinely offered outpatient CR as it is deﬁned in our study [55–61].
Whilst our criteria were less stringent regarding design, they were
more stringent regarding patient group; we included only core cardiac
rehabilitation patients: MI-sufferers, elective and emergency revascu-
larisation recipients and valvuloplasty patients. These criteria, the use
of ﬁtness as our primary outcome and the undertaking of subgroup
analysis on this outcome make the two studies very distinct from one
another.
Within the literature, two generalisedmodels of CRhave been inves-
tigated; both of which contain an exercise training element. Compre-
hensive cardiac rehabilitation refers to programmes which contain
elements of patient education or behaviour change (such as smoking
cessation) in addition to exercise training and it is of note that these
seem to be less effective in reducing cardiac and all-cause mortality
when compared with exercise-only interventions [3, 65].y ﬁtness in cardiac rehabilitation patients: A meta-analysis, Int J Car-
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only) is just one ofmany examples showing the heterogeneousmanner
of interventions described as CR. Guidelines for the delivery of CR
programmes are available over much of the developed world including
the US [57] and Europe [67] but variations in written guidance, in local
interpretation of such guidance and ﬁnancial constraints mean service
delivery is far more heterogeneous than might be expected of, for
instance, a pharmacological intervention. It was for this reason that
we expected heterogeneity of our ﬁndings (which was conﬁrmed;
Q=852, pb0.001) and also why we performed sub-group analyses.
4.2. Subgroup analyses: exploring the heterogeneity in responses to cardiac
rehabilitation
It is widely accepted that there are large individual differences in
response to exercise training [68]. The varied nature of exercise pre-
scription also means that variations in how exercise is prescribed are
likely to contribute to the heterogeneous between-study response
observed. To our knowledge no previous study has investigated the
heterogeneity of patients' ﬁtness responses to CR although an overall
estimate of CR's impact on ﬁtness has been made [66]. Swain et al.
[20] assessed the cardioprotective effects of exercise training by com-
pared the responses of subjects trained at different exercise intensities.
In general, they found that higher intensity exercise resulted in more
pronounced changes in blood pressure and blood lipids and proposed
a threshold of 6 METs as a lower limit for the intensity of exercise con-
sidered cardioprotective. Other authors have suggested no lower limit
exists and suggested that intensities as low as 45% V⋅O2max may be
sufﬁcient [69]. Differences in prescribed exercise intensity may account
for some of the very large degree of heterogeneity observed in our anal-
ysis. Unfortunately, the heterogeneous methods used for reporting
training intensities (%V⋅O2max, %V⋅O2peak, %HRmax, RPE scores or being
‘symptom limited’) coupledwith the oftenwide and overlapping values
prescribed (50–85% of V⋅O2peak)made subgroup analysis of this exercise
variable impossible. While intensity is widely regarded as the most
important determinant of an exercise prescription's effectiveness at
increasing V⋅O2peak and improving health [20, 22, 69] there are many
other factors which may affect the response. The next section discusses
each of our subgroup analyses systematically including; justiﬁcation for
the subgroup selection, an explanation of the results, potential explana-
tions for the ﬁndings and limitations.
4.3. Programme duration
The duration of the programmes reported ranged from 4 weeks to
12 months. The duration of an exercise programme typically shows
positive relationshipwith the increases in ﬁtness observed. In untrained
individuals, however, most gains are realised in the ﬁrst 4–12 weeks of
a training. Twelve weeks was both the median and modal value for du-
ration and conforms with some local recommendations for programme
duration [57, 58]. Most programmes were ≤12 weeks long but the 11
groups of patients involved in longer programmes showed only very
slightly greater increases in cardiorespiratory ﬁtness. Signiﬁcant
within-group heterogeneity remained evident in both these subgroups.
These results agree with studies that have compared interventions of
different lengths and show little or no further increases in ﬁtness fol-
lowing initial gains [27, 33, 51]. Duration is limited as a component of
exercise prescription and a better assessment of total exercise ‘dose’ of
exercise was performed by analysing differences between subgroups
created according to the total number of exercise sessions prescribed.
4.4. Number of exercise sessions
There was a wide variety in the number of exercise sessions pre-
scribed in programmes (range n=4–144). Total sessions represents
a measure of the total exercise ‘dose’ and we hypothesised thatPlease cite this article as: Sandercock G, et al, Changes in cardiorespirator
diol (2011), doi:10.1016/j.ijcard.2011.11.068more sessions would result in greater ﬁtness gains. Like programme
duration, there was a common mode and median value (n=36) for
the number of exercise sessions prescribed. This most often repre-
sented three weekly exercise sessions over 12 weeks.
Patients in programmes including >36 exercise sessions had much
greater gains in ﬁtness than those receiving less than this number.
There was no further difference between groups of patients receiving
exactly 36 or b36 sessions although the latter did show the smallest
overall gains in ﬁtness. The data suggest 36 sessions is sufﬁcient to
promote gains in ﬁtness close to the overall mean difference, but that
there may be some additional beneﬁt in prescribing more than this
number of sessions. The number of studies including >36 sessions
was small (n=5), due probably to the potential cost implications and
the burden placed on the patient. Further research is needed to deter-
mine just how important any beneﬁts gained from >36 sessions really
are. One limitation of this analysis was the large variance in session
number in the b36 group (4–28 sessions). Identifying the minimum
‘dose’ of exercise capable of eliciting a meaningful change in patients'
ﬁtness should be a research priority as shorter programmes have
lower costs and may promote better adherence.
4.5. Exercise modality
The mode of exercise undertaken directly inﬂuences the physiolog-
ical adaptations observed. Given that we analysed measures represent-
ing change in peak oxygen uptake, we assumed that aerobic-type
exercise would promote the largest changes. Our data supported this
idea, suggesting that aerobic exercise was more effective than resis-
tance training alone, although the small number of resistance training
studies suggests caution. Studies which have directly compared resis-
tance and aerobic training in other populations support this notion
[70]. Gains in ﬁtness were almost identical between the aerobic and
‘mixed’ exercise groups. The latter typically combine aerobic and resis-
tance training and this ﬁndings supports the idea that improvements in
cardiorespiratory ﬁtness can be gained by adding resistance training to
aerobic activities, particularly in patients who are detrained and may
lack muscle strength needed to perform vigorous aerobic exercise
[71]. A combination of exercise modalities may also be more appealing,
manageable and results in better adherence to programmes than a sin-
gle modality prescription. As very few studies contained any details of
adherence, we cannot comment on this point.
4.6. Comprehensive vs. exercise-only cardiac rehabilitation programmes
This subgroup analysis was logically determined based on existing
meta-analytical differences in patient survival between the two broad
models of CR. Based both on survival data and the well-documented
relationship between changes in ﬁtness and survival we hypothesised
that exercise-only programmes would show the largest improve-
ments in ﬁtness. Whilst there was no signiﬁcant between-group het-
erogeneity in these ﬁndings, there was a clear trend toward larger
gains in exercise-only programmes. Exercise-only programmes are
associated with higher patient survival rates than comprehensive CR
programmes. There is also some rather counterintuitive evidence
that exercise-only programmes can reduce certain behavioural risk
facts like smoking [4] while psychological interventions used during
CR may be less effective [72]. Given the importance of low ﬁtness as
a risk factor, the relationship between gains in ﬁtness and reduced
mortality and the trend towards greater gains in exercise-only pro-
grammes seen here, we recommend that CR should focus primarily
on delivery of exercise sessions. There is little evidence that addition-
al psychological or educational input to programmes has beneﬁt for
patients. This analysis is, however, limited by the way in which com-
prehensive CR is described in the literature. Few studies gave details
regarding the nature of any additional interventions, when these
were identiﬁed, it was not stated whether educational sessionsy ﬁtness in cardiac rehabilitation patients: A meta-analysis, Int J Car-
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exercise sessions. Few data on the number of sessions provided and no
data on patient attendance at these sessions were given.
4.7. Treadmill protocol
It is well documented that themodality of testing can affect the out-
comeof any ﬁtness test. Itwas for this reason thatwe limited our results
to incremental treadmill protocols.Within these studies there remained
a variety of protocols reported. Whereas most authors gave sufﬁcient
detail to replicate the test, data from six studies merely reported that
an ‘incremental test’was used. Thesewere grouped together (Not Spec-
iﬁed) as were a rather homogeneous subgroup of studies in which the
authors devised and used their own protocols; the latter being usually
well-described. The changes in ﬁtness observed in patients from studies
where treadmill protocol was not speciﬁed were well below the overall
mean (ES=0.48; 95% CI 0.22–0.74 METs) but are difﬁcult to comment
on due to this lack of detail. Estimateswere similar between the remain-
ing subgroups except for those studieswhich reportedusing theNaugh-
ton protocol, in which the effect size was much larger than all other
subgroups and the overall mean difference (ES=2.4, 95% CI 1.08–3.74
METs). Overall, these data suggest caution when comparing ﬁtness
gains between studies using different protocols. The studies using
Naughton protocol were unremarkable in terms of duration, modality
or patient factors which may inﬂuence gains in ﬁtness except for
containing one large group with exceptionally large increases [30].
We can only speculate as to why these studies show such large gains
but it may be that the Naughton protocol's shorter stages with more
gentle transitions between workloads is better-suited to cardiac pa-
tients than the next most commonly-reported protocol, Bruce. Typical-
ly, where researchers used their own protocol (which resulted in the
next highest subgroup mean estimate) the protocols also tended to
have smaller transitions and shorter stages and bemore like Naughton's
protocol than that of Bruce. These differences warrant further
investigation.
4.8. Study design: cohort vs. trial
The cohort versus trial subgroup analysis was performed to deter-
mine whether trials of CR, designed and implemented primarily by
researchers produced different changes in ﬁtness compared with
more naturalistic observations drawn from service evaluations, or
cohort studies. The analysis was designed to conﬁrm whether we
were justiﬁed in combining data from wide variety of study designs.
We hypothesised that trials might produce larger gains in ﬁtness
(pre- versus post-test) due to better adherence, the inﬂuence of
researchers, the selective nature of study participants, and patients'
knowledge that they were in a trial.
There was no difference in ﬁtness gains between the two study
designs. Effect sizes were near identical and, logically, also very close
to the overall mean value. These ﬁndings are analogous to those of
Conn et al. [5] who found that study funding status had no mediating
effect on changes in patients' physical activity levels. We are therefore,
conﬁdent that we have introduced no bias into our results by including
this mixture of study designs. This analysis was limited by the subjec-
tive nature of subgroup allocation.We found a number of cohort studies
(with no control group) which had received funding and some studies
were difﬁcult to classify due to poor description of purpose and patient
recruitment.
4.9. Summary: programme-level moderators
It appears that some of the heterogeneity in ﬁtness gains observed
can be explained by the choice of different treadmill protocols between
studies. There was a moderate modifying effect of exercise modality,
where mixed-modality exercise programmes faired best and withPlease cite this article as: Sandercock G, et al, Changes in cardiorespirator
diol (2011), doi:10.1016/j.ijcard.2011.11.068total exercise dose, with 36 sessions proving most favourable.
Programme length, being exercise only or comprehensive and whether
the programme was part of a trial had no signiﬁcant effect on patients'
ﬁtness gains. There are, however, also differences at the level of the
patient which may moderate changes in ﬁtness observed.4.10. Patient-level subgroup analyses
There is little information on how the sexes may beneﬁt differently
from CR, but there is a well-documented gender-bias in CR toward
male patients [73–75] who also tend to report better programme ad-
herence [76, 77]. The bias in CR may be historical as CVD is more prev-
alent in males and whilst it may still be perceived as a predominantly
male disease, CVD remains the biggest killer of adultwomen inmost de-
veloped countries [78].
This gender-bias was supported in our analysis, with only three
female-only patient groups versus 19 which were male only. While
this small number makes interpretation difﬁcult, signiﬁcant between-
group heterogeneity was observed. Males had higher gains in ﬁtness
than females but the difference was much greater between male-only
and mixed groups. This was surprising as most of the mixed groups
were predominantly male. We did not analyse group gender composi-
tion but a previous report found only 25% of CR participants were fe-
male [79]. This may represent difﬁculties in running mixed-sex
exercise training groups. Given the group-exercise nature of most CR
programmes it may be that males in mixed groups do not work at the
same intensity as they would in a male-only environment. It may be
that male-only groups provide a more competitive environment in
which male patients ‘push’ themselves more. The main limitation of
this analysis is thatwhilst of interest, it has little clinical signiﬁcance ex-
cept to suggest that if possible, patientsmay beneﬁt more from exercis-
ing in same-sex classes. Whether ﬁnancial, spatial or temporal
limitations will practically allow this in CR clinics is questionable.
Like patients' sex, their age is a non-modiﬁable factor. In agreement
with previous studies [31, 34], we found signiﬁcantly greater gains in
ﬁtness in younger patients than in older (or the oldest) patients. This
may represent some reduction in physiological adaptability, particular-
ly in the oldest patients, in whom the effect size was less than half that
of the young patients. This is of note for practitionerswhen setting goals
for patients, as older individualswould be expected to show lower gains
when ﬁtness is expressed in absolute terms as in this analysis. If
expressed as percentage gains, the changes in the older patients may
be equal to or even exceed those of younger patients due to lower base-
line ﬁtness values.4.11. Baseline ﬁtness values
The pattern by which individuals with low initial ﬁtness may dem-
onstrate the largest overall gains due to a training programme is
referred to as the law of initial values. Statistically, this phenomena rep-
resents regression to the population mean; it is well-documented in
general exercise physiology [68] and has been shown in cardiac rehabil-
itation patients [80]. We divided patients into two groups according to
their baseline ﬁtness values, hypothesising that lower baseline ﬁtness
would be associated with greater ﬁtness gains. The hypothesis was
not supported by the data, which showed almost no between-group
difference. The similarities may be due to effective implementation of
exercise prescription at the level of the individual, as reported in most
studies. By doing this, patients can exercise as similar relative exercise
intensities thereby realising similar overall gains in ﬁtness. While this
result is encouraging the subgroup analysis itself is limited as it is
based on the arbitrary ﬁgure of 6.6METs determined simply by median
split, limiting the generalisability of this ﬁnding to patients with more
varied baseline ﬁtness values.y ﬁtness in cardiac rehabilitation patients: A meta-analysis, Int J Car-
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Therewas a trend toward greater gains in ﬁtness in post-MI patients
than those being rehabilitated for revascularisation or other reasons.
The between-group heterogeneity was not signiﬁcant and the small
number of studies in each speciﬁc subgroupmakes interpretation prob-
lematic. This is a limitation of the analysis but is duemostly to themixed
patient-group nature of studies which simply reﬂects the wide range of
patients eligible for cardiac rehabilitation.
4.13. Summary: patient-level moderators
In summary, despite a large degree of heterogeneity between stud-
ies, gains in ﬁtness were only signiﬁcantly moderated by patients' sex
(being male) and age (being younger). Practitioners may wish to take
note of these non-modiﬁable factors when designing CR services as it
seems that younger, male patients may particularly beneﬁt from
exercising separately from other patients where they are able to exer-
cise in more vigorous manner to promote ﬁtness gains.
5. Conclusions and limitations
Previousmeta-analyses have conﬁrmed the efﬁcacy of cardiac reha-
bilitation as a treatment to reduce patient mortality and morbidity.
Rehabilitation programmes produce these reductions through themod-
iﬁcation of cardiovascular disease risk factors and by promoting gains in
cardiorespiratory ﬁtness. Higher cardiorespiratory ﬁtness is associated
with reduced risk of cardiovascular mortality and morbidity, as is the
magnitude of gains in ﬁtness due to exercise training.
A recent meta-analysis of wide-ranging interventions aimed at
increasing physical activity in cardiac patients found that programme
features including; more contact time with practitioners, greater expo-
sure to supervised exercise sessions and ﬁtness testing were associated
with higher levels of physical activity. Fitness is amore powerful predic-
tor of health than physical activity but Conn et al. [5] did not examine
the factors which were associated with increases in ﬁtness. Despite
the inherent aim of cardiac rehabilitation to improve cardiovascular
ﬁtness and the direct relationship ﬁtness has with many patient out-
comes [6, 17–19, 64] no study has systematically analysed the factors
which may modulate ﬁtness gains.
This is the ﬁrst detailed evaluation of changes in cardiorespiratory
ﬁtness in cardiac rehabilitation patients and shows patients can
expect a 1.5 metabolic equivalent (MET) increase in cardiorespiratory
ﬁtness. This increase could equate to a 16–54% reduction in cardiac
mortality depending on the estimate used. The studies reviewed here
which were used to provide this mean estimate are, however, highly
heterogeneous. We found that the optimal features of CR to promote
these changes were that it comprised >36 sessions of aerobic or
mixed aerobic and resistance exercise delivered over a 12 week period.
We found no evidence that longer programmes had additional beneﬁts
and no evidence that the addition of patient education (comprehensive
cardiac rehabilitation) increased ﬁtness gains. Froma scientiﬁc perspec-
tive, it seems that the treadmill protocol chosen has a major potential
impact on ﬁtness gains and caution should be employedwhen compar-
ing studies which use different protocols. From a patient perspective,
young patients andmales may beneﬁt more from cardiac rehabilitation
than older patients and females. Provision for same-sex exercise groups
towhich patients are allocated according to their agemay help patients
achieve optimal gains in cardiorespiratory ﬁtness.
We found strong evidence of systematic publication bias, whereby
signiﬁcant ﬁndings from larger studies were substantially more likely
to have been published. Conclusions from this analysis are limited due
to the inclusion of non-randomised and cohort-based study designs
but it is the inclusion of these that allowedus to perform subgroup anal-
ysis to determine the potential moderators of the cardiovascular ﬁtness
response to cardiac rehabilitation.Please cite this article as: Sandercock G, et al, Changes in cardiorespirator
diol (2011), doi:10.1016/j.ijcard.2011.11.068Acknowledgement
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ABSTRACT
Background Exercise training is a key component of
cardiac rehabilitation but there is a discrepancy between
the high volume of exercise prescribed in trials
comprising the evidence base and the lower volume
prescribed to UK patients.
Objective To quantify prescribed exercise volume and
changes in cardiorespiratory ﬁtness in UK cardiac
rehabilitation patients.
Methods We accessed n=950 patients who
completed cardiac rehabilitation at four UK centres and
extracted clinical data and details of cardiorespiratory
ﬁtness testing pre- and post-rehabilitation. We calculated
mean and effect size (d) for change in ﬁtness at each
centre and converted values to metabolic equivalent
(METs). We calculated a ﬁxed-effects estimate of change
in ﬁtness expressed as METs and d.
Results Patients completed 6 to 16 (median 8)
supervised exercise sessions. Effect sizes for changes in
ﬁtness were d=0.34–0.99 in test-speciﬁc raw units and
d=0.34–0.96 expressed as METs. The pooled ﬁxed
effect estimate for change in ﬁtness was 0.52 METs
(95% CI 0.51 to 0.53); or an effect size of d=0.59
(95% CI 0.58 to 0.60).
Conclusion Gains in ﬁtness varied by centre and
ﬁtness assessment protocol but the overall increase in
ﬁtness (0.52 METs) was only a third the mean estimate
reported in a recent systematic review (1.55 METs). The
starkest difference in clinical practice in the UK centres
we sampled and the trials which comprise the evidence-
base for cardiac rehabilitation was the small volume of
exercise completed by UK patients. The exercise training
volume prescribed was also only a third that reported in
most international studies. If representative of UK
services, these low training volumes and small increases
in cardiorespiratory ﬁtness may partially explain the
reported inefﬁcacy of UK cardiac rehabilitation to reduce
patient mortality and morbidity.
INTRODUCTION
Current UK national service guidelines for cardiac
rehabilitation1 2 cite evidence from systematic
reviews3–5 of randomised controlled trials showing a
∼20% reduction in mortality for patients who com-
plete exercise-based cardiac rehabilitation. The trials
from which this ﬁgure was synthesised were largely
completed 20–30 years ago and represent a historical
vision of modern cardiac rehabilitation,6 a version
particularly unrepresentative of current pharmaco-
logical practice.6 A more recent meta-analysis7
provided a more conservative estimate of the effect-
iveness of cardiac rehabilitation to reduce mortality
and rejected its efﬁcacy in reducing secondary
cardiac events. The exact studies included within
each of the numerous systematic reviews published
vary due to inclusion/exclusion criteria, but
common to all these reviews is the paucity of UK
data. The UK’s contribution to the evidence-base is
two studies, both completed >20 years ago.8 9
Neither signiﬁcantly reduced the risk of either total
mortality or cardiac mortality in patients receiving
cardiac rehabilitation compared with the usual prac-
tice group.
The recent publication of data from the RAMIT
group6 has posed some serious doubts as to the
efﬁcacy of the UK cardiac rehabilitation pro-
gramme’s ability to reduce patient mortality10 and
morbidity or increase quality of life. It has been
suggested that data from RAMIT are already out-
dated and do not fully represent current practice
guidelines.11 Nevertheless, RAMIT still represents
the most detailed randomised controlled trial of
comprehensive cardiac rehabilitation in the UK.
The authors suggest that the decline in the appar-
ent effectiveness of cardiac rehabilitation is due to
improved medical management (that received by
intervention as well as usual practice).
Historical data suggest exercise training is an
effective and fundamental element of cardiac
rehabilitation (CR),4 5 and more recent large-scale
trials of psychological interventions alone report
poor efﬁcacy of such approaches when used in iso-
lation.12 13 A primary outcome of any exercise pro-
gramme is the measurement of individuals’
response to training such as changes in strength,
or, as more typically reported in cardiac rehabilita-
tion trials, cardiovascular ﬁtness.
A 1% increase in VO2peak is associated with a 2%
reduction in mortality14; each 1 metabolic equiva-
lent (MET) increase in ﬁtness may infer a 12%
decrease in mortality.15 Increases in ﬁtness are
independently associated with reduced mortality
and morbidity and improved quality of life.16
Individuals who have good levels of ﬁtness are sig-
niﬁcantly less likely to suffer cardiovascular
disease.17–19 Our recent systematic review sug-
gested cardiac rehabilitation may produce a 1.55
(95% CI 1.22 to 1.89) MET increase in ﬁtness.20
There is a relative paucity of data on changes in
cardiorespiratory ﬁtness in UK cardiac rehabilita-
tion patients; we were not able to include any in
our meta-analysis.
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A fundamental difference between UK cardiac rehabilitation
services and the practice reported in many international trials
which make up the body of evidence supporting the efﬁcacy of
cardiac rehabilitation is the exercise ‘dose’. In general, a greater
volume of training is associated with greater improvements in
ﬁtness,20 but UK cardiac rehabilitation patients are typically
only prescribed around one third the volume of exercise train-
ing21 typically received by patients in the USA or Europe.20
Along with changes in clinical practice improving survival
of ‘control’ patients, it may simply be that UK cardiac
rehabilitation does not elicit a large enough training response
to provide secondary prevention of cardiovascular disease. The
RAMIT study6 was detailed, but provided no information on
changes in patient ﬁtness due to cardiac rehabilitation. Given
the paucity of such data, the aim of this study was to quan-
tify the changes in cardiorespiratory ﬁtness in a large, contem-
porary, multicentre sample of UK cardiac rehabilitation
patients.
METHODS
Study design and service characteristics
Cardiac rehabilitation services were recruited through an email
invitation sent by the British Association of Cardiovascular
Prevention and Rehabilitation (BACPR) via their mailing list of
UK centres. Inclusion criteria were that the cardiac rehabilita-
tion service routinely performed cardiorespiratory ﬁtness
testing pre- and post-cardiac rehabilitation and that their clin-
ical practice conformed to the recommendations of the then
BACPR.22 This organisation, now the BACR, has recently
updated these recommendations.23 Multicentre study ethical
approval was obtained via the Integrated Research Application
Service, and permission to access speciﬁed parts of records
without patients’ consent was obtained via the National
Information Governance Bureau. However, local ethical
approval could still not be obtained in two centres. Of the six
services which originally volunteered, the study was completed
in only four.
Data were obtained via retrospective analysis of patient
records obtained during supervised outpatient cardiac rehabili-
tation. Patients’ age, sex, body mass and primary diagnosis
(reason for attending CR) were recorded from individual
records. Patients’ reason for attending cardiac rehabilitation was
classiﬁed as being due to myocardial infarction (post-MI),
having received elective revascularisation therapy including cor-
onary artery bypass grafting (CABG), percutaneous coronary
intervention (PCI) or other (angina pectoris, valvuloplasty). We
did not include patients with congestive heart failure. We also
recorded the type of test used and individual performance on
the test at both pre- and post-CR. The metric used to describe
performance depended on the test performed.
At the level of the service, we recorded the types of exercise
test used and reasons for test selection. We also recorded the
average duration (weeks), frequency (sessions per week) and
type of exercise training used in the rehabilitation programme.
All services included a core component of supervised exercise
training and some aspect of formal patient education or coun-
selling on lifestyle change. All services used mixed circuit-based
(aerobic and resistance) exercise training sessions of 60 min dur-
ation, including a 15 min warm-up and cool-down performed
at beginning and end.1 The characteristics of the four services
evaluated are given in table 1 and are broadly comparable with
national survey data.21
Data extraction and treatment
The cardiac rehabilitation services used four different exercise
tests: the Bruce treadmill protocol, the 6-min walk test
(6MWT), the incremental shuttle walking test (ISWT), and an
incremental cycle ergometer test. The data extracted from
records to compare these are brieﬂy described below; pre- and
post-cardiac rehabilitation tests were treated identically in all
cases. The Bruce treadmill protocol is a standardised incremen-
tal treadmill test with 3-min stages. Time completed on the
test was recorded as a measure of test performance. Time was
converted ﬁrst to Vo2peak (ml/kg/min) and then to METs. One
centre used an incremental cycling test using an electronically-
braked cycle ergometer. The test comprised 2-min stages of
increasing speed which was titrated at individual level based on
sex, body size and self-reported ﬁtness and physical activity.
Final work-rate (Watts) was recorded as a measure of test per-
formance for each patient and converted to METs based on
standard equations.24 The 6MWT is a self-paced ﬁeld test of
functional capacity most commonly used in patients with
heart failure. The total distance walked by patients in 6 min
was recorded as a measure of test performance and converted
to average walking speed, then METs.24 The ISWT is currently
recommended for use in cardiac rehabilitation patients.1
Distance walked by each patient was recorded as a measure of
test performance, then converted to VO2peak (ml/kg/min)25 and
then to METs for comparability with other tests.
Statistical analysis
Each of the tests used reported performance in different units.
For each test, we calculated the pre- versus post-test difference
in performance measures and reported mean change with 95%
CI for the given units.26 27 We also reported change in perform-
ance in METs and as standardised effect size (Cohen’s d) as
these are both readily understood and make our ﬁndings easily
comparable with those of other studies. Finally, we calculated a
ﬁxed-effects pooled estimate of change in performance pre-
versus post-cardiac rehabilitation expressed as METs and effect
size (d).
RESULTS
The descriptive characteristics of the different patient groups
within the four cardiac rehabilitation centres are given in table 1.
There were differences in routine testing practice between
centres. Centre A used the Bruce treadmill protocol to assess
post-MI and valve replacement patients, but used the ISWT to
assess revascularisation patients. Centre A used the 6MWT to
assess a more heterogeneous group of patients, mainly those
receiving valvuloplasty. Centre B used a mixture of cycle ergome-
try and ISWT to assess all patients eligible for cardiac rehabilita-
tion (choice of test was dependent on space and availability of
equipment). Centres C and D exclusively used the ISWT in all
patients. Patients in centre B were equally likely to be attending
cardiac rehabilitation following elective revascularisation or MI,
but the majority of patients in centres C and D were attending
cardiac rehabilitation following elective revascularisation. Table 2
shows the changes in cardiorespiratory ﬁtness test performance in
each group of patients in each cardiac rehabilitation centre.
Patients in centre A showed a large improvement (d=0.85) in
time spent on the Bruce treadmill protocol, corresponding to an
increase of 0.76 METs. The mixed patient group from centre B,
assessed by cycle ergometry, showed a moderate increase in car-
diorespiratory ﬁtness, expressed as peak volitional work-rate
achieved (W) (d=0.57); equivalent to an increase of 0.50 METs.
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Change in distance walked on the 6MWT in the patients receiv-
ing elective revascularisation and valvuloplasty (centre A) was
small (d=0.34), equivalent to only 0.33 METs.
All centres reported using the ISWT in at least some
patients; in two centres (C and D) this was the only test rou-
tinely used and was employed in the assessment of all patients
who could complete it. The predominantly elective revasculari-
sation patients (centre A) improved their test performance by a
mean of 160 m, producing a large effect size (d=0.99). Patients
from mixed MI and revascularisation groups (centres B, C, D)
showed relatively homogenous changes in ISWT performance,
with means ranging from 67.0 to 82.5 m (d=0.46–0.49).
Converting these changes in distance to METs, patients from
centre A improved their ﬁtness by an average of 0.70 METs
which resulted in a larger effect size (d=0.96) than patients
from centres B, C and D, who improved by 0.40, 0.37 and 0.51
METs respectively (effect sizes: d=0.57, d=0.46 and d=0.58).
The pooled ﬁxed effect estimate for mean change in cardio-
respiratory ﬁtness in all (n=950) patients was 0.52 (95% CI
0.51 to 0.53) METs. This was equivalent to a moderate overall
effect size for change in ﬁtness of d=0.59 (95% CI 0.58
to 0.60).
DISCUSSION
The aim of this study was to quantify changes in cardiorespira-
tory ﬁtness in patients receiving cardiac rehabilitation in the
UK. The results of this study suggest that the supervised exer-
cise training prescribed as part of UK cardiac rehabilitation does
not produce changes in cardiorespiratory ﬁtness comparable
with international studies. It also appears that changes in
ﬁtness vary greatly between UK cardiac rehabilitation centres,
all of which adhere to the same practice guidelines, and that
the assessment protocols used to measure change in ﬁtness
may account for at least some of this heterogeneity.
Compared with a recent meta-analysis of international
studies,20 which reported a mean increase of 1.55 METs, the
overall increase reported here (0.52 METs) is very conservative.
The meta-analysis was based on treadmill test data, the gold
standard assessment for cardiorespiratory ﬁtness, and concluded
that the treadmill test protocol was a signiﬁcant source of the
between-trial heterogeneity. There are very few comparable UK
studies of change in ﬁtness due to cardiac rehabilitation, but
survey data suggest this gold standard measure is rarely used in
routine assessment of patients both pre- and post-cardiac
rehabilitation. One study,28 which was not included in the
recent meta-analysis due to omissions in data reporting,
demonstrated a 90 s increase in treadmill time for CABG
patients assessed using the Bruce protocol; the same protocol
used to assess as post-MI patients in centre A. This is equiva-
lent to an increase of approximately 0.60 METs, which is less
than the value reported here. This was despite patients receiv-
ing 16 supervised exercise sessions compared with only eight in
Table 1 Sample characteristics by exercise test groups and basic exercise prescription data at each centre for all patients (n=950)
Centre
Patient groups and
exercise tests Sample size, n Dates
Mean (SD) age
(years) Sex
Primary
diagnoses
Programme
duration (weeks)
Weekly exercise
sessions
A i. Bruce treadmill test 125 2006–10 64.1 (10.2) Male: 73%
Female: 27%
Post-MI: 76%
Other: 34%
8 1
ii. ISWT 104 2006–10 67.5 (10.2) Male: 82%
Female: 18%
Post-MI: 2%
Revasc: 76%
Other: 12%
1
iii. 6-min walk test 54 2006–10 69.4 (7.7) Male: 73%
Female: 27%
Post-MI: 37%
Revasc: 22%
Other: 41%
1
B Incremental cycle ergometry
and ISWT
221 2009–11 69.5 (9.7) Male: 73%
Female: 27%
Post-MI 40%
Revasc: 42%
Other: 18%
8 1 or 2
C ISWT 81 2007–10 57 (11) Male: 85%
Female: 15%
Post-MI: 25%
Revasc:71%
Other: 4%
6 1 or 2
D ISWT 365 2001–10 62.9 (15.2) Male: 73%
Female: 27%
Post-MI: 34%
Revasc: 64%
Other: 2%
8 1
ISWT, incremental shuttle walking test; Post-MI, post-myocardial infarction; Revasc, post-elective revascularisation therapy (CABG or PCI); Other, patients receiving cardiac rehabilitation for
other treatments and conditions (angina pectoris, valvuloplasty recipients, resynchronisation therapy).
Table 2 Changes in cardiorespiratory fitness test performance in original units and METs pre- vs post-cardiac rehabilitation (CR)
Test*
Sample
size Pre-CR Post-CR Change (95% CI)
Effect
size
(d)
Pre
(METs)
Post
(METs) Change (95% CI)
Effect size
(d)
aBruce treadmill test (s) n=125 329 (132) 451 (153) 121 (81 to 140) 0.85 6.8 (2.1) 7.5 (2.4) 0.76 (0.40 to 1.12) 0.58
aIncremental shuttle test (m) n=104 295 (132) 455 (190) 160.1 (136.2 to 184.1) 0.99 4.4 (0.59) 5.1 (0.85) 0.70 (0.58 to 0.86) 0.96
a6-min walk test (m) n=54 279 (144) 329 (148) 50.3 (18.8 to 81.6) 0.34 3.2 (0.97) 3.6 (0.99) 0.33 (0.13 to 0.54) 0.34
bIncremental cycle ergometry (W) n=103 87.6 (19.1) 98.5 (19.1) 10.9 (8.6 to 12.2) 0.57 5.6 (0.8) 6.0 (0.8) 0.40 (0.31 to 0.51) 0.55
bIncremental shuttle test (m) n=118 295 (139) 362 (155) 67.0 (51.6 to 83.6) 0.46 4.6 (0.7) 5.0 (0.7) 0.40 (0.30 to 0.52) 0.57
cIncremental shuttle test (m) n=81 420 (157) 503 (179) 82.5 (53.9 to 111.3) 0.49 5.2 (0.76) 5.5 (0.84) 0.37 (0.25 to 0.48) 0.46
dIncremental shuttle test (m) n=365 341 (165) 411 (230) 71.5 (57.6 to 85.4) 0.46 4.9 (0.83) 5.4 (0.94) 0.51 (0.46 to 0.56) 0.58
Pooled fixed effect model: n=950 0.52 (0.51 to 0.53) 0.59 (95%CI
0.58 to 0.60)
*Superscripts a–d designate the four centres which participated.
Effect size (d), Cohen’s d; MET, metabolic equivalent; Post-CR, exercise test at exit from phase III cardiac rehabilitation; Pre-CR, exercise test at entry to phase III cardiac rehabilitation.
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the present study. One reason for the larger increase in ﬁtness
observed in the present study may be differences in the clinical
characteristics of the patient groups. Post-MI patients increased
their ﬁtness by more than elective revascularisation patients in
our recent meta-analysis (d=2.08 vs d=0.97). Both these effect
sizes are well in excess of that reported presently (d=0.77), but
our estimate is actually quite similar to that which we previ-
ously reported for change in studies using the Bruce treadmill
protocol (d=0.79). The Bruce protocol is characterised by large
increments29 and may not be the most suitable protocol for the
assessment of older patients, such as cardiac rehabilitation reci-
pients who often present with orthopaedic co-morbidities.
Treadmill testing is also costly and time consuming, which
has lead to many UK cardiac rehabilitation centres employing
ﬁeld-based estimates of cardiorespiratory ﬁtness. There are rela-
tively few data regarding the value of incremental cycle ergo-
metry in assessing cardiac rehabilitation patients. Exercise test
performance during cycle ergometry appears to be sensitive to
changes in ﬁtness due to cardiac rehabilitation and can provide
important prognostic information.30 Di Valentino et al30
reported differences of 148 (±47) versus 124 (±38) W between
surviving and non-surviving cardiac rehabilitation patients.
They also reported an improvement in work capacity of 24 W;
more than twice that observed in the patients from centre B
(10.4 W). Differences in the test protocol may account for
some of the variation in improvement, but the very large differ-
ences in exercise training seem more likely. Di Valentino et al30
describe in detail the exercise training protocol in this German
rehabilitation programme as comprising a 4-week build-up
phase with daily rehabilitation activities taking up to 3 h per
day, then a consolidation phase of 8 weeks, exercising 3×2 h
per week. The total exercise dose over 12 weeks was, therefore,
132 h (84 intense plus 48 h consolidation). In comparison,
patients at centre B received either 1- or 2-hourly sessions over
a maximum of 8 weeks, equating to only 8–16 h total exercise.
The 6MWT is commonly used in the assessment of patients
with heart failure, but few data are available in typical cardiac
rehabilitation patients31 and we found no data comparable to
those for changes in ﬁtness due to exercise programmes like
those reported here. Even in patients with heart failure, the
6MWT does not appear to be as sensitive to changes in ﬁtness
as the ISWT32; this lack of sensitivity may explain the small
effect size for change in test performance observed here.
The most commonly used ﬁeld test in UK cardiac rehabilita-
tion centres is the ISWT,21 and a number of studies have
reported changes in ISWT performance of 60–100 m due to
cardiac rehabilitation.33–36 Little has been reported on the
potential dose–response between exercise and changes in ﬁtness
test performance using this protocol. Arnold et al37 recently
reported no difference in a sample of cardiac patients exercising
once or twice per week, but their results are difﬁcult to inter-
pret due to differences in test performance at baseline.38
A more recent study in patients with very similar baseline
scores also reported no differences in training response of
patients exercising either once or twice per week.38 Of interest,
this study is one of the few to report ISWT performance in
METs as opposed to the distance walked during the test. This
detail may be of some importance and deserves elucidation.
The ISWT, as the name implies, is an incremental test in
which the patient is required to walk faster during each sequen-
tial stage. The use of distance to describe ﬁtness test perform-
ance is clearly useful in the clinical setting. Distance is a metric
readily understood by practitioners and patients and changes in
shuttle walking tests can be easily monitored and expressed as
change in m. The magnitude of change in walking distance is
commonly reported to be around 100 m in patients receiving
outpatient cardiac rehabilitation.33–38 Cardiorespiratory ﬁtness
itself, however, represents the ability to produce and maintain a
given work rate, not a work capacity. From an exercise physi-
ology perspective therefore, it would be more correct to express
ISWT performance as walking speed (m/s or km/h), or better
still, as estimated VO2peak (ml/kg/min)25 or METs. This practice
is uncommon within the scientiﬁc literature and to our knowl-
edge only two studies have reported such metrics.38 39 There are
additional drawbacks with the use of distance as an expression
of an individual’s ﬁtness. While study results are often highly
statistically signiﬁcant (p<0.01), there is little evidence of
power analyses in any of the published data. Due to this, such
changes have been interpreted as clinically signiﬁcant despite no
clinically meaningful lower cut-off being available. Like any
ﬁxed stage time incremental protocol, there are many more
shuttles per level in the latter stages of the test than there are
early on. This means that changes in distance walked in excess
of 100 m can be attained without the need for and individual to
increase walking speed (work rate). Changes in walking speed
(and therefore estimated METs) are therefore commonly much
smaller than changes in distance walked, with many patients
not increasing work rate (ﬁtness) at all. In the quest for easily
interpretable values and statistical signiﬁcance, it appears that
some authors have neglected to assess whether the changes in
distance walked during the ISWTrepresent a clinically meaning-
ful improvement in cardiorespiratory ﬁtness.
Our data suggest that patients attending UK cardiac rehabili-
tation centres can only expect a 0.59 MET increase in their car-
diorespiratory ﬁtness over a typical 6–8-week programme. This
value may be slightly smaller if their ﬁtness is assessed using
the ISWT (0.54 METs). These values represent approximately
one third the improvement in ﬁtness reported in the litera-
ture.20 While testing modality may account for some of this
difference, it is of interest that even in the group who improved
most in the present study (post-MI patients tested on a tread-
mill), the magnitude of change was less than half the value
synthesised from international studies.
The starkest difference between the studies analysed in the
recent systematic review and the present groups is the total
volume of exercise completed during outpatient cardiac rehabilita-
tion. We previously found that total number of exercise bouts
was a signiﬁcant mediator of change in ﬁtness. Using a median
split of the number exercise sessions, we have previously reported
greater gains in ﬁtness for patients receiving >36 exercise sessions
than in those receiving 36 or less. Brodie et al21 reported that UK
patients undertake a mean of 11.6 exercise sessions. In common
with the magnitude of change in ﬁtness, the UK exercise dose is
also one third that reported in the literature.20 Patients in the
present study received a modal value of 8 exercise sessions (range
6–16); the lower end of this range is similar to the exercise pre-
scription which had no signiﬁcant impact on clinical outcomes in
RAMIT.6
There is a clear dose–response between increases in ﬁtness
and reductions in mortality.14 Given that a 1 MET increase in
ﬁtness is needed to elicit a 12% reduction in mortality,15 it
seems unsurprising therefore that the UK cardiac rehabilitation
services examined in RAMIT did not signiﬁcantly reduce
mortality.6
Strengths and limitations
The strengths of the present study lie in the large sample size
and the inclusive nature of the study population afforded by
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the retrospective design. Conversely, a major limitation is the
lack of any control group. The cohort design means we cannot
quantify how much of the reported improvement in ﬁtness is
due to cardiac rehabilitation per se. There is evidence of some
spontaneous recovery in ﬁtness in patients following revascular-
isation and MI,40 41 suggesting that the current study is likely
to overestimate the real effect that cardiac rehabilitation has on
patients’ cardiorespiratory ﬁtness. The use of patient records
allowed us to quickly gather a large sample without the bias of
requiring consent to participate in a research study; it was also
a limitation as there were differences in the recording methods
used between centres. All centres described the testing proto-
cols as ‘symptom limited’ and all included attainment of 85%
peak predicted maximum heart rate as termination criteria.
While not reported here, patient records indicated that vol-
itional termination was by far the most common reason for
stopping the incremental exercise tests. All centres reported
that they applied the ISWT according to national guidance,1
but this was often performed by a variety of individuals
(nurses, physiotherapists, exercise physiologists) within each
centre. Our retrospective design does not allow us to standard-
ise test variables such as ‘encouragement’ or ‘patient motiv-
ation’ either within or between centres.
For the purpose of this study we only included patients with
complete data necessary for this analysis. This meant the rejec-
tion of >1200 patient records due primarily to having either
incomplete or insufﬁcient data, but also due to the patients’
failure to complete the rehabilitation programme or to return
for retesting.
CONCLUSIONS
Our ﬁndings suggest that the outpatient cardiac rehabilitation
programmes sampled in our study commonly prescribed a dose
of exercise insufﬁcient to provide meaningful beneﬁts to
patients. The volume of exercise prescribed is equivalent to
approximately one third that which a patient in North
America typically receives. Many of the trials systematically
reviewed to produce estimates of cardiac rehabilitation’s ability
to reduce mortality contain a much higher volume of exercise
than typical UK services prescribe. While we cannot conﬁrm
the representativeness of our sample in terms of UK outpatient
cardiac rehabilitation, these ﬁndings may offer some insight to
explain the somewhat disappointing results of RAMIT.6 When
increases in patient ﬁtness are quantiﬁed, the response of the
UK cardiac rehabilitation patients receiving between 6 and 16
supervised exercise sessions is much less than that reported in
our systematic review of international trials in which a median
of 36 sessions was prescribed.20 We suggest that cardiac
rehabilitation patients in the UK are not receiving the full
potential beneﬁt available from supervised outpatient cardiac
rehabilitation. As an example, if international trials of a drug
demonstrated its efﬁcacy at a daily dose of 600 mg, it seems
unlikely that doctors would routinely prescribe 200 mg to UK
patients. Whether this is through ignorance of the ﬁneries of
exercise prescription, or to spatial, temporal and ﬁnancial
restrictions in service provision, such under-prescription of exer-
cise seems to be common practice in UK cardiac rehabilitation.
In summary, there is clear incongruence between the evi-
dence base for cardiac rehabilitation and current clinical practice
in the UK. Clearly, further trials and systematic reviews of UK
cardiac rehabilitation data are needed to conﬁrm our ﬁndings,
but it seems likely that increased funding to facilitate a greatly
increased frequency and/or duration of exercise training during
outpatient rehabilitation is needed. Such changes will of course
produce new challenges to cardiac rehabilitation practitioners,
not only ﬁnancial in nature but also with regard to patients’
motivation to take up and adhere to exercise training.
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CORRESPONDENCE
Cardiorespiratory ﬁtness
changes in patients receiving
comprehensive outpatient
cardiac rehabilitation in the
UK: a multicentre study
The Authors’ reply We welcome the com-
ments of Dr Ingle and Professor Carroll
comparing our recent work1 and their
own important ﬁndings.2 We agree with
their suggestion that exercise test modality
partially explains the relatively small gains
in ﬁtness reported for UK cardiac rehabili-
tation patients. The 1 metabolic equiva-
lent (MET) gain reported by Carroll
et al2 appears clinically important and
such ﬁndings should serve to illustrate to
commissioners that important health-
related gains in ﬁtness can be achieved in
outpatient cardiac rehabilitation. The 1
MET ﬁtness gain is broadly comparable
with that reported for one of our1 centres
which used treadmill testing (0.76 METs
(95% CI 0.4 to 1.12)). We3 have previ-
ously illustrated that exercise testing
modality mediates ﬁtness gains by report-
ing substantially larger effect sizes (ES) for
ﬁtness gains in patients assessed using
the Naughton (ES=2.4, 95% CI 1.08 to
3.74) rather than the Bruce (ES=0.79,
95% CI 0.60 to 0.98) treadmill protocol.
Our treadmill data and those of Carroll
et al2 still suggest that ﬁtness gains of UK
cardiac rehabilitation patients remain
below international values. We strongly
believe this to be due to the relatively
small dose of exercise routinely prescribed
to UK patients.4 To discern the degree to
which exercise prescription inﬂuences
ﬁtness gains in cardiac rehabilitation inde-
pendent of exercise test protocol we cur-
rently seek to recruit more centres and
expand our current multicentre patient
record study better-represent typical UK
cardiac rehabilitation.
Such data will help us to discern the
relative impact of exercise dose and exer-
cise test protocol in ﬁtness gains. We
concur with Ingle and Carroll that test
protocols may inﬂuence gains in cardiac
rehabilitation but believe that there is a
need for a controlled trial using gold-
standard exercise assessment to directly
compare ﬁtness improvements in UK
cardiac rehabilitation patients receiving
usual care (n=8–12 exercise sessions)4
with an exercise dose more typical
(n=24–36 sessions) of that prescribed
internationally.3
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ABSTRACT
Objective: To determine if the metabolic cost of the
incremental shuttle-walking test protocol is the same
as treadmill walking or predicted values of walking-
speed equations.
Setting: Primary care (community-based cardiac
rehabilitation).
Participants: Eight Caucasian cardiac rehabilitation
patients (7 males) with a mean age of 67±5.2 years.
Primary and secondary outcome measures:
Oxygen consumption, metabolic power and energy
cost of walking during treadmill and shuttle walking
performed in a balanced order with 1 week between
trials.
Results: Average overall energy cost per metre was
higher during treadmill walking (3.22±0.55 J kg/m)
than during shuttle walking (3.00±0.41 J kg/m). There
were significant post hoc effects at 0.67 m/s (p<0.004)
and 0.84 m/s (p<0.001), where the energy cost of
treadmill walking was significantly higher than that of
shuttle walking. This pattern was reversed at walking
speeds 1.52 m/s (p<0.042) and 1.69 m/s (p<0.007)
where shuttle walking had a greater energy cost per
metre than treadmill walking. At all walking speeds, the
energy cost of shuttle walking was higher than that
predicted using the American College of Sports
Medicine walking equations.
Conclusions: The energetic demands of shuttle
walking were fundamentally different from those of
treadmill walking and should not be directly compared.
We warn against estimating the metabolic cost of the
incremental shuttle-walking test using the current
walking-speed equations.
INTRODUCTION
Since its conception as an alternative to
incremental treadmill testing of patients with
chronic obstructive pulmonary disease, the
incremental shuttle-walking test (ISWT) has
gained popularity as an estimate of func-
tional capacity in numerous clinical popula-
tions. The ISWT appears adequately reliable1
and is sensitive to changes in functional cap-
acity.2 3 However, the ISWT’s validity as an
estimate of cardiovascular ﬁtness is only
moderate,3 and the use of the test to esti-
mate oxygen consumption exercise capacity
in metabolic equivalents (METs) is
questionable.4
Woolf-May and Ferret4 reported acceptable
agreement between the energy cost of tread-
mill walking and the ISWT in healthy volun-
teers using linear regression analyses, but did
not assess this relationship in cardiac
patients. The authors reported higher energy
demands of shuttle walking in cardiac
patients compared with healthy controls.
They suggested this may be due to poorer
walking economy in the former; they did not
report walking economy during ISWT or
make comparisons between shuttle-walking
and treadmill-walking economy.
Strengths and limitations of this study
▪ We provide the first direct comparison of the
metabolic cost of shuttle walking and treadmill
walking in cardiac patients.
▪ Our data suggest that metabolic demands of
these exercise modalities appear fundamentally
different.
▪ We suggest that current methods to estimate the
metabolic cost of shuttle walking are flawed. We
warn against risk stratification of cardiac patients
based on estimated oxygen costs using the
American College of Sports Medicine walking
equations during the incremental shuttle-walking
test.
▪ The sample size limits generalisability, particu-
larly in female patients who are not represented
at higher walking speeds—a larger study of
metabolic cost of the incremental shuttle-walking
test is warranted.
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Treadmill-walking and shuttle-walking tests are rou-
tinely used to assess patients with cardiovascular disease
and we have previously reported discrete values for
change in ﬁtness measured using these tests.5 Prior to
undertaking a proposed multicentre study to identify
predictors of change in cardiorespiratory ﬁtness due to
cardiac rehabilitation, we performed the present pilot
study. We examined whether there were differences in
the metabolic demands and energy cost of treadmill and
shuttle walking in cardiac rehabilitation patients in
order to determine whether we could combine data
from these tests in our multicentre study. We also com-
pared metabolic cost of the ISWT with values predicted
from treadmill-walking equations6 and published
estimates.4 7
METHODS
Participants (n=8; 7 males; 67±5.2 years: 86.6±10.1 kg)
were stable cardiac patients attending community-based
rehabilitation following elective cardiac revascularisation.
All patients gave written, informed consent.
Equipment
The ISWT was performed on a non-slip ﬂoor using two
cones placed 9 m apart and a portable CD player. The
treadmill test was performed on a motorised treadmill
(Quaser, HP Cosmos, Nussdorf, Germany). During both
tests a portable gas analyser (K4b2 Mobile Breath by
Breath Metabolic System, COSMED Pulmonary Function
Equipment, Rome, Italy) was used to record expired gas
collected via a face and nose mask (Hans Rudolph,
Shawnee, Kansas, US A). This was calibrated using gases
of a known concentration and a syringe before each test.
Protocol
Patients completed the ISWT and the treadmill test in a
balanced order with 1 week between trials. The ISWT
was performed in accordance with national recommen-
dations for cardiac patients.8 Brieﬂy, the 12-stage proto-
col starts at a walking speed of 0.5 m/s (1.12 mph) and
increases by 0.17 m/s (0.38 mph) each minute. An iden-
tical incremental protocol was programmed into the
treadmill. Patients were accustomed to treadmill walking
but received a brief period of familiarisation in which
they were required to walk without holding the treadmill
handles before the ISWT protocol was also performed.
Calculation of metabolic power and energy cost of walking
We assumed a standard resting metabolic rate of 4 mL/
kg/min based on reference standards.9 Metabolic power
was then calculated via indirect calorimetry from _VO2
and _VCO2 above rest and from body mass: metabolic
power [W/kg]=( _VO2 - _VO2rest) [mL/kg/s] respiratory
exchange ratio adjusted caloric equivalent [J/mL].10 11
To analyse the relationship between speed and meta-
bolic power of walking, the metabolic power was
predicted as a quadratic function of speed: metabolic
power=a+b v2.10 12–16 The energy cost of walking per
metre distance was calculated by: energy cost [J/kg/m]
=metabolic power [W/kg]/speed [m/s].10 11 17
Statistical analyses
Descriptive results are presented as mean±SD. A test
modality-by-walking speed analysis of variance (ANOVA)
with shuttle versus treadmill walking as within-participants
factor and walking speed as the between-participants
factor was performed. Signiﬁcant interactions and main
effects were further analysed using one-way ANOVA and
paired samples t tests as appropriate. Based on the clas-
sical descriptions of walking energy cost,18–20 non-linear
regression models were chosen to identify signiﬁcant
inter-relationships between metabolic power, energy cost
per metre and walking speed, respectively. All analyses
were completed using SPSS V.19.0 (SPSS Inc and IBM
Company, Chicago, Illinois, USA) and statistical signiﬁ-
cance was deﬁned as p<0.05.
RESULTS
Figure 1 shows the oxygen uptake at each of seven stages
completed by at least seven patients. There was a signiﬁ-
cant main effect for walking speed on oxygen uptake
and a signiﬁcant interaction between treadmill walking
and shuttle walking on the ground. Oxygen uptake was
higher in treadmill walking than shuttle walking at
0.67 m/s (p=0.006; n=8) and 0.84 m/s (p=0.003; n=8)
but the signiﬁcantly steeper increases in oxygen demand
during shuttle walking meant the opposite was true at
1.69 m/s (p<0.006; n=7).
Figure 2 shows the metabolic power of treadmill
walking and shuttle walking. There was a main effect for
walking speed on metabolic power during treadmill as
well as shuttle walking (p<0.05). The different effects of
walking modality on metabolic power were more pro-
nounced if power was predicted as a function of walking
Figure 1 The oxygen uptake of treadmill walking (black line)
and shuttle walking (grey line) at each of the seven stages; *
treadmill walking different from shuttle walking, p<0.05.
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speed with power treadmill walking=2.028+1.115 v2 and
power shuttle walking on the ground=1.126+1.665 v2
where 99% of the variance of power was explained by
the quadratic curve ﬁts in both modalities (both
p<0.001). The difference in response to each modality
was indicated by a signiﬁcant interaction between modal-
ity and speed. There were signiﬁcantly higher metabolic
power requirements for treadmill walking at 0.67 m/s
(p<0.004; n=8) and 0.84 m/s (p<0.001; n=8). Owing to
the steeper increase observed in shuttle walking the
metabolic power was signiﬁcantly higher at 1.52 m/s
(p=0.042; n=7) and 1.69 m/s (p=0.007; n=7) compared
with treadmill walking.
Figure 3 shows the relative energy cost (per metre) of
walking for both modalities. There were signiﬁcant main
effects for modality and speed in relative energy cost of
walking, which was well described as a function of speed
by the above approximated parameters for both walking
modalities (energy cost treadmill walking=2.028/v+1.115
v and energy cost shuttle walking on the ground=1.126/
v+1.665 v; both p<0.001). Average overall energy cost per
metre (kg/m) was higher during treadmill walking (3.22
±0.55 J kg/m) than during shuttle walking (3.00
±0.41 J kg/m). There were signiﬁcant post hoc effects at
0.67 m/s (p<0.004; n=8) and 0.84 m/s (p<0.001; n=8),
where the energy cost of treadmill walking was higher
than that of shuttle walking. Again, this pattern was
reversed at higher walking speeds of 1.52 m/s (p<0.042)
and 1.69 m/s (p<0.007) where shuttle walking had a
greater energy cost per metre (for the n=7 patients
achieving this level) than treadmill walking.
DISCUSSION
This is the ﬁrst comparative investigation of the meta-
bolic demands and energy cost per metre walking of
incremental treadmill walking and shuttle walking in
cardiac rehabilitation patients. We found differences in
the oxygen requirements and energy cost of shuttle and
treadmill walking large enough to suggest results from
these exercise modalities should not be pooled in any
future analyses.
Economy and energy requirements recorded during
level 1 are difﬁcult to interpret as they are most affected
by oxygen kinetics and patients’ unusually long stance
phase during their gait cycle at this very slow walking
speed and were excluded from our ﬁgures. The change
in walking energy cost per metre on the treadmill show
the expected pattern. Slow speeds are associated with
higher cost per metre, which decreases as optimal (com-
fortable) walking speed approaches. Continuing to
increase walking speed above this pace requires a
greater cost per metre. In contrast to this, the energy
cost per metre in shuttle walking decreases only very
little and only following the ﬁrst (very slow) walking
pace in the initial stage. The energy cost then increases
stage-by-stage throughout the protocol. The cost is only
consistent between treadmill and shuttle walking
between 1.2 and 1.4 m/s (close to comfortable walking
speed) and the increase in energy requirements is much
greater in shuttle walking. Based on these pilot data, we
intend to report cardiorespiratory ﬁtness values separ-
ately according to test modality and recommend this
practice to others.
The classical description of the energy cost during loco-
motion is of a U-shaped relationship18—as speed increases
or decreases from the optimal (1.11–1.3 m/s18–20) the
energy cost of locomotion increases. For the treadmill
protocol our data support this relationship. At slow
speeds (0.6–0.8 m/s), energy cost was greater than at
optimal speeds (1.2–1.4 m/s). As walking speed
increased (1.6–1.8 m/s) the energy cost again began to
increase. This is comparable to Berryman et al,21 who
reported a similar energy cost pattern for their
Figure 3 Energy cost above rest (CN) per metre distance of
treadmill walking (black line) and shuttle walking (grey line) at
each of the seven stages, * treadmill walking different from
shuttle walking, p<0.05.
Figure 2 Metabolic power above rest (PN) of treadmill
walking (black line) and shuttle walking (grey line) at each of
the seven stages, * treadmill walking different from shuttle
walking, p<0.05.
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participants (healthy elderly aged 68.9±4.6 years) when
walking on a treadmill at speeds ranging from 0.67–
1.56 m/s and the optimal walking speed was 1.33 m/s.
Furthermore, our results also suggest that at lower
speeds (0.50–0.84 m/s), the energy cost of walking on a
treadmill is greater than on the ground. Berryman
et al21 also showed that there was greater energy cost of
treadmill walking compared with ground walking at all
the speeds they tested. The reason for the increased
energy cost may be due to a greater need for stabilisa-
tion via muscular contraction while treadmill walking
than when walking on the ground.21
Conversely, the oxygen requirements of shuttle
walking are comparatively higher from level 7 (1.52 m/
s) onwards than for treadmill walking at the same speed.
The requirements are also much higher (18 mL/kg/
min) than the value predicted by the American College
of Sports Medicine (ACSM) walking speed equations6
(12.6 mL/kg/min) that are used to estimate cardio-
respiratory ﬁtness from ISWT performance.4 In addition
to differences in oxygen requirements of ground and
treadmill walking, shuttle walking may have a higher cost
due to repeated acceleration/deceleration phases or the
negotiation of turns.7 We propose, therefore, that any
clinical cut-offs for walking tests should be developed
using the same testing modality as those for which they
are proposed for use in (ie, treadmill or ground).
Cardiac patients’ exercise capacity is commonly
expressed as METs. We calculated metabolic cost in
METs (gross _VO2 [mL/kg/min]/3.5) and compared
MET values at all ISWT stages with those reported previ-
ously4 and the ACSM-predicted values (table 1). It
should be noted that the values predicted using the
ACSM walking equations by Woolf-May and Ferret4 are
incorrect. The MET values they reported in cardiac
patients are almost double the predicted values using
the ACSM equations and much higher than those
reported presently. Woolf-May and Ferrett’s4 MET values
further appear anomalous as they are more than double
those of age-matched controls and signiﬁcantly higher
than recently reported values in cardiac patients during
the ISWT.7 These latter values7 do, however, broadly
agree with those presently reported.
Current recommendations suggest patients be classed
as high risk if their exercise capacity is <5 METs. Failure
to reach this criterion standard may lead to patients
being prevented from entering community-based
rehabilitation.22 Woolf-May and Ferret’s4 suggestion that
ISWT level 4 elicits a 5 MET energy cost in cardiac
patients is inconsistent with recent data from Woolf-May
and Meadows7 and those of the present study, both of
which suggest the 5 MET threshold is nearer level 7 or 8.
Fitter patients can be successfully ‘fast tracked’ to com-
munity rehabilitation, saving capacity and money to the
health providers.23 However, where exactly in the ISWT
protocol this threshold occurs should be determined in
a larger, more representative cohort of cardiac patients.
Beyond level 7 (1.52 m/s, 3.8 mph) shuttle walking
incurred an additional extra energy cost compared with
treadmill walking, which may make it difﬁcult to show
small improvements in functional capacity if reported as
estimated MET values. The exercise capacity of cardiac
patients measured before outpatient rehabilitation tends
to be lower when estimated from ISWT24 than when
standard treadmill protocols are used.25 26
Study limitations and conclusions
Along with sample size, this study is also limited due to
including predominantly male patients and indeed only
including data from male participants at the highest
Table 1 Comparison of predicted values, published values and measured metabolic cost (METs) of the incremental
shuttle-walking test
ISWT protocol
level
Walking
speed (m/s)
ACSM predicted
METs
Published
ISWT METs
Recorded METs:
treadmill walking
Mean (range)
Recorded METs:
shuttle walking
Mean (range)
1 0.50 1.9 3.0 2.3 (1.6–2.6) 2.0 (1.6–2.2)
2 0.67 2.1 3.7 3.3 (2.8–4.0) 2.7 (2.5–3.1)
3 0.84 2.4 4.4 3.6 (3.1–4.3) 3.1 (2.8–3.3)
4 1.01 2.7 5.1 3.8 (3.2–4.6) 3.6 (3.2–3.8)
5 1.18 3.0 5.9 4.0 (3.6–4.7) 4.0 (3.6–4.6)
6 1.35 3.3 6.6 4.4 (4.3–5.9) 4.4 (4.0–4.9)
7 1.52 3.6 7.3 5.0 (4.6–6.2) 5.3 (4.8–5.6)
8 1.69 3.9 8.0 5.5 (5.0–6.7)* 6.1 (5.7–6.6)*
9 1.86 4.2 8.7 – –
10 2.03 4.5/7.9** 9.4 – –
11 2.20 4.8/8.5** 10.2 – –
12 2.37 5.1/9.1** 10.9 – –
ACSM, American College of Sports Medicine; ISWT, incremental shuttle walking test; MET, metabolic equivalent (calculated as: gross _VO2
[mL/kg/min]/3.5).
Published ISWT METs in cardiac patients from Woolf-May and Ferrett.4
*n=7 participants only. Predicted METs calculated using formula for walking or jogging** from ACSM.6
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walking speeds. The comparison of treadmill and shuttle
walking may have been improved by increasing treadmill
gradient, as is common practice. We omitted to do this
for comparability with previous work.4 6 The accuracy of
energy costs calculations would also be improved by
including a resting metabolic measure pre-exercise
instead of an assumed value of 4 mL/kg/m.9
In conclusion, the ISWT may have clinical utility as a
measure of functional capacity to use in exercise pre-
scription and patient monitoring, but we question its
use as an estimate of cardiorespiratory ﬁtness in
cardiac patients. Importantly, the ACSM walking equa-
tions grossly underestimate the actual energy cost of
shuttle walking and should not be used in research or
clinical practice. Our comparison using METs also
reveals that some published4 estimates of the ISWT’s
energy cost in cardiac patients appear erroneously
high. Given these two shortcomings, we strongly warn
against clinical decision-making or patient risk stratiﬁ-
cation based on achieving the 5 MET threshold esti-
mated using the ISWT. We recommend a more
accurate assessment of the ISWT’s energy cost be per-
formed in a larger, more generalisable sample of
cardiac patients.
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ABSTRACT
The incremental shuttle walk test (ISWT) is used to assess functional capacity of patients entering
cardiac rehabilitation. Factors such as age and sex account for a proportion of the variance in test
performance in healthy individuals but there are no reference values for patients with cardiovascular
disease. The aim of this study was to produce reference values for the ISWT. Participants were n = 548
patients referred to outpatient cardiac rehabilitation who underwent a clinical examination and
performed the ISWT. We used regression to identify predictors of performance and produced centile
values using the generalised additive model for location, scale and shape model. Men walked
significantly further than women (395 ± 165 vs. 269 ± 118 m; t = 9.5, P < 0.001) so data were analysed
separately by sex. Age (years) was the strongest predictor of performance in men (β = −5.9; 95% CI:
−7.1 to −4.6 m) and women (β = −4.8; 95% CI: −6.3 to 3.3). Centile curves demonstrated a broadly
linear decrease in expected ISWT values in males (25–85 years) and a more curvilinear trend in
females. Patients entering cardiac rehabilitation present with highly heterogeneous ISWT values.
Much of the variance in performance can be explained by patients’ age and sex. Comparing absolute
values with age-and sex-specific reference values may aid interpretation of ISWT performance during
initial patient assessment at entry to cardiac rehabilitation.
ARTICLE HISTORY
Accepted 4 February 2016
KEYWORDS
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Introduction
The incremental shuttle walk test (ISWT) is recommended as a
measure of functional capacity in cardiac rehabilitation (SIGN,
2002) and is the most commonly used exercise test in UK
programmes (Brodie, Bethell, & Breen, 2006). The ISWT is a
useful adjunct to risk stratification and exercise prescription
when performed as patients enter cardiac rehabilitation pro-
grammes (SIGN, 2002). Repeat-testing on completion of reha-
bilitation is less common (Brodie et al., 2006), but the ISWT
offers a safe and reliable (Jolly, Taylor, Lip, & Singh, 2008) tool
with which to evaluate changes in patients’ functional capa-
city (Almodhy, Sandercock, & Richards, 2012; Sandercock,
Grocott-Mason, & Brodie, 2007).
Patients’ ISWT performance is typically expressed as the
total distance walked during the test (Almodhy et al., 2012;
Arnold, Sewel, & Singh, 2007; Robinson, Samani, & Singh,
2011). In common with other walking tests (Enright &
Sherrill, 1998; Fiorina et al., 2007), the distance patients walk
during initial application of the ISWT varies according to their
age, sex (Harrison et al., 2013) and anthropometric character-
istics (Jurgensen et al., 2011; Luxton, Alison, Wu, & Mackey,
2008; Pepera, Cardoso, Taylor, Peristeropoulos, & Sandercock,
2013; Probst et al., 2012). The National Audit of Cardiac
Rehabilitation (NACR) shows UK programmes cater for patients
of both sexes, from 17 to 106 years-of-age, who may present
with numerous clinical diagnoses and comorbidities (Doherty,
2014). Such a varied population results in highly heteroge-
neous ISWT performance values when patients are assessed at
entry to cardiac rehabilitation (Almodhy et al., 2012; Arnold
et al., 2007; Sandercock, Cardoso, Almodhy, & Pepera, 2013;
Sandercock et al., 2007). Despite numerous studies showing
how ISWT performance differs according to the age, sex and
anthropometric characteristics of healthy adults (Harrison
et al., 2013; Jurgensen et al., 2011; Probst et al., 2012), there
are as yet no reference values available for patients with
cardiovascular disease.
Our aim, therefore, was to produce reference values for
ISWT performance in patients with cardiovascular disease
assessed at entry to outpatient cardiac rehabilitation. Our
hope is that these reference values may be used to
improve clinicians’ interpretation of initial ISWT values
and patients’ understanding of their own functional
capacity.
Methods
Participants
Ethical approval for this study was obtained through the
Integrated Research Application Service (REC reference: 09/
H0305/102). Individuals’ consent to participate in the study
was not obtained, instead approval to assess patient
records was sought via a request to the National
CONTACT Gavin R.H. Sandercock gavins@essex.ac.uk Centre for Sport and Exercise Science, University of Essex, Colchester CO33TR, UK
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Information Governance Bureau (Request: ECC 1-04(e)/
2010). We accessed clinical records of n = 547 (n = 415,
76% males) patients aged 63.1 (±11.3) years who had
entered outpatient cardiac rehabilitation at four UK hospi-
tals. We included data from patients eligible for referral to
outpatient cardiac rehabilitation according to current UK
guidelines (NICE, 2007). We excluded the records of
patients with severe orthopaedic limitations and patients
with a primary diagnosis of congestive heart failure.
Table 1 describes patients’ demographic, anthropometric
and clinical characteristics. Primary diagnosis indicates the
acute coronary event or the underlying condition which had
prompted referral to cardiac rehabilitation. Primary treatment
was the most-recent intervention patients had received either
electively or as part of their treatment following an acute
coronary event.
Procedures and data collection
All participating hospitals delivered cardiac rehabilitation in
keeping with UK national standards (BACPR, 2012). All routi-
nely assessed patients using the ISWT in accordance with
national guidance including; standardised test administration,
test termination criteria and employed the same contraindica-
tions to exercise testing (SIGN, 2002).
Statistical analysis
Independent t-tests were used to confirm expected
between-sex differences in ISWT performance (expressed
as total distance walked). Stepwise linear regression was
used to identify the strongest, independent predictors of
ISWT performance and determine the most appropriate
variables to use when creating reference data. We decided
a priori to consider only those variables accounting for
>5% additional variance in each regression model. These
analyses were performed using SPSS 18.0 (SPSS, an IBM
Company, Armon, NY).
Reference data were provided as tables and centile curves
were constructed to describe ISWT performance (total dis-
tance walked) using the generalised additive models for loca-
tion, scale and shape (GAMLSS) (Rigby & Stasinopoulos, 2006).
GAMLSS models are part as a package in the statistical soft-
ware R and this method is used by the World Health
Organization Multicentre Growth Reference Study Group
(Borghi et al., 2006).
Results
The demographic and clinical characteristics of patients are
provided in Table 1. Patients’ mean age was (63 ± 11) and 76%
of the sample was male. ISWT performance ranged from 75 to
1145 m, with a mean of 365 (±164) m. Men (395 ± 165 m)
walked significantly (t = 9.5, P < 0.001) further than women
(269 ± 118 m). As sex accounted for 11% of total variance in
distance walked, regression analyses to identify the predictors
of ISWT performance were performed separately for males and
females.
Table 2 shows age was negatively associated with distance
walked in males (β = −5.9, 95% CI: −7.1 to −4.6 m) and females
(β = −4.8, 95% CI: −6.3 to −3.3 m). As age was the strongest
predictor of ISWT performance in both sexes, we constructed
reference data according to age and sex.
Reference data: centile curves
Figures 1 and 2 show the centile curves for each sex (reference
values are shown in Table 3). Male values were higher than
those of females across the age range (25–85 years) for which
centiles were constructed. In males, the relationship between
Table 1. Descriptive characteristics of patients at entry to outpatient cardiac
rehabilitation.
Demographic and clinical characteristics Mean (SD) or % (n = )
Number of patients n = 547
Sex Males 76% (n = 415)
Females 24% (n = 132)
Ethnicity Whitea 79.5% (n = 435)
South Asianb 20.1% (n = 110)
Blackc 0.4% (n = 2)
Age (years) 63.1 (11.3)
Height (cm) 170.6 (8.7)
Weight (kg) 81.5 (17.3)
Body mass Index (kg m−2) 27.8 (5.2)
Diabetic 28.0% (n = 153)
Current smoker 25.6% (n = 140)
Time from event (or treatment) to ISWT (days) 53 (34–95)d
Primary diagnosis
Post-MI 68.6% (n = 375)
CHD (elective revascularisation) 21.8% (n = 119)
Other 9.6% (n = 53)
Primary Treatment
CABG 48.1% (n = 263)
PCI 42.1% (n = 230)
Valvuloplasty 6.6% (n = 36)
None 3.3% (n = 18)
Primary Diagnosis – extracted from patient records as most recent event and
reason for attendance at cardiac rehabilitation. Primary treatment – extracted
from patient record as most recent intervention received (Overall percentage
is >100 due to some patients receiving multiple interventions, e.g., emergency
PCI followed by CABG). CHD: coronary heart disease; MI: myocardial infarction;
Other include: valvular dysfunction, arrhythmia, angina pectoris and periph-
eral vascular disease. CABG: coronary artery bypass surgery; PCI: percutaneous
coronary intervention (includes balloon angioplasty emergency and non-
emergency stenting).
aIncludes White British, Irish and any other white category.
bIncludes Indian, Pakistani, Bangladeshi and any other South Asian background.
cIncludes Caribbean, African and any other black category.
dIndicates median value (interquartile range) due to skewed distribution.
Table 2. Predictors of incremental shuttle walk test performance (distance
walked, m) in n = 415 male and n = 127 female patients assessed at entry to
outpatient cardiac rehabilitation.
Predictors: Males β (95% CI) R2 SEE (m)
Age (years) β = −5.9 (−7.1 to −4.6) m 0.16 152
Height (cm) β = 5.0 (3.1 to 6.8) m 0.20 148
BMI (kg/m2) β = −5.1 (−7.9 to −2.2) m 0.23 145
Presence of diabetes β = −48.7(−17.3 to −80.2) m 0.25 144
Predictors: Females β (95% CI) R2 SEE (m)
Age (years) β = −4.8 (−6.3 to −3.3) m 0.20 108
Presence of diabetes β = −80 (−39.5 to −120.5) m 0.23 103
Height (cm) β = 2.8 (0.11 to 5.5) m 0.24 102
Multivariate β coefficients provided using a stepwise model (final model only-
shown with strongest predictor first). Only significant (P < 0.05) predictors are
shown. R2: cumulative variance accounted for by each (additional) factor; SEE:
standard error of estimation for each model.
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age and performance was broadly linear. The median ISWT
performance of females was more curvilinear with a steeper
decrease in younger women (25–60 years) followed by a
more-shallow, linear decrease from age 60 onwards.
The median (50th percentile) expected value for the young-
est patients was more than double that of the oldest in males
and females. There was still, however, a twofold difference in
expected values between the 3rd and the 97th percentile in
both sexes and at all ages.
Discussion
We present reference values for the ISWT in patients with
cardiovascular disease at entry to outpatient cardiac rehabili-
tation. Patients’ mean age (63 ± 11 years) was slightly lower
than that of typical UK cardiac rehabilitation patients (66–
70 years) reported in the NACR (Doherty, 2014). Male patients
had a mean age (62 years) similar to that reported for men in
the NACR (66 years). The mean age of female patients
(63 years) meant they were, on average, 7 years younger
than females (70 years) typically attending cardiac rehabilita-
tion in the UK (Doherty, 2014). The age difference and smaller
sample size mean our reference values for female patients
may be less generalisable. A smaller sample of females is to
be expected in a study accessing the records of consecutive
patients. Nationally, men account for 70% of cardiac rehabili-
tation patients slightly lower than the 76% value in our sam-
ple. The proportion of white participants (79.5%) was similar to
national data (80%). Our median time from event to ISWT was
53 days. Post-MI patients typically start rehabilitation 40 days
following treatment with percutaneous coronary intervention
(PCI); patients receiving CABG start an average of 54 days after
referral (Doherty, 2014). Comparable times for our sample
were 42 days (for post-MI, patients receiving PCI) and
63 days for CABG patients. Again, both these figures are
close to nationally reported values suggesting this was a
broadly typical cohort of UK cardiac rehabilitation patients.
Age and sex accounted for 25% of variance in test perfor-
mance in the population as a whole. Age alone explained the
highest proportion of variance in ISWT performance in both
male (16%) and female (20%) patients.
Median distance walked varied more than twofold across the
age-range in females; the 50th percentile fell from 507 m at age
Table 3. Centile values for total distance walked during the incremental shuttle
walk test by patients (age 25–85 years) with cardiovascular disease assessed at
entry to outpatient cardiac rehabilitation.
Males age C3 C10 C25 C50 C75 C90 C97 Mean SD
25 277 413 413 609 699 860 1145 635 237
30 256 381 492 579 676 833 1092 603 221
35 236 351 458 549 651 803 1036 571 208
40 217 322 424 519 625 771 978 539 196
45 199 295 392 489 597 735 918 507 186
50 182 269 361 459 569 698 858 475 176
55 166 245 331 429 539 658 798 444 166
60 150 221 302 399 507 618 739 412 156
65 135 199 274 369 475 575 680 380 146
70 120 178 247 339 441 532 621 349 136
75 106 157 221 309 406 488 564 317 126
80 93 137 196 279 370 443 507 286 116
85 79 118 171 250 333 397 450 254 105
Females age C3 C10 C25 C50 C75 C90 C97 Mean SD
25 150 263 384 507 616 704 784 495 168
30 132 237 349 466 570 655 732 455 159
35 116 214 318 428 527 609 684 455 150
40 103 193 290 393 487 567 640 386 143
45 93 175 265 361 451 527 600 356 134
50 85 160 242 332 417 491 562 329 126
55 79 148 222 305 386 458 528 304 119
60 77 138 205 281 358 427 496 282 111
65 76 130 189 259 332 399 467 263 104
70 77 123 176 239 308 373 441 245 97
75 77 117 163 221 286 349 417 228 90
80 77 111 151 204 265 327 395 213 85
85 75 104 140 189 246 307 375 199 81
Age (years) grouped according to 5-year increments using patients’ decimal age
rounded down to nearest whole year. C: centile value for age grouping
(distance walked in m); SD: standard deviation.
Figure 1. Smoothed centile curves showing incremental shuttle walk test per-
formance in male patients (age 25–85 years) assessed at entry to outpatient
cardiac rehabilitation.
Figure 2. Smoothed centile curves showing incremental shuttle walk test per-
formance in female patients (age 30–90 years) assessed at entry to outpatient
cardiac rehabilitation.
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25 years to only 189 m at age 85. Age-related variation in the
median value for males was even also more than twofold; the
50th percentile at age 25 years was 609 m falling to only 250 m
by age 85. The centile curves provide the first set of reference
values in cardiac patients. These age- and sex-specific values
now allow practitioners to individualise the interpretation of
patient’s ISWT performance at entry to cardiac rehabilitation.
Predictors of ISWT performance
Verification of age and sex as important predictors of ISWT
performance in patients agrees with data from healthy indivi-
duals (Dourado, Guerra, Tanni, Antunes, & Godoy, 2013;
Dourado, Vidotto, & Guerra, 2011; Harrison et al., 2013;
Jurgensen et al., 2011; Probst et al., 2012). Such studies are
only of value in cardiac rehabilitation if the factors which
predict ISWT performance of healthy individuals also predict
the performance of cardiac patients. Unfortunately, none of
the equations developed in healthy populations have been
cross-validated in a sample of cardiac patients. Healthy indivi-
duals tend to walk twice as far during the ISWT (600–800 m)
than cardiac patients (300–400 m). Such large differences
hinder any generalisation of findings in healthy individuals to
cardiac patients entering rehabilitation.
The difference in distance walked between males and
females agrees with the limited data which are available in
cardiac patients (Pepera et al., 2013). These authors (Pepera
et al., 2013) also found height predicted 17% of variance in
ISWT performance in their small sample including both men
and women. We could not confirm this in our analysis in
females, but height (cm) did explain a further 5% of variance
in males’ ISWT performance. In an additional post hoc analysis
using a binary dummy variable for height (short vs. tall based
on a median split), we found tall males walked 52 m further
than shorter patients independent of age. There may be some
benefit from future studies which create different sets of
reference values for taller and shorter males although this
may cause confusion when interpreting scores of patients
whose height sits just above and below any cut-off value.
The presence of diabetes accounted for a significant addi-
tional proportion of the variance in distance walked by female
patients. Diabetics walked 80 m less than non-diabetic female
patients. There may be some need to take diabetes into con-
sideration when interpreting ISWT performance. However, this
finding should be interpreted cautiously as it was based on a
very small (n = 35) sample of female patients.
Clinical use and interpretation of ISWT performance
Patients’ results from initial assessment using the ISWT are
currently used in risk stratification and exercise prescription.
Results can also be used in goal setting and if a retest is
performed at the end of rehabilitation change in ISWT is an
excellent way to evaluate improvements in functional capacity
(Sandercock et al., 2013). Improved functional capacity is one
of the goals for exercise-based cardiac rehabilitation, and
assessing groups of patient’s change in ISWT performance
during outpatient CR allows researchers and clinicians to
identify the elements of effective programmes (Sandercock,
Hurtado, & Cardoso, 2011).
However, the heterogeneity of patients entering contem-
porary cardiac rehabilitation programmes (in terms of sex, age,
diagnosis, treatment, comorbidities) and variation in the time
between patients’ cardiac event or surgery and when they first
perform the ISWT (median 53 [34–95] days) are all likely con-
tributors to the large inter-patient variation in initial ISWT
performance. Numerous studies have demonstrated that
non-modifiable characteristics are associated with ISWT per-
formance (Dourado et al., 2013; Harrison et al., 2013;
Jurgensen et al., 2011; Pepera et al., 2013; Probst et al.,
2012). To our knowledge, there is currently no guidance avail-
able as to how clinicians should account for such factors when
interpreting patients’ ISWT performance. Where age is asso-
ciated with an outcome variable, it is common practice to
interpret actual (raw) scores by comparing them with refer-
ence data in the form of centile curves (Cole & Green, 1992).
This is common practice in anthropometry but also when
assessing children’s performance on tests of motor function
(Hanna, Bartlett, Rivard, & Russell, 2008) or cardiorespiratory
fitness (Sandercock, Voss, Cohen, Taylor, & Stasinopoulos,
2012). Performance on the 6-min walk test is commonly
expressed as a relative score by calculating patients actual
test performance as a percentage of typical values derived
from healthy age-matched individuals (Dourado et al., 2011;
Enright & Sherrill, 1998). The ISWT is the protocol most com-
monly used to assess patients’ functional capacity in UK car-
diac rehabilitation centres (Brodie et al., 2006), but no
comparable use of reference data or expression of test perfor-
mance relative to patients’ age or sex has yet been adopted.
The ISWT has been successfully used to “triage” patients
more accurately at entry to outpatient CR; by identifying
individuals to be “fast tracked” to community rehabilitation
(Robinson et al., 2011) Interpretation of ISWT performance
in absolute (distance walked) terms creates an obvious
preference for younger, male patients to meet potential
fast-track criteria regardless of their actual functional capa-
city. This is clearly evident in the population characteristics
of the fast-tracked patients (Robinson et al., 2011).
We suggest practitioners may be able to make more
meaningful interpretation of test scores when combined
with these reference data. This practice may aid clinical
decision-making, improve patient understanding and goal
setting at entry to outpatient cardiac rehabilitation. For
example, an 80-year-old female walking 200 m is performing
at the expected level (50th Percentile) and her goal during
rehabilitation may be to improve by 50 m – taking her
performance to the 70th percentile whereas the same abso-
lute ISWT distance of 200 m would place a 50-year-old male
below the 5th percentile for age and sex. Creating relative
scores from reference data like ours demonstrates the need
to improve fitness is greater in the latter patient; he could
be set a greater goal for improvement such as 200 m, which
would still be well within the expected range of values for
ISWT performance. Setting the same 200 m goal for the 80-
year-old female would be inappropriate; she simply would
not be expected to be able to perform to this level at her
age. There are as yet, no cut-offs to define a meaningful
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improvement on the ISWT; such as there are for changes in
the 6-min walk test (Cacciatore et al., 2012). A recent sug-
gestion that 38.5 m (4 shuttles) could represent a minimal
clinically important difference (MCID) was based on per-
ceived improvement in patients’ symptoms (Houchen-
Wolloff, Boyce, & Singh, 2015). The ISWT protocol is itself
reproducible (Jolly et al., 2008), but the subjective symptom
ratings used by Houchen-Wolloff et al. (2015) were not;
neither did these ratings correlate well with actual changes
in ISWT. Research to identify age- and sex-specific MCIDs for
the ISWT is needed to improve its utility both in patient
monitoring and prediction of risk.
Patients ISWT performance is sometimes converted to
metabolic equivalents using a linear equation to predict the
oxygen cost of walking. We recently reported that the oxygen
cost of walking during the ISWT is actually curvilinear
(Almodhy, Beneke, Cardoso, Taylor, & Sandercock, 2014) espe-
cially at the higher walking speeds required in later test stages.
This means that patients who perform well during initial test-
ing may express smaller than expected gains in absolute
performance when retested. This problem might be particu-
larly acute in older patients; especially older females with
good initial test performance if clinicians rely only on the
difference in absolute test scores to describe changes in func-
tional capacity. Expressing ISWT performance in relative terms
would demonstrate to patients that their initial score is
already higher than expected for their age and sex and
could be used to set more realistic goals for functional capa-
city gains. Future research should determine whether using
centile curves or calculating age- and sex-specific relative
scores can improve clinical interpretation and patient under-
standing of results from the ISWT performed as part of cardiac
rehabilitation.
Study limitations
Our sample is broadly typical of cardiac rehabilitation patients
in England but may not be internationally generalisable. Given
the potential influence of height (males) and presence of
diabetes (females), these reference data should be used with
caution in males at extremes of the normal height distribution
and diabetic patients. Future research is needed to confirm or
refute the predictors of ISWT performance identified here and
the shape and distribution of our centile curves. Future
research should identify whether it is necessary to produce
additional reference data for specific populations such as
diabetics. The LMS method provides robust estimates of cen-
tile values across the age-range of sample and we can be
more confident in our estimates (including the youngest and
oldest patients) than if we had used regression to predict ISWT
performance as others have (Jurgensen et al., 2011; Luxton
et al., 2008; Pepera et al., 2013; Probst et al., 2012).
Nevertheless, due to the relatively small number of females,
reference values presented here for female patients should be
interpreted with some caution.
These reference values provide only expected walking dis-
tances in patients entering cardiac rehabilitation and we can-
not suggest an MCID or clinical cut-off for “good” test
performance nor assess how ISWT performance may change
due to cardiac rehabilitation (Sandercock et al., 2013). Our
findings do not address the usefulness of ISWT performance
in patient risk stratification. To improve the ISWT’s role in risk
stratification and exercise prescription, research is needed to
identify predictors of change in ISWT performance in patients
receiving exercise-based cardiac rehabilitation.
Conclusion
We provide the first reference data for the incremental shuttle
walking test in patients at entry to cardiac rehabilitation. We
propose that clinicians should assess test scores by compar-
ison with these age- and sex-specific reference values. This
practice will provide a more meaningful and individualised
assessment of patients’ functional capacity at the start of
their cardiac rehabilitation programmes.
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Abstract
Background The incremental shuttle walk test (ISWT) is
a standardised assessment for cardiac rehabilitation. Three
studies have reported oxygen costs (VO2)/metabolic
equivalents (METs) of the ISWT. In spite of classic rep-
resentations from these studies graphically showing
curvilinear VO2 responses to incremented walking speeds,
linear regression techniques (also used by the American
College of Sports Medicine [ACSM]) have been used to
estimate VO2.
Purpose The two main aims of this study were to (i) re-
solve currently reported discrepancies in the ISWT VO2-
walking speed relationship, and (ii) derive an appropriate
VO2 versus walking speed regression equation.
Methods VO2 was measured continuously during an
ISWT in 32 coronary heart disease [cardiac] rehabilitation
(CHD-CR) participants and 30 age-matched controls.
Results Both CHD-CR and control group VO2 responses
were curvilinear in nature. For CHD-CR VO2 = 4.4-
e0.23 9 walkingspeed (km/h). The integrated area under the
curve (iAUC) VO2 across nine ISWT stages was greater in
the CHD-CR group versus the control group (p\ 0.001):
CHD-CR = 423 (±86) mlkg-1min-1kmh-1; con-
trol = 316 (±52) mlkg-1min-1kmh-1.
Conclusions CHD-CR group vs. control VO2 was up to
30 % greater at higher ISWT stages. The curvilinear nature
of VO2 responses during the ISWT concur with classic
studies reported over 100 years. VO2 estimates for walking
using linear regression models (including the ACSM)
clearly underestimate values in healthy and CHD-CR par-
ticipants, and this study provides a resolution to this when
the ISWT is used for CHD-CR populations.
Key Points
The change in oxygen cost (VO2) during a
standardised incremental walking test in healthy and
cardiac rehabilitation participants responds in a
classic curvilinear nature; linear regression should
not be used to estimate oxygen uptake (VO2/
metabolic equivalents) from walking speed.
Coronary heart disease patients performing
incremental walking tests require up to 30 % more
oxygen compared with age-matched non-CHD
controls.
1 Introduction
The 10-m incremental shuttle walk test (ISWT) was orig-
inally developed in 1992 for assessing peak exercise
capacity in patients with pulmonary disease [1, 2]. The
concept of the shuttle protocol (‘bleep test’) was derived
from a 20-m shuttle test for athletes [3]. The ISWT has
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now become a standardised tool for assessing aerobic fit-
ness in cardiac populations attending exercise-based reha-
bilitation [4–7]. A known or estimated peak oxygen
consumption (VO2peak) attained during exercise can pro-
vide valuable information for decision making in cardiac
rehabilitation, including patient risk stratification [6, 8, 9].
The gold-standard measurement for assessing VO2peak is
an incremental and maximal exercise test (e.g. treadmill or
cycle ergometer), but in its absence the ISWT has been
widely recommended for cardiac rehabilitation [6, 7, 10,
11]. The ISWT can provide practical valuable information
for physical activity guidance and exercise prescription,
along with more traditional information for evaluating
changes in exercise capacity, either as an outcome measure
for individual patients or whole service delivery [12, 13].
To date, only three studies (summarised in Fig. 1) have
reported the oxygen cost (VO2) or metabolic equivalents
(METs) for each stage of the ISWT in cardiac populations
compared with age-matched controls [12, 14, 15]. The data
from these studies make it possible to compare measured
VO2 values with VO2 estimates derived from a linear
regression equation recommended by the American Col-
lege of Sports Medicine (ACSM) [9]. In all cases, the
values reported in both the healthy and, in particular, car-
diac populations were greater than those estimated by the
ACSM [9]. The first study by Woolf-May and Ferrett [14]
reported VO2 values for cardiac patients up to 40 % greater
than estimated by the ACSM during the initial test stages of
the ISWT, and up to 90 % greater during the latter stages.
In comparison to age-matched healthy individuals, the
measured VO2 of cardiac patients was 26 and 47 % greater
at the lower and upper stages, respectively. However, the
second study from the same group [15] reported recorded
VO2 values during the ISWT that were similar to the
ACSM estimates at stages 1–5. The values then increased
in a curvilinear fashion until they were 20 % greater than
estimated by the ACSM equation at stage 9—far less than
the 90 % difference they previously reported in a similar
population. Also contrary to their former study, the VO2
values differed very little between cardiac rehabilitation
participants and age-matched controls. Such inconsisten-
cies without any comment from the same group of
researchers means that cardiac rehabilitation professionals
are currently faced with some confusion over estimating
the oxygen costs of the ISWT, whether for the purpose of
exercise prescription or risk stratification.
An initial step towards resolving these ISWT VO2
inconsistencies has more recently been provided by
Almodhy et al. [12], albeit in a small pilot study of cardiac
patients (n = 8). As illustrated in Fig. 1, these investigators
reported VO2 values residing between those reported previ-
ously by Woolf-May et al. [14, 15]. Almodhy et al. [12] also
demonstrated that VO2 responses to the ISWT were funda-
mentally different to those of treadmill exercise, the gold-
standard method of assessing VO2peak in cardiac patients
and the reference standard for the ACSM equations.
Another area of concern with the extant descriptions of
the ISWT’s oxygen cost reported by Woolf-May et al. are
the authors’ interpretations of recorded data and the
application of the ACSM estimation equations [9]; both
assume a linear relationship between increments in walking
speed and VO2 [14, 15]. This assumption is contrary to the
accepted findings of numerous studies dating back to the
classic work by Douglas and Haldane in 1912 [16], which
have all consistently reported VO2 responding as a positive
curvilinear function of speed during walking exercise.
Figures 2 and 3 illustrate the historical findings of such
classic works from 1912 to 1976, including a composite
estimate of the VO2 response from studies published up to
1938 by Passmore and Durnin [17], followed by Margaria
et al. [18], Menier and Pugh [19], and Falls and Humphrey
[20]. The ACSM equations have been based on the work by
Dill [21], Naughton and Nagle et al. [22], and Margaria
et al. [18] (for VO2 during incremental treadmill exercise
speed and gradient, and box stepping). The total number of
participants in the walking assessments was only five. The
approach the ACSM has applied has involved creating two
different equations for walking and running, but because
they have not employed a curvilinear analysis for walking
as the classic studies demonstrated, a[50 % gap or ‘jump’
in the VO2 estimates occurs during the transition speed
from walking to running (approximately 7–8 kmh-1). The
range of horizontal walking speeds reported in the three
participants assessed by Dill [21] ranged between 3.6 and
7.2 kmh-1 and clearly showed a classic positively accel-
erating curve. Dill [21] cited the work of both Margaria
Fig. 1 Oxygen cost of the incremental shuttle walk test in cardiac
rehabilitation participants and age-matched healthy controls [9, 12,
14, 15]. ACSM American College of Sports Medicine, CHD coronary
heart disease
J. P. Buckley et al.
123
et al. [18] and Passmore and Durnin [17] but did not
note the curvilinearity in these data. One of the most
popular exercise physiology text books from the US, first
published in 1981 and its latest edition published in
2014, has consistently highlighted, with each successive
edition, the curvilinearity of VO2 as a function of
walking speed [23]. The VO2 curvilinearity related to
treadmill walking speed has been further supported in
young, healthy participants by more recent detailed
mathematical modelling [24].
Just as the historical data have shown, upon simple
visual examination of the more recent ISWT studies
(Fig. 1), there is clearly a curvilinear relationship between
VO2 and walking speed for both treadmill and overground
walking. The curvilinearity of these values is made very
apparent when the predictive linear equation recommended
by the ACSM [9] is plotted as a reference line. The
responses of heart rate and ratings of perceived exertion
(RPE) reported by Woolf-May and Meadows [15] also
demonstrated clear and corresponding curvilinear patterns,
confirming the traditional assumption that these measures
are strong correlates of measured VO2. The VO2 values in
Fig. 1 for the ISWT have been reported from stages 1–9;
stages 10–12 have not been included because these repre-
sent speeds for running (7.5–8.0 kmh-1 or
4.7–5.0 mih-1). Traditionally, VO2 for running has shown
a linear relationship (Fig. 3) [20].
The disparity of findings between studies, the potentially
flawed assumption of a linear relationship, and the inade-
quacy of the prediction equation to estimate the ISWT’s
oxygen cost are problematic. Further data are needed to
promote confidence in cardiac rehabilitation professionals
when wishing to apply assumptions of the VO2 values in
patients who have been assessed with the ISWT.
2 Aims
The aims of this study have therefore been twofold: (i) to
determine an appropriate VO2 estimation equation (curvi-
linear or linear?) for walking speeds during the ISWT; and
(ii) to resolve the currently reported discrepancies in the
VO2-walking speed relationship for cardiac patients.
3 Methods
3.1 Participants
Following ethical approval from the University of Essex,
the University of Chester and the National Health Service’s
Northwest Region (Liverpool/Manchester) ethics commit-
tees, cardiac rehabilitation participants from two stan-
dardised community-based cardiac rehabilitation
programmes (using British Association for Cardiovascular
Prevention and Rehabilitation [BACPR] standards, 2013)
[25] were recruited via open invitations to any patient
diagnosed with and being treated for cardiac disease as per
national guidelines [26]. Inclusion criteria were based on
standard eligibility for a UK cardiac rehabilitation service
[27]. Patients were excluded from participating for the
following reasons: an auditory impairment that did not
allow them to hear the audio shuttle-pacing bleeps of the
ISWT; cognitive impairment that prevented them from
understanding how to perform the test or comprehend
Fig. 2 Summary of historical studies (1912–1938) on the energy
expenditure response to walking speeds 1–9 kmh-1
(0.6–5.6 mih-1). Reproduced from Passmore and Durnin [17], with
licensed permission from Physiological Reviews, American Physio-
logical Society
Fig. 3 Relationship between energy expenditure and speed of
progression in walking and running. Reproduced from Falls and
Humphrey [20], with licensed permission from Medicine and Science
in Sports and Exercise
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instructions to remain in independent control of their
walking pace; a diagnosis of heart failure or chronic
obstructive pulmonary disease that would affect normal
pulmonary responses to exertion; or a significant neuro-
musculoskeletal or vascular condition that impaired them
from being able to safely perform and complete at least five
stages of the ISWT while comfortably tolerating walking
up to a steady vigorous pace. Age-matched controls were
then recruited, under the same exclusion criteria as the
coronary heart disease (CHD) patients, but with inclusion
criteria set for people within the same age range as the
agreed volunteering CHD group. The control group was
already attending the same community centres, either for
personal health-promoting exercise or as participants from
their local primary-care exercise referral programme who
had been referred for an elevated risk of cardiometabolic
disease. As this was a convenience sample, exact matching
for numbers and gender was not possible, but previous
reports on VO2 during walking have shown little difference
between genders [20, 28].
3.2 Sample Size
For 85 % power, a VO2 of 1.75 mlkg-1min-1 was
determined to represent a clinically important difference in
oxygen cost, based on the pilot data from Almodhy et al.
[12]. In conjunction with this clinical significance, and
where participants were assumed to have enough fitness to
complete five stages at an estimated VO2 of 14 mlkg-1-
min-1, 30 participants per group were deemed suitable for
achieving the effect size of at least 10 %, as well as an a of
p\ 0.05 and b = 0.8.
3.3 Procedures
Prior to testing, all participants were health screened for
clearance to perform moderate to vigorous exercise by way
of standarised procedures [6, 11], which were employed by
qualified cardiac rehabilitation staff. Measurements inclu-
ded resting heart rate, blood pressure, height, age and body
mass, where all of these were also required for measuring
the cardiopulmonary gas exchange.
All participants performed the recommended ISWT
practice test [1, 5], which also included familiarisation in
wearing the respiratory face mask although not connected
to the gas analysis system. Participants then rested for the
required 30 min before performing the actual data collec-
tion test. The test endpoint, in keeping with BACPR (2015)
and Association of Chartered Physiotherapists in Cardiac
Rehabilitation (ACPICR; 2015) [6, 11] recommendations,
was the attainment of 75 % of heart rate reserve (approx-
imately 80–85 % HRmax) and/or an RPE of 14–15 on
Borg’s scale [29]. During the ISWT, cardiopulmonary gas
exchange was measured continuously via a portable gas
analysis system (K4b2 Mobile Breath-by-Breath Metabolic
System; COSMED, Rome, Italy). The expired air and gas
concentrations were measured via a pneumotach connected
to the face mask (Hans Rudolph, Inc., Shawnee Mission,
KS, USA). The system was calibrated for each participant
using known concentrations of oxygen and carbon dioxide
and a 3-l syringe to calibrate for the volume of pulmonary
air exchanged. Heart rate was measured using a Polar chest
strap telemetry system (Polar Electro, Kempele, Finland).
For data analyses, the average VO2, heart rate and RPE
captured in the last 15 s of each of the 1-min stages was
recorded and entered into the statistical analyses computer
software package (SPSS for Windows, version 20; IBM
Corporation, Armonk, NY, USA).
3.4 Data Analyses
Group descriptive data are represented as means ± 1
standard deviation (SD). Curvilinear exponent regression
analysis of VO2 responses was performed as a function of
the ISWT stage (transformed into continuous data as
walking speed in kilometres/hour; kmh-1), where
y = VO2; b is the constant y-intercept value when x = 0;
e = the natural exponent constant of 2.71828183 raised to
the power of a (representing the acceleration component of
the regression curve); and x = walking speed in kmh-1.
Due to the expected curvilinear nature of the data and
multiple stages of the ISWT, the oxygen cost for each
participant’s completed test was calculated using an inte-
grated area under the curve (iAUC) trapezoidal method.
Independent t tests were performed to compare data
between the cardiac group and the age-matched controls.
Where data were compared with group mean values from
previous studies, a one-sample t test was performed.
4 Results
4.1 General Participant Data
Thirty-two cardiac rehabilitation participants and 30 age-
matched controls completed the ISWT to stage 5 or higher.
Group comparisons are summarised in Tables 1, 2 and 4.
The control group walked 152 m further (p\ 0.001) than
the cardiac group (Table 2), and this difference remained
when participants were divided into subgroups of males
and females.
Participants’ age (64.5 ± 7.8 years) was near to the
mean age of those attending cardiac rehabilitation in the
UK (66 years), but our study had a greater proportion of
females 44 % compared with the national average of 30 %
[7].
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4.2 Oxygen Cost of the Incremental Shuttle Walk
Test (ISWT) Within this Study
Within the control group, a subgroup analysis was per-
formed between those with identified health conditions
(n = 17) and those without (n = 13). No difference was
observed in the oxygen cost of walking in these two groups
at any stage, which allowed the data to be pooled into one
complete control group (n = 30). The same was true for
male and female participants. Analyses of the data was
capped at ISWT stage 9 so as to focus on the evaluation
just for walking; all participants who proceeded on to
stage 10 or higher had to run, which is commensurate with
a similar walk–run threshold reported in classic studies
(Fig. 3) [20]. Both the cardiac and control group VO2
responses were curvilinear in nature (Fig. 4). While there
was no significant difference in the VO2 y-intercept values
between the two groups (cardiac = 4.5, control = 5.1;
p = 0.064), the cardiac participants’ responded with a
significantly steeper growth curve exponent of 0.27 ± 0.06
versus 0.20 ± 0.04 (p\ 0.0001) (Fig. 4).
For the purpose of comparing the between-groups total
ISWT VO2 from the iAUC, only data from those partici-
pants in both groups who completed nine stages of the
ISWT were included for analysis (n = 18 of 32 cardiac
patients, n = 25 of 30 controls). As illustrated in Fig. 5,
the total ISWT iAUC oxygen cost across these nine ISWT
stages was significantly greater in the cardiac group com-
pared with the control group (p\ 0.0001), for which the
values were:
– iAUC cardiac group = 423 (±86) mlkg-1min-1
kmh-1
Table 1 Descriptive characteristics of participants
Cardiac
group
Age-matched
controls
N (no. on b-blocker
medication)
32 (20) 30
Sex, male (%) 18 (56) 11 (35)
Age, years 64.5 ± 7.8 63.4 ± 8.6
Height, cm 173.1 ± 8.2 168.8 ± 7.1*
Mass, kg 85.4 ± 11.2) 78.7 ± 16.9
Body mass index 28.6 ± 3.2 27.6 ± 5.2
Walking distance, m
Male 548 ± 183 687 ± 158**
Female 464 ± 152 650 ± 192**
Total 512 ± 173 664 ± 179**
Data are expressed as mean ± standard deviation unless otherwise
stated
Control versus cardiac group
* p = 0.032
** p B 0.001
Table 2 Participants’ conditions/treatments
Cardiac group n Age-matched controls n
Angina 3 Hypertension 4
Myocardial infarction 7 Orthopaedic 5
Angioplasty 8 Obese 3
Coronary bypass 9 Smoking 2
Others 5 Others
Nothing reported
3
13
Others: atrial fibrillation, dilated cardiomyopathy, pacemaker, valve
replacement
Age-matched controls others: stroke, chronic fatigue, diabetes
Fig. 4 Curvilinear regression analysis of the oxygen cost of the
incremental shuttle walk test in coronary heart disease cardiac
rehabilitation participants and age-matched controls. ACSM the linear
regression line for estimating the oxygen cost of walking by the
American College of Sports Medicine [9]
Fig. 5 Integrated area under the curve for the oxygen costs
(VO2 9 walking speed; mlkg-1min-1kmh-1) of cardiac rehabili-
tation participants and age-matched controls performing the incre-
mental shuttle walk test up to stage 9. *p\ 0.001 cardiac group
compared with control, and control with ACSM estimate [9]. ACSM
American College of Sports Medicine
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– iAUC control group = 316 (±52) mlkg-1min-1
kmh-1
With the reduced sample size of the cardiac group down
to 18 from 32 for these iAUC differences between cardiac
and controls analysis, the effect size was 1.24, with a power
of 95 %.
4.3 Oxygen Cost Trend Comparisons with Previous
Studies
Curvilinear regression equations and iAUC VO2 values
were calculated from and compared with previous ISWT
studies and historical data. The historical data were
reproduced from values presented in Figs. 1 and 3, and
with regression equations formulated from these data
(Table 3). Regression lines from Passmore and Durnin [17]
and Menier and Pugh [19] (Figs. 2, 3) were almost iden-
tical, therefore these data were pooled to create a single
regression equation (Table 3). The ACSM [9] linear
equation returned the lowest iAUC VO2 value compared
with all other studies (Table 3; Fig. 5).
No significant difference was observed in the iAUC VO2
of the cardiac group in this current study when compared
with the cardiac group of Almodhy et al. [12], and also
with the healthy young participants from the historical and
classic studies (1912–1938) summarised by Passmore and
Durnin [17] and Falls and Humphrey [20] (Table 3). The
original ISWT METs study by Woolf-May and Ferrett [14]
(cardiac group) had iAUC VO2 values significantly greater
than the cardiac group of this present study; the remaining
data sets all had significantly lower iAUC VO2 values
(Woolf-May and Ferrett [14], healthy; Woolf-May and
Meadows [15], cardiac and healthy). It was decided not to
include the athletes’ study of Margaria et al. [18] in the
comparative analysis because only two participants were
assessed within a narrow range of walking speeds, with the
lowest speed being 5 kmh-1.
In the data sets of six of the eight previous studies, the y-
intercept value ‘b’ of the regression equations, which the-
oretically represents the VO2 at walking speed as zero (s-
tanding), were all within ±0.5 mlkg-1min-1 of the y-
intercept value of this current study’s cardiac group.
Although the differences were statistically significant, they
were small in terms of the clinical significance threshold as
set by the expected effect size of 1.75 mlkg-1min-1. In
the remaining cardiac group data set of Woolf-May and
Ferrett [14], the y-intercept VO2 was significantly greater
(statistically and clinically) by up to 2.5 mlkg-1min-1.
These differences corresponded to the much greater iAUC
VO2 values noted above. The steepness of the regression
curve in the cardiac group of this current study, as denoted
by the ‘exponent x’ value (0.27x), was significantly greater
compared with the data sets of all other studies (cardiac and
healthy) (Table 3).
4.4 Conversion to Metabolic Equivalents (METs)
for Cardiac Groups
For the purposes of practically applying this information in
monitoring or guiding exercise intensity in cardiac reha-
bilitation, Table 4 summarises the oxygen cost in units of
METs at each ISWT stage. These values are based on the
assumption that 1 MET equals a VO2 of 3.5 mlkg-1-
min-1 [30]. MET values from Almodhy et al. [12] agree
most closely with this current study, where the mean dif-
ference for stages 1–8 is 0.2 METs (range 0.1–0.4 METs).
At stage 9, the values differed by 0.7 METs. This agree-
ment is statistically corroborated by the non-significant
difference in the iAUC reported in Table 3.
Compared with this current study, Table 4 shows that
the Woolf-May and Meadows [15] cardiac participant
values were lower at all stages—0.6 METs lower at
stage 2, increasing to 1.7 METs lower at stage 8 and 2.6
METs at stage 9. In comparing the values of this current
study with the original study on METs by Woolf-May and
Ferrett [14], this range of differences was of a similar
magnitude, but these values were systematically greater
across the nine ISWT stages, ranging in difference by
0.8–2.0 METs, respectively.
5 Discussion
The ISWT is widely used during patient assessment at entry
to and exit from outpatient cardiac rehabilitation. This most
recent study on the oxygen costs of walking during the ISWT
in CHD cardiac rehabilitation patients provides the first
comprehensive comparison of a new data set with data from
similar previous studies. We believe this is the first published
critique of such studies against the historical background of
classic studies on the energy costs of walking. It terms of this
being a representative sample (64.5 years, 85 % with CHD),
it was similar to the national averages for age (66 years) with
regard to CHD [7]; however, future evaluation is required to
apply these findings for other typical and older populations
now attending cardiac rehabilitation (heart failure, valve
disease, arrhythmia or those with other morbidity, i.e. dia-
betes and pulmonary disease).
The present data demonstrate that the oxygen cost of
overground walking in people with CHD responds as a
positively accelerating (curvilinear) function of speed,
which is independent of testing protocol, participant age
and clinical status. In light of this finding from our data
alone, or when combined with findings from extant studies
that have reported this phenomenon for over a century, it is
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surprising that the ACSM [9] continues to recommend the
use of a linear regression equation to predict oxygen cost of
walking. Such existing linear equations clearly and con-
sistently underestimate VO2 for walking speeds[3 kmh-1
([2 minh-1) (Table 3).
The median curvilinear exponent value for estimating
VO2 from the walking speed (x) in all studies (including
this current study) was ?0.23x (range ?0.19x to ?0.27x),
where the highest value was in the current data from car-
diac patients. This curve exponent value for our cardiac
patients was statistically greater than that calculated from
similar data sets in all other studies, but was the same for
control participants compared with two of the other healthy
participant studies [15, 17, 20]. However, from a clinically
significant effect-size perspective, the values were close to
those reported by Almodhy et al. [12], which supports
confidence in the recommended regression equation for
estimating VO2 and METs, i.e. VO2 = 4.4e
0.23 9 speed
(Table 4), to be used by cardiac rehabilitation professionals
in guiding CHD patients.
We found y-intercept constants (speed of x = 0 kmh-1;
standing still) for the regression lines from this current
study to be 4.5 mlkg-1min-1 in cardiac patients and
5.1 mlkg-1min-1 in age-matched controls. In six of the
eight historical data sets, the y-intercepts were in a similar
range of 4.0–5.0 mlkg-1min-1. This seems to make
sense, where standing up adds an additional VO2 of
between 0.5 and 1.0 mlkg-1min-1 to typically reported
resting VO2s of approximately 3.5 mlkg-1min-1 in
healthy individuals, or 2.5–3.0 mlkg-1min-1 in older or
b-blocked cardiac patients [30–33]. Even though the VO2
y-intercept (rest) values in this current study were statisti-
cally different from the other studies (Table 3), from a
clinical perspective this significance actually represents a
small difference (±0.5 mlkg-1min-1 or one-seventh of
an MET), unlikely to be clinically important and within the
expected range of measurement error.
Woolf-May and Ferrett [14] reported much higher VO2
values in cardiac participants when compared with data
from all other measures of cardiac groups (including this
current study). It would now seem that their values appear
systematically inflated from some potential anomaly in
their measurements.
Using all other data on cardiac participants, we estimate
that a satisfactory median regression equation (Table 4) for
estimating VO2 (y) from walking speed (kmh-1) would be
y = 4.4e0.23x
In general, from the data in Table 3 (iAUC VO2), and
clearly from observation of the regression curves (Figs. 1,
4), any differences in oxygen cost across all studies would
therefore be related more to the differences found in the
steepness of the regression curve rather than from the
differences in the y-intercept constant. It must be
acknowledged that some of the statistical power of the
iAUC analysis is reduced as it was based on 18 of 31
CHD patients who were able to complete all nine stages
of the ISWT. Nonetheless, a general pattern now
appearing from the four data sets comparing the VO2 in
cardiac participants with age-matched controls during the
ISWT is that most cardiac participants require an oxygen
Table 4 METs derived from the oxygen costs of the Incremental Shuttle-Walking Test in cardiac rehabilitation participants: current findings
compared with similar studies [12, 14, 15]
ISWT stage 1 2 3 4 5 6 7 8 9
ISWT walking speed
mih-1 (minmi-1)
1.1 (54.5) 1.5 (40.0) 1.9 (31.6) 2.3 (26.5) 2.6 (22.7) 3.0 (20.0) 3.4 (17.6) 3.8 (15.8) 4.2 (14.3)
ISWT walking speed
km.h-1 (mmin-1)
1.8 (30.0) 2.4 (40.0) 3.1 (51.7) 3.7 (61.7) 4.2 (70) 4.8 (80) 5.5 (91.7) 6.1 (101.7) 6.8 (113.3)
METs for cardiac groups
This study’s
METs ± SD (n)
1.7 ± 0.4
(32)
2.5 ± 0.5
(32)
3.2 ± 0.6
(32)
3.7 ± 0.7
(32)
4.2 ± 0.9
(32)
4.8 ± 1.0
(27)
5.5 ± 1.0
(21)
6.3 ± 1.3
(17)
7.6 ± 1.7
(11)
Almodhy et al. [12] 2.0 2.7 3.1 3.6 4.0 4.4 5.3 6.1 6.9
Woolf-May and
Meadows [15]
0.7 2.1 2.6 2.9 3.1 3.6 4.2 4.6 5.1
Woolf-May and Ferret
[14]
2.5 3.8 4.3 4.8 5.5 6.3 7.5 8 8.2
Recommended MET
values for cardiac
rehabilitation derived
from
VO2 = 4.4e
0.23 3 speed
2.1 2.8 3.5 4.2 4.9 5.6 6.3 7.0 7.7
METs metabolic equivalents, ISWT incremental shuttle walk test, SD standard deviation, VO2 oxygen cost
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uptake of 25–30 % more than age-matched controls,
which is mainly found in the final three walking test
stages (stages 7, 8 and 9).
A study by Pepera et al. [34] explored anthropometric
factors of height, body mass and body mass index, which
can influence ISWT performance, but they did not
directly measure VO2. Taller individuals were found to
perform better, and this relationship increased in strength
at higher speeds. However, in this current study the car-
diac group was significantly taller (Table 1) and yet were
still less economical in VO2 than the control group; no
between-group differences in body mass index were
observed.
Another phenomenon, which is not accounted for in all
the ISWT data sets thus far, is that the ISWT stages are
only 1 min in duration. In healthy individuals exercising
at a constant intensity, a duration of between 40 and 60 s
is required for VO2 to rise to a submaximal constant,
whereas in patients with cardiovascular disease this can
take up to 90 s [35, 36]. Under b-blockade, which is
standard treatment for patients with ischaemic heart dis-
ease or heart failure, the VO2 kinetics have been reported
to be slower [37, 38]. In all cases affected by disease or
medication, or both, the VO2 values during the 1 min
stages of the ISWT should theoretically be diminished in
cardiac patients compared with non-b-blocked healthy
individuals; therefore, the differences in cardiac patients
versus healthy controls could potentially be even greater
than what is currently being reported. Future studies in
comparing VO2 between cardiac patients and healthy
controls at a point after the VO2 slow component [39] are
required to determine a possible correction factor if
practitioners wish to transpose exercise intensity infor-
mation from the ISWT into steady-state exercise pre-
scriptions of other activities. However, once steady-state
exercise is established, b-blockade has been reported to
not significantly alter VO2 for any given submaximal
work rate; it only appears to reduce VO2max, but not in all
cases, and the effect diminishes with long-term use of this
medication [40–43].
5.1 Potential Impact of Findings on the Use
and Interpretation of the ISWT in Cardiac
Rehabilitation Patients
It is clear that the ACSM [9] equations should not be used
to estimate oxygen cost of the ISWT, and this recom-
mendation also looks likely to be extended to walking
speed in all adult populations. The acceptance of linear
predictions of oxygen costs means the estimates of
improvement in VO2 in patients attending cardiac reha-
bilitation following an ISWT could be underestimated.
6 Conclusions
In light of historical studies on the oxygen costs of walking,
and then comparing and critiquing the current results and
those of previous similar studies on the ISWT, there is further
confirmation of the curvilinear nature ofVO2 as a function of
walking speed. During the ISWT, it appears that cardiac
rehabilitation participants have aVO2 up to 30 % higher than
age-matched controls. Together, these findings suggest
studies may have underestimated the VO2 of cardiac patients
as well as improvements in VO2 following a programme of
exercise-based cardiac rehabilitation. Furthermore, the
application of the ACSM’s ‘linear’ regression for either
healthy or cardiac populations, based on only a few partici-
pants from studies in the 1960s, does not respect the con-
sistently demonstrated curvilinear VO2 response to
incremented walking speeds on flat ground, and thus in all
cases greatly underestimates VO2. We recommend that in
estimating VO2 from the walking speeds of the ISWT in
CHD cardiac rehabilitation participants, the following
equation should be used:VO2 = 4.4e
0.23 9 walkingspeed (km/h).
For healthy participants (Table 3), a median equation from
four reports (contemporary and historical) would be
VO2 = 4.6e
0.22 9 walkingspeed (km/h).
Future work is required to make similar evaluations in
other populations that use the ISWT as an outcome mea-
sure and physical activity intensity guidance. In more
accurately achieving the transposition of the relationship
between walking speed and VO2 (METs) during the ISWT
to physical activity guidance, a correction factor may be
required to accommodate the limited oxygen kinetics
information that coincides with only 1-min stages of the
ISWT.
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